+

TW202019888A - 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative and noxious organism control agent - Google Patents

5-(1,2,4-triazol-5-yl) benzoic acid amide derivative and noxious organism control agent Download PDF

Info

Publication number
TW202019888A
TW202019888A TW108129125A TW108129125A TW202019888A TW 202019888 A TW202019888 A TW 202019888A TW 108129125 A TW108129125 A TW 108129125A TW 108129125 A TW108129125 A TW 108129125A TW 202019888 A TW202019888 A TW 202019888A
Authority
TW
Taiwan
Prior art keywords
alkyl
group
mono
substituted
unsubstituted
Prior art date
Application number
TW108129125A
Other languages
Chinese (zh)
Inventor
榎本幸浩
志鎌大介
村松義浩
近藤寛起
鳥谷部啓二
中谷昌央
阿部晋
高根澤陽
松田武
Original Assignee
日商組合化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商組合化學工業股份有限公司 filed Critical 日商組合化學工業股份有限公司
Publication of TW202019888A publication Critical patent/TW202019888A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention provides a 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative or a salt thereof having an excellent noxious organism control effect, and a noxious organism control agent and a production intermediate containing it as an active ingredient. Provided is a 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative represented by the general formula [I] or a salt thereof, and a noxious organism control agent characterized by containing it as an active ingredient. [In the formula, R1 represents a hydrogen atom, a C1-C6 alkyl group, a C3-C6 cycloalkyl group or the like; R2 represents a hydrogen atom or the like; A represents an oxygen atom or a sulfur atom; B represents a single bond, a group -O-or the like; n represents an integer of 0, 1, 2, or 3; m represents an integer of 0, 1, or 2; R3 represents a halogen atom, a C1-C6 alkyl group or the like; R4 represents a halogen atom, a cyano group or the like; R5 represents a C1-C6 alkyl group, a C3-C6 cycloalkyl group or the like; R6 represents a hydrogen atom or a C1-C6 alkyl group.].

Description

5-(1,2,4-三唑-5-基)苯甲醯胺衍生物及有害生物防除劑 5-(1,2,4-triazol-5-yl)benzamide derivatives and pest control agents

本發明是關於一種新穎的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽、含有該衍生物作為有效成分的有害生物防除劑及製造中間物。 The present invention relates to a novel 5-(1,2,4-triazol-5-yl)benzamide derivative or its agriculturally acceptable salt, and pest control containing the derivative as an active ingredient Agent and manufacturing intermediates.

在專利文獻1、2、3及4中,揭示控制脂肪酸合成的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物,惟,在專利文獻1、2、3及4所記載的化合物係限定成醯胺鍵的胺部分為1-[4-(取代苯基)哌啶]基。再者,沒有關於有害生物防除效果的記載。 Patent documents 1, 2, 3, and 4 disclose 5-(1,2,4-triazol-5-yl)benzamide derivatives that control the synthesis of fatty acids. However, in patent documents 1, 2, 3 The compounds described in 4 and 4 are limited so that the amine portion of the amide bond is 1-[4-(substituted phenyl) piperidinyl] group. Furthermore, there is no record of the effects of pest control.

在專利文獻5及6有記載控制脂肪酸合成的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物,惟,專利文獻5及6所記載的化合物係限定成醯胺鍵的胺部分為1-[3-(取代苯基)氮雜環丁烷(azetidinyl)]基或1-[4-(取代苯基)哌啶]基。再者,沒有關於有害生物防除效果的記載。 Patent documents 5 and 6 describe 5-(1,2,4-triazol-5-yl)benzamide derivatives that control the synthesis of fatty acids, but the compounds described in patent documents 5 and 6 are limited to amides The amine part of the amine bond is 1-[3-(substituted phenyl)azetidinyl]yl or 1-[4-(substituted phenyl)piperidinyl]yl. Furthermore, there is no record of the effects of pest control.

在專利文獻7及8中有記載具有有害生物防除效果的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物,惟,專利文獻7及8所記載的化合物是限定成在三唑環的3號位經取代為1-甲基-3-五氟乙基-4-三氟甲基吡唑-5-基的衍生 物。 Patent Documents 7 and 8 describe 5-(1,2,4-triazol-5-yl)benzamide derivatives having pest control effects, but the compounds described in Patent Documents 7 and 8 are Derivatives defined as substituted with 1-methyl-3-pentafluoroethyl-4-trifluoromethylpyrazol-5-yl at position 3 of the triazole ring Thing.

但是,在專利文獻1、2、3、4、5及6沒有關於醯胺鍵的胺部分有1-[3-(取代苯基)氮雜環丁烷(azetidinyl)]基或1-[4-(取代苯基)哌啶]基以外的取代基的衍生物的記載。再者,三唑環1號位是限定為無取代,亦沒有關於1號位的烷基取代物的記載。另一方面,在專利文獻7、8中三唑環的3號位是1-甲基-3-五氟乙基-4-三氟甲基吡唑-5-基,且沒有關於相當於本發明化合物[I]的R4的部位是限定為氯原子的組合以外的取代基的記載,亦沒有關於本發明化合物的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物的記載。 However, in Patent Documents 1, 2, 3, 4, 5, and 6, there is no amine moiety related to an amide bond having a 1-[3-(substituted phenyl)azetidinyl] group or 1-[4 -Description of derivatives of substituents other than (substituted phenyl) piperidinyl] group. In addition, the 1st position of the triazole ring is limited to no substitution, and there is no description about the alkyl substituent at the 1st position. On the other hand, in Patent Documents 7 and 8, the 3-position of the triazole ring is 1-methyl-3-pentafluoroethyl-4-trifluoromethylpyrazol-5-yl, and there is no equivalent The position of R 4 of the compound [I] of the invention is described as a substituent other than the combination of chlorine atoms, and there is no 5-(1,2,4-triazol-5-yl) benzoyl compound of the compound of the invention Description of amine derivatives.

[先前技術文獻] [Prior Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]國際公開第2012/122391號公報 [Patent Document 1] International Publication No. 2012/122391

[專利文獻2]國際公開第2016/025816號公報 [Patent Document 2] International Publication No. 2016/025816

[專利文獻3]國際公開第2016/149271號公報 [Patent Document 3] International Publication No. 2016/149271

[專利文獻4]美國公開第20170119786號公報 [Patent Document 4] US Publication No. 20170119786

[專利文獻5]國際公開第2014/008197號公報 [Patent Document 5] International Publication No. 2014/008197

[專利文獻6]國際公開第2015/095767號公報 [Patent Document 6] International Publication No. 2015/095767

[專利文獻7]國際公開第2015/150442號公報 [Patent Document 7] International Publication No. 2015/150442

[專利文獻8]國際公開第2017/012970號公報 [Patent Document 8] International Publication No. 2017/012970

對有用作物使用的有害生物防除劑期望為施用於土壤或莖葉,並且以低藥量顯示充分的有害生物防除效果的藥劑。再者,由於對化學物質的安全性、環境的影響的要求逐漸提高,期望開發出更安全的有害生物防除劑。再者,近年來,由於長期地使用殺蟲劑及殺蟎劑等有害生物防除劑,而出現對有害生物防除劑獲得抵抗性的有害生物,因此,變得難以完全地防除有害生物。再者,關於高人畜毒性的有害生物防除劑的使用,也對作業者的安全性等方面成為問題。 The pest control agent used for useful crops is desirably an agent that is applied to soil, stems and leaves, and shows a sufficient pest control effect at a low dose. Furthermore, as requirements for the safety of chemical substances and environmental impact are gradually increasing, it is desired to develop safer pest control agents. In addition, in recent years, pest control agents such as insecticides and acaricides have been used for a long period of time, and pests that have acquired resistance to pest control agents have appeared. Therefore, it has become difficult to completely control pests. In addition, the use of pest control agents with high human and animal toxicity also poses a problem to the safety of the operator.

本發明的課題是在如此的情況中,提供一種有害生物防除劑,其係可以解決以往的有害生物防除劑所具有的如前述的問題點,並且,具有優異的安全性、防除效果、殘效性等。 The subject of the present invention is to provide a pest control agent under such circumstances, which can solve the above-mentioned problems of the conventional pest control agent, and has excellent safety, control effect, residual effect Wait.

本發明者等為了開發具有前述的理想特性的有害生物防除劑起見,合成各種5-(1,2,4-三唑-5-基)苯甲醯胺衍生物,並針對其生理活性進行精心檢討。其結果,發現下述通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物(以下,亦稱為本發明化合物)對各種有害生物表現桌越的效果,更繼續研究進而完成本發明。 The present inventors synthesized various 5-(1,2,4-triazol-5-yl)benzamide derivatives for the purpose of developing a pest control agent having the above-mentioned ideal characteristics, and carried out according to their physiological activities Carefully reviewed. As a result, it was found that 5-(1,2,4-triazol-5-yl)benzamide derivatives represented by the following general formula [I] (hereinafter, also referred to as the compounds of the present invention) exhibit various harmful organisms The effect of the tabletop is further studied to complete the present invention.

亦即,本發明係具有下述特徵作為要旨者。 That is, the present invention has the following characteristics as the gist.

(1)一種下述通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽。 (1) A 5-(1,2,4-triazol-5-yl)benzamide derivative represented by the following general formula [I] or an agriculturally acceptable salt thereof.

Figure 108126125-A0202-12-0004-213
Figure 108126125-A0202-12-0004-213

[式中, [Where,

n表示0、1、2或3的整數, n represents an integer of 0, 1, 2 or 3,

m表示0、1或2的整數, m represents an integer of 0, 1, or 2,

A表示氧原子或硫原子, A represents an oxygen atom or a sulfur atom,

B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, radical -O-, radical -S(=O) m -or radical -N(-R 7 )-,

R1及R2是各自獨立地表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6炔基、C2至C6烯基、C2至C6鹵炔基、C2至C6鹵烯基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、氰基、氰基C1至C6烷基、氰基C3至C6環烷基、C1至C6烷氧基羰基C3至C6環烷基、羥基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、甲醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、C1至C6烷基羰基、C1至C6烷氧基C1至C6烷基羰基、C3至C6環烷基羰基、C3至C6環烷基C1至C6烷基羰基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、二(C1至C6烷基)胺基羰基、C1至C6烷氧基羰基C1至C6烷基胺基、單(C1至C6烷氧基羰基)胺基、 無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基、(C1至C6烷基硫基)羰基、(C1至C6烷基)硫基羰基、(C1至C6烷氧基)硫基羰基、胺硫甲醯基、單(C1至C6烷基)胺基硫基羰基、二(C1至C6烷基)胺基硫基羰基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺磺醯基、單(C1至C6烷基)胺基磺醯基、二(C1至C6烷基)胺基磺醯基、C1至C6烷氧基羰基C1至C6烷基、胺基羰基C1至C6烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、C1至C6鹵烷基羰基C1至C6烷基、羥基亞胺基、C1至C6烷氧基亞胺基、羥基亞胺基C1至C6烷基、C1至C6烷氧基亞胺基C1至C6烷基、C1至C6鹵烷氧基亞胺基C1至C6烷基、雜環烷基、或雜環烷基C1至C6烷基,再者,R1及R2也可與該等所鍵結的氮原子共同形成3至8員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至8員的雜環,該雜環亦可經鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基、C1至C6鹵烷基或側氧基取代, R 1 and R 2 independently represent a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkynyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkynyl, C 2 to C 6 haloalkenyl, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 haloalkyl, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, unsubstituted or substituent group selected via substituent group α Substituted or polysubstituted phenyl, unsubstituted or substituted by substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or selected by substituent group α Substituent monosubstituted or polysubstituted heteroaryl, unsubstituted or selected via substituent group α Monosubstituted or polysubstituted heteroaryl C 1 to C 3 alkyl, cyano, cyano C 1 To C 6 alkyl, cyano C 3 to C 6 cycloalkyl, C 1 to C 6 alkoxycarbonyl C 3 to C 6 cycloalkyl, hydroxy, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, methyl amide, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, C 1 to C 6 Alkylcarbonyl, C 1 to C 6 alkoxy C 1 to C 6 alkylcarbonyl, C 3 to C 6 cycloalkylcarbonyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkylcarbonyl, C 1 To C 6 alkoxycarbonyl, aminecarboxamide, mono(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, C 1 to C 6 alkoxycarbonyl C 1 to C 6 alkylamino group, mono(C 1 to C 6 alkoxycarbonyl) amine group, unsubstituted or substituted group selected by substituent group α, mono- or poly-substituted phenylcarbonyl group, ( C 1 to C 6 alkylthio) carbonyl, (C 1 to C 6 alkyl) thiocarbonyl, (C 1 to C 6 alkoxy) thiocarbonyl, amine thiocarboxamide, mono (C 1 to C 6 alkyl)aminothiocarbonyl, di(C 1 to C 6 alkyl)aminothiocarbonyl, C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, Sulfasulfonamide, mono(C 1 to C 6 alkyl)aminosulfonyl, di(C 1 to C 6 alkyl)aminosulfonyl, C 1 to C 6 alkoxycarbonyl C 1 to C 6 alkyl, aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl , C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylcarbonyl C 1 to C 6 alkyl, hydroxyimino, C 1 to C 6 alkoxyimino , Hydroxyimino group C 1 to C 6 alkyl, C 1 to C 6 alkoxyimino C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy imino C 1 to C 6 alkyl, heterocycloalkyl , Or heterocycloalkyl C 1 to C 6 alkyl, and R 1 and R 2 may also form a 3 to 8 membered heterocyclic ring together with these bonded nitrogen atoms, or have 1 to 4 choices A heterocyclic ring of 3 to 8 members from a heteroatom of an oxygen atom, a sulfur atom and a nitrogen atom, the heterocyclic ring may also be halogenated, cyano, nitro, C 1 to C 6 alkyl, C 1 to C 6 alkyl Oxy, C 1 to C 6 haloalkyl or pendant oxy substitution,

R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl,

R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫 基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl,

R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代 基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經 由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基,再者,R5及R7也可與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl) amino C 1 to C 6 alkyl, N-(C 1 to C 6 alkylsulfonate Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α Substituent Mono- or poly-substituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkane Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfonate Acyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, unsubstituted Phenylthio C 1 to C3 alkyl substituted by the substituent selected by the substituent group α, unsubstituted or substituted by the substituent selected by the substituent group α Sulfenyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted or Heteroarylthio C 1 to C3 alkyl substituted by substituents selected through substituent group α, unsubstituted or substituted monosubstituted or polysubstituted heteroaromatic groups selected through substituent group α Sulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Or mono- or poly-substituted phenyl C 1 to C 3 alkylthio C 1 to C 3 alkyl, unsubstituted or selected by substituent group α Substituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α, mono- or poly-substituted phenyl C 1 To C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted heteroaryl C 1 to C 3 alkylthio C 1 To C3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl selected from the substituents selected through the substituent group α, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted by a substituent group α, mono- or polysubstituted phenylcarbonyl C 1 to C 3 alkyl, Heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy, unsubstituted or selected via substituent group α Carbonyl C 1 to C 3 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 to C 3 alkyl, nitro, amine, carboxamide, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine carboxamide, mono (C 1 to C 6 alkyl )Aminocarbonyl, mono(C 1 to C 6 haloalkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, in addition, R 5 and R 7 can also form 3 to 3 together with these bonded nitrogen atoms 6-membered heterocyclic ring, or 3 to 6-membered heterocyclic ring having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom,

R6表示氫原子或C1至C6烷基, R 6 represents a hydrogen atom or a C 1 to C 6 alkyl group,

R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl ,

取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至 C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.

(2)一種農藥組成物,該農藥組成物係含有前述(1)所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為有效成分。 (2) A pesticide composition containing the 5-(1,2,4-triazol-5-yl)benzamide derivative described in (1) or its agriculturally acceptable Salt as an active ingredient.

(3)如前述(2)所述之農藥組成物,該農藥組成物更含有界面活性劑。 (3) The pesticide composition as described in (2) above, which further contains a surfactant.

(4)一種有害生物防除劑,該有害生物防除劑係含有前述(1)所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為活性成分。 (4) A pest control agent containing the 5-(1,2,4-triazol-5-yl)benzamide derivative described in (1) or its agricultural application Tolerable salts are used as active ingredients.

(5)如前述(4)所述之有害生物防除劑,其中,該有害生物防除劑係殺蟲劑、殺線蟲劑及殺蟎劑。 (5) The pest control agent as described in (4) above, wherein the pest control agent is an insecticide, nematicide and acaricide.

(6)如前述(5)所述之有害生物防除劑,該有害生物防除劑係對栽培農園藝用植物的水田、旱田、草地、果樹園、非農耕地、溫室、育苗設施、或植物工廠中之有害生物具有防除效力。 (6) The pest control agent as described in (5) above, which is suitable for paddy fields, dry fields, grasslands, orchards, non-agricultural land, greenhouses, nursery facilities, or plant factories in which agricultural and horticultural plants are cultivated. The pests in it have the control effect.

(7)如(6)所述之有害生物防除劑,其中,農園藝用植物是以育種法或基因重組技術而賦有抗性的植物。 (7) The pest control agent according to (6), wherein the agricultural and horticultural plant is a plant imparted with resistance by breeding methods or gene recombination technology.

(8)一種有害生物的防除方法,該防除方法係使用前述(1)所述之 5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽的有效成分量。 (8) A pest control method using the method described in (1) above Amount of active ingredient of 5-(1,2,4-triazol-5-yl)benzamide derivative or its agriculturally acceptable salt.

(9)一種有害生物的防除方法,該防除方法係將前述(1)所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或含有其在農業上可容許的鹽作為有效成分的農藥組成物,同時或分批施用於農園藝用作物或者是欲栽培或正栽培農園藝用作物的場所。 (9) A method for controlling harmful organisms, which comprises the 5-(1,2,4-triazol-5-yl)benzamide derivative described in (1) above or containing it in agriculture The permissible salt as an active ingredient of the pesticide composition is applied simultaneously or in batches to the agricultural or horticultural use or the place where the agricultural or horticultural use is to be cultivated or being cultivated.

(10)如前述(8)或(9)所述之有害生物的防除方法,其中,施用有害生物防除劑的場所係水田、旱田、草地、果樹園、非農耕地、溫室、育苗設施、或植物工廠。 (10) The pest control method as described in (8) or (9) above, wherein the place where the pest control agent is applied is a paddy field, dry field, grassland, orchard, non-agricultural land, greenhouse, nursery facility, or Plant factory.

(11)如前述(8)至(10)中的任一項所述之有害生物的防除方法,其中,將前述(1)所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽使用為殺蟲劑、殺線蟲劑及殺蟎劑。 (11) The pest control method according to any one of (8) to (10) above, wherein the 5-(1,2,4-triazole-5- Base) benzamide derivatives or their agriculturally acceptable salts are used as insecticides, nematicides and acaricides.

(12)一種有害生物防除劑的使用方法,該使用方法係將前述(4)至(7)中的任一項所述之有害生物防除劑使用於防除農園藝用作物之有害生物。 (12) A method for using a pest control agent using the pest control agent described in any one of (4) to (7) above for controlling pests for agricultural and horticultural use.

(13)一種下述通式[II]表示的5-(1,2,4-三唑-5-基)苯甲酸衍生物或其鹽。 (13) A 5-(1,2,4-triazol-5-yl)benzoic acid derivative represented by the following general formula [II] or a salt thereof.

Figure 108126125-A0202-12-0010-214
Figure 108126125-A0202-12-0010-214

式中, In the formula,

m表示0、1或2的整數, m represents an integer of 0, 1, or 2,

n表示0、1、2或3的整數, n represents an integer of 0, 1, 2 or 3,

B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, radical -O-, radical -S(=O) m -or radical -N(-R 7 )-,

R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl,

R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl,

R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N- (C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選 出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1 至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基、再者,R5及R7也可與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl)amino C 1 to C 6 alkyl, N- (C 1 to C 6 alkylsulfonate) Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α replace Mono- or polysubstituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 ring Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl , C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkyl Sulfonyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, none Substituted or selected substituents through substituent group α are mono- or multi-substituted phenylthio C 1 to C 3 alkyl groups, unsubstituted or selected through substituent group α are mono- or poly-substituted Phenylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroarylthio C 1 to C 3 alkyl group selected by the substituent group α, unsubstituted or a mono- or poly-substituted hetero group substituted by the substituent group α Arylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Phenyl C 1 to C 3 alkylthio C 1 to C 3 alkyl, unsubstituted or substituent selected by substituent group α Monosubstituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or selected via substituent group α, monosubstituted or polysubstituted phenyl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryl C 1 to C 3 alkylthio C 1 to C3 alkyl, unsubstituted or selected by substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Substituted or mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl , C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted by the substituent group α selected mono- or multi-substituted phenylcarbonyl C 1 to C 3 alkyl , Unsubstituted or selected via substituent group α, mono- or poly-substituted heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy Alkylcarbonyl C 1 to C 3 alkyl, mono(C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 Alkyl, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di( C 1 to C 6 alkyl) Aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 To C 3 alkyl, nitro, amine, methyl acetyl, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine methyl, mono(C 1 to C 6 alkyl Group) aminocarbonyl, mono(C 1 to C 6 haloalkyl) aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, Or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, and R 5 and R 7 can also form together with these bonded nitrogen atoms 3 Heterocycles up to 6 members, or heterocycles 3 to 6 members having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom,

R6及R8各自獨立地表示氫原子或C1至C6烷基, R 6 and R 8 each independently represent a hydrogen atom or a C 1 to C 6 alkyl group,

R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl ,

取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.

(14)一種下述通式[III]表示的5-苯基-1,2,4-三唑衍生物或其鹽。 (14) A 5-phenyl-1,2,4-triazole derivative represented by the following general formula [III] or a salt thereof.

Figure 108126125-A0202-12-0015-215
Figure 108126125-A0202-12-0015-215

式中, In the formula,

m表示0、1或2的整數, m represents an integer of 0, 1, or 2,

n表示0、1、或2的整數, n represents an integer of 0, 1, or 2,

B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, base-O-, base-S(=O)m- or base-N(-R 7 )-,

R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl,

R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl,

R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6 烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯 基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、 羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基、再者,R5及R7也可與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl) amino C 1 to C 6 alkyl, N-(C 1 to C 6 alkylsulfonate Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α Substituent Mono- or poly-substituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkane Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfonate Acyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, unsubstituted Phenylthio C 1 to C3 alkyl substituted by the substituent selected by the substituent group α, unsubstituted or substituted by the substituent selected by the substituent group α Sulfenyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted or Heteroarylthio C 1 to C3 alkyl substituted by substituents selected through substituent group α, unsubstituted or substituted monosubstituted or polysubstituted heteroaromatic groups selected through substituent group α Sulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Or mono- or poly-substituted phenyl C 1 to C 3 alkylthio C 1 to C 3 alkyl, unsubstituted or selected by substituent group α Substituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α, mono- or poly-substituted phenyl C 1 To C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted heteroaryl C 1 to C 3 alkylthio C 1 To C3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl selected from the substituents selected through the substituent group α, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted by a substituent group α, mono- or polysubstituted phenylcarbonyl C 1 to C 3 alkyl, Heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy, unsubstituted or selected via substituent group α Carbonyl C 1 to C 3 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 to C 3 alkyl, nitro, amine, carboxamide, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine carboxamide, mono (C 1 to C 6 alkyl )Aminocarbonyl, mono(C 1 to C 6 haloalkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, and R 5 and R 7 can also form 3 to 3 together with these bonded nitrogen atoms 6-membered heterocyclic ring, or 3 to 6-membered heterocyclic ring having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom,

R6表示氫原子或C1至C6烷基, R 6 represents a hydrogen atom or a C 1 to C 6 alkyl group,

R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl ,

R9表示氫原子、鹵原子或氰基, R 9 represents a hydrogen atom, a halogen atom or a cyano group,

取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基 羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.

含有本發明的化合物之有害生物防除劑係對半翅目(Hemiptera)害蟲、鱗翅目(Lepidoptera)害蟲、鞘翅目(Coleoptera)害蟲、雙翅目(Diptera)害蟲、膜翅目(Hymenoptera)害蟲、直翅目(Orthoptera)害蟲、纓翅目(Thysanoptera)害蟲、蟎目害蟲、植物寄生性線蟲類等廣範圍的有害生物表現優異的防除效果,再者,也可以防除獲得抗藥性的有害生物。 The pest control agent containing the compound of the present invention is against Hemiptera pests, Lepidoptera pests, Coleoptera pests, Diptera pests, Hymenoptera pests, Orthoptera pests, Thysanoptera pests, mite pests, plant parasitic nematodes and other wide-ranging pests exhibit excellent control effects. Furthermore, pests that have acquired resistance can also be controlled.

特別是,含有本發明的化合物的有害生物防除劑係對以二點葉蟎(Tetranychus urticae Koch)、神澤氏葉蟎(Tetranychus kanzawai Kishida)、柑橘葉蟎(Panonychus citri)等為代表的葉蟎類;以褐飛蝨(Nilaparvata lugens stal)、偽黑尾葉蟬(Nephotettix cincticeps)、棉蚜(Aphis gossypii Glover)等為代表的半翅目害蟲;以水稻水象鼻蟲(Lissorhoptrus oryzophilus Kuschel)、負泥蟲(Oulema oryzae)、豔金龜(Mimela splendens)等為代表的鞘翅目害蟲;根瘤線蟲(Meloidogyne incognita)等線蟲類;及以小菜蛾(Plutella xylostella)、二化螟(Chilo suppressalis)、番茄夜蛾(Helicoverpa armigera)等為代表的鱗翅目害蟲顯示出桌越的效果。再者,由於滲透移行性優異,所以可以採用以土壤處理進行之安全並且省力的施用方法。 In particular, the pest control agent containing the compound of the present invention is a spider mite represented by Tetranychus urticae Koch, Tetranychus kanzawai Kishida, Panonychus citri, etc. Hemiptera pests represented by brown planthopper (Nilaparvata lugens stal), pseudo black-tailed leafhopper (Nephotettix cincticeps), cotton aphid (Aphis gossypii Glover), etc.; represented by rice water weevils (Lissorhoptrus oryzophilus Kuschel), negative mud Coleoptera pests such as Oulema oryzae, Mimela splendens, etc.; nematodes such as Meloidogyne incognita; and Plutella xylostella, Chilo suppressalis, and Spodoptera exigua (Helicoverpa armigera) and other lepidopteran pests have shown the effect of the table. Furthermore, because of its excellent permeability and migration properties, it is possible to adopt a safe and labor-saving application method by soil treatment.

[實施發明的形態] [Forms for carrying out the invention]

以下說明本說明書所記載的記號及用語。 The symbols and terms described in this manual are explained below.

在本發明中,「有害生物防除劑」意指在農園藝領域、家畜 及寵物等動物、家庭用或防疫用的殺蟲劑、殺蟎劑、殺線蟲劑等。 In the present invention, "harm control agent" means in the field of agriculture and horticulture, livestock And insecticides, acaricides, nematicides for pets and other animals, household or epidemic prevention.

本發明中,「鹵原子」表示氟原子、氯原子、溴原子、碘原子。 In the present invention, "halogen atom" means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.

本發明中,「C1至C6」等標示意指接續其後的取代基碳數於此時為1至6。 In the present invention, “C 1 to C 6 ”and other symbols indicate that the carbon number of the substituent that follows is 1 to 6 at this time.

本發明中,「C1至C6烷基」在無特別限定下係表示碳數為1至6的直鏈或支鏈狀的烷基,例如可舉:甲基、乙基、正丙基、異丙基、正丁基、第二丁基、異丁基、第三丁基、正戊基、1-甲基丁基、2-甲基丁基、3-甲基丁基、1-乙基丙基、1,1-二甲基丙基、1,2-二甲基丙基、新戊基、正己基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基、1-乙基丁基、2-乙基丁基、1,1-二甲基丁基、1,2-二甲基丁基、1,3-二甲基丁基、2,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1,1,2-三甲基丙基、1,2,2-三甲基丙基、1-乙基-1-甲基丙基或1-乙基-2-甲基丙基等基。 In the present invention, "C 1 to C 6 alkyl group" means a linear or branched alkyl group having 1 to 6 carbon atoms without particular limitation, for example, methyl, ethyl, n-propyl , Isopropyl, n-butyl, second butyl, isobutyl, third butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1- Ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methyl Amyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethyl Butyl butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2, Groups such as 2-trimethylpropyl, 1-ethyl-1-methylpropyl, or 1-ethyl-2-methylpropyl.

本發明中,「C3至C6環烷基」在無特別限定下係表示碳數為3至6的環烷基,例如可舉:環丙基、環丁基、環戊基或環己基等基。 In the present invention, "C 3 to C 6 cycloalkyl" means a cycloalkyl group having 3 to 6 carbon atoms without particular limitation, for example, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl Equal base.

本發明中,「C3至C6環烷基C1至C6烷基」在無特別限定下係表示環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-(C1至C6烷基)-基,例如可舉:環丙基甲基、環丁基甲基、環戊基甲基、環己基甲基、1-(環丙基)乙基、2-(環丙基)乙基或1-(環丙基)丙基等基。 In the present invention, "C 3 to C 6 cycloalkyl C 1 to C 6 alkyl" means a cycloalkyl moiety and an alkyl moiety having the above meaning (C 3 to C 6 cycloalkyl), without particular limitation -(C 1 to C 6 alkyl)-yl, for example, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-(cyclopropyl)ethyl, 2- Groups such as (cyclopropyl)ethyl or 1-(cyclopropyl)propyl.

本發明中,「C2至C6烯基」在無特別限定下係表示碳數為2至6的直鏈或支鏈狀的烯基,例如可舉:乙烯基、1-丙烯基、異丙烯基、2-丙烯基、1-丁烯基、1-甲基-1-丙烯基、2-丁烯基、1-甲基-2-丙烯基、3-丁烯基、2-甲基-1-丙烯基、2-甲基-2-丙烯基、1,3-丁二烯基、1-戊烯基、1- 乙基-2-丙烯基、2-戊烯基、1-甲基-1-丁烯基、3-戊烯基、1-甲基-2-丁烯基、4-戊烯基、1-甲基-3-丁烯基、3-甲基-1-丁烯基、1,2-二甲基-2-丙烯基、1,1-二甲基-2-丙烯基、2-甲基-2-丁烯基、3-甲基-2-丁烯基、1,2-二甲基-1-丙烯基、2-甲基-3-丁烯基、3-甲基-3-丁烯基、1,3-戊二烯基、1-乙烯基-2-丙烯基、1-己烯基、1-丙基-2-丙烯基、2-己烯基、1-甲基-1-戊烯基、1-乙基-2-丁烯基、3-己烯基、4-己烯基、5-己烯基、1-甲基-4-戊烯基、1-乙基-3-丁烯基、1-(異丁基)乙烯基、1-乙基-1-甲基-2-丙烯基、1-乙基-2-甲基-2-丙烯基、1-(異丙基)-2-丙烯基、2-甲基-2-戊烯基、3-甲基-3-戊烯基、4-甲基-3-戊烯基、1,3-二甲基-2-丁烯基、1,1-二甲基-3-丁烯基、3-甲基-4-戊烯基、4-甲基-4-戊烯基、1,2-二甲基-3-丁烯基、1,3-二甲基-3-丁烯基、1,1,2-三甲基-2-丙烯基、1,5-己二烯基、1-乙烯基-3-丁烯基或2,4-己二烯基等基。 In the present invention, "C 2 to C 6 alkenyl group" means a straight or branched alkenyl group having 2 to 6 carbon atoms without particular limitation, and examples include vinyl, 1-propenyl, and iso Propenyl, 2-propenyl, 1-butenyl, 1-methyl-1-propenyl, 2-butenyl, 1-methyl-2-propenyl, 3-butenyl, 2-methyl -1-propenyl, 2-methyl-2-propenyl, 1,3-butadienyl, 1-pentenyl, 1-ethyl-2-propenyl, 2-pentenyl, 1-methyl 1-butenyl, 3-pentenyl, 1-methyl-2-butenyl, 4-pentenyl, 1-methyl-3-butenyl, 3-methyl-1-butenyl Alkenyl, 1,2-dimethyl-2-propenyl, 1,1-dimethyl-2-propenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl , 1,2-dimethyl-1-propenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,3-pentadienyl, 1-vinyl- 2-propenyl, 1-hexenyl, 1-propyl-2-propenyl, 2-hexenyl, 1-methyl-1-pentenyl, 1-ethyl-2-butenyl, 3 -Hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-4-pentenyl, 1-ethyl-3-butenyl, 1-(isobutyl)vinyl, 1 -Ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-2-propenyl, 1-(isopropyl)-2-propenyl, 2-methyl-2-pentan Alkenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1,3-dimethyl-2-butenyl, 1,1-dimethyl-3-butene Alkenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-3-butene Groups such as alkenyl, 1,1,2-trimethyl-2-propenyl, 1,5-hexadienyl, 1-vinyl-3-butenyl, or 2,4-hexadienyl.

本發明中,「C3至C6環烷基C2至C6烯基」在無特別限定下係表示環烷基部分及烯基部分為上述意義的(C3至C6環烷基)-(C2至C6烯基)-基,例如可舉:2-環丙基乙烯基、2-環丁基乙烯基、2-環戊基乙烯基或2-環己基乙烯基等基。 In the present invention, "C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl" means that the cycloalkyl portion and the alkenyl portion have the above meanings (C 3 to C 6 cycloalkyl) without particular limitation. -(C 2 to C 6 alkenyl)-yl, for example, 2-cyclopropylvinyl, 2-cyclobutylvinyl, 2-cyclopentylvinyl or 2-cyclohexylvinyl, etc.

本發明中,「C2至C6炔基」在無特別限定下係表示碳數為2至6的直鏈或支鏈狀的炔基,例如可舉:乙炔基、1-丙炔基、2-丙炔基、1-丁炔基、1-甲基-2-丙炔基、2-丁炔基、3-丁炔基、1-戊炔基、1-乙基-2-丙炔基、2-戊炔基、3-戊炔基、1-甲基-2-丁炔基、4-戊炔基、1-甲基-3-丁炔基、2-甲基-3-丁炔基、1-己炔基、1-(正丙基)-2-丙炔基、2-己炔基、1-乙基-2-丁炔基、3-己炔基、1-甲基-2-戊炔基、1-甲基-3-己炔基、4-甲基-1-戊炔基、3-甲基-1-戊炔基、5-己炔基、1-乙基-3-丁炔基、1-乙基-1-甲基-2-丙 炔基、1-(異丙基)-2-丙炔基、1,1-二甲基-2-丁炔基或2,2-二甲基-3-丁炔基等基。 In the present invention, "C 2 to C 6 alkynyl" refers to a linear or branched alkynyl group having 2 to 6 carbon atoms without particular limitation, and examples thereof include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl Group, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl Alkynyl, 1-hexynyl, 1-(n-propyl)-2-propynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl -2-pentynyl, 1-methyl-3-hexynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl, 1-ethyl -3-butynyl, 1-ethyl-1-methyl-2-propynyl, 1-(isopropyl)-2-propynyl, 1,1-dimethyl-2-butynyl Or 2,2-dimethyl-3-butynyl and other groups.

本發明中,「C3至C6環烷基C2至C6炔基」在無特別限定下係表示環烷基部分及炔基部分表示上述意義的(C3至C6環烷基)-(C2至C6炔基)-基,例如可舉:環丙基乙炔基、環丁基乙炔基、環戊基乙炔基或環己基乙炔基等基。 In the present invention, "C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl" means a cycloalkyl moiety and an alkynyl moiety expresses the above meaning without limitation (C 3 to C 6 cycloalkyl) The -(C 2 to C 6 alkynyl)-yl group includes, for example, groups such as cyclopropylethynyl, cyclobutylethynyl, cyclopentylethynyl, and cyclohexylethynyl.

本發明中,「C2至C6鹵炔基」在無特別限定下係表示經相同或相異的1至9個鹵原子取代之碳數2至6的直鏈或支鏈狀的炔基,例如可舉:氟乙炔基、氯乙炔基、溴乙炔基、碘乙炔基、3-氟-2-丙炔基、3-氯-2-丙炔基、3-溴-2-丙炔基、3-碘-2-丙炔基、4-氟-3-丁炔基、4-氯-3-丁炔基、4-溴-3-丁炔基、4-碘-3-丁炔基、4,4-二氟-2-丁炔基、4,4-二氯-2-丁炔基、4,4,4-三氟-2-丁炔基、4,4,4-三氯-2-丁炔基、3-氟-1-甲基-2-丙炔基、3-氯-1-甲基-2-丙炔基、5-氟-4-戊炔基、5-氯-4-戊炔基、5,5,5-三氟-3-戊炔基、5,5,5-三氯-3-戊炔基、4-氟-2-甲基-3-丁炔基、4-氯-2-甲基-3-丁炔基、6-氟-5-己炔基、6-氯-5-己炔基、6,6,6-三氟-4-己炔基、6,6,6-三氯-4-己炔基、5-氟-3-甲基-4-戊炔基或5-氯-3-甲基-4-戊炔基等基。 In the present invention, "C 2 to C 6 haloalkynyl" means a straight or branched alkynyl group having 2 to 6 carbon atoms substituted with the same or different 1 to 9 halogen atoms, without particular limitation , For example, fluoroethynyl, chloroethynyl, bromoethynyl, iodoethynyl, 3-fluoro-2-propynyl, 3-chloro-2-propynyl, 3-bromo-2-propynyl , 3-iodo-2-propynyl, 4-fluoro-3-butynyl, 4-chloro-3-butynyl, 4-bromo-3-butynyl, 4-iodo-3-butynyl , 4,4-difluoro-2-butynyl, 4,4-dichloro-2-butynyl, 4,4,4-trifluoro-2-butynyl, 4,4,4-trichloro -2-butynyl, 3-fluoro-1-methyl-2-propynyl, 3-chloro-1-methyl-2-propynyl, 5-fluoro-4-pentynyl, 5-chloro -4-pentynyl, 5,5,5-trifluoro-3-pentynyl, 5,5,5-trichloro-3-pentynyl, 4-fluoro-2-methyl-3-butyn Group, 4-chloro-2-methyl-3-butynyl, 6-fluoro-5-hexynyl, 6-chloro-5-hexynyl, 6,6,6-trifluoro-4-hexyne Group, 6,6,6-trichloro-4-hexynyl, 5-fluoro-3-methyl-4-pentynyl or 5-chloro-3-methyl-4-pentynyl.

本發明中,「C2至C6鹵烯基」在無特別限定下係表示經相同或相異的1至11個鹵原子取代之碳數2至6的直鏈或支鏈狀的烯基,例如可舉:1-氟乙烯基、2-氟乙烯基、1,2-二氟乙烯基、2,2-二氟乙烯基、三氟乙烯基、1-氯乙烯基、2-氯乙烯基、1,2-二氯乙烯基、2,2-二氯乙烯基、三氯乙烯基、1,2-二溴乙烯基、2,2-二溴乙烯基、三溴乙烯基、1,2-二碘乙烯基、2,2-二碘乙烯基、三碘乙烯基、1-氟-2-丙烯基、2-氟-2-丙烯基、3-氟-2-丙烯基、2,3-二氟-2-丙烯基、3,3-二氟-2-丙烯基、3,3-二氟-1-丙烯基、 2,3,3-三氟-2-丙烯基、3,3,3-三氟-1-丙烯基、2-氯-3,3,3-三氟-1-丙烯基、1,2,3,3,3-五氟-1-丙烯基、1-氯-2-丙烯基、2-氯-2-丙烯基、3-氯-2-丙烯基、2,3-二氯-2-丙烯基、3,3-二氯-2-丙烯基、3,3-二氯-1-丙烯基、2,3,3-三氯-2-丙烯基、3,3,3-三氯-1-丙烯基、3-溴-2-丙烯基、3,3-二溴-2-丙烯基、3,3-二碘-2-丙烯基、2,2-二氟-1-丙烯-2-基、3,3,3-三氟-1-丙烯-2-基、3,3,3-三氯-1-丙烯-2-基、4-氟-3-丁烯基、4,4-二氟-3-丁烯基、4,4-二氟-3-丁烯-2-基、4,4,4-三氟-2-丁烯基、3,4,4-三氟-3-丁烯基、2-三氟甲基-2-丙烯基、2-三氟甲基-3,3-二氟-2-丙烯基、4,4,4-三氟-3-氯-2-丁烯基、4,4-二氯-3-丁烯基、4,4,4-三氯-2-丁烯基、2-三氯甲基-2-丙烯基、5,5-二氟-4-戊烯基、4,5,5-三氟-4-戊烯基、5,5,5-三氟-3-戊烯基、4,4,4-三氟-3-甲基-2-丁烯基、4,4,4-三氟-3-三氟甲基-2-丁烯基、5,5-二氯-4-戊烯基、4,4,4-三氯-3-甲基-2-丁烯基、6,6-二氟-5-己烯基、5,6,6-三氟-5-戊烯基、6,6,6-三氟-4-戊烯基、5,5,5-三氟-4-甲基-3-戊烯基、5,5,5-三氟-4-三氟甲基-3-戊烯基、6,6-二氯-5-己烯基或5,5,5-三氯-4-甲基-3-戊烯基等基。 In the present invention, "C 2 to C 6 haloalkenyl" means a straight or branched alkenyl group having 2 to 6 carbon atoms substituted with the same or different 1 to 11 halogen atoms without particular limitation , For example: 1-fluorovinyl, 2-fluorovinyl, 1,2-difluorovinyl, 2,2-difluorovinyl, trifluorovinyl, 1-chlorovinyl, 2-chlorovinyl Group, 1,2-dichlorovinyl, 2,2-dichlorovinyl, trichlorovinyl, 1,2-dibromovinyl, 2,2-dibromovinyl, tribromovinyl, 1, 2-diiodovinyl, 2,2-diiodovinyl, triiodovinyl, 1-fluoro-2-propenyl, 2-fluoro-2-propenyl, 3-fluoro-2-propenyl, 2, 3-difluoro-2-propenyl, 3,3-difluoro-2-propenyl, 3,3-difluoro-1-propenyl, 2,3,3-trifluoro-2-propenyl, 3, 3,3-trifluoro-1-propenyl, 2-chloro-3,3,3-trifluoro-1-propenyl, 1,2,3,3,3-pentafluoro-1-propenyl, 1- Chloro-2-propenyl, 2-chloro-2-propenyl, 3-chloro-2-propenyl, 2,3-dichloro-2-propenyl, 3,3-dichloro-2-propenyl, 3 ,3-dichloro-1-propenyl, 2,3,3-trichloro-2-propenyl, 3,3,3-trichloro-1-propenyl, 3-bromo-2-propenyl, 3, 3-dibromo-2-propenyl, 3,3-diiodo-2-propenyl, 2,2-difluoro-1-propen-2-yl, 3,3,3-trifluoro-1-propenyl- 2-yl, 3,3,3-trichloro-1-propen-2-yl, 4-fluoro-3-butenyl, 4,4-difluoro-3-butenyl, 4,4-difluoro -3-buten-2-yl, 4,4,4-trifluoro-2-butenyl, 3,4,4-trifluoro-3-butenyl, 2-trifluoromethyl-2-propene Group, 2-trifluoromethyl-3,3-difluoro-2-propenyl, 4,4,4-trifluoro-3-chloro-2-butenyl, 4,4-dichloro-3-butene Alkenyl, 4,4,4-trichloro-2-butenyl, 2-trichloromethyl-2-propenyl, 5,5-difluoro-4-pentenyl, 4,5,5-tri Fluoro-4-pentenyl, 5,5,5-trifluoro-3-pentenyl, 4,4,4-trifluoro-3-methyl-2-butenyl, 4,4,4-triene Fluoro-3-trifluoromethyl-2-butenyl, 5,5-dichloro-4-pentenyl, 4,4,4-trichloro-3-methyl-2-butenyl, 6, 6-difluoro-5-hexenyl, 5,6,6-trifluoro-5-pentenyl, 6,6,6-trifluoro-4-pentenyl, 5,5,5-trifluoro- 4-methyl-3-pentenyl, 5,5,5-trifluoro-4-trifluoromethyl-3-pentenyl, 6,6-dichloro-5-hexenyl or 5,5, 5-trichloro-4-methyl-3-pentenyl and other groups.

本發明中,「C1至C6鹵烷基」在無特別限定下係表示經相同或相異的鹵原子1至13個取代之碳數1至6的直鏈或支鏈的烷基,例如可舉:表示鹵烷基,例如可舉:氟甲基、二氟甲基、三氟甲基、氯甲基、二氯甲基、三氯甲基、溴甲基、二溴甲基、三溴甲基、碘甲基、氯二氟甲基、二氯氟甲基、1-氟乙基、2-氟乙基、1,1-二氟乙基、2,2-二氟乙基、2,2,2-三氟乙基、1,1,2,2-四氟乙基、五氟乙基、1-氯乙基、2-氯乙基、1,1-二氯乙基、2,2-二氯乙基、2,2,2-三氯乙基、1,1,2,2-四氯乙基、五氯乙基、1-溴乙基、2-溴乙基、2,2,2-三溴乙基、1-碘乙基、2-碘乙基、2-氯-2,2-二氟乙基、2,2-二氯-2-氟乙基、1-氟丙基、2-氟丙基、3-氟丙基、1,1-二氟丙 基、2,2-二氟丙基、3,3-二氟丙基、3,3,3-三氟丙基、2,2,3,3,3-五氟丙基、1,1,2,3,3,3-六氟丙基、七氟丙基、1-氟丙烷-2-基、2-氟丙烷-2-基、1,1-二氟丙烷-2-基、1,2-二氟丙烷-2-基、1,3-二氟丙烷-2-基、1,2,3-三氟丙烷-2-基、1,1,3,3-四氟丙烷-2-基、1,1,1,3,3,3-六氟丙烷-2-基、七氟丙烷-2-基、1-氯丙基、2-氯丙基、3-氯丙基、1,1-二氯丙基、2,2-二氯丙基、3,3-二氯丙基、3,3,3-三氯丙基、2,2,3,3,3-五氯丙基、七氯丙基、1-氯丙烷-2-基、2-氯丙烷-2-基、1,1-二氯丙烷-2-基、1,2-二氯丙烷-2-基、1,3-二氯丙烷-2-基、1,2,3-三氯丙烷-2-基、1,1,3,3-四氯丙烷-2-基、1,1,1,3,3,3-六氯丙烷-2-基、七氯丙烷-2-基、1-溴丙基、2-溴丙基、3-溴丙基、1-溴丙烷-2-基、2-溴丙烷-2-基、1-碘丙基、2-碘丙基、3-碘丙基、1-碘丙烷-2-基、2-碘丙烷-2-基、1-氟丁基、2-氟丁基、3-氟丁基、4-氟丁基、4,4-二氟丁基、4,4,4-三氟丁基、4,4,4-三氟-3-甲基丁基、3,3,4,4,4-五氟丁基、2,2,3,4,4,4-六氟丁基、2,2,3,3,4,4,4-七氟丁基、九氟丁基、1,1,1-三氟丁烷-2-基、4,4,4-三氟丁烷-2-基、3,3,4,4,4-五氟丁烷-2-基、九氟丁烷-2-基、1,1,1,3,3,3-六氟-2-(三氟甲基)丙烷-2-基、1-氯丁基、2-氯丁基、3-氯丁基、4-氯丁基、4,4-二氯丁基、4,4,4-三氯丁基、九氯丁基、1,1,1-三氯丁烷-2-基、4,4,4-三氯丁烷-2-基、九氯丁烷-2-基、1-溴丁基、2-溴丁基、3-溴丁基、4-溴丁基、1-碘丁基、2-碘丁基、3-碘丁基、4-碘丁基、4-氯-1,1,2,2,3,3,4,4-八氟丁基、4-溴-1,1,2,2,3,3,4,4-八氟丁基、1-氟戊基、2-氟戊基、3-氟戊基、4-氟戊基、5-氟戊基、5,5,5-三氟戊基、4,4,5,5,5-五氟戊基、3,3,4,4,5,5,5-七氟戊基、2,2,3,3,4,4,5,5-八氟戊基、2,2,3,3,4,4,5,5,5-九氟戊基、十一氟戊基、1-氯戊基、2-氯戊基、3-氯戊基、4-氯戊基、5-氯戊基、5,5,5-三氯戊基、4,4,5,5,5-五氯戊基、3,3,4,4,5,5,5-七氯戊基、2,2,3,3,4,4,5,5,5-九氯戊基、 十一氯戊基、1-溴戊基、2-溴戊基、3-溴戊基、4-溴戊基、5-溴戊基、5-碘戊基、1-氟己基、2-氟己基、3-氟己基、4-氟己基、5-氟己基、6-氟己基、6,6,6-三氟己基、5,5,6,6,6-五氟己基、4,4,5,5,6,6,6-七氟己基、3,3,4,4,5,5,6,6,6-九氟己基、2,2,3,3,4,4,5,5,6,6,6-十一氟己基、2,2,3,3,4,4,5,5,6,6-十氟己基、十三氟己基、1-氯己基、2-氯己基、3-氯己基、4-氯己基、5-氯己基、6-氯己基、5-溴己基、6-溴己基、5-碘己基或6-碘己基等基。 In the present invention, "C 1 to C 6 haloalkyl" means a straight or branched alkyl group having 1 to 6 carbon atoms substituted with 1 to 13 halogen atoms of the same or different halogen atoms, without particular limitation, For example, it may mean a haloalkyl group, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, Tribromomethyl, iodomethyl, chlorodifluoromethyl, dichlorofluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl , 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, 1-chloroethyl, 2-chloroethyl, 1,1-dichloroethyl , 2,2-dichloroethyl, 2,2,2-trichloroethyl, 1,1,2,2-tetrachloroethyl, pentachloroethyl, 1-bromoethyl, 2-bromoethyl , 2,2,2-tribromoethyl, 1-iodoethyl, 2-iodoethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 1-fluoropropyl, 2-fluoropropyl, 3-fluoropropyl, 1,1-difluoropropyl, 2,2-difluoropropyl, 3,3-difluoropropyl, 3,3,3 -Trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, 1,1,2,3,3,3-hexafluoropropyl, heptafluoropropyl, 1-fluoropropane-2- Group, 2-fluoropropane-2-yl, 1,1-difluoropropane-2-yl, 1,2-difluoropropane-2-yl, 1,3-difluoropropane-2-yl, 1,2 ,3-trifluoropropane-2-yl, 1,1,3,3-tetrafluoropropane-2-yl, 1,1,1,3,3,3-hexafluoropropane-2-yl, heptafluoropropane-2 -Group, 1-chloropropyl, 2-chloropropyl, 3-chloropropyl, 1,1-dichloropropyl, 2,2-dichloropropyl, 3,3-dichloropropyl, 3, 3,3-trichloropropyl, 2,2,3,3,3-pentachloropropyl, heptachloropropyl, 1-chloropropane-2-yl, 2-chloropropane-2-yl, 1,1 -Dichloropropane-2-yl, 1,2-dichloropropane-2-yl, 1,3-dichloropropane-2-yl, 1,2,3-trichloropropane-2-yl, 1,1 ,3,3-tetrachloropropane-2-yl, 1,1,1,3,3,3-hexachloropropane-2-yl, heptachloropropane-2-yl, 1-bromopropyl, 2-bromo Propyl, 3-bromopropyl, 1-bromopropane-2-yl, 2-bromopropane-2-yl, 1-iodopropyl, 2-iodopropyl, 3-iodopropyl, 1-iodopropane- 2-yl, 2-iodopropane-2-yl, 1-fluorobutyl, 2-fluorobutyl, 3-fluorobutyl, 4-fluorobutyl, 4,4-difluorobutyl, 4,4, 4-trifluorobutyl, 4,4,4-trifluoro-3-methylbutyl, 3,3,4,4,4-pentafluorobutyl, 2,2,3,4,4,4- Hexafluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, nonafluorobutyl, 1,1,1-trifluorobutan-2-yl, 4,4,4- Trifluorobutane-2-yl, 3,3,4,4,4-pentafluorobutane-2-yl, nonafluorobutane-2-yl, 1,1,1,3,3,3-hexa Fluoro-2-(trifluoromethyl)propane- 2-yl, 1-chlorobutyl, 2-chlorobutyl, 3-chlorobutyl, 4-chlorobutyl, 4,4-dichlorobutyl, 4,4,4-trichlorobutyl, nonachloro Butyl, 1,1,1-trichlorobutan-2-yl, 4,4,4-trichlorobutan-2-yl, nonachlorobutan-2-yl, 1-bromobutyl, 2- Bromobutyl, 3-bromobutyl, 4-bromobutyl, 1-iodobutyl, 2-iodobutyl, 3-iodobutyl, 4-iodobutyl, 4-chloro-1,1,2, 2,3,3,4,4-octafluorobutyl, 4-bromo-1,1,2,2,3,3,4,4-octafluorobutyl, 1-fluoropentyl, 2-fluoropentane Group, 3-fluoropentyl, 4-fluoropentyl, 5-fluoropentyl, 5,5,5-trifluoropentyl, 4,4,5,5,5-pentafluoropentyl, 3,3, 4,4,5,5,5-heptafluoropentyl, 2,2,3,3,4,4,5,5-octafluoropentyl, 2,2,3,3,4,4,5, 5,5-nonafluoropentyl, undecafluoropentyl, 1-chloropentyl, 2-chloropentyl, 3-chloropentyl, 4-chloropentyl, 5-chloropentyl, 5,5,5 -Trichloropentyl, 4,4,5,5,5-pentachloropentyl, 3,3,4,4,5,5,5-heptachloropentyl, 2,2,3,3,4, 4,5,5,5-nonachloropentyl, undecylpentyl, 1-bromopentyl, 2-bromopentyl, 3-bromopentyl, 4-bromopentyl, 5-bromopentyl, 5 -Iodopentyl, 1-fluorohexyl, 2-fluorohexyl, 3-fluorohexyl, 4-fluorohexyl, 5-fluorohexyl, 6-fluorohexyl, 6,6,6-trifluorohexyl, 5,5,6 ,6,6-pentafluorohexyl, 4,4,5,5,6,6,6-heptafluorohexyl, 3,3,4,4,5,5,6,6,6-nonafluorohexyl, 2 ,2,3,3,4,4,5,5,6,6,6-undecylfluorohexyl, 2,2,3,3,4,4,5,5,6,6-decafluorohexyl, Tridecylfluorohexyl, 1-chlorohexyl, 2-chlorohexyl, 3-chlorohexyl, 4-chlorohexyl, 5-chlorohexyl, 6-chlorohexyl, 5-bromohexyl, 6-bromohexyl, 5-iodohexyl or 6-iodohexyl and other groups.

本發明中,「C1至C6烷氧基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-O-基,例如可舉:甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基、正戊氧基、1-甲基丁氧基、2-甲基丁氧基、3-甲基丁氧基、1-乙基丙氧基、1,1-二甲基丙氧基、1,2-二甲基丙氧基或正己氧基等基。 In the present invention, the "C 1 to C 6 alkoxy group" is an (C 1 to C 6 alkyl)-O- group in the above sense unless otherwise specified. Examples include: methoxy, ethyl Oxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy, third butoxy, n-pentoxy, 1-methylbutoxy, 2- Groups such as methylbutoxy, 3-methylbutoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy or n-hexyloxy.

本發明中,「C1至C6鹵烷氧基」在無特別限定下係鹵烷基部分為上述意義的(C1至C6鹵烷基)-O-基,例如可舉:二氟甲氧基、二氯甲氧基、三氟甲氧基、三氯甲氧基、三溴甲氧基、氯二氟甲氧基、溴二氟甲氧基、2-氟乙氧基、1-氯乙氧基、2-氯乙氧基、1-溴乙氧基、2-溴乙氧基、2,2-二氟乙氧基、1,2-二氯乙氧基、2,2-二氯乙氧基、2,2,2-三氟乙氧基、2,2,2-三氯乙氧基、1,1,2,2-四氟乙氧基、五氟乙氧基、2-溴-2-氯乙氧基、2-氯-1,1,2,2-四氟乙氧基、1-氯-1,2,2,2-四氟乙氧基、1-氯丙氧基、2-氯丙氧基、3-氯丙氧基、2-溴丙氧基、3-溴丙氧基、2-溴-1-甲基乙氧基、3-碘丙氧基、2,3-二氯丙氧基、2,3-二溴丙氧基、3,3,3-三氟丙氧基、3,3,3-三氟-2-丙氧基、3,3,3-三氯丙氧基、3-溴-3,3-二氟丙氧基、2,2-二氟丙氧基、3,3-二氯-3-氟丙氧基、2,2,3,3-四氟丙氧基、1-溴-3,3,3-三氟丙氧基、 2,2,3,3,3-五氟丙氧基、2,2,2-三氟-1-三氟甲基乙氧基、七氟丙氧基、七氟-2-丙氧基、1,2,2,2-四氟-1-三氟甲基乙氧基、1,1,2,3,3,3-六氟丙氧基、2-氯丁氧基、3-氯丁氧基、4-氯丁氧基、2-氯-1,1-二甲基乙氧基、4-溴丁氧基、3-溴-2-甲基丙氧基、2-溴-1,1-二甲基乙氧基、2,2-二氯-1,1-二甲基乙氧基、2-氯-1-氯甲基-2-甲基乙氧基、4,4,4-三氟丁氧基、3,3,3-三氟-1-甲基丙氧基、3,3,3-三氟-2-甲基丙氧基、2,3,4-三氯丁氧基、2,2,2-三氯-1,1-二甲基乙氧基、4-氯-4,4-二氟丁氧基、4,4-二氯-4-氟丁氧基、4-溴-4,4-二氟丁氧基、2,4-二溴-4,4-二氟丁氧基、3,4-二氯-3,4,4-三氟丁氧基、3,3-二氯-4,4,4-三氟丁氧基、4-溴-3,3,4,4-四氟丁氧基、4-溴-3-氯-3,4,4-三氟丁氧基、2,2,3,3,4,4-六氟丁氧基、2,2,3,4,4,4-六氟丁氧基、2,2,2-三氟-1-甲基-1-三氟甲基乙氧基、3,3,3-三氟-2-三氟甲基丙氧基、2,2,3,3,4,4,4-七氟丁氧基、3,3,4,4,4-五氟-2-丁氧基、2,3,3,3-四氟-2-三氟甲基丙氧基、1,1,2,2,3,3,4,4-八氟丁氧基、九氟丁氧基、全氟-第三丁氧基、4-氯-1,1,2,2,3,3,4,4-八氟丁氧基、5,5,5-三氟戊氧基、4,4,5,5,5-五氟戊氧基、3,3,4,4,5,5,5-七氟戊氧基、3,3,4,4,5,5,5-七氟-2-戊氧基、2,2,3,3,4,4,5,5,5-九氟戊氧基、2,2,3,3,4,4,5,5-八氟戊氧基、全氟戊氧基、4,4,5,5,5-五氟-2-丁氧基、2,2-雙(三氟甲基)丙氧基、2,2,3,3,4,4,5,5,6,6,6-十一氟己氧基、3,3,4,4,5,5,6,6,6-九氟己氧基、4,4,5,5,6,6,6-七氟己氧基、2,2,3,3,4,4,5,5,6,6-十氟己氧基、4,4,4-三氟-3,3-雙(三氟甲基)丁氧基或全氟己氧基等基。 In the present invention, "C 1 to C 6 haloalkoxy" is a (C 1 to C 6 haloalkyl)-O- group with the above meaning unless otherwise specified. The haloalkyl moiety is, for example, difluoro Methoxy, dichloromethoxy, trifluoromethoxy, trichloromethoxy, tribromomethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2-fluoroethoxy, 1 -Chloroethoxy, 2-chloroethoxy, 1-bromoethoxy, 2-bromoethoxy, 2,2-difluoroethoxy, 1,2-dichloroethoxy, 2,2 -Dichloroethoxy, 2,2,2-trifluoroethoxy, 2,2,2-trichloroethoxy, 1,1,2,2-tetrafluoroethoxy, pentafluoroethoxy , 2-bromo-2-chloroethoxy, 2-chloro-1,1,2,2-tetrafluoroethoxy, 1-chloro-1,2,2,2-tetrafluoroethoxy, 1- Chloropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 2-bromo-1-methylethoxy, 3-iodopropoxy Group, 2,3-dichloropropoxy, 2,3-dibromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trifluoro-2-propoxy, 3 ,3,3-trichloropropoxy, 3-bromo-3,3-difluoropropoxy, 2,2-difluoropropoxy, 3,3-dichloro-3-fluoropropoxy, 2 ,2,3,3-tetrafluoropropoxy, 1-bromo-3,3,3-trifluoropropoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2,2 -Trifluoro-1-trifluoromethylethoxy, heptafluoropropoxy, heptafluoro-2-propoxy, 1,2,2,2-tetrafluoro-1-trifluoromethylethoxy, 1,1,2,3,3,3-hexafluoropropoxy, 2-chlorobutoxy, 3-chlorobutoxy, 4-chlorobutoxy, 2-chloro-1,1-dimethyl Ethoxy, 4-bromobutoxy, 3-bromo-2-methylpropoxy, 2-bromo-1,1-dimethylethoxy, 2,2-dichloro-1,1-di Methylethoxy, 2-chloro-1-chloromethyl-2-methylethoxy, 4,4,4-trifluorobutoxy, 3,3,3-trifluoro-1-methylpropane Oxygen, 3,3,3-trifluoro-2-methylpropoxy, 2,3,4-trichlorobutoxy, 2,2,2-trichloro-1,1-dimethylethoxy Group, 4-chloro-4,4-difluorobutoxy, 4,4-dichloro-4-fluorobutoxy, 4-bromo-4,4-difluorobutoxy, 2,4-dibromo -4,4-difluorobutoxy, 3,4-dichloro-3,4,4-trifluorobutoxy, 3,3-dichloro-4,4,4-trifluorobutoxy, 4 -Bromo-3,3,4,4-tetrafluorobutoxy, 4-bromo-3-chloro-3,4,4-trifluorobutoxy, 2,2,3,3,4,4-hexa Fluorobutoxy, 2,2,3,4,4,4-hexafluorobutoxy, 2,2,2-trifluoro-1-methyl-1-trifluoromethylethoxy, 3,3 ,3-trifluoro-2-trifluoromethylpropoxy, 2,2,3,3,4,4,4-heptafluorobutoxy, 3,3,4,4,4-pentafluoro-2 -Butoxy, 2,3,3,3-tetrafluoro-2-trifluoromethylpropoxy, 1,1,2,2,3,3, 4,4-octafluorobutoxy, nonafluorobutoxy, perfluoro-third butoxy, 4-chloro-1,1,2,2,3,3,4,4-octafluorobutoxy , 5,5,5-trifluoropentyloxy, 4,4,5,5,5-pentafluoropentyloxy, 3,3,4,4,5,5,5-heptafluoropentyloxy, 3 ,3,4,4,5,5,5-heptafluoro-2-pentyloxy, 2,2,3,3,4,4,5,5,5-nonafluoropentyloxy, 2,2, 3,3,4,4,5,5-octafluoropentyloxy, perfluoropentyloxy, 4,4,5,5,5-pentafluoro-2-butoxy, 2,2-bis(three (Fluoromethyl) propoxy, 2,2,3,3,4,4,5,5,6,6,6-undecylfluorohexyloxy, 3,3,4,4,5,5,6 ,6,6-nonafluorohexyloxy, 4,4,5,5,6,6,6-heptafluorohexyloxy, 2,2,3,3,4,4,5,5,6,6 -Groups such as decafluorohexyloxy, 4,4,4-trifluoro-3,3-bis(trifluoromethyl)butoxy or perfluorohexyloxy.

本發明中,「C3至C6鹵環烷基」在無特別限定下係經相同或相異的1至11個鹵原子取代的碳數為3至6的環烷基,例如可舉:1-氟環丙基、2-氟環丙基、2,2-二氟環丙基、2,2,3,3-四氟環丙基、1-氯環丙基、2-氯環丙基、2,2-二氯環丙基、2,2,3,3-四氯環丙基、2,2-二溴環丙基、2,2-二 碘環丙基、1-氟環丁基、2-氟環丁基、3-氟環丁基、3,3-二氟環丁基、七氟環丁基、2-氯環丁基、3-氯環丁基、3,3-二氯環丁基、3,3-二溴環丁基、3,3-二碘環丁基、1-氟環戊基、2-氟環戊基、3-氟環戊基、2,2-二氟環戊基、3,3-二氟環戊基、九氟環戊基、2,2-二氯環戊基、3,3-二氯環戊基、2,2-二溴環戊基、3,3-二溴環戊基、2,2-二碘環戊基、3,3-二碘環戊基、1-氟環己基、2-氟環己基、3-氟環己基、4-氟環己基、2,2-二氟環己基、3,3-二氟環己基、4,4-二氟環己基、1-氯環己基、2-氯環己基、3-氯環己基、4-氯環己基、2,2-二氯環己基、3,3-二氯環己基、4,4-二氯環己基、3,3-二溴環己基、4,4-二溴環己基、3,3-二碘環己基或4,4-二碘環己基等基。 In the present invention, "C 3 to C 6 halocycloalkyl" is a cycloalkyl group having 3 to 6 carbon atoms substituted with the same or different 1 to 11 halogen atoms without particular limitation, for example: 1-fluorocyclopropyl, 2-fluorocyclopropyl, 2,2-difluorocyclopropyl, 2,2,3,3-tetrafluorocyclopropyl, 1-chlorocyclopropyl, 2-chlorocyclopropyl Group, 2,2-dichlorocyclopropyl, 2,2,3,3-tetrachlorocyclopropyl, 2,2-dibromocyclopropyl, 2,2-diiodocyclopropyl, 1-fluorocyclo Butyl, 2-fluorocyclobutyl, 3-fluorocyclobutyl, 3,3-difluorocyclobutyl, heptafluorocyclobutyl, 2-chlorocyclobutyl, 3-chlorocyclobutyl, 3,3 -Dichlorocyclobutyl, 3,3-dibromocyclobutyl, 3,3-diiodocyclobutyl, 1-fluorocyclopentyl, 2-fluorocyclopentyl, 3-fluorocyclopentyl, 2, 2-difluorocyclopentyl, 3,3-difluorocyclopentyl, nonafluorocyclopentyl, 2,2-dichlorocyclopentyl, 3,3-dichlorocyclopentyl, 2,2-dibromo Cyclopentyl, 3,3-dibromocyclopentyl, 2,2-diiodocyclopentyl, 3,3-diiodocyclopentyl, 1-fluorocyclohexyl, 2-fluorocyclohexyl, 3-fluorocyclo Hexyl, 4-fluorocyclohexyl, 2,2-difluorocyclohexyl, 3,3-difluorocyclohexyl, 4,4-difluorocyclohexyl, 1-chlorocyclohexyl, 2-chlorocyclohexyl, 3-chloro Cyclohexyl, 4-chlorocyclohexyl, 2,2-dichlorocyclohexyl, 3,3-dichlorocyclohexyl, 4,4-dichlorocyclohexyl, 3,3-dibromocyclohexyl, 4,4-di Groups such as bromocyclohexyl, 3,3-diiodocyclohexyl or 4,4-diiodocyclohexyl.

本發明中,「C3至C6鹵環烷基C1至C6烷基」在無特別限定下係表示鹵環烷基部分及烷基為上述意義的(C3至C6鹵環烷基)-(C1至C6烷基)-基,例如可舉:2,2-二氟環丙基甲基、2,2-二氯環丙基甲基、1-(2,2-二氟環丙基)乙基、2-(2,2-二氟環丙基)乙基、1-(2,2-二氯環丙基)乙基、2-(2,2-二氯環丙基)乙基、2-(2,2-二氟環丙基)丙基、3,3-二氟環丁基甲基、2,2,3,3-四氟環丁基甲基、2-(2,2,3,3-四氟環丁基)乙基、2-(3,3-二氟環丁基)乙基、2-(3,3-二氟環丁基)丙基、3,3-二氟環戊基甲基或2-(3,3-二氟環戊基)丙基等基。 In the present invention, "C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl" means a halocycloalkyl moiety and the alkyl group has the above meaning (C 3 to C 6 halocycloalkane) Group)-(C 1 to C 6 alkyl)- group, for example, 2,2-difluorocyclopropylmethyl, 2,2-dichlorocyclopropylmethyl, 1-(2,2- Difluorocyclopropyl)ethyl, 2-(2,2-difluorocyclopropyl)ethyl, 1-(2,2-dichlorocyclopropyl)ethyl, 2-(2,2-dichloro Cyclopropyl)ethyl, 2-(2,2-difluorocyclopropyl)propyl, 3,3-difluorocyclobutylmethyl, 2,2,3,3-tetrafluorocyclobutylmethyl, 2-( 2,2,3,3-tetrafluorocyclobutyl)ethyl, 2-(3,3-difluorocyclobutyl)ethyl, 2-(3,3-difluorocyclobutyl)propyl, 3 , 3-difluorocyclopentylmethyl or 2-(3,3-difluorocyclopentyl)propyl and other groups.

本發明中,「苯基C1至C3烷基」在無特別限定下係表示(苯基)-(C1至C3烷基),例如可舉:苄基、1-苯基乙基、2-苯基乙基或2-苯基丙基等基。 In the present invention, "phenyl C 1 to C 3 alkyl" means (phenyl)-(C 1 to C 3 alkyl) without limitation, for example, benzyl, 1-phenylethyl , 2-phenylethyl or 2-phenylpropyl and other groups.

本發明中,「苯基C1至C3鹵烷基」在無特別限定下係表示(苯基)-(C1至C3鹵烷基),例如可舉:2-苯基-2,2-二氟乙基等基。 In the present invention, "phenyl C 1 to C 3 haloalkyl" means (phenyl)-(C 1 to C 3 haloalkyl) without particular limitation, for example, 2-phenyl-2, 2-Difluoroethyl and other groups.

本發明中,「雜芳基」在無特別限定下係表示除碳原子之 外,具有1至6個選自氮原子、氧原子及硫原子中的雜原子的5員或6員的單環雜環,例如可舉:噻吩-2-基、噻吩-3-基、呋喃-2-基、呋喃-3-基、吡咯-1-基、吡咯-2-基、吡咯-3-基、

Figure 108126125-A0202-12-0028-110
唑-2-基、
Figure 108126125-A0202-12-0028-111
唑-4-基、
Figure 108126125-A0202-12-0028-112
唑-5-基、異
Figure 108126125-A0202-12-0028-113
唑-3-基、異
Figure 108126125-A0202-12-0028-114
唑-4-基、異
Figure 108126125-A0202-12-0028-115
唑-5-基、噻唑-2-基、噻唑-4-基、噻唑-5-基、異噻唑-3-基、異噻唑-4-基、異噻唑-5-基、咪唑-1-基、咪唑-2-基、咪唑-4-基、吡唑-1-基、吡唑-3-基、吡唑-4-基、吡唑-5-基、1,3,4-
Figure 108126125-A0202-12-0028-116
二唑-2-基、1,2,3-
Figure 108126125-A0202-12-0028-117
二唑-4-基、1,2,3-
Figure 108126125-A0202-12-0028-118
二唑-5-基、1,2,4-
Figure 108126125-A0202-12-0028-119
二唑-3-基、1,2,4-
Figure 108126125-A0202-12-0028-120
二唑-5-基、1,2,5-
Figure 108126125-A0202-12-0028-121
二唑-3-基、1,3,4-噻二唑-2-基、1,2,3-噻二唑-4-基、1,2,3-噻二唑-5-基、1,2,4-噻二唑-3-基、1,2,4-噻二唑-5-基、1,2,5-噻二唑-3-基、1,2,4-三唑-3-基、1,2,4-三唑-1-基、1,2,3-三唑-1-基、1,2,3-三唑-2-基、1,3,4-三唑-1-基、四唑-1-基、四唑-2-基、四唑-5-基、吡啶-2-基、吡啶-3-基、吡啶-4-基、嘧啶-2-基、嘧啶-4-基、嘧啶-5-基、嗒
Figure 108126125-A0202-12-0028-122
-3-基、嗒
Figure 108126125-A0202-12-0028-123
-4-基、吡
Figure 108126125-A0202-12-0028-124
-2-基、1,3,5-三
Figure 108126125-A0202-12-0028-125
-2-基等基。 In the present invention, "heteroaryl" refers to a 5-membered or 6-membered monocyclic ring having 1 to 6 heteroatoms selected from a nitrogen atom, an oxygen atom, and a sulfur atom, except for carbon atoms. Heterocycles include, for example, thiophen-2-yl, thiophen-3-yl, furan-2-yl, furan-3-yl, pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl,
Figure 108126125-A0202-12-0028-110
Oxazol-2-yl,
Figure 108126125-A0202-12-0028-111
Oxazol-4-yl,
Figure 108126125-A0202-12-0028-112
Oxazol-5-yl, iso
Figure 108126125-A0202-12-0028-113
Oxazol-3-yl, iso
Figure 108126125-A0202-12-0028-114
Oxazol-4-yl, iso
Figure 108126125-A0202-12-0028-115
Azole-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, imidazol-1-yl , Imidazol-2-yl, imidazol-4-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, 1,3,4-
Figure 108126125-A0202-12-0028-116
Diazol-2-yl, 1,2,3-
Figure 108126125-A0202-12-0028-117
Diazol-4-yl, 1,2,3-
Figure 108126125-A0202-12-0028-118
Diazol-5-yl, 1,2,4-
Figure 108126125-A0202-12-0028-119
Diazol-3-yl, 1,2,4-
Figure 108126125-A0202-12-0028-120
Diazol-5-yl, 1,2,5-
Figure 108126125-A0202-12-0028-121
Diazol-3-yl, 1,3,4-thiadiazol-2-yl, 1,2,3-thiadiazol-4-yl, 1,2,3-thiadiazol-5-yl, 1 ,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,2,5-thiadiazol-3-yl, 1,2,4-triazole- 3-yl, 1,2,4-triazol-1-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,3,4-tri Azole-1-yl, tetrazole-1-yl, tetrazole-2-yl, tetrazole-5-yl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, pyrimidin-2-yl , Pyrimidine-4-yl, pyrimidine-5-yl, ta
Figure 108126125-A0202-12-0028-122
-3-base, click
Figure 108126125-A0202-12-0028-123
-4-yl, pyridine
Figure 108126125-A0202-12-0028-124
-2-yl, 1,3,5-tri
Figure 108126125-A0202-12-0028-125
-2-yl and other groups.

本發明中,「雜芳基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述的意義相同的(雜芳基)-(C1至C3烷基),例如可舉:(吡啶-2-基)甲基、(吡啶-3-基)甲基、(吡啶-4-基)甲基、(噻唑-2-基)甲基、(噻唑-4-基)甲基、(噻唑-5-基)甲基、(吡唑-1-基)甲基、(吡唑-3-基)甲基、(吡唑-4-基)甲基或(吡唑-5-基)甲基等基。 In the present invention, "heteroaryl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above-mentioned (heteroaryl)-(C 1 to C 3 alkyl), unless otherwise specified. For example, (pyridin-2-yl)methyl, (pyridin-3-yl)methyl, (pyridin-4-yl)methyl, (thiazol-2-yl)methyl, (thiazol-4-yl )Methyl, (thiazol-5-yl)methyl, (pyrazol-1-yl)methyl, (pyrazol-3-yl)methyl, (pyrazol-4-yl)methyl or (pyrazole -5-yl)methyl and other groups.

本發明中,「雜芳基C1至C3鹵烷基」在無特別限定下係雜芳基部分為上述意義的(雜芳基)-(C1至C3鹵烷基),例如可舉:2-(吡啶-2-基)-2,2-二氟乙基、2-(吡啶-3-基)-2,2-二氟乙基等基。 In the present invention, the "heteroaryl C 1 to C 3 haloalkyl group" is a heteroaryl moiety which is (heteroaryl)-(C 1 to C 3 haloalkyl) of the above meaning without particular limitation, for example, Examples include groups such as 2-(pyridin-2-yl)-2,2-difluoroethyl and 2-(pyridin-3-yl)-2,2-difluoroethyl.

本發明中,「氰基C1至C6烷基」在無特別限定下係表示烷基 部分為上述意義的(氰基)-(C1至C6烷基),例如可舉:氰基甲基、1-氰基乙基、2-氰基乙基、1-氰基丙基、3-氰基丙基、2-氰基丙烷-2-基、1-氰基丁基、4-氰基丁基、5-氰基戊基或6-氰基己基等基。 In the present invention, “cyano C 1 to C 6 alkyl” means (cyano)-(C 1 to C 6 alkyl) of the above-mentioned meaning of the alkyl portion without particular limitation, for example, cyano Methyl, 1-cyanoethyl, 2-cyanoethyl, 1-cyanopropyl, 3-cyanopropyl, 2-cyanopropan-2-yl, 1-cyanobutyl, 4- Groups such as cyanobutyl, 5-cyanopentyl or 6-cyanohexyl.

本發明中,「氰基C3至C6環烷基」在無特別限定下係環烷基部分為上述意義的(氰基)-(C3至C6環烷基),例如可舉:1-氰基環丙基、2-氰基環丙基、1-氰基環丁基、3-氰基環丁基、1-氰基環戊基等基。 In the present invention, the "cyano C 3 to C 6 cycloalkyl group", unless otherwise specified, is a cycloalkyl moiety which is (cyano)-(C 3 to C 6 cycloalkyl) of the above meaning, for example: Groups such as 1-cyanocyclopropyl, 2-cyanocyclopropyl, 1-cyanocyclobutyl, 3-cyanocyclobutyl, 1-cyanocyclopentyl and the like.

本發明中,「C1至C6烷氧基羰基C3至C6環烷基」在無特別限定下係表示烷氧基羰基部分及環烷基部分為上述意義的(C1至C6烷氧基)-C(=O)-(C3至C6環烷基),例如可舉:1-甲氧基羰基環丙基、1-乙氧基羰基環丙基、1-正丙氧基羰基環丙基、2-甲氧基羰基環丙基等基。 In the present invention, "C 1 to C 6 alkoxycarbonyl C 3 to C 6 cycloalkyl" means that the alkoxycarbonyl moiety and the cycloalkyl moiety have the above meanings without limitation (C 1 to C 6 Alkoxy)-C(=O)-(C 3 to C 6 cycloalkyl), for example: 1-methoxycarbonylcyclopropyl, 1-ethoxycarbonylcyclopropyl, 1-n-propyl Groups such as oxycarbonylcyclopropyl, 2-methoxycarbonylcyclopropyl and the like.

本發明中,「羥基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(羥基)-(C1至C6烷基),例如可舉:羥甲基、1-羥乙基、2-羥乙基、1-羥丙基、2-羥丙基、3-羥丙基、1-羥丁基或4-羥丁基等基。 In the present invention, "hydroxy C 1 to C 6 alkyl" means that the alkyl portion is (hydroxy)-(C 1 to C 6 alkyl) in the above meaning without particular limitation, for example, hydroxymethyl, Groups such as 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxybutyl or 4-hydroxybutyl.

本發明中,「C1至C6烷氧基C1至C6烷基」在無特別限定下係烷氧基部分及烷基部分為上述意義的(C1至C6烷氧基)-(C1至C6烷基)-基,例如可舉:甲氧基甲基、1-甲氧基乙基、2-甲氧基乙基、2-乙氧基乙基、2-甲氧基丙基、3-甲氧基丙基、2-乙氧基丙基、3-乙氧基丙基、1-甲基-3-甲氧基丁基或3-丁氧基丁基等基。 In the present invention, "C 1 to C 6 alkoxy C 1 to C 6 alkyl" is an alkoxy moiety and an alkyl moiety having the above meaning (C 1 to C 6 alkoxy)- (C 1 to C 6 alkyl)-yl, for example, methoxymethyl, 1-methoxyethyl, 2-methoxyethyl, 2-ethoxyethyl, 2-methoxy Propyl, 3-methoxypropyl, 2-ethoxypropyl, 3-ethoxypropyl, 1-methyl-3-methoxybutyl or 3-butoxybutyl .

本發明中,「單(C1至C6烷基)胺基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-NH-基,例如可舉:甲基胺基、乙基胺基、正丙基胺基或異丙基胺基等基。 In the present invention, the "mono(C 1 to C 6 alkyl)amino group" is an (C 1 to C 6 alkyl)-NH- group having the above meaning unless otherwise specified. For example, a: Groups such as amino amine, ethyl amine, n-propyl amine or isopropyl amine.

本發明中,「二(C1至C6烷基)胺基」在無特別限定下係表 示烷基部分為上述意義的(C1至C6烷基)2-N-基,2個烷基亦可彼此相異,例如可舉:二甲基胺基、二乙基胺基或N-乙基-N-甲基胺基等基。 In the present invention, "di(C 1 to C 6 alkyl)amino group" means (C 1 to C 6 alkyl) 2 -N- group, two alkyl The groups may be different from each other, and examples include groups such as a dimethylamino group, a diethylamino group, and N-ethyl-N-methylamino group.

本發明中,「C1至C6烷基羰基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-C(=O)-基,例如可舉:乙醯基、丙醯基、2-甲基丙醯基、2,2-二甲基丙醯基、丁醯基、2-甲基丁醯基、3-甲基丁醯基、2-乙基丁醯基、2,2-二甲基丁醯基、2,3-二甲基丁醯基、3,3-二甲基丁醯基、戊醯基、2-甲基戊醯基、3-甲基戊醯基、4-甲基戊醯基或己醯基等基。 In the present invention, "C 1 to C 6 alkylcarbonyl" means (C 1 to C 6 alkyl)-C(=O)- group in which the alkyl part has the above meaning unless otherwise specified, for example: Ethyl, propyl, 2-methyl propyl, 2,2-dimethyl propyl, butyl acetyl, 2-methyl butyl acetyl, 3-methyl butyl acetyl, 2-ethyl butyl acetyl, 2,2 -Dimethylbutylamide, 2,3-dimethylbutylamide, 3,3-dimethylbutylamide, pentylamide, 2-methylpentylamide, 3-methylpentylamide, 4-methylpentylamide Radicals or acetylene radicals.

本發明中,「C1至C6烷氧基C1至C6烷基羰基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-O-(C1至C6烷基)-C(=O)-基,例如可舉:甲氧基乙醯基、乙氧基乙醯基、丙氧基乙醯基、異丙氧基乙醯基、丁氧基乙醯基、2-甲氧基丙醯基、3-甲氧基丙醯基、2-乙氧基丙醯基、3-乙氧基丙醯基、2-甲氧基丁醯基、4-甲氧基丁醯基、2-甲氧基戊醯基或5-甲氧基戊醯基等基。 In the present invention, "C 1 to C 6 alkoxy C 1 to C 6 alkylcarbonyl" is an alkyl portion of the above meaning (C 1 to C 6 alkyl)-O-(C 1 without limitation) To C 6 alkyl)-C(=O)- group, for example: methoxyethoxyacetyl, ethoxyethoxy, propoxyethoxy, isopropoxyethoxy, butoxy Ethyl acetyl group, 2-methoxy propyl group, 3-methoxy propyl group, 2-ethoxy propyl group, 3-ethoxy propyl group, 2-methoxy butyl group, 4- Groups such as methoxybutyralyl, 2-methoxypentyl, or 5-methoxypentyl.

本發明中,「C3至C6環烷基羰基」在無特別限定下係環烷基部分為上述意義的(C3至C6環烷基)-C(=O)-基,例如可舉:環丙烷基羰基、環丁烷基羰基、環戊烷基羰基或環己烷基羰基等基。 In the present invention, the "C 3 to C 6 cycloalkylcarbonyl group" is a (C 3 to C 6 cycloalkyl)-C(=O)- group in the above meaning unless otherwise specified. Examples include groups such as cyclopropanylcarbonyl, cyclobutanylcarbonyl, cyclopentylcarbonyl or cyclohexanecarbonyl.

本發明中,「C3至C6環烷基C1至C6烷基羰基」在無特別限定下係環烷基部分為上述意義的(C3至C6環烷基C1至C6烷基)-C(=O)-基,例如可舉:2-環丙基乙醯基、2-環丁基乙醯基、2-環戊基乙醯基、2-環己基乙醯基、2-環丙基丙醯基或2-環丙基丁醯基等基。 In the present invention, "C 3 to C 6 cycloalkyl C 1 to C 6 alkylcarbonyl" is a cycloalkyl moiety of the above meaning without particular limitation (C 3 to C 6 cycloalkyl C 1 to C 6 Alkyl)-C(=O)-yl, for example: 2-cyclopropylacetyl, 2-cyclobutylacetyl, 2-cyclopentylethyl, 2-cyclohexylacetyl , 2-cyclopropylpropionyl or 2-cyclopropylbutyryl and other groups.

本發明中,「C1至C6烷氧基羰基」在無特別限定下係烷氧基部分為上述意義的(C1至C6烷氧基)-C(=O)-基,例如可舉:甲氧基羰 基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、正丁氧基羰基、異丁氧基羰基、第二丁氧基羰基、第三丁氧基羰基、正戊氧基羰基、1-甲基丁氧基羰基、2-甲基丁氧基羰基、3-甲基丁氧基羰基、1-乙基丙氧基羰基、1,1-二甲基丙氧基羰基、1,2-二甲基丙氧基羰基或2,2-二甲基丙氧基羰基等基。 In the present invention, the "C 1 to C 6 alkoxycarbonyl group" is an alkoxy moiety which is (C 1 to C 6 alkoxy)-C(=O)- group in the above meaning without particular limitation, for example, Examples: methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, second butoxycarbonyl, third butoxycarbonyl, N-pentyloxycarbonyl, 1-methylbutoxycarbonyl, 2-methylbutoxycarbonyl, 3-methylbutoxycarbonyl, 1-ethylpropoxycarbonyl, 1,1-dimethylpropane Groups such as oxycarbonyl, 1,2-dimethylpropoxycarbonyl or 2,2-dimethylpropoxycarbonyl.

本發明中,「單(C1至C6烷基)胺基羰基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-NH-C(=O)-基,例如可舉:甲基胺基羰基、乙基胺基羰基、正丙基胺基羰基、異丙基胺基羰基、正丁基胺基羰基、異丁基胺基羰基、第二丁基胺基羰基、第三丁基胺基羰基、正戊基胺基羰基、1-甲基丁基胺基羰基、2-甲基丁基胺基羰基、3-甲基丁基胺基羰基、1-乙基丙基胺基羰基、1,1-二甲基丙基胺基羰基、1,2-二甲基丙基胺基羰基、2,2-二甲基丙基胺基羰基或正己基胺基羰基等基。 In the present invention, "mono(C 1 to C 6 alkyl)aminocarbonyl" is an alkyl moiety of the above meaning (C 1 to C 6 alkyl)-NH-C(=O)- Examples include methylaminocarbonyl, ethylaminocarbonyl, n-propylaminocarbonyl, isopropylaminocarbonyl, n-butylaminocarbonyl, isobutylaminocarbonyl, and second butyl Aminocarbonyl, third butylaminocarbonyl, n-pentylaminocarbonyl, 1-methylbutylaminocarbonyl, 2-methylbutylaminocarbonyl, 3-methylbutylaminocarbonyl, 1 -Ethylpropylaminocarbonyl, 1,1-dimethylpropylaminocarbonyl, 1,2-dimethylpropylaminocarbonyl, 2,2-dimethylpropylaminocarbonyl or n-hexyl Aminocarbonyl and other groups.

本發明中,「二(C1至C6烷基)胺基羰基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)2N-C(=O)-基,2個烷基亦可彼此相異,例如可舉:二甲基胺基羰基、二乙基胺基羰基、二(正丙基)胺基羰基、二異丙基胺基羰基、二丁基胺基羰基、N-乙基-N-甲基胺基羰基、N-甲基-N-丙基胺基羰基、N-異丙基-N-甲基胺基羰基、N-丁基-N-甲基胺基羰基、N-(第二丁基)-N-甲基胺基羰基、N-異丁基-N-甲基胺基羰基、N-戊基-N-甲基胺基羰基、N-乙基-N-丙基胺基羰基、N-乙基-N-異丙基胺基羰基或N-乙基-N-丁基胺基羰基等基。 In the present invention, the "di(C 1 to C 6 alkyl)aminocarbonyl group" is an (C 1 to C 6 alkyl) 2 NC(=O)- group in the above sense, unless otherwise specified. Two alkyl groups may also be different from each other, for example: dimethylaminocarbonyl, diethylaminocarbonyl, di(n-propyl)aminocarbonyl, diisopropylaminocarbonyl, dibutylamine Carbonyl, N-ethyl-N-methylaminocarbonyl, N-methyl-N-propylaminocarbonyl, N-isopropyl-N-methylaminocarbonyl, N-butyl-N- Methylaminocarbonyl, N-(second butyl)-N-methylaminocarbonyl, N-isobutyl-N-methylaminocarbonyl, N-pentyl-N-methylaminocarbonyl, Groups such as N-ethyl-N-propylaminocarbonyl, N-ethyl-N-isopropylaminocarbonyl, or N-ethyl-N-butylaminocarbonyl.

本發明中,「C1至C6烷氧基羰基C1至C6烷基胺基」在無特別限定下係例如可舉:甲氧基羰基甲基胺基、乙氧基羰基甲基胺基、第三丁氧基羰基甲基胺基或1-[1-(第三丁氧基羰基)乙基]胺基等基。 In the present invention, "C 1 to C 6 alkoxycarbonyl C 1 to C 6 alkylamine" is not particularly limited, and examples thereof include: methoxycarbonylmethylamine, ethoxycarbonylmethylamine Group, third butoxycarbonylmethylamine group or 1-[1-(third butoxycarbonyl)ethyl]amine group and other groups.

本發明中,「單(C1至C6烷氧基羰基)胺基」在無特別限定 下係例如可舉:甲氧基羰基胺基、乙氧基羰基胺基、異丙氧基羰基胺基、第三丁氧基羰基胺基或異丁氧基羰基胺基等基。 In the present invention, the "mono(C 1 to C 6 alkoxycarbonyl) amine group" is not particularly limited, and examples thereof include: methoxycarbonylamino group, ethoxycarbonylamino group, isopropoxycarbonylamine Group, a third butoxycarbonylamino group or an isobutoxycarbonylamino group.

本發明中,「(C1至C6烷基硫基)羰基」在無特別限定下係表示烷基硫基部分為上述意義的(C1至C6烷基硫基)-C(=O)-基,例如可舉:甲基硫基羰基、乙基硫基羰基或異丙基硫基羰基等基。 In the present invention, "(C 1 to C 6 alkylthio)carbonyl" means (C 1 to C 6 alkylthio)-C(=O )- group, for example, a group such as methylthiocarbonyl, ethylthiocarbonyl, or isopropylthiocarbonyl.

本發明中,「(C1至C6烷基)硫基羰基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-C(=S)-基,例如可舉:甲基硫基羰基、乙基硫基羰基、正丙基硫基羰基、異丙基硫基羰基、正丁基硫基羰基、異丁基硫基羰基、第二丁基硫基羰基、第三丁基硫基羰基或正戊基硫基羰基等基。 In the present invention, "(C 1 to C 6 alkyl)thiocarbonyl" means that the alkyl portion is a (C 1 to C 6 alkyl)-C(=S)- group in the above meaning, without particular limitation, Examples include methylthiocarbonyl, ethylthiocarbonyl, n-propylthiocarbonyl, isopropylthiocarbonyl, n-butylthiocarbonyl, isobutylthiocarbonyl, and second butylthio Groups such as carbonyl, tert-butylthiocarbonyl or n-pentylthiocarbonyl.

本發明中,「(C1至C6烷氧基)硫基羰基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-O-C(=S)-基,例如可舉:甲氧基硫基羰基、乙氧基硫基羰基、正丙氧基硫基羰基、異丙氧基硫基羰基、正丁氧基硫基羰基、異丁氧基硫基羰基、第二丁氧基硫基羰基、第三丁氧基硫基羰基、正戊氧基硫基羰基、1-甲基丁氧基硫基羰基、2-甲基丁氧基硫基羰基、3-甲基丁氧基硫基羰基、1-乙基丙氧基硫基羰基、1,1-二甲基丙氧基硫基羰基、1,2-二甲基丙氧基硫基羰基或2,2-二甲基丙氧基硫基羰基等基。 In the present invention, "(C 1 to C 6 alkoxy)thiocarbonyl" refers to (C 1 to C 6 alkyl)-OC(=S)- group in which the alkyl portion has the above meaning unless otherwise specified. , For example: methoxythiocarbonyl, ethoxythiocarbonyl, n-propoxythiocarbonyl, isopropoxythiocarbonyl, n-butoxythiocarbonyl, isobutoxythiocarbonyl , Second butoxythiocarbonyl, third butoxythiocarbonyl, n-pentyloxythiocarbonyl, 1-methylbutoxythiocarbonyl, 2-methylbutoxythiocarbonyl, 3 -Methylbutoxythiocarbonyl, 1-ethylpropoxythiocarbonyl, 1,1-dimethylpropoxythiocarbonyl, 1,2-dimethylpropoxythiocarbonyl or 2 , 2-dimethylpropoxythiocarbonyl and other groups.

本發明中,「單(C1至C6烷基)胺基硫基羰基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-NH-C(=S)-基,例如可舉:甲基胺基硫基羰基、乙基胺基硫基羰基、正丙基胺基硫基羰基、異丙基胺基硫基羰基、正丁基胺基硫基羰基、異丁基胺基硫基羰基、第二丁基胺基硫基羰基、第三丁基胺基硫基羰基、正戊基胺基硫基羰基、1-甲 基丁基胺基硫基羰基、2-甲基丁基胺基硫基羰基、3-甲基丁基胺基硫基羰基、1-乙基丙基胺基硫基羰基、1,1-二甲基丙基胺基硫基羰基、1,2-二甲基丙基胺基硫基羰基、2,2-二甲基丙基胺基硫基羰基或正己基胺基硫基羰基等基。 In the present invention, "mono(C 1 to C 6 alkyl)aminothiocarbonyl" means (C 1 to C 6 alkyl)-NH-C(= S)- group, for example, methylaminothiocarbonyl, ethylaminothiocarbonyl, n-propylaminothiocarbonyl, isopropylaminothiocarbonyl, n-butylaminothio Carbonyl, isobutylaminothiocarbonyl, second butylaminothiocarbonyl, third butylaminothiocarbonyl, n-pentylaminothiocarbonyl, 1-methylbutylaminothio Carbonyl, 2-methylbutylaminothiocarbonyl, 3-methylbutylaminothiocarbonyl, 1-ethylpropylaminothiocarbonyl, 1,1-dimethylpropylaminothio Groups such as carbonylcarbonyl, 1,2-dimethylpropylaminothiocarbonyl, 2,2-dimethylpropylaminothiocarbonyl or n-hexylaminothiocarbonyl.

本發明中,「二(C1至C6烷基)胺基硫基羰基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)2-N-C(=S)-基,2個烷基亦可彼此相異,例如可舉:二甲基胺基硫基羰基、二乙胺基硫基羰基、二(正丙基)胺基硫基羰基、二異丙胺基硫基羰基、二丁基胺基硫基羰基、N-乙基-N-甲基胺基硫基羰基、N-甲基-N-丙基胺基硫基羰基、N-異丙基-N-甲基胺基硫基羰基、N-丁基-N-甲基胺基硫基羰基、N-(第二丁基)-N-甲基胺基硫基羰基、N-異丁基-N-甲基胺基硫基羰基、N-戊基-N-甲基胺基硫基羰基、N-乙基-N-丙基胺基硫基羰基、N-乙基-N-異丙基胺基硫基羰基或N-乙基-N-丁基胺基硫基羰基等基。 In the present invention, “di(C 1 to C 6 alkyl)aminothiocarbonyl” means (C 1 to C 6 alkyl) 2 -NC(=S )- group, two alkyl groups may also be different from each other, for example: dimethylaminothiocarbonyl, diethylaminothiocarbonyl, di(n-propyl)aminothiocarbonyl, diisopropylamine Thiocarbonyl, dibutylaminothiocarbonyl, N-ethyl-N-methylaminothiocarbonyl, N-methyl-N-propylaminothiocarbonyl, N-isopropyl- N-methylaminothiocarbonyl, N-butyl-N-methylaminothiocarbonyl, N-(second butyl)-N-methylaminothiocarbonyl, N-isobutyl- N-methylaminothiocarbonyl, N-pentyl-N-methylaminothiocarbonyl, N-ethyl-N-propylaminothiocarbonyl, N-ethyl-N-isopropyl Groups such as aminothiocarbonyl or N-ethyl-N-butylaminothiocarbonyl.

本發明中,「C1至C6烷基磺醯基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-S(=O)2-基,例如可舉:甲基磺醯基、乙基磺醯基、正丙基磺醯基、異丙基磺醯基、正丁基磺醯基、異丁基磺醯基、第二丁基磺醯基或第三丁基磺醯基等基。 In the present invention, "C 1 to C 6 alkylsulfonyl" means that the alkyl portion is a (C 1 to C 6 alkyl)-S(=O) 2 -group having the above meaning without limitation, for example Mentioned: methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, second butylsulfonyl Or tertiary butylsulfonyl and other groups.

本發明中,「C1至C6鹵烷基磺醯基」在無特別限定下係表示鹵烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)2-基,例如可舉:二氟甲基磺醯基、三氟甲基磺醯基、三氯甲基磺醯基、2,2,2-三氟乙基磺醯基、五氟乙基磺醯基、3,3,3-三氟丙基磺醯基、七氟丙基磺醯基、或七氟-2-丙基磺醯基等基。 In the present invention, "C 1 to C 6 haloalkylsulfonyl" means (C 1 to C 6 haloalkyl)-S(=O) 2- Examples include difluoromethylsulfonyl, trifluoromethylsulfonyl, trichloromethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, pentafluoroethylsulfonyl Group, 3,3,3-trifluoropropylsulfonyl, heptafluoropropylsulfonyl, or heptafluoro-2-propylsulfonyl and other groups.

本發明中,「單(C1至C6烷基)胺基磺醯基」在無特別限定 下係表示烷基部分為上述意義的(C1至C6烷基)-NH-S(=O)-基,例如可舉:甲基胺基磺醯基、乙基胺基磺醯基、正丙基胺基磺醯基、異丙基胺基磺醯基、正丁基胺基磺醯基、異丁基胺基磺醯基、第二丁基胺基磺醯基、第三丁基胺基磺醯基、正戊基胺基磺醯基、1-甲基丁基胺基磺醯基、2-甲基丁基胺基磺醯基、3-甲基丁基胺基磺醯基、1-乙基丙基胺基磺醯基、1,1-二甲基丙基胺基磺醯基、1,2-二甲基丙基胺基磺醯基、2,2-二甲基丙基胺基磺醯基或正己基胺基磺醯基等基。 In the present invention, "mono(C 1 to C 6 alkyl)aminosulfonyl" means (C 1 to C 6 alkyl)-NH-S(= O)- group, for example: methylaminosulfonyl, ethylaminosulfonyl, n-propylaminosulfonyl, isopropylaminosulfonyl, n-butylaminosulfonyl Group, isobutylaminosulfonyl, second butylaminosulfonyl, third butylaminosulfonyl, n-pentylaminosulfonyl, 1-methylbutylaminosulfonyl Group, 2-methylbutylaminosulfonamide, 3-methylbutylaminosulfonamide, 1-ethylpropylaminosulfonamide, 1,1-dimethylpropylsulfonamide Acyl, 1,2-dimethylpropylaminosulfonyl, 2,2-dimethylpropylaminosulfonyl, or n-hexylaminosulfonyl and other groups.

本發明中,「二(C1至C6烷基)胺基磺醯基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)2-N-S(=O)2-基,2個烷基亦可彼此相異,例如可舉:二甲基胺基磺醯基、二乙基胺基磺醯基、二(正丙基胺基磺醯基)、二異丙基胺基磺醯基、二丁基胺基磺醯基、N-乙基-N-甲基胺基磺醯基、N-甲基-N-丙基胺基磺醯基、N-異丙基-N-甲基胺基磺醯基、N-丁基-N-甲基胺基磺醯基、N-(第二丁基)-N-甲基胺基磺醯基、N-異丁基-N-甲基胺基磺醯基、N-戊基-N-甲基胺基磺醯基、N-乙基-N-丙基胺磺羰基、N-乙基-N-異丙基胺磺羰基或N-乙基-N-丁基胺基磺醯基等基。 In the present invention, "di(C 1 to C 6 alkyl)aminosulfonyl" means that (C 1 to C 6 alkyl) 2 -NS(=O ) 2 -group, two alkyl groups may also be different from each other, for example: dimethylaminosulfonyl, diethylaminosulfonyl, bis (n-propylaminosulfonyl), di Isopropylaminosulfonyl, dibutylaminosulfonyl, N-ethyl-N-methylaminosulfonyl, N-methyl-N-propylaminosulfonyl, N- Isopropyl-N-methylaminosulfonyl, N-butyl-N-methylaminosulfonyl, N-(second butyl)-N-methylaminosulfonyl, N- Isobutyl-N-methylaminosulfonamide, N-pentyl-N-methylaminosulfonamide, N-ethyl-N-propylsulfonamide, N-ethyl-N-iso Groups such as propylsulfamoylcarbonyl or N-ethyl-N-butylaminosulfamoyl.

本發明中,「C1至C6烷氧基羰基C1至C6烷基」在無特別限定下係烷氧基部分及烷基部分為上述意義的(C1至C6烷氧基)-C(=O)-(C1至C6烷基)-基,例如可舉:甲氧基羰基甲基、乙氧基羰基甲基、正丙氧基羰基甲基、異丙氧基羰基甲基、第三丁氧基羰基甲基、1-(甲氧基羰基)乙基、2-(甲氧基羰基)乙基、1-(乙氧基羰基)乙基、2-(乙氧基羰基)乙基、1-(甲氧基羰基)-1-甲基乙基、1-(乙氧基羰基)-1-甲基乙基、或2-(第三丁氧基羰基)乙基等基。 In the present invention, "C 1 to C 6 alkoxycarbonyl C 1 to C 6 alkyl" is an alkoxy moiety and an alkyl moiety having the above meaning (C 1 to C 6 alkoxy) unless otherwise specified. -C(=O)-(C 1 to C 6 alkyl)- group, for example: methoxycarbonylmethyl, ethoxycarbonylmethyl, n-propoxycarbonylmethyl, isopropoxycarbonyl Methyl, third butoxycarbonylmethyl, 1-(methoxycarbonyl)ethyl, 2-(methoxycarbonyl)ethyl, 1-(ethoxycarbonyl)ethyl, 2-(ethoxy Carbonyl)ethyl, 1-(methoxycarbonyl)-1-methylethyl, 1-(ethoxycarbonyl)-1-methylethyl, or 2-(third butoxycarbonyl)ethyl基等基。 Base and other base.

本發明中,「胺基羰基C1至C6烷基」在無特別限定下係表示烷基部分是上述意義的H2N-C(=O)-(C1至C6烷基)-基,例如可舉:胺甲醯基甲基、1-胺甲醯基乙基、2-胺甲醯基乙基等基。 In the present invention, "aminocarbonyl C 1 to C 6 alkyl" means an H 2 NC(=O)-(C 1 to C 6 alkyl)- group, the alkyl part of which is the above-mentioned meaning, without particular limitation, For example, groups such as carbamoylmethyl, 1-aminomethylethyl, and 2-aminomethylethyl may be mentioned.

本發明中,「單(C1至C6烷基)胺基羰基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-NH-C(=O)-(C1至C6烷基)-基,例如可舉:N-甲基胺甲醯基甲基、N-乙基胺甲醯基甲基或N-(第三丁基)胺甲醯基甲基等基。 In the present invention, "mono(C 1 to C 6 alkyl)aminocarbonyl C 1 to C 6 alkyl" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl) without limitation. NH-C(=O)-(C 1 to C 6 alkyl)- group, for example, N-methylaminomethylamide, N-ethylaminemethylamide or N-(section Tributyl) amine methylmethyl and other groups.

本發明中,「單(C3至C6環烷基)胺基羰基C1至C6烷基」在無特別限定下係環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-NH-C(=O)-(C1至C6烷基)-基,例如可舉:N-環丙基胺甲醯基甲基、N-環丁基胺甲醯基甲基、N-環戊基胺甲醯基甲基或N-環己基胺甲醯基甲基等基。 In the present invention, "mono(C 3 to C 6 cycloalkyl)aminocarbonyl C 1 to C 6 alkyl" is a cycloalkyl moiety and an alkyl moiety having the above meanings (C 3 to C without limitation) 6 cycloalkyl)-NH-C(=O)-(C 1 to C 6 alkyl)- group, for example: N-cyclopropylamine methylamide, N-cyclobutylamine methylamide Groups such as methyl, N-cyclopentylamine, methylmethyl or N-cyclohexylamine, methylmethyl.

本發明中,「單(C3至C6鹵環烷基)胺基羰基C1至C6烷基」在無特別限定下係鹵環烷基部分及烷基部分為上述意義的(C3至C6鹵環烷基)-NH-C(=O)-(C1至C6烷基)-基,例如可舉:N-(2,2-二氟環丙基)胺甲醯基甲基等基。 In the present invention, "mono(C 3 to C 6 halocycloalkyl)aminocarbonyl C 1 to C 6 alkyl" is a halocycloalkyl moiety and an alkyl moiety of the above meaning (C 3 without limitation) To C 6 halocycloalkyl)-NH-C(=O)-(C 1 to C 6 alkyl)- group, for example: N-(2,2-difluorocyclopropyl)aminecarboxamide Methyl and other groups.

本發明中,「單(C1至C6鹵烷基)胺基羰基C1至C6烷基」在無特別限定下係鹵烷基部分為上述意義的(C1至C6鹵烷基)-NH-C(=O)-(C1至C6烷基)-基,例如可舉:N-(2,2-二氟乙基)胺甲醯基甲基、N-(2,2,2-三氟乙基)胺甲醯基甲基、1-{N-(2,2-二氟乙基)胺甲醯基}乙基、1-{N-(2,2-三氟乙基)胺甲醯基]}乙基、1-{N-(2,2-二氟乙基)胺甲醯基}-1-甲基乙基或1-{N-(2,2-三氟乙基)胺甲醯基}-1-甲基乙基等基。 In the present invention, "mono(C 1 to C 6 haloalkyl)aminocarbonyl C 1 to C 6 alkyl" is a haloalkyl moiety of the above meaning (C 1 to C 6 haloalkyl) without particular limitation )-NH-C(=O)-(C 1 to C 6 alkyl)-yl, for example: N-(2,2-difluoroethyl)amine methylmethyl, N-(2, 2,2-trifluoroethyl)aminomethanylmethyl, 1-{N-(2,2-difluoroethyl)aminomethanyl}ethyl, 1-{N-(2,2-tri (Fluoroethyl)aminecarboxamide]}ethyl, 1-{N-(2,2-difluoroethyl)aminecarboxamide}-1-methylethyl or 1-{N-(2,2 -Trifluoroethyl) amine formyl}-1-methylethyl and other groups.

本發明中,「二(C1至C6烷基)胺基羰基C1至C6烷基」在無 特別限定下係表示烷基部分為上述意義的(C1至C6烷基)2-N-C(=O)-(C1至C6烷基)-基,2個烷基亦可彼此相異,例如可舉:N,N-二甲基胺甲醯基甲基、N,N-二乙基胺甲醯基甲基、N,N-二丙基胺甲醯基甲基、N-乙基-N-甲基胺甲醯基甲基、N-甲基-N-丙基胺甲醯基甲基等基。 In the present invention, "di(C 1 to C 6 alkyl)aminocarbonyl C 1 to C 6 alkyl" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl) 2 without particular limitation. -NC(=O)-(C 1 to C 6 alkyl)- group, the two alkyl groups may also be different from each other, for example: N,N-dimethylamine, methyl amide, N,N -Diethylamine methylamide, N,N-dipropylamine methylmethyl, N-ethyl-N-methylamine methylmethyl, N-methyl-N-propyl Aminomethyl and other groups.

本發明中,「C1至C6烷基羰基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-C(=O)-(C1至C6烷基),例如可舉:丙酮基、丙醯基甲基、2-甲基丙醯基甲基、三甲基乙醯基(pivaloyl)甲基、2-乙醯基乙基、2-丙醯基乙基、2(2-甲基丙醯基)乙基、2-三甲基乙醯基乙基、3-乙醯基丙基、3-丙醯基丙基、3(2-甲基丙醯基)丙基或3-三甲基乙醯基丙基等基。 In the present invention, "C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl)-C(=O), without particular limitation -(C 1 to C 6 alkyl), for example, acetone, propionylmethyl, 2-methylpropionylmethyl, trimethylpivaloylmethyl, 2-acetoyl Ethyl, 2-propionylethyl, 2(2-methylpropanyl)ethyl, 2-trimethylethenylethyl, 3-ethenylpropyl, 3-propenylpropyl Radicals, 3(2-methylpropionyl)propyl or 3-trimethylacetopropyl and other groups.

本發明中,「C1至C6鹵烷基羰基C1至C6烷基」在無特別限定下係鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-C(=O)-(C1至C6烷基),例如可舉:2-側氧基-3,3-二氟丙基、3-氯-2-側氧基-3,3-二氟丙基、2-側氧基-3,3,3-三氟丙基、3-側氧基-4,4-二氟丁基、4-氯-3-側氧基-4,4-二氟丁基、3-側氧基-4,4,4-三氟丁基、3-側氧基-4,4,5,5,5-五氟戊基、4-側氧基-5,5,5-三氟戊基或4-側氧基-5,5,6,6,6-五氟己基等基。 In the present invention, "C 1 to C 6 haloalkylcarbonyl C 1 to C 6 alkyl" is a haloalkyl moiety and an alkyl moiety having the above-mentioned meanings (C 1 to C 6 haloalkyl) unless otherwise specified. -C(=O)-(C 1 to C 6 alkyl), for example: 2-oxo-3,3-difluoropropyl, 3-chloro-2-oxo-3,3- Difluoropropyl, 2-oxo-3,3,3-trifluoropropyl, 3-oxo-4,4-difluorobutyl, 4-chloro-3-oxo-4,4 -Difluorobutyl, 3-oxo-4,4,4-trifluorobutyl, 3-oxo-4,4,5,5,5-pentafluoropentyl, 4-oxo- 5,5,5-trifluoropentyl or 4-oxo-5,5,6,6,6-pentafluorohexyl and other groups.

本發明中,「羥基亞胺基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的HO-N=(C1至C6烷基),例如可舉:1-(羥基亞胺基)乙基、2-(羥基亞胺基)乙基、1-(羥基亞胺基)丙基、2-(羥基亞胺基)丙基或3-(羥基亞胺基)丙基等基。 In the present invention, “hydroxyimino group C 1 to C 6 alkyl group” means, without particular limitation, that the alkyl part has the above meaning HO-N=(C 1 to C 6 alkyl group), for example: 1 -(Hydroxyimino)ethyl, 2-(hydroxyimino)ethyl, 1-(hydroxyimino)propyl, 2-(hydroxyimino)propyl or 3-(hydroxyimino) ) Propyl and other groups.

本發明中,「C1至C6烷氧基亞胺基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-O-N=C-基,例如可舉:甲氧基亞胺基、乙氧基亞胺基或異丙氧基亞胺基等基。 In the present invention, "C 1 to C 6 alkoxyimino group" means that (C 1 to C 6 alkyl)-ON=C- group whose alkyl portion has the above meaning without particular limitation, for example, : Methoxyimino, ethoxyimino or isopropoxyimino and other groups.

本發明中,「C1至C6烷氧基亞胺基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-O-N=(C1至C6烷基),例如可舉:1-(甲氧基亞胺基)乙基、2-(甲氧基亞胺基)乙基、1-(甲氧基亞胺基)丙基、2-(甲氧基亞胺基)丙基、3-(甲氧基亞胺基)丙基、1-(乙氧基亞胺基)乙基、2-(乙氧基亞胺基)乙基、1-(乙氧基亞胺基)丙基、2-(乙氧基亞胺基)丙基、3-(乙氧基亞胺基)丙基、1-(異丙氧基亞胺基)乙基或2-(異丙氧基亞胺基)乙基等基。 In the present invention, "C 1 to C 6 alkoxyimino group C 1 to C 6 alkyl group" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl group) -ON= (C 1 to C 6 alkyl), for example: 1-(methoxyimino)ethyl, 2-(methoxyimino)ethyl, 1-(methoxyimino) Propyl, 2-(methoxyimino)propyl, 3-(methoxyimino)propyl, 1-(ethoxyimino)ethyl, 2-(ethoxyimino) Group) ethyl, 1-(ethoxyimino)propyl, 2-(ethoxyimino)propyl, 3-(ethoxyimino)propyl, 1-(isopropoxy Groups such as imino)ethyl or 2-(isopropoxyimino)ethyl.

本發明中,「C1至C6鹵烷氧基亞胺基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(C1至C6鹵烷基)-O-N=(C1至C6烷基),例如可舉:2-(2,2-二氟乙氧基亞胺基)乙基、2-(2,2,2-三氟乙氧基亞胺基)乙基、2-(2,2,2-三氟乙氧基亞胺基)丙基或3-(2,2,2-三氟乙氧基亞胺基)丙基等基。 In the present invention, "C 1 to C 6 haloalkoxyimino group C 1 to C 6 alkyl group" means, without particular limitation, that the alkyl portion has the above meaning (C 1 to C 6 haloalkyl group)- ON=(C 1 to C 6 alkyl), for example: 2-(2,2-difluoroethoxyimino)ethyl, 2-(2,2,2-trifluoroethoxyimino Amino)ethyl, 2-(2,2,2-trifluoroethoxyiminoimino)propyl or 3-(2,2,2-trifluoroethoxyiminoimino)propyl and other groups.

本發明中,「雜環烷基」在無特別限定下係表示除了碳原子以外含有1個以上選自氧原子、氮原子、硫原子的原子之3員至6員的飽和雜環,例如可舉:氧雜環丁烷-2-基、氧雜環丁烷-3-基、四氫呋喃-2-基、四氫呋喃-3-基、四氫吡喃-2-基、四氫吡喃-3-基或四氫吡喃-4-基等基。 In the present invention, "heterocycloalkyl" means a saturated heterocyclic ring having 3 to 6 members including at least one atom selected from an oxygen atom, a nitrogen atom, and a sulfur atom in addition to a carbon atom, for example, Examples: oxetane-2-yl, oxetane-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl Radicals or tetrahydropyran-4-yl and other radicals.

本發明中,「雜環烷基C1至C6烷基」在無特別限定下係表示雜環烷基部分及烷基部分為上述意義的(C3至C6雜環烷基)-(C1至C6烷基),例如可舉:(氧雜環丁烷-3-基)甲基、(四氫呋喃-2-基)甲基、(四氫呋喃-3-基)甲基、(四氫吡喃-2-基)甲基、(四氫吡喃-3-基)甲基或(四氫吡喃-4-基)甲基等基。 In the present invention, "heterocyclic alkyl C 1 to C 6 alkyl" means a heterocyclic alkyl moiety and the alkyl moiety is (C 3 to C 6 heterocycloalkyl)-( C 1 to C 6 alkyl), for example: (oxetan-3-yl)methyl, (tetrahydrofuran-2-yl)methyl, (tetrahydrofuran-3-yl)methyl, (tetrahydro Groups such as pyran-2-yl)methyl, (tetrahydropyran-3-yl)methyl or (tetrahydropyran-4-yl)methyl.

本發明中,「C1至C6烷基硫基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)-S-基,例如可舉:甲基硫基、乙基硫 基、正丙基硫基、異丙基硫基、正丁基硫基、異丁基硫基、第二丁基硫基或第三丁基硫基等基。 In the present invention, "C 1 to C 6 alkylthio group" means (C 1 to C 6 alkyl)-S- group whose alkyl portion has the above-mentioned meaning, without particular limitation, for example, methylsulfide Group, ethylthio group, n-propylthio group, isopropylthio group, n-butylthio group, isobutylthio group, second butylthio group or third butylthio group.

本發明中,「C1至C6烷基亞磺醯基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-S(=O)-基,例如可舉:甲基亞磺醯基、乙基亞磺醯基、正丙基亞磺醯基、異丙基亞磺醯基、正丁基亞磺醯基、異丁基亞磺醯基、第二丁基亞磺醯基或第三丁基亞磺醯基等基。 In the present invention, the "C 1 to C 6 alkylsulfinyl" group is an (C 1 to C 6 alkyl)-S(=O)- group in the above meaning unless otherwise specified. For example, Examples: methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, second Groups such as butylsulfinyl or tertiary butylsulfinyl.

本發明中,「C1至C6鹵烷氧基C1至C6烷基」在無特別限定下係鹵烷氧基部分為上述意義的(C1至C6鹵烷氧基)-(C1至C6烷基)-基,例如可舉:2-(二氟甲氧基)乙基、2-(三氟甲氧基)乙基、2-(2,2-二氟乙氧基)乙基或2-(2,2,2-三氟乙氧基)乙基等基。 In the present invention, "C 1 to C 6 haloalkoxy C 1 to C 6 alkyl" is a haloalkoxy part of the above meaning (C 1 to C 6 haloalkoxy)-( C 1 to C 6 alkyl)-yl, for example: 2-(difluoromethoxy)ethyl, 2-(trifluoromethoxy)ethyl, 2-(2,2-difluoroethoxy Radicals) ethyl or 2-(2,2,2-trifluoroethoxy)ethyl and other radicals.

本發明中,「C1至C6鹵烷氧基C1至C6鹵烷基」在無特別限定下係鹵烷氧基部分及鹵烷基部分為上述意義的(C1至C6鹵烷氧基)-(C1至C6鹵烷基)-基,例如可舉:1,1,2-三氟-2-(三氟甲氧基)乙基、1,1,2-三氟-2-(五氟乙氧基)乙基或1,1,2-三氟-2-(七氟丙氧基)乙基等基。 In the present invention, "C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl" is a haloalkoxy moiety and a haloalkyl moiety in the above sense (C 1 to C 6 halo Alkoxy)-(C 1 to C 6 haloalkyl)-yl, for example: 1,1,2-trifluoro-2-(trifluoromethoxy)ethyl, 1,1,2-tri Fluoro-2-(pentafluoroethoxy)ethyl or 1,1,2-trifluoro-2-(heptafluoropropoxy)ethyl and other groups.

本發明中,「C3至C6環烷氧基C1至C6烷基」在無特別限定下係環烷氧基部分及烷基部分為上述意義的(C3至C6環烷氧基)-(C1至C6烷基),例如可舉:環丙氧基甲基、1-(環丙氧基)乙基、2-(環丙氧基)乙基、2-(環丙氧基)丙基、3-(環丙氧基)丙基、1-甲基-3-(環丙氧基)丁基或3-(環丙氧基)丁基、環丁氧基甲基、環戊氧基甲基、環己氧基甲基等基。 In the present invention, "C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl" is a cycloalkoxy moiety and an alkyl moiety in the above meaning (C 3 to C 6 cycloalkoxy) Group)-(C 1 to C 6 alkyl), for example, cyclopropoxymethyl, 1-(cyclopropoxy)ethyl, 2-(cyclopropoxy)ethyl, 2-(cyclo Propoxy)propyl, 3-(cyclopropoxy)propyl, 1-methyl-3-(cyclopropoxy)butyl or 3-(cyclopropoxy)butyl, cyclobutoxymethyl Radicals, cyclopentoxymethyl, cyclohexyloxymethyl and other radicals.

本發明中,「C3至C6鹵環烷氧基C1至C6烷基」在無特別限定下係鹵環烷氧基部分及烷基部分為上述意義的(C3至C6鹵環烷氧基)- (C1至C6烷基),例如可舉:2,2-二氟環丙氧基甲基、2,2-二氯環丙氧基甲基、1-(2,2-二氟環丙氧基)乙基、2-(2,2-二氟環丙氧基)乙基、1-(2,2-二氯環丙氧基)乙基、2-(2,2-二氯環丙氧基)乙基、2-(2,2-二氟環丙氧基)丙基、3,3-二氟環丁氧基甲基、3,3-二氟環戊氧基甲基或2-(3,3-二氟環戊氧基)丙基等基。 In the present invention, "C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl" is a halocycloalkoxy moiety and an alkyl moiety in the above sense (C 3 to C 6 halo Cycloalkoxy)-(C 1 to C 6 alkyl), for example: 2,2-difluorocyclopropoxymethyl, 2,2-dichlorocyclopropoxymethyl, 1-(2 ,2-difluorocyclopropoxy)ethyl, 2-(2,2-difluorocyclopropoxy)ethyl, 1-(2,2-dichlorocyclopropoxy)ethyl, 2-( 2,2-dichlorocyclopropoxy)ethyl, 2-(2,2-difluorocyclopropoxy)propyl, 3,3-difluorocyclobutoxymethyl, 3,3-difluoro Groups such as cyclopentyloxymethyl or 2-(3,3-difluorocyclopentyloxy)propyl.

本發明中,「巰基C1至C6烷基」在無特別限定下係烷基部分是上述意義的HS-(C1至C6烷基)-基,例如可舉:巰基甲基、1-巰基乙基或2-巰基乙基等基。 In the present invention, the "mercapto C 1 to C 6 alkyl group" is an HS-(C 1 to C 6 alkyl)- group with the above meaning unless otherwise specified. Examples include mercaptomethyl, 1 -Groups such as mercaptoethyl or 2-mercaptoethyl.

本發明中,「C1至C6烷基硫基C1至C6烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-S-(C1至C6烷基)-基,例如可舉:甲基硫基甲基、乙基硫基甲基、正丙基硫基甲基、異丙基硫基甲基、1-(甲基硫基)乙基、2-(甲基硫基)乙基、2-(乙基硫基)乙基、1-(正丙基硫基)乙基、2-(正丙基硫基)乙基、1-(異丙基硫基)乙基、2-(異丙基硫基)乙基、1-(甲基硫基)丙基、2-(甲基硫基)丙基、3-(甲基硫基)丙基、1-(乙基硫基)丙基、2-(乙基硫基)丙基、3-(乙基硫基)丙基、1-(正丙基硫基)丙基、2-(正丙基硫基)丙基、3-(正丙基硫基)丙基、1-(甲基硫基)丁基、2-(甲基硫基)丁基、3-(甲基硫基)丁基、4-(甲基硫基)丁基、1-(甲基硫基)戊基、2-(甲基硫基)戊基、3-(甲基硫基)戊基、4-(甲基硫基)戊基、5-(甲基硫基)戊基、2-(正丁基硫基)乙基、2-(異丁基硫基)乙基、第二丁基硫乙基、2-(第三丁基硫基)乙基、戊基硫甲基或己基硫甲基等基。 In the present invention, "C 1 to C 6 alkylthio C 1 to C 6 alkyl" is an alkyl portion of the above meaning (C 1 to C 6 alkyl)-S-(C 1 without limitation) To C 6 alkyl)- group, for example, methylthiomethyl, ethylthiomethyl, n-propylthiomethyl, isopropylthiomethyl, 1-(methylthio )Ethyl, 2-(methylthio)ethyl, 2-(ethylthio)ethyl, 1-(n-propylthio)ethyl, 2-(n-propylthio)ethyl, 1-(isopropylthio)ethyl, 2-(isopropylthio)ethyl, 1-(methylthio)propyl, 2-(methylthio)propyl, 3-(methyl Thio)propyl, 1-(ethylthio)propyl, 2-(ethylthio)propyl, 3-(ethylthio)propyl, 1-(n-propylthio)propyl Group, 2-(n-propylthio)propyl, 3-(n-propylthio)propyl, 1-(methylthio)butyl, 2-(methylthio)butyl, 3- (Methylthio)butyl, 4-(methylthio)butyl, 1-(methylthio)pentyl, 2-(methylthio)pentyl, 3-(methylthio) Amyl, 4-(methylthio)pentyl, 5-(methylthio)pentyl, 2-(n-butylthio)ethyl, 2-(isobutylthio)ethyl, Groups such as dibutylthioethyl, 2-(third butylthio)ethyl, pentylthiomethyl or hexylthiomethyl.

本發明中,「C1至C6烷基亞磺醯基C1至C6烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-S(=O)-(C1至C6烷基) -基,例如可舉:甲基亞磺醯基甲基、乙基亞磺醯基甲基、正丙基亞磺醯基甲基、異丙基亞磺醯基甲基、1-(甲基亞磺醯基)乙基、2-(甲基亞磺醯基)乙基、2-(乙基亞磺醯基)乙基、1-(正丙基亞磺醯基)乙基、2-(正丙基亞磺醯基)乙基、1-(異丙基亞磺醯基)乙基、2-(異丙基亞磺醯基)乙基、1-(甲基亞磺醯基)丙基、2-(甲基亞磺醯基)丙基、3-(甲基亞磺醯基)丙基、1-(乙基亞磺醯基)丙基、2-(乙基亞磺醯基)丙基、3-(乙基亞磺醯基)丙基、1-(正丙基亞磺醯基)丙基、2-(正丙基亞磺醯基)丙基、3-(正丙基亞磺醯基)丙基、1-(甲基亞磺醯基)丁基、2-(甲基亞磺醯基)丁基、3-(甲基亞磺醯基)丁基、4-(甲基亞磺醯基)丁基、1-(甲基亞磺醯基)戊基、2-(甲基亞磺醯基)戊基、3-(甲基亞磺醯基)戊基、4-(甲基亞磺醯基)戊基、5-(甲基亞磺醯基)戊基、2-(正丁基亞磺醯基)乙基、2-(異丁基亞磺醯基)乙基、第二丁基亞磺醯基乙基、2-(第三丁基亞磺醯基)乙基、戊基亞磺醯基甲基或己基亞磺醯基甲基等基。 In the present invention, the "C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl group" is an alkyl moiety of the above meaning (C 1 to C 6 alkyl)-S(= O)-(C 1 to C 6 alkyl)-group, for example, methylsulfinylmethyl, ethylsulfinylmethyl, n-propylsulfinylmethyl, isopropyl Sulfonylmethyl, 1-(methylsulfinyl)ethyl, 2-(methylsulfinyl)ethyl, 2-(ethylsulfinyl)ethyl, 1-(n Propylsulfinyl)ethyl, 2-(n-propylsulfinyl)ethyl, 1-(isopropylsulfinyl)ethyl, 2-(isopropylsulfinyl)ethyl Group, 1-(methylsulfinyl)propyl, 2-(methylsulfinyl)propyl, 3-(methylsulfinyl)propyl, 1-(ethylsulfinyl) )Propyl, 2-(ethylsulfinyl)propyl, 3-(ethylsulfinyl)propyl, 1-(n-propylsulfinyl)propyl, 2-(n-propyl Sulfenyl)propyl, 3-(n-propylsulfinyl)propyl, 1-(methylsulfinyl)butyl, 2-(methylsulfinyl)butyl, 3- (Methylsulfinyl)butyl, 4-(methylsulfinyl)butyl, 1-(methylsulfinyl)pentyl, 2-(methylsulfinyl)pentyl, 3-(methylsulfinyl)pentyl, 4-(methylsulfinyl)pentyl, 5-(methylsulfinyl)pentyl, 2-(n-butylsulfinyl) Ethyl, 2-(isobutylsulfinylsulfonyl)ethyl, second butylsulfinylethyl, 2-(third butylsulfinyl)ethyl, pentylsulfinylmethyl Group or hexylsulfinylmethyl group.

本發明中,「C1至C6烷基磺醯基C1至C6烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-S(=O)2-(C1至C6烷基)-基,例如可舉:甲基磺醯基甲基、乙基磺醯基甲基、正丙基磺醯基甲基、異丙基磺醯基甲基、1-(甲基磺醯基)乙基、2-(甲基磺醯基)乙基、2-(乙基磺醯基)乙基、1-(正丙基磺醯基)乙基、2-(正丙基磺醯基)乙基、1-(異丙基磺醯基)乙基、2-(異丙基磺醯基)乙基、1-(甲基磺醯基)丙基、2-(甲基磺醯基)丙基、3-(甲基磺醯基)丙基、1-(乙基磺醯基)丙基、2-(乙基磺醯基)丙基、3-(乙基磺醯基)丙基、1-(正丙基磺醯基)丙基、2-(正丙基磺醯基)丙基、3-(正丙基磺醯基)丙基、 1-(甲基磺醯基)丁基、2-(甲基磺醯基)丁基、3-(甲基磺醯基)丁基、4-(甲基磺醯基)丁基、1-(甲基磺醯基)戊基、2-(甲基磺醯基)戊基、3-(甲基磺醯基)戊基、4-(甲基磺醯基)戊基、5-(甲基磺醯基)戊基、2-(正丁基磺醯基)乙基、2-(異丁基磺醯基)乙基、第二丁基磺醯基乙基、2-(第三丁基磺醯基)乙基、戊基磺醯基甲基或己基磺醯基甲基等基。 In the present invention, "C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl" is an alkyl portion of the above meaning (C 1 to C 6 alkyl)-S(=O ) 2 -(C 1 to C 6 alkyl)-yl, for example: methylsulfonylmethyl, ethylsulfonylmethyl, n-propylsulfonylmethyl, isopropylsulfonyl Methyl, 1-(methylsulfonyl)ethyl, 2-(methylsulfonyl)ethyl, 2-(ethylsulfonyl)ethyl, 1-(n-propylsulfonyl)ethyl Group, 2-(n-propylsulfonyl)ethyl, 1-(isopropylsulfonyl)ethyl, 2-(isopropylsulfonyl)ethyl, 1-(methylsulfonyl) Propyl, 2-(methylsulfonyl)propyl, 3-(methylsulfonyl)propyl, 1-(ethylsulfonyl)propyl, 2-(ethylsulfonyl)propyl , 3-(ethylsulfonyl)propyl, 1-(n-propylsulfonyl)propyl, 2-(n-propylsulfonyl)propyl, 3-(n-propylsulfonyl)propyl Group, 1-(methylsulfonyl)butyl, 2-(methylsulfonyl)butyl, 3-(methylsulfonyl)butyl, 4-(methylsulfonyl)butyl, 1-(methylsulfonyl)pentyl, 2-(methylsulfonyl)pentyl, 3-(methylsulfonyl)pentyl, 4-(methylsulfonyl)pentyl, 5- (Methylsulfonyl)pentyl, 2-(n-butylsulfonyl)ethyl, 2-(isobutylsulfonyl)ethyl, second butylsulfonylethyl, 2-(section Tributylsulfonyl) ethyl, pentylsulfonylmethyl or hexylsulfonylmethyl and other groups.

本發明中,「C1至C6鹵烷基硫基C1至C6烷基」在無特別限定下係鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-S-(C1至C6烷基)-基,例如可舉:2-(二氟甲基硫基)乙基、2-(三氟甲基硫基)乙基、2-(2,2-二氟乙基硫基)乙基、2-(2,2,2-三氟乙基硫基)乙基、2-(3,3-二氟丙基硫基)乙基、2-(3,3,3-三氟乙基硫基)乙基、3-(二氟甲基硫基)丙基、3-(三氟甲基硫基)丙基、3-(2,2-二氟乙基硫基)丙基、3-(2,2,2-三氟乙基硫基)丙基、3-(3,3-二氟丙基硫基)丙基、3-(3,3,3-三氟丙基硫基)丙基、4-(三氟甲基硫基)丁基或5-(三氟甲基硫基)戊基等基。 In the present invention, "C 1 to C 6 haloalkylthio C 1 to C 6 alkyl" is a haloalkyl moiety and an alkyl moiety having the above meaning (C 1 to C 6 haloalkyl) )-S-(C 1 to C 6 alkyl)-yl, for example, 2-(difluoromethylthio)ethyl, 2-(trifluoromethylthio)ethyl, 2-(2 ,2-difluoroethylthio)ethyl, 2-(2,2,2-trifluoroethylthio)ethyl, 2-(3,3-difluoropropylthio)ethyl, 2 -(3,3,3-trifluoroethylthio)ethyl, 3-(difluoromethylthio)propyl, 3-(trifluoromethylthio)propyl, 3-(2,2 -Difluoroethylthio)propyl, 3-(2,2,2-trifluoroethylthio)propyl, 3-(3,3-difluoropropylthio)propyl, 3-( Groups such as 3,3,3-trifluoropropylthio)propyl, 4-(trifluoromethylthio)butyl or 5-(trifluoromethylthio)pentyl.

本發明中,「C1至C6鹵烷基亞磺醯基C1至C6烷基」在無特別限定下係鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)-(C1至C6烷基)-基,例如可舉:2-(二氟甲基亞磺醯基)乙基、2-(三氟甲基亞磺醯基)乙基、2-(2,2-二氟乙基亞磺醯基)乙基、2-(2,2,2-三氟乙基亞磺醯基)乙基、2-(3,3-二氟丙基亞磺醯基)乙基、2-(3,3,3-三氟乙基亞磺醯基)乙基、3-(二氟甲基亞磺醯基)丙基、3-(三氟甲基亞磺醯基)丙基、3-(2,2-二氟乙基亞磺醯基)丙基、3-(2,2,2-三氟乙基亞磺醯基)丙基、3-(3,3-二氟丙基亞磺醯基)丙基、3-(3,3,3-三 氟丙基亞磺醯基)丙基、4-(三氟甲基亞磺醯基)丁基或5-(三氟甲基亞磺醯基)戊基等基。 In the present invention, "C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl" is a haloalkyl portion and an alkyl portion of the above meaning (C 1 to C 6 halo Alkyl)-S(=O)-(C 1 to C 6 alkyl)-yl, for example: 2-(difluoromethylsulfinyl)ethyl, 2-(trifluoromethylsulfinyl) Acyl)ethyl, 2-(2,2-difluoroethylsulfinyl)ethyl, 2-(2,2,2-trifluoroethylsulfinyl)ethyl, 2-(3 ,3-difluoropropylsulfinyl)ethyl, 2-(3,3,3-trifluoroethylsulfinyl)ethyl, 3-(difluoromethylsulfinyl)propyl , 3-(trifluoromethylsulfinyl)propyl, 3-(2,2-difluoroethylsulfinyl)propyl, 3-(2,2,2-trifluoroethylsulfinyl Acyl)propyl, 3-(3,3-difluoropropylsulfinyl)propyl, 3-(3,3,3-trifluoropropylsulfinyl)propyl, 4-(tri Fluoromethylsulfinyl)butyl or 5-(trifluoromethylsulfinyl)pentyl and other groups.

本發明中,「C1至C6鹵烷基磺醯基C1至C6烷基」在無特別限定下係鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)2-(C1至C6烷基)-基,例如可舉:2-(二氟甲基磺醯基)乙基、2-(三氟甲基磺醯基)乙基、2-(2,2-二氟乙基磺醯基)乙基、2-(2,2,2-三氟乙基磺醯基)乙基、2-(3,3-二氟丙基磺醯基)乙基、2-(3,3,3-三氟乙基磺醯基)乙基、3-(二氟甲基磺醯基)丙基、3-(三氟甲基磺醯基)丙基、3-(2,2-二氟乙基磺醯基)丙基、3-(2,2,2-三氟乙基磺醯基)丙基、3-(3,3-二氟丙基磺醯基)丙基、3-(3,3,3-三氟丙基磺醯基)丙基、4-(三氟甲基磺醯基)丁基或5-(三氟甲基磺醯基)戊基等基。 In the present invention, "C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl" is a haloalkyl moiety and an alkyl moiety having the above meanings without particular limitation (C 1 to C 6 haloalkane Group)-S(=O) 2 -(C 1 to C 6 alkyl)- group, for example, 2-(difluoromethylsulfonyl)ethyl, 2-(trifluoromethylsulfonyl) )Ethyl, 2-(2,2-difluoroethylsulfonyl)ethyl, 2-(2,2,2-trifluoroethylsulfonyl)ethyl, 2-(3,3-di Fluoropropylsulfonyl)ethyl, 2-(3,3,3-trifluoroethylsulfonyl)ethyl, 3-(difluoromethylsulfonyl)propyl, 3-(trifluoromethyl Sulfosulfonyl)propyl, 3-(2,2-difluoroethylsulfonyl)propyl, 3-(2,2,2-trifluoroethylsulfonyl)propyl, 3-(3 ,3-difluoropropylsulfonyl)propyl, 3-(3,3,3-trifluoropropylsulfonyl)propyl, 4-(trifluoromethylsulfonyl)butyl or 5- (Trifluoromethylsulfonyl) pentyl and other groups.

本發明中,「C3至C6環烷基硫基C1至C6烷基」在無特別限定下係環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-S-(C1至C6烷基)-基,例如可舉:環丙基硫基甲基、環戊基硫基甲基、1-(環丙基硫基)乙基或2-(環丙基硫基)乙基等基。 In the present invention, "C 3 to C 6 cycloalkylthio C 1 to C 6 alkyl" is a cycloalkyl moiety and an alkyl moiety having the above meanings (C 3 to C 6 cycloalkyl) )-S-(C 1 to C 6 alkyl)-yl, for example, cyclopropylthiomethyl, cyclopentylthiomethyl, 1-(cyclopropylthio)ethyl or 2- (Cyclopropylthio) ethyl and other groups.

本發明中,「C3至C6環烷基亞磺醯基C1至C6烷基」在無特別限定下係環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-S(=O)-(C1至C6烷基)-基,例如可舉:環丙基亞磺醯基甲基、環戊基亞磺醯基甲基、1-(環丙基亞磺醯基)乙基或2-(環丙基亞磺醯基)乙基等基。 In the present invention, the "C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl group" is a cycloalkyl moiety and an alkyl moiety in the above sense (C 3 to C 6 Alkyl)-S(=O)-(C 1 to C 6 alkyl)-, for example, cyclopropylsulfinylmethyl, cyclopentylsulfinylmethyl, 1-(cyclo Groups such as propylsulfinyl)ethyl or 2-(cyclopropylsulfinyl)ethyl.

本發明中,「C3至C6環烷基磺醯基C1至C6烷基」在無特別限定下係環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-S(=O)2-(C1至C6烷基)-基,例如可舉:環丙基磺醯基甲基、環戊基磺醯基甲 基、1-(環丙基磺醯基)乙基或2-(環丙基磺醯基)乙基等基。 In the present invention, "C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl" is a cycloalkyl moiety and an alkyl moiety having the above meaning (C 3 to C 6 cycloalkyl Group)-S(=O) 2 -(C 1 to C 6 alkyl)- group, for example: cyclopropylsulfonylmethyl, cyclopentylsulfonylmethyl, 1-(cyclopropyl Sulfonyl)ethyl or 2-(cyclopropylsulfonyl)ethyl and other groups.

本發明中,「C3至C6鹵環烷基硫基C1至C6烷基」在無特別限定下係鹵環烷基部分及烷基部分為上述意義的(C3至C6鹵環烷基)-S-(C1至C6烷基)-基,例如可舉:2,2-二氟環丙基硫基甲基、1-(2,2-二氟環丙基硫基)乙基或2-(2,2-二氟環丙基硫基)乙基等基。 In the present invention, "C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl" is a halocycloalkyl moiety and an alkyl moiety of the above meaning (C 3 to C 6 halo Cycloalkyl)-S-(C 1 to C 6 alkyl)-yl, for example: 2,2-difluorocyclopropylthiomethyl, 1-(2,2-difluorocyclopropylthio Group) ethyl or 2-(2,2-difluorocyclopropylthio)ethyl and other groups.

本發明中,「C3至C6鹵環烷基亞磺醯基C1至C6烷基」在無特別限定下係鹵環烷基部分及烷基部分為上述意義的(C3至C6鹵環烷基)-S(=O)-(C1至C6烷基)-基,例如可舉:2,2-二氟環丙基亞磺醯基甲基、1-(2,2-二氟環丙基亞磺醯基)乙基或2-(2,2-二氟環丙基亞磺醯基)乙基等基。 In the present invention, "C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl" is a halocycloalkyl moiety and an alkyl moiety of the above meaning (C 3 to C without limitation) 6- halocycloalkyl)-S(=O)-(C 1 to C 6 alkyl)-yl, for example: 2,2-difluorocyclopropylsulfinylmethyl, 1-(2, 2-Difluorocyclopropylsulfinyl)ethyl or 2-(2,2-difluorocyclopropylsulfinyl)ethyl and other groups.

本發明中,「C3至C6鹵環烷基磺醯基C1至C6烷基」在無特別限定下係鹵環烷基部分及烷基部分為上述意義的(C3至C6鹵環烷基)-S(=O)2-(C1至C6烷基)-基,例如可舉:2,2-二氟環丙基磺醯基甲基、1-(2,2-二氟環丙基磺醯基)乙基或2-(2,2-二氟環丙基磺醯基)乙基等基。 In the present invention, "C 3 to C 6 halocycloalkylsulfonyl C 1 to C 6 alkyl" is a halocycloalkyl moiety and an alkyl moiety of the above meaning (C 3 to C 6 without limitation) Halocycloalkyl)-S(=O) 2 -(C 1 to C 6 alkyl)-yl, for example: 2,2-difluorocyclopropylsulfonylmethyl, 1-(2,2 -Difluorocyclopropylsulfonyl)ethyl or 2-(2,2-difluorocyclopropylsulfonyl)ethyl and other groups.

本發明中,「C1至C6烷基磺醯基氧基C1至C6烷基」在無特別限定下係烷基磺醯基氧基部分及烷基部分為上述意義的(C1至C6烷基)-S(=O)2-O-(C1至C6烷基)-基,例如可舉:甲烷基磺醯基氧基甲基等基。 In the present invention, "C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl" is an alkylsulfonyloxy moiety and an alkyl moiety of the above meaning (C 1 without limitation) To C 6 alkyl)-S(=O) 2 -O-(C 1 to C 6 alkyl)- group, for example, a group such as methanesulfonyloxymethyl.

本發明中,「C1至C6烷基羰基硫基C1至C3烷基」在無特別限定下係烷基羰基硫部分及烷基部分為上述意義的(C1至C6烷基)-C(=O)-S-(C1至C3烷基)-基,例如可舉:甲基羰基硫基甲基等基。 In the present invention, "C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl" is an alkylcarbonyl sulfur moiety and an alkyl moiety having the above meanings (C 1 to C 6 alkyl) )-C(=O)-S-(C 1 to C 3 alkyl)- group, for example, groups such as methylcarbonylthiomethyl.

本發明中,「胺基C1至C6烷基」在無特別限定下係烷基部分是上述H2N-(C1至C6烷基),例如可舉:胺甲基、1-胺基乙基、2-胺基乙 基、1-胺基丙基、3-胺基丙基、2-胺基丙烷-2-基、1-胺基丁基、4-胺基丁基、5-胺基戊基或6-胺基己基等基。 In the present invention, the "amino group C 1 to C 6 alkyl group" is an H 2 N-(C 1 to C 6 alkyl group)-based alkyl moiety unless otherwise specified, and examples include amine methyl, 1- Aminoethyl, 2-aminoethyl, 1-aminopropyl, 3-aminopropyl, 2-aminopropane-2-yl, 1-aminobutyl, 4-aminobutyl, Groups such as 5-aminopentyl or 6-aminohexyl.

本發明中,「單(C1至C6烷基羰基)胺基C1至C6烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-C(=O)-NH-(C1至C6烷基)-基,例如可舉:2-(乙醯基胺基)乙基、2-(丙醯基胺基)乙基、2-(異丙醯基胺基)乙基、3-(乙醯基胺基)丙基或3-(乙醯基胺基)丁基等基。 In the present invention, "mono(C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl" is an alkyl portion of the above meaning (C 1 to C 6 alkyl)-C without any particular limitation (=O)-NH-(C 1 to C 6 alkyl)-yl, for example: 2-(ethylaminoamino)ethyl, 2-(propylaminoamino)ethyl, 2-( Isopropylamino) ethyl, 3-(ethylamino)propyl or 3-(ethylamino)butyl and other groups.

本發明中,「單(C1至C6鹵烷基羰基)胺基C1至C6烷基」在無特別限定下係表示表示鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-C(=O)-NH-(C1至C6烷基)-基,例如可舉:氯乙醯基胺基甲基、二氯乙醯基胺基甲基、二氟乙醯基胺基甲基、三氟乙醯基胺基甲基、1-(三氟乙醯基胺基)乙基、2-(三氟乙醯基胺基)乙基、1-(二氟乙醯基胺基)乙基或2-(二氟乙醯基胺基)乙基等基。 In the present invention, "mono(C 1 to C 6 haloalkylcarbonyl)amino C 1 to C 6 alkyl" means (C 1 which means that the haloalkyl portion and the alkyl portion have the above meanings unless otherwise specified) To C 6 haloalkyl)-C(=O)-NH-(C 1 to C 6 alkyl)- group, for example: chloroethylamidomethyl, dichloroethylamidomethyl , Difluoroethylamidomethyl, trifluoroethylamidomethyl, 1-(trifluoroethylamido)ethyl, 2-(trifluoroethylamido)ethyl, 1 -Groups such as (difluoroethylamido)ethyl or 2-(difluoroethylamido)ethyl.

本發明中,「單(C3至C6環烷基羰基)胺基C1至C6烷基」在無特別限定下係環烷基部分及烷基部分為上述意義的(C3至C6環烷基)-C(=O)-NH-(C1至C6烷基)-基,例如可舉:1-(環丙醯基胺基)乙基、1-(環戊醯基胺基)乙基、2-(環丙醯基胺基)乙基或2-(環戊醯基胺基)乙基等基。 In the present invention, "mono(C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl" is a cycloalkyl moiety and an alkyl moiety in the above sense (C 3 to C without limitation) 6 cycloalkyl)-C(=O)-NH-(C 1 to C 6 alkyl)-yl, for example: 1-(cyclopropionylamino) ethyl, 1-(cyclopentyl) Amino) ethyl, 2-(cyclopropyl amide amino) ethyl or 2-(cyclopentyl amide amino) ethyl and other groups.

本發明中,「單(C1至C6烷氧基羰基)胺基C1至C6烷基」在無特別限定下係烷氧基部分及烷基部分為上述意義的(C1至C6烷氧基)-C(=O)-NH-(C1至C6烷基)-基,例如可舉:2-(甲氧基羰基胺基)乙基、2-(乙氧基羰基胺基)乙基或2-(第三丁基羰基胺基)乙基等基。 In the present invention, "mono(C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl" is an alkoxy moiety and an alkyl moiety in the above sense (C 1 to C without limitation) 6 alkoxy)-C(=O)-NH-(C 1 to C 6 alkyl)-yl, for example: 2-(methoxycarbonylamino)ethyl, 2-(ethoxycarbonyl Amino) ethyl or 2-(third butylcarbonylamino) ethyl and other groups.

本發明中,「單(C1至C6烷基)胺基羰基胺基C1至C6烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-NH-C(=O)- NH-(C1至C6烷基)-基,例如可舉:甲基胺基羰基胺基甲基、乙胺基羰基胺基甲基、異丙胺基羰基胺基甲基或第三丁基胺基羰基胺基甲基等基。 In the present invention, the "mono(C 1 to C 6 alkyl)aminocarbonylamino group C 1 to C 6 alkyl" is an alkyl moiety of the above meaning (C 1 to C 6 alkyl) unless otherwise specified. -NH-C(=O)-NH-(C 1 to C 6 alkyl)- group, for example, methylaminocarbonylaminomethyl, ethylaminocarbonylaminomethyl, isopropylaminocarbonyl Aminomethyl or tertiary butylaminocarbonylaminomethyl and other groups.

本發明中,「二(C1至C6烷基)胺基羰基胺基C1至C6烷基」在無特別限定下係表示烷基部分為上述意義的(C1至C6烷基)2N-C(=O)-NH-(C1至C6烷基)-基,烷基亦可彼此相異,例如可舉:二甲基胺基羰基胺基甲基、二乙胺基羰基胺基甲基或N-甲基-N-乙胺基羰基胺基甲基等基。 In the present invention, "di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl) without particular limitation. ) 2 NC(=O)-NH-(C 1 to C 6 alkyl)- group, the alkyl groups may also be different from each other, for example: dimethylaminocarbonylaminomethyl, diethylaminocarbonyl Groups such as aminomethyl or N-methyl-N-ethylaminocarbonylaminomethyl.

本發明中,「單(C1至C6烷基磺醯基)胺基C1至C6烷基」在無特別限定下係表烷基部分為上述意義的(C1至C6烷基)-S(=O)2-NH-(C1至C6烷基)-基,例如可舉:2-(甲基磺醯基胺基)乙基、2-(乙基磺醯基胺基)乙基、2-(異丙基磺醯基胺基)乙基、3-(甲基磺醯基胺基)丙基或4-(甲基磺醯基胺基)丁基等基。 In the present invention, "mono(C 1 to C 6 alkylsulfonyl)amino group C 1 to C 6 alkyl group" means that the alkyl portion has the above meaning (C 1 to C 6 alkyl group) without particular limitation. )-S(=O) 2 -NH-(C 1 to C 6 alkyl)-yl, for example: 2-(methylsulfonylamino)ethyl, 2-(ethylsulfonylamino) Group) ethyl, 2-(isopropylsulfonylamido)ethyl, 3-(methylsulfonylamido)propyl or 4-(methylsulfonylamido)butyl and other groups.

本發明中,「單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基」在無特別限定下係表示鹵烷基部分及烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)2-NH-(C1至C6烷基)-基,例如可舉:2-(二氟甲基磺醯基胺基)乙基、2-(三氟甲基磺醯基胺基)乙基、3-(二氟甲基磺醯基胺基)丙基、3-(三氟甲基磺醯基胺基)丙基等基。 In the present invention, "mono(C 1 to C 6 haloalkylsulfonyl)amino group C 1 to C 6 alkyl" means, without particular limitation, that the haloalkyl portion and the alkyl portion have the above meaning (C 1 to C 6 haloalkyl)-S(=O) 2 -NH-(C 1 to C 6 alkyl)- group, for example, 2-(difluoromethylsulfonylamino)ethyl, Groups such as 2-(trifluoromethylsulfonylamino)ethyl, 3-(difluoromethylsulfonylamino)propyl, 3-(trifluoromethylsulfonylamino)propyl and the like.

本發明中,「N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基」在無特別限定下係表示上述的胺基C1至C6烷基的胺基的2個氫原子是分別經(C1至C6烷基)-S(=O)2-基及(C1至C6烷基)-基取代的基,例如可舉:(N-甲基磺醯基-N-甲基)胺基甲基、(N-乙基磺醯基-N-甲基)胺基甲基、(N-甲基磺醯基-N-乙基)胺基甲基或(N-乙基磺醯基-N-甲基)胺基乙基等基。 In the present invention, "N-(C 1 to C 6 alkylsulfonyl)-N-(C 1 to C 6 alkyl)amino C 1 to C 6 alkyl" means the above without limitation. The two hydrogen atoms of the amino group of the amino group C 1 to C 6 alkyl group are respectively (C 1 to C 6 alkyl)-S(=O) 2 -group and (C 1 to C 6 alkyl)- group Examples of substituted groups include (N-methylsulfonyl-N-methyl)aminomethyl, (N-ethylsulfonyl-N-methyl)aminomethyl, (N-methyl Groups such as sulfamoyl-N-ethyl)aminomethyl or (N-ethylsulfonyl-N-methyl)aminoethyl.

本發明中,「N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基」在無特別限定下係表示上述的胺基C1至C6烷基的胺基的2個氫原子分別經(C1至C6鹵烷基)-S(=O)2-基及(C1至C6烷基)-基取代的基,例如可舉:(N-二氟甲基磺醯基-N-甲基)胺基甲基、(N-三氟甲基磺醯基-N-甲基)胺基甲基、(N-九氟丁基磺醯基-N-甲基)胺基甲基、(N-二氟甲基磺醯基-N-乙基)胺基甲基、(N-三氟甲基磺醯基-N-乙基)胺基甲基或(N-九氟丁基磺醯基-N-乙基)胺基甲基等基。 In the present invention, "N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino C 1 to C 6 alkyl" means the above without particular limitation The two hydrogen atoms of the amine group C 1 to C 6 alkyl group are respectively (C 1 to C 6 haloalkyl)-S(=O) 2 -group and (C 1 to C 6 alkyl group)- Examples of the group substituted with a group include (N-difluoromethylsulfonyl-N-methyl)aminomethyl, (N-trifluoromethylsulfonyl-N-methyl)aminomethyl , (N-nonafluorobutylsulfonyl-N-methyl)aminomethyl, (N-difluoromethylsulfonyl-N-ethyl)aminomethyl, (N-trifluoromethyl Sulfonyl-N-ethyl)aminomethyl or (N-nonafluorobutylsulfonyl-N-ethyl)aminomethyl and other groups.

本發明中,「苯氧基C1至C3烷基」在無特別限定下係表示(苯基)-O-(C1至C3烷基)-基,例如可舉:苯氧基甲基、1-苯氧基乙基或2-苯氧基乙基等基。 In the present invention, "phenoxy C 1 to C 3 alkyl group" means (phenyl)-O-(C 1 to C 3 alkyl)- group without particular limitation, for example, phenoxymethyl Radical, 1-phenoxyethyl or 2-phenoxyethyl.

本發明中,「雜芳基氧基C1至C3烷基」在無特別限定下係表示雜芳基部分為上述意義的(雜芳基)-O-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)氧基甲基、(吡啶-3-基)氧基甲基、(吡啶-4-基)氧基甲基、(噻唑-2-基)氧基甲基、(噻唑-4-基)氧基甲基、(噻唑-5-基)氧基甲基、(吡唑-1-基)氧基甲基、(吡唑-3-基)氧基甲基、(吡唑-4-基)氧基甲基或(吡唑-5-基)氧基甲基等基。 In the present invention, "heteroaryloxy C 1 to C 3 alkyl group" means (heteroaryl)-O-(C 1 to C 3 alkyl group) whose heteroaryl part has the above meaning unless otherwise specified. -Group, for example, (pyridin-2-yl)oxymethyl, (pyridin-3-yl)oxymethyl, (pyridin-4-yl)oxymethyl, (thiazol-2-yl) Oxymethyl, (thiazol-4-yl)oxymethyl, (thiazol-5-yl)oxymethyl, (pyrazol-1-yl)oxymethyl, (pyrazol-3-yl) Groups such as oxymethyl, (pyrazol-4-yl)oxymethyl or (pyrazol-5-yl)oxymethyl.

本發明中,「苯基C1至C3烷氧基C1至C3烷基」在無特別限定下係表示(苯基)-(C1至C3烷基)-O-(C1至C3烷基)-基,例如可舉:苄基氧基甲基、1-苄基氧基乙基或2-苄基氧基乙基等基。 In the present invention, "phenyl C 1 to C3 alkoxy C 1 to C3 alkyl" means (phenyl)-(C 1 to C 3 alkyl)-O-(C 1 to C without limitation) Examples of 3 alkyl)-yl include benzyloxymethyl, 1-benzyloxyethyl or 2-benzyloxyethyl.

本發明中,「雜芳基C1至C3烷氧基C1至C3烷基」在無特別限定下係表示雜芳基部分為上述意義的(雜芳基)-(C1至C3烷基)-O-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)甲基氧基甲基、(吡啶-3-基)甲基氧基甲基、(吡啶-4-基)甲基氧基甲基、(噻唑-2-基)甲基氧 基甲基、(噻唑-4-基)甲基氧基甲基、(噻唑-5-基)甲基氧基甲基、(吡唑-1-基)甲基氧基甲基、(吡唑-3-基)甲基氧基甲基、(吡唑-4-基)甲基氧基甲基或(吡唑-5-基)甲基氧基甲基等基。 In the present invention, "heteroaryl C 1 to C3 alkoxy C 1 to C3 alkyl" means (heteroaryl)-(C 1 to C 3 Group)-O-(C 1 to C 3 alkyl)- group, for example, (pyridin-2-yl)methyloxymethyl, (pyridin-3-yl)methyloxymethyl, ( Pyridin-4-yl)methyloxymethyl, (thiazol-2-yl)methyloxymethyl, (thiazol-4-yl)methyloxymethyl, (thiazol-5-yl)methyl Oxymethyl, (pyrazol-1-yl)methyloxymethyl, (pyrazol-3-yl)methyloxymethyl, (pyrazol-4-yl)methyloxymethyl or (Pyrazol-5-yl) methyloxymethyl and other groups.

本發明中,「苯基硫基C1至C3烷基」在無特別限定下係表示(苯基)-S-(C1至C3烷基)-基,例如可舉:苯基硫基甲基、1-苯基硫基乙基或2-苯基硫基乙基等基。 In the present invention, "phenylthio C 1 to C 3 alkyl" means (phenyl)-S-(C 1 to C 3 alkyl)-, without particular limitation, for example: phenylthio Groups such as methyl, 1-phenylthioethyl or 2-phenylthioethyl.

本發明中,「苯基亞磺醯基C1至C3烷基」在無特別限定下係表示(苯基)-S(=O)-(C1至C3烷基)-基,例如可舉:苯基亞磺醯基甲基、1-苯基亞磺醯基乙基或2-苯基亞磺醯基乙基等基。 In the present invention, "phenylsulfinyl C 1 to C 3 alkyl" means (phenyl)-S(=O)-(C 1 to C 3 alkyl)-yl without limitation, for example Examples include groups such as phenylsulfinylmethyl, 1-phenylsulfinylethyl, or 2-phenylsulfinylethyl.

本發明中,「苯基磺醯基C1至C3烷基」在無特別限定下係表示(苯基)-S(=O)2-(C1至C3烷基)-基,例如可舉:苯基磺醯基甲基、1-苯基磺醯基乙基或2-苯基磺醯基乙基等基。 In the present invention, "phenylsulfonyl C 1 to C 3 alkyl" represents (phenyl)-S(=O) 2 -(C 1 to C 3 alkyl)-yl without limitation, for example Examples include groups such as phenylsulfonylmethyl, 1-phenylsulfonylethyl, or 2-phenylsulfonylethyl.

本發明中,「雜芳基硫基C1至C3烷基」在無特別限定下係表示雜芳基部分是上述意義相同的(雜芳基)-S-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)硫基甲基、(吡啶-3-基)硫基甲基、(吡啶-4-基)硫基甲基、(噻唑-2-基)硫基甲基、(噻唑-4-基)硫基甲基、(噻唑-5-基)硫基甲基、(吡唑-1-基)硫基甲基、(吡唑-3-基)硫基甲基、(吡唑-4-基)硫基甲基或(吡唑-5-基)硫基甲基等基。 In the present invention, "heteroarylthio C 1 to C3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl)-S-(C 1 to C 3 alkyl) unless otherwise specified. -Group, for example, (pyridin-2-yl)thiomethyl, (pyridin-3-yl)thiomethyl, (pyridin-4-yl)thiomethyl, (thiazol-2-yl) Thiomethyl, (thiazol-4-yl)thiomethyl, (thiazol-5-yl)thiomethyl, (pyrazol-1-yl)thiomethyl, (pyrazol-3-yl) Groups such as thiomethyl, (pyrazol-4-yl)thiomethyl or (pyrazol-5-yl)thiomethyl.

本發明中,「雜芳基亞磺醯基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-S(=O)-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)亞磺醯基甲基、(吡啶-3-基)亞磺醯基甲基、(吡啶-4-基)亞磺醯基甲基、(噻唑-2-基)亞磺醯基甲基、(噻唑-4-基)亞磺醯基甲基、(噻唑-5-基)亞磺醯基甲基、(吡唑-1- 基)亞磺醯基甲基、(吡唑-3-基)亞磺醯基甲基、(吡唑-4-基)亞磺醯基甲基或(吡唑-5-基)亞磺醯基甲基等基。 In the present invention, "heteroarylsulfinyl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl)-S(=O)-( C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)sulfinylmethyl, (pyridin-3-yl)sulfinylmethyl, (pyridin-4-yl) Sulfonylmethyl, (thiazol-2-yl)sulfinylmethyl, (thiazol-4-yl)sulfinylmethyl, (thiazol-5-yl)sulfinylmethyl, ( Pyrazol-1-yl)sulfinylmethyl, (pyrazol-3-yl)sulfinylmethyl, (pyrazol-4-yl)sulfinylmethyl or (pyrazole-5- Group) sulfenylmethyl and other groups.

本發明中,「雜芳基磺醯基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-S(=O)2-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)磺醯基甲基、(吡啶-3-基)磺醯基甲基、(吡啶-4-基)磺醯基甲基、(噻唑-2-基)磺醯基甲基、(噻唑-4-基)磺醯基甲基、(噻唑-5-基)磺醯基甲基、(吡唑-1-基)磺醯基甲基、(吡唑-3-基)磺醯基甲基、(吡唑-4-基)磺醯基甲基或(吡唑-5-基)磺醯基甲基等基。 In the present invention, "heteroarylsulfonyl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl)-S(=O) 2 -( C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)sulfonylmethyl, (pyridin-3-yl)sulfonylmethyl, (pyridin-4-yl)sulfonyl Methyl, (thiazol-2-yl)sulfonylmethyl, (thiazol-4-yl)sulfonylmethyl, (thiazol-5-yl)sulfonylmethyl, (pyrazol-1-yl ) Sulfonylmethyl, (pyrazol-3-yl)sulfonylmethyl, (pyrazol-4-yl)sulfonylmethyl or (pyrazol-5-yl)sulfonylmethyl and other groups .

本發明中,「苯基C1至C3烷基硫基C1至C3烷基」在無特別限定下係表示(苯基)-(C1至C3烷基)-S-(C1至C3烷基)-基,例如可舉:苄基硫基甲基、1-苄基硫基乙基或2-苄基硫基乙基等基。 In the present invention, "phenyl C 1 to C 3 alkylthio C 1 to C3 alkyl" means (phenyl)-(C 1 to C 3 alkyl)-S-(C 1 without limitation) Examples of the C 3 alkyl)-yl group include benzylthiomethyl, 1-benzylthioethyl, or 2-benzylthioethyl.

本發明中,「苯基C1至C3烷基亞磺醯基C1至C3烷基」在無特別限定下係表示(苯基)-(C1至C3烷基)-S(=O)-(C1至C3烷基)-基,例如可舉:苄基亞磺醯基甲基、1-苄基亞磺醯基乙基或2-苄基亞磺醯基乙基等基。 In the present invention, "phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl" means (phenyl)-(C 1 to C 3 alkyl)-S( =O)-(C 1 to C 3 alkyl)-yl, for example: benzylsulfinylmethyl, 1-benzylsulfinylethyl or 2-benzylsulfinylethyl Equal base.

本發明中,「苯基C1至C3烷基磺醯基C1至C3烷基」在無特別限定下係表示(苯基)-(C1至C3烷基)-S(=O)2-(C1至C3烷基)-基,例如可舉:苄基磺醯基甲基、1-苄基磺醯基乙基或2-苄基磺醯基乙基等基。 In the present invention, "phenyl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl" means (phenyl)-(C 1 to C 3 alkyl)-S(= O) 2 -(C 1 to C 3 alkyl)-yl, for example, a group such as benzylsulfonylmethyl, 1-benzylsulfonylethyl, or 2-benzylsulfonylethyl.

本發明中,「雜芳基C1至C3烷基硫基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-(C1至C3烷基)-S-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)甲基硫基甲基、 (吡啶-3-基)甲基硫基甲基、(吡啶-4-基)甲基硫基甲基、(噻唑-2-基)甲基硫基甲基、(噻唑-4-基)甲基硫基甲基、(噻唑-5-基)甲基硫基甲基、(吡唑-1-基)甲基硫基甲基、(吡唑-3-基)甲基硫基甲基、(吡唑-4-基)甲基硫基甲基或(吡唑-5-基)甲基硫基甲基等基。 In the present invention, "heteroaryl C 1 to C 3 alkylthio C 1 to C3 alkyl" means that the heteroaryl portion is the same as the above (heteroaryl)-(C 1 To C 3 alkyl)-S-(C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)methylthiomethyl, (pyridin-3-yl)methylthio Methyl, (pyridin-4-yl)methylthiomethyl, (thiazol-2-yl)methylthiomethyl, (thiazol-4-yl)methylthiomethyl, (thiazole-5- Yl)methylthiomethyl, (pyrazol-1-yl)methylthiomethyl, (pyrazol-3-yl)methylthiomethyl, (pyrazol-4-yl)methylthio Ylmethyl or (pyrazol-5-yl)methylthiomethyl and other groups.

本發明中,「雜芳基C1至C3烷基亞磺醯基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-(C1至C3烷基)-S(=O)-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)甲基亞磺醯基甲基、(吡啶-3-基)甲基亞磺醯基甲基、(吡啶-4-基)甲基亞磺醯基甲基、(噻唑-2-基)甲基亞磺醯基甲基、(噻唑-4-基)甲基亞磺醯基甲基、(噻唑-5-基)甲基亞磺醯基甲基、(吡唑-1-基)甲基亞磺醯基甲基、(吡唑-3-基)甲基亞磺醯基甲基、(吡唑-4-基)甲基亞磺醯基甲基或(吡唑-5-基)甲基亞磺醯基甲基等基。 In the present invention, "heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl) unless otherwise specified. (C 1 to C 3 alkyl)-S(=O)-(C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)methylsulfinylmethyl, (pyridine -3-yl)methylsulfinylmethyl, (pyridin-4-yl)methylsulfinylmethyl, (thiazol-2-yl)methylsulfinylmethyl, (thiazole-4 -Yl)methylsulfinylmethyl, (thiazol-5-yl)methylsulfinylmethyl, (pyrazol-1-yl)methylsulfinylmethyl, (pyrazole-3 -Yl)methylsulfinylmethyl, (pyrazol-4-yl)methylsulfinylmethyl or (pyrazol-5-yl)methylsulfinylmethyl and other groups.

本發明中,「雜芳基C1至C3烷基磺醯基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-(C1至C3烷基)-S(=O)2-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)甲基磺醯基甲基、(吡啶-3-基)甲基磺醯基甲基、(吡啶-4-基)甲基磺醯基甲基、(噻唑-2-基)甲基磺醯基甲基、(噻唑-4-基)甲基磺醯基甲基、(噻唑-5-基)甲基磺醯基甲基、(吡唑-1-基)甲基磺醯基甲基、(吡唑-3-基)甲基磺醯基甲基、(吡唑-4-基)甲基磺醯基甲基或(吡唑-5-基)甲基磺醯基甲基等基。 In the present invention, "heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl)-( C 1 to C 3 alkyl)-S(=O) 2 -(C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)methylsulfonylmethyl, (pyridine- 3-yl)methylsulfonylmethyl, (pyridin-4-yl)methylsulfonylmethyl, (thiazol-2-yl)methylsulfonylmethyl, (thiazol-4-yl)methyl Sulfonylmethyl, (thiazol-5-yl)methylsulfonylmethyl, (pyrazol-1-yl)methylsulfonylmethyl, (pyrazol-3-yl)methylsulfonyl Groups such as methylmethyl, (pyrazol-4-yl)methylsulfonylmethyl or (pyrazol-5-yl)methylsulfonylmethyl.

本發明中,「苯基羰基C1至C3烷基」在無特別限定下係表示(苯基)-C(=O)-(C1至C3烷基)-基,例如可舉:苯基羰基甲基、1-苯基羰基乙基、2-苯基羰基乙基、1-苯基羰基丙基、3-苯基羰基丙基等 基。 In the present invention, "phenylcarbonyl C 1 to C 3 alkyl group" means (phenyl)-C(=O)-(C 1 to C 3 alkyl)- group without particular limitation, for example: Phenylcarbonylmethyl, 1-phenylcarbonylethyl, 2-phenylcarbonylethyl, 1-phenylcarbonylpropyl, 3-phenylcarbonylpropyl and other groups.

本發明中,「雜芳基羰基C1至C3烷基」在無特別限定下係表示雜芳基部分是與上述意義相同的(雜芳基)-C(=O)-(C1至C3烷基)-基,例如可舉:(吡啶-2-基)羰基甲基、1-(吡啶-2-基)羰基乙基、2-(吡啶-2-基)羰基乙基、1-(吡啶-2-基)羰基丙基、3-(吡啶-2-基)羰基丙基等基。 In the present invention, "heteroarylcarbonyl C 1 to C 3 alkyl" means that the heteroaryl moiety is the same as the above (heteroaryl)-C(=O)-(C 1 to C 3 alkyl)-yl, for example: (pyridin-2-yl)carbonylmethyl, 1-(pyridin-2-yl)carbonylethyl, 2-(pyridin-2-yl)carbonylethyl, 1 -(Pyridin-2-yl)carbonylpropyl, 3-(pyridin-2-yl)carbonylpropyl and other groups.

本發明中,「羥基羰基C1至C6烷基」在無特別限定下係烷基部分為上述意義的HO-C(=O)-(C1至C6烷基)-基,例如可舉,羥基羰基甲基、羥基羰基乙基、羥基羰基丙基等基。 In the present invention, the "hydroxycarbonyl C 1 to C 6 alkyl group" is an HO-C(=O)-(C 1 to C 6 alkyl)- group in the above meaning unless otherwise specified. Examples include groups such as hydroxycarbonylmethyl, hydroxycarbonylethyl, and hydroxycarbonylpropyl.

本發明中,「C1至C6鹵烷基硫基」在無特別限定下係鹵烷基部分為上述意義的(C1至C6鹵烷基)-S-基,例如可舉:氟甲基硫基、二氟甲基硫基、三氟甲基硫基、三氯甲基硫基、2,2,2-三氟乙基硫基、五氟乙基硫基、2,2,2-三氯乙基硫基、3,3,3-三氟丙基硫基、1,1,2,3,3,3-六氟丙基硫基、七氟丙基硫基、1,1,1,3,3,3-六氟丙烷-2-硫基、七氟丙烷-2-硫基或4,4,4-三氟丁基硫基等基。 In the present invention, the "C 1 to C 6 haloalkylthio group" is a (C 1 to C 6 haloalkyl)-S- group in the above sense unless otherwise specified. The haloalkyl moiety is, for example, fluorine Methylthio, difluoromethylthio, trifluoromethylthio, trichloromethylthio, 2,2,2-trifluoroethylthio, pentafluoroethylthio, 2,2, 2-trichloroethylthio, 3,3,3-trifluoropropylthio, 1,1,2,3,3,3-hexafluoropropylthio, heptafluoropropylthio, 1, Groups such as 1,1,3,3,3-hexafluoropropane-2-thio, heptafluoropropane-2-thio or 4,4,4-trifluorobutylthio.

本發明中,「C1至C6鹵烷基亞磺醯基」在無特別限定下係鹵烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)-基,例如可舉:二氟甲基亞磺醯基、三氟甲基亞磺醯基、三氯甲基亞磺醯基、2,2,2-三氟乙基亞磺醯基、2,2,2-三氯乙基亞磺醯基、五氟乙基亞磺醯基、3,3,3-三氟丙基亞磺醯基、七氟丙基亞磺醯基或七氟-2-丙基亞磺醯基等基。 In the present invention, "C 1 to C 6 haloalkylsulfinyl" is a (C 1 to C 6 haloalkyl)-S(=O)- group in the above meaning unless otherwise specified , For example: difluoromethylsulfinyl, trifluoromethylsulfinyl, trichloromethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2,2 ,2-trichloroethylsulfinyl, pentafluoroethylsulfinyl, 3,3,3-trifluoropropylsulfinyl, heptafluoropropylsulfinyl, or heptafluoro-2- Propylsulfinyl and other groups.

本發明中,「單(C1至C6鹵烷基)胺基羰基」在無特別限定下係鹵烷基部分是與上述意義相同的(C1至C6鹵烷基)-NH-C(=O)-基,例如可舉:(2,2-二氟乙基)胺基羰基、(2-氯-2,2-二氟乙基)胺基 羰基、(2,2,2-三氟乙基)胺基羰基、(3,3,3-三氟丙基)胺基羰基或(2,2-二氟丙基)胺基羰基等基。 In the present invention, the "mono(C 1 to C 6 haloalkyl)aminocarbonyl group" is a haloalkyl moiety which is the same as the above (C 1 to C 6 haloalkyl)-NH-C unless otherwise specified. (=O)- group, for example: (2,2-difluoroethyl)aminocarbonyl, (2-chloro-2,2-difluoroethyl)aminocarbonyl, (2,2,2- Groups such as trifluoroethyl)aminocarbonyl, (3,3,3-trifluoropropyl)aminocarbonyl or (2,2-difluoropropyl)aminocarbonyl.

本發明中,「二(C1至C6鹵烷基)胺基羰基」在無特別限定下係鹵烷基部分是與上述意義相同的(C1至C6鹵烷基)2-N-C(=O)-基,2個鹵烷基亦可彼此相異,例如可舉:二(2,2-二氟乙基)胺基羰基、二(2,2,2-三氟乙基)胺基羰基、N-(2,2-二氟乙基)-N-(2,2,2-三氟乙基)胺基羰基、N-(2-氯-2,2-二氟乙基)-N-(2,2,2-三氟乙基)胺基羰基或N-(2,2,2-三氟乙基)-N-(2,2,2-三氟丙基)胺基羰基等基。 In the present invention, "di(C 1 to C 6 haloalkyl)aminocarbonyl" is a haloalkyl moiety which is the same as above (C 1 to C 6 haloalkyl) 2 -NC( =O)- group, two haloalkyl groups can also be different from each other, for example: di(2,2-difluoroethyl)aminocarbonyl, di(2,2,2-trifluoroethyl)amine Carbonyl, N-(2,2-difluoroethyl)-N-(2,2,2-trifluoroethyl)aminocarbonyl, N-(2-chloro-2,2-difluoroethyl) -N-(2,2,2-trifluoroethyl)aminocarbonyl or N-(2,2,2-trifluoroethyl)-N-(2,2,2-trifluoropropyl)amino Carbonyl and other groups.

本發明中,「(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基」在無特別限定下係烷基部分是與上述意義相同的(1,3-二側氧基異二氫吲哚-2-基)-(C1至C3烷基)-基,例如可舉:(1,3-二側氧基異二氫吲哚-2-基)甲基等基。 In the present invention, "(1,3-bi- pendant isoindoline-2-yl)C 1 to C 3 alkyl" is an alkyl moiety having the same meaning as described above (1, 3-dioxoisoindoline-2-yl)-(C 1 to C 3 alkyl)-yl, for example: (1,3-dioxoisoindolin-2-yl Group) methyl and other groups.

本發明中,「N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基」在無特別限定下係胺基的2個氫原子分別經(C1至C6烷基)-S(=O)2-基及經(C1至C6烷基)-基取代的基,例如可舉:(N-甲基磺醯基-N-甲基)胺基、(N-乙基磺醯基-N-甲基)胺基、(N-甲基磺醯基-N-乙基)胺基或(N-乙基磺醯基-N-甲基)胺基等基。 In the present invention, "N-(C 1 to C 6 alkylsulfonyl)-N-(C 1 to C 6 alkyl)amino group", without particular limitation, the two hydrogen atoms of the amine group respectively pass ( C 1 to C 6 alkyl)-S(=O) 2 -group and a group substituted with (C 1 to C 6 alkyl)- group, for example: (N-methylsulfonyl-N-methyl )Amino, (N-ethylsulfonyl-N-methyl)amino, (N-methylsulfonyl-N-ethyl)amino or (N-ethylsulfonyl-N-ethyl) Methyl) amine and other groups.

本發明中,「N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基」在無特別限定下係表示胺基的2個氫原子分別經(C1至C6鹵烷基)-S(=O)2-基及(C1至C6烷基)-基取代的基,例如可舉:(N-二氟甲基磺醯基-N-甲基)胺基、(N-三氟甲基磺醯基-N-甲基)胺基、(N-九氟丁基磺醯基-N-甲基)胺基、(N-二氟甲基磺醯基-N-乙基)胺基、(N-三氟甲基磺醯基-N-乙基)胺基或(N-九氟丁基磺醯基-N-乙基)胺基等 基。 In the present invention, "N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino group" means, without particular limitation, two hydrogen atoms of the amine group Groups substituted with (C 1 to C 6 haloalkyl)-S(=O) 2 -groups and (C 1 to C 6 alkyl)- groups, for example: (N-difluoromethylsulfonyl) -N-methyl)amino, (N-trifluoromethylsulfonyl-N-methyl)amino, (N-nonafluorobutylsulfonyl-N-methyl)amino, (N- Difluoromethylsulfonyl-N-ethyl)amine, (N-trifluoromethylsulfonyl-N-ethyl)amine or (N-nonafluorobutylsulfonyl-N-ethyl ) Amino groups and other groups.

本發明中,「單(C1至C6烷基磺醯基)胺基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-S(=O)2-NH-基,例如可舉:甲基磺醯基胺基、乙基磺醯基胺基或異丙基磺醯基胺基等基。 In the present invention, the "mono(C 1 to C 6 alkylsulfonyl)amino group" is an alkyl moiety of the above meaning (C 1 to C 6 alkyl)-S(=O) 2 unless otherwise specified. The -NH- group includes, for example, groups such as a methylsulfonylamino group, an ethylsulfonylamino group, or an isopropylsulfonylamino group.

本發明中,「單(C1至C6鹵烷基磺醯基)胺基」在無特別限定下係鹵烷基部分為上述意義的(C1至C6鹵烷基)-S(=O)2-NH-基,例如可舉:二氟甲基磺醯基胺基或三氟甲基磺醯基胺基、二氟甲基磺醯基胺基等基。 In the present invention, the "mono(C 1 to C 6 haloalkylsulfonyl)amino group" is a haloalkyl part of the above meaning (C 1 to C 6 haloalkyl)-S(= O) 2 -NH- group, for example, a group such as difluoromethylsulfonylamino group, trifluoromethylsulfonylamino group, difluoromethylsulfonylamino group or the like.

本發明中,「C1至C6烷基羰基氧基C1至C3烷基」在無特別限定下係烷基部分為上述意義的(C1至C6烷基)-C(=O)-O-(C1至C3烷基)-基,例如可舉:甲基羰基氧基甲基等基。 In the present invention, "C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl" is an alkyl portion of the above meaning (C 1 to C 6 alkyl)-C(=O )-O-(C 1 to C 3 alkyl)- group, for example, a group such as methylcarbonyloxymethyl.

本發明中,「C1至C6鹵烷基羰基氧基C1至C3烷基」在無特別限定下係烷基部分為上述意義的(C1至C6鹵烷基)-C(=O)-O-(C1至C3烷基)-基,例如可舉:三氟甲基羰基氧基甲基等基。 In the present invention, "C 1 to C 6 haloalkylcarbonyloxy C 1 to C 3 alkyl" is an alkyl portion of the above meaning (C 1 to C 6 haloalkyl)-C( =O)-O-(C 1 to C 3 alkyl)- group, for example, groups such as trifluoromethylcarbonyloxymethyl.

本發明中,農業上可容許的鹽,在通式[I]或[II]表示的本發明化合物中,在其結構中存在羥基、羧基或胺基等時或吡啶環的氮原子,意指此等與金屬或有機鹼的鹽或無機酸或有機酸的鹽;金屬可舉鈉或鉀等鹼金屬、或鎂或鈣等鹼土類金屬,有機鹼可舉:三乙基胺或二異丙基胺等,無機酸可舉:磷酸、鹽酸、氫溴酸、氫碘酸、硼酸、或硫酸等,再者,有機酸可舉:甲酸、乙酸、乳酸、抗壞血酸、琥珀酸、反丁烯二酸、順丁烯二酸、草酸、檸檬酸、苯甲酸、水楊酸、酒石酸、甲磺酸、4-甲苯磺酸或三氟甲磺酸等。 In the present invention, the agriculturally acceptable salt, in the compound of the present invention represented by the general formula [I] or [II], when a hydroxyl group, a carboxyl group, an amine group or the like is present in its structure or a nitrogen atom of a pyridine ring means These salts with metals or organic bases or salts of inorganic acids or organic acids; metals can include alkali metals such as sodium or potassium, or alkaline earth metals such as magnesium or calcium, and organic alkalis can include triethylamine or diisopropyl Basic amines, inorganic acids include phosphoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, boric acid, sulfuric acid, etc. Furthermore, organic acids include formic acid, acetic acid, lactic acid, ascorbic acid, succinic acid, fumaric acid Acid, maleic acid, oxalic acid, citric acid, benzoic acid, salicylic acid, tartaric acid, methanesulfonic acid, 4-toluenesulfonic acid or trifluoromethanesulfonic acid, etc.

其次,將包含在通式[I]表示的本發明的5-(1,2,4-三唑-5-基)苯 甲醯胺衍生物的化合物的代表性化合物例示於第1表至第43表,將包含在通式[II]表示的本發明的5-(1,2,4-三唑-5-基)苯甲酸衍生物的化合物的代表性化合物例示於第44表至第74表,將包含在通式[III]表示的本發明的5-苯基-1,2,4-三唑衍生物的化合物的代表性化合物例示於第75表至第77表。但是,包含在本發明的衍生物的化合物不限定於該等。再者,表中的化合物號碼是在後續記載中被參照。 Next, the 5-(1,2,4-triazol-5-yl)benzene of the present invention represented by the general formula [I] Representative compounds of the compounds of formamide derivatives are exemplified in Tables 1 to 43, and are included in the 5-(1,2,4-triazol-5-yl) of the present invention represented by the general formula [II] Representative compounds of compounds of benzoic acid derivatives are shown in Table 44 to Table 74, and include compounds of the 5-phenyl-1,2,4-triazole derivative of the present invention represented by the general formula [III] Representative examples of compounds are shown in Table 75 to Table 77. However, the compounds included in the derivatives of the present invention are not limited to these. In addition, the compound numbers in the table are referred to in the subsequent description.

此外,包含在本發明的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物、5-(1,2,4-三唑-5-基)苯甲酸衍生物或5-苯基-1,2,4-三唑衍生物的化合物是視其取代基的種類而會有E-體及Z-體的幾何異構物的存在,本發明是包含該等以任意的比率含有E-體、Z-體或E-體及Z-體的混合物。再者,包含在本發明的化合物係具有起因於存在1個或2個以上的不對稱碳原子及不對稱硫原子所致之光學異構物的存在的情況,本發明包含所有的光學活性物、外消旋物或非鏡像異構物。 In addition, the 5-(1,2,4-triazol-5-yl)benzamide derivatives and 5-(1,2,4-triazol-5-yl)benzoic acid derivatives contained in the present invention Or 5-phenyl-1,2,4-triazole derivative compounds, depending on the type of substituents, there may be geometric isomers of E-form and Z-form, the present invention includes such The arbitrary ratio contains E-body, Z-body, or a mixture of E-body and Z-body. Furthermore, the compounds included in the present invention may have optical isomers due to the presence of one or more asymmetric carbon atoms and asymmetric sulfur atoms, and the present invention includes all optically active substances. , Racemate or diastereomer.

本說明書中的表中的下述標示係分別如下述表示的基。 The following symbols in the tables in this specification are as shown below.

Me:甲基; Me: methyl;

Et:乙基; Et: ethyl;

Pr:正丙基; Pr: n-propyl;

i-Pr:異丙基或iso-丙基; i-Pr: isopropyl or iso-propyl;

t-Bu:第三丁基; t-Bu: tertiary butyl;

Bu:正丁基 Bu: n-butyl

i-Bu:異丁基或iso-丁基; i-Bu: isobutyl or iso-butyl;

s-Bu:第二丁基; s-Bu: second butyl;

Pen:正戊基; Pen: n-pentyl;

Hex:正己基; Hex: n-hexyl;

c-Pr:環丙基; c-Pr: cyclopropyl;

c-Bu:環丁基; c-Bu: cyclobutyl;

c-Pen:環戊基; c-Pen: cyclopentyl;

c-Hex:環己基; c-Hex: cyclohexyl;

CHF2:二氟甲基; CHF 2 : difluoromethyl;

CF3:三氟甲基; CF 3 : trifluoromethyl;

(4-CF3)Ph:4-三氟甲基苯基; (4-CF 3 )Ph: 4-trifluoromethylphenyl;

(2-F-4-CF3)Ph:2-氟-4-三氟甲基苯基; (2-F-4-CF 3 )Ph: 2-fluoro-4-trifluoromethylphenyl;

(2,2-F2)c-Pr:2,2-二氟環丙基; (2,2-F 2 )c-Pr: 2,2-difluorocyclopropyl;

THF:四氫呋喃; THF: tetrahydrofuran;

THP:四氫吡喃; THP: tetrahydropyran;

NPhth:酞醯亞胺 NPhth: phthalimide

Figure 108126125-A0202-12-0055-216
Figure 108126125-A0202-12-0055-216

Figure 108126125-A0202-12-0056-217
Figure 108126125-A0202-12-0056-217

Figure 108126125-A0202-12-0057-218
Figure 108126125-A0202-12-0057-218

Figure 108126125-A0202-12-0058-219
Figure 108126125-A0202-12-0058-219

Figure 108126125-A0202-12-0059-220
Figure 108126125-A0202-12-0059-220

Figure 108126125-A0202-12-0060-221
Figure 108126125-A0202-12-0060-221

Figure 108126125-A0202-12-0061-222
Figure 108126125-A0202-12-0061-222

Figure 108126125-A0202-12-0062-223
Figure 108126125-A0202-12-0062-223

Figure 108126125-A0202-12-0063-224
Figure 108126125-A0202-12-0063-224

Figure 108126125-A0202-12-0064-225
Figure 108126125-A0202-12-0064-225

Figure 108126125-A0202-12-0065-226
Figure 108126125-A0202-12-0065-226

Figure 108126125-A0202-12-0066-227
Figure 108126125-A0202-12-0066-227

Figure 108126125-A0202-12-0067-228
Figure 108126125-A0202-12-0067-228

Figure 108126125-A0202-12-0068-229
Figure 108126125-A0202-12-0068-229

Figure 108126125-A0202-12-0069-230
Figure 108126125-A0202-12-0069-230

Figure 108126125-A0202-12-0070-231
Figure 108126125-A0202-12-0070-231

Figure 108126125-A0202-12-0071-232
Figure 108126125-A0202-12-0071-232

Figure 108126125-A0202-12-0072-233
Figure 108126125-A0202-12-0072-233

Figure 108126125-A0202-12-0073-234
Figure 108126125-A0202-12-0073-234

Figure 108126125-A0202-12-0074-235
Figure 108126125-A0202-12-0074-235

Figure 108126125-A0202-12-0075-236
Figure 108126125-A0202-12-0075-236

Figure 108126125-A0202-12-0076-237
Figure 108126125-A0202-12-0076-237

Figure 108126125-A0202-12-0077-238
Figure 108126125-A0202-12-0077-238

Figure 108126125-A0202-12-0078-239
Figure 108126125-A0202-12-0078-239

Figure 108126125-A0202-12-0079-240
Figure 108126125-A0202-12-0079-240

Figure 108126125-A0202-12-0080-241
Figure 108126125-A0202-12-0080-241

Figure 108126125-A0202-12-0081-242
Figure 108126125-A0202-12-0081-242

Figure 108126125-A0202-12-0082-243
Figure 108126125-A0202-12-0082-243

Figure 108126125-A0202-12-0083-244
Figure 108126125-A0202-12-0083-244

Figure 108126125-A0202-12-0084-245
Figure 108126125-A0202-12-0084-245

Figure 108126125-A0202-12-0085-246
Figure 108126125-A0202-12-0085-246

Figure 108126125-A0202-12-0086-247
Figure 108126125-A0202-12-0086-247

Figure 108126125-A0202-12-0087-248
Figure 108126125-A0202-12-0087-248

Figure 108126125-A0202-12-0088-249
Figure 108126125-A0202-12-0088-249

Figure 108126125-A0202-12-0089-250
Figure 108126125-A0202-12-0089-250

Figure 108126125-A0202-12-0090-251
Figure 108126125-A0202-12-0090-251

Figure 108126125-A0202-12-0091-252
Figure 108126125-A0202-12-0091-252

Figure 108126125-A0202-12-0092-253
Figure 108126125-A0202-12-0092-253

Figure 108126125-A0202-12-0093-254
Figure 108126125-A0202-12-0093-254

Figure 108126125-A0202-12-0094-255
Figure 108126125-A0202-12-0094-255

Figure 108126125-A0202-12-0095-256
Figure 108126125-A0202-12-0095-256

Figure 108126125-A0202-12-0095-257
Figure 108126125-A0202-12-0095-257

Figure 108126125-A0202-12-0096-258
Figure 108126125-A0202-12-0096-258

Figure 108126125-A0202-12-0097-259
Figure 108126125-A0202-12-0097-259

Figure 108126125-A0202-12-0098-260
Figure 108126125-A0202-12-0098-260

Figure 108126125-A0202-12-0099-261
Figure 108126125-A0202-12-0099-261

Figure 108126125-A0202-12-0100-262
Figure 108126125-A0202-12-0100-262

Figure 108126125-A0202-12-0101-263
Figure 108126125-A0202-12-0101-263

Figure 108126125-A0202-12-0102-264
Figure 108126125-A0202-12-0102-264

Figure 108126125-A0202-12-0103-265
Figure 108126125-A0202-12-0103-265

Figure 108126125-A0202-12-0104-266
Figure 108126125-A0202-12-0104-266

Figure 108126125-A0202-12-0105-267
Figure 108126125-A0202-12-0105-267

Figure 108126125-A0202-12-0106-268
Figure 108126125-A0202-12-0106-268

Figure 108126125-A0202-12-0107-269
Figure 108126125-A0202-12-0107-269

Figure 108126125-A0202-12-0108-270
Figure 108126125-A0202-12-0108-270

Figure 108126125-A0202-12-0109-271
Figure 108126125-A0202-12-0109-271

Figure 108126125-A0202-12-0110-272
Figure 108126125-A0202-12-0110-272

Figure 108126125-A0202-12-0111-273
Figure 108126125-A0202-12-0111-273

Figure 108126125-A0202-12-0112-274
Figure 108126125-A0202-12-0112-274

Figure 108126125-A0202-12-0113-275
Figure 108126125-A0202-12-0113-275

Figure 108126125-A0202-12-0114-276
Figure 108126125-A0202-12-0114-276

Figure 108126125-A0202-12-0115-277
Figure 108126125-A0202-12-0115-277

Figure 108126125-A0202-12-0116-278
Figure 108126125-A0202-12-0116-278

Figure 108126125-A0202-12-0117-279
Figure 108126125-A0202-12-0117-279

Figure 108126125-A0202-12-0118-280
Figure 108126125-A0202-12-0118-280

Figure 108126125-A0202-12-0119-281
Figure 108126125-A0202-12-0119-281

Figure 108126125-A0202-12-0120-282
Figure 108126125-A0202-12-0120-282

Figure 108126125-A0202-12-0121-283
Figure 108126125-A0202-12-0121-283

Figure 108126125-A0202-12-0122-284
Figure 108126125-A0202-12-0122-284

Figure 108126125-A0202-12-0123-285
Figure 108126125-A0202-12-0123-285

Figure 108126125-A0202-12-0124-286
Figure 108126125-A0202-12-0124-286

Figure 108126125-A0202-12-0125-287
Figure 108126125-A0202-12-0125-287

Figure 108126125-A0202-12-0126-288
Figure 108126125-A0202-12-0126-288

Figure 108126125-A0202-12-0127-289
Figure 108126125-A0202-12-0127-289

Figure 108126125-A0202-12-0128-290
Figure 108126125-A0202-12-0128-290

Figure 108126125-A0202-12-0129-291
Figure 108126125-A0202-12-0129-291

Figure 108126125-A0202-12-0130-292
Figure 108126125-A0202-12-0130-292

另一方面,通式[I]、[II]或[III]表示的本發明化合物可依照下述所示的製造法製造,惟,不限定於此等方法。此外,以下,例如「通式[I]表示的化合物」、「式[I]表示的化合物」及「化合物[I]」均係相同意義。 On the other hand, the compound of the present invention represented by the general formula [I], [II] or [III] can be produced according to the production method shown below, but it is not limited to these methods. In addition, hereinafter, for example, "a compound represented by the general formula [I]", "a compound represented by the formula [I]", and "compound [I]" all have the same meaning.

<製造方法1> <Manufacturing method 1>

本發明化合物中,通式[II-2]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [II-2] can be produced according to the following method, for example.

麻煩打字室將[0227]至[0440]出現的圖中的「製程」改為「步驟」 Trouble typing room to change the "process" in the figure from [0227] to [0440] to "step"

Figure 108126125-A0202-12-0131-293
Figure 108126125-A0202-12-0131-293

(式中,X1表示鹵原子,R10表示C1至C6烷基等,B、R3、R4、R5、R6及n表示與前述相同意義) (In the formula, X 1 represents a halogen atom, R 10 represents a C 1 to C 6 alkyl group, etc., B, R 3 , R 4 , R 5 , R 6 and n represent the same meaning as above)

亦即,通式[II-2]表示的化合物是可在(步驟1-1)適當的溶媒中,適當的觸媒的存在下或不存在下獲得通式[III-1]表示的化合物經氰基化的化合物[III-2]後,(步驟1-2)在適當的溶媒中,將通式[III-2]表示的化合物在適當的酸或鹼的存在下水解而製造。 That is, the compound represented by the general formula [II-2] is a compound represented by the general formula [III-1] that can be obtained in the appropriate solvent (step 1-1) in the presence or absence of an appropriate catalyst After the cyanated compound [III-2], (Step 1-2), the compound represented by the general formula [III-2] is hydrolyzed in an appropriate solvent in the presence of an appropriate acid or base to produce it.

再者,(步驟1-3)在適當的溶媒中,將通式[III-1]表示的化合物在適當的觸媒及適當的鹼的存在下,進行一氧化碳插入反應而得到本發明化合物中[II-1]表示的化合物後,(步驟1-4)在適當的溶媒中,將通式[II-1]表示的化合物在適當的酸或鹼的存在下,水解而可製造化合物[II-2]。再者,(步驟1-5)在水中或水及適當的溶劑的混合溶劑中,將通式[III-1]表示的 化合物在適當的觸媒及適當的鹼的存在下,進行一氧化碳插入反應而可製造化合物[II-2]。 Furthermore, (Step 1-3) In a suitable solvent, the compound represented by the general formula [III-1] is subjected to a carbon monoxide insertion reaction in the presence of a suitable catalyst and a suitable base to obtain the compound of the present invention [ After the compound represented by II-1] (Step 1-4), the compound represented by the general formula [II-1] is hydrolyzed in an appropriate solvent in the presence of an appropriate acid or base to produce the compound [II- 2]. Furthermore, (Step 1-5) In water or a mixed solvent of water and an appropriate solvent, the general formula [III-1] The compound can produce a compound [II-2] by performing a carbon monoxide insertion reaction in the presence of a suitable catalyst and a suitable base.

(步驟1-1) (Step 1-1)

本反應使用的氰化物例如可舉:氰化鈉、氰化鉀、氰化銨、氰化鋅、氰化銅或此等的混合物。此外,相對於化合物[III-1]1莫耳,氰化物的使用量通常是在1至100莫耳的範圍適當地選擇即可,佳者是1.0至5.0莫耳。 Examples of the cyanide used in this reaction include sodium cyanide, potassium cyanide, ammonium cyanide, zinc cyanide, copper cyanide, and mixtures thereof. In addition, the amount of cyanide used is usually appropriately selected in the range of 1 to 100 moles relative to 1 mole of compound [III-1], and preferably 1.0 to 5.0 moles.

本反應使用的觸媒可舉:四(三苯基膦)鈀、二氯化[1,1-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物等。此外,相對於化合物[III-1]1莫耳,觸媒的使用量通常是在0.001至0.5莫耳的範圍適當地選擇即可,佳者是0.01至0.2莫耳。 The catalyst used in this reaction may include tetrakis(triphenylphosphine)palladium, [1,1-bis(diphenylphosphino)ironxin]palladium(II)dichloromethane adduct of dichloride. In addition, the amount of catalyst used is usually appropriately selected in the range of 0.001 to 0.5 moles relative to 1 mole of compound [III-1], and preferably 0.01 to 0.2 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0132-126
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸(sulfolane)、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;吡啶、甲基吡啶等吡啶類;水,或此等混合溶劑等。此外,相對於化合物[III-1]1莫耳,溶劑的使用量是0.1至500公升,佳者是0.3至50公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0132-126
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; N,N-dimethylformamide, Non-protons such as N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane, 1,3-dimethyl-2-imidazolidinone Polar polar solvents; alcohols such as methanol, ethanol, 2-propanol; nitriles such as acetonitrile, propionitrile; esters such as ethyl acetate, butyl acetate, ethyl propionate; pentane, hexane, cyclohexane , Aliphatic hydrocarbons such as heptane; pyridines such as pyridine and picoline; water, or mixed solvents such as these. In addition, the amount of the solvent used is 0.1 to 500 liters relative to 1 mole of compound [III-1], preferably 0.3 to 50 liters.

本反應的反應溫度通常是由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually selected from an arbitrary temperature range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有 不同,惟,通常是10分鐘至72小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc. Different, but usually 10 minutes to 72 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[III-2]。單離的化合物[III-2]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated to separate the compound [III-2]. The isolated compound [III-2] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟1-2) (Step 1-2)

在本反應可使用的酸例如可舉:鹽酸、氫溴酸或硫酸等無機酸類;乙酸、丙酸、三氟乙酸等羧酸類;甲磺酸或三氟甲磺酸等磺酸類等。此外,相對於化合物[III-2]1莫耳,酸的使用量是在1至相當於溶劑量的莫耳的範圍適當地選擇即可,佳者是1.0至100.0莫耳。 Examples of acids that can be used in this reaction include inorganic acids such as hydrochloric acid, hydrobromic acid, and sulfuric acid; carboxylic acids such as acetic acid, propionic acid, and trifluoroacetic acid; and sulfonic acids such as methanesulfonic acid or trifluoromethanesulfonic acid. In addition, the amount of the acid used may be appropriately selected from the range of 1 to the molar amount corresponding to the amount of the solvent relative to 1 mole of the compound [III-2], preferably 1.0 to 100.0 moles.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類,氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類,碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類,碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類等。此外,相對於化合物[III-2]1莫耳,鹼的使用量是在0.1至50莫耳的範圍適當地選擇即可,佳者是0.5至20.0莫耳。 Examples of the base usable in this reaction include hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide, hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide, and sodium carbonate , Carbonates of alkali metals such as potassium carbonate, and inorganic bases such as alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate. In addition, the amount of the base used may be appropriately selected in the range of 0.1 to 50 moles relative to 1 mole of the compound [III-2], preferably 0.5 to 20.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0133-109
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;丙酮、甲基乙基酮、環己酮等酮類;水或此等混合溶劑等。此外,相對於化合物[III-2]1莫耳,溶劑的使用量是0.1至500公升,佳者是0.3至30公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0133-109
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrole Aprotic polar solvents such as ketones, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; alcohols such as methanol, ethanol, 2-propanol; acetonitrile, propionitrile, etc. Nitriles; ketones such as acetone, methyl ethyl ketone, cyclohexanone; water or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 500 liters relative to 1 mole of compound [III-2], preferably 0.3 to 30 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為 佳。 The reaction temperature of this reaction is usually any temperature in the temperature range from -30°C to the reflux temperature of the reaction system, but it is preferably carried out in the range of 0°C to 150°C. good.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是10分鐘至72小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 72 hours.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[II-2]。單離的化合物[II-2]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and the precipitated solid is filtered out or extracted with an organic solvent and then concentrated, thereby isolating the compound [II-2]. The isolated compound [II-2] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟1-3) (Steps 1-3)

在本反應可使用的觸媒係可使用過度金屬錯合物或過度金屬與配位子的組合,過度金屬錯合物例如可舉:四(三苯基膦)鈀或二氯[1,1’-雙(二苯基膦基)鐵莘]鈀-二氯甲烷加成物,過度金屬可舉:氯化鈀、溴化鈀、乙酸鈀等,配位子可舉:三甲基膦、三乙基膦、三丁基膦、三苯基膦、1,3-雙二甲基膦基丙烷、1,2-雙二苯基膦基乙烷、1,3-雙二苯基膦基丙烷等。此外,相對於化合物[III-1]1莫耳,觸媒的使用量是0.001至0.1莫耳,佳者是0.01至0.05莫耳。 The catalyst system that can be used in this reaction can use a transition metal complex or a combination of a transition metal and a ligand. Examples of the transition metal complex include tetrakis(triphenylphosphine)palladium or dichloro[1,1 '-Bis(diphenylphosphino)ironxin] palladium-dichloromethane adducts, transition metals include: palladium chloride, palladium bromide, palladium acetate, etc., ligands include trimethylphosphine, Triethylphosphine, tributylphosphine, triphenylphosphine, 1,3-bisdimethylphosphinopropane, 1,2-bisdiphenylphosphinoethane, 1,3-bisdiphenylphosphino Propane, etc. In addition, the amount of the catalyst used is 0.001 to 0.1 mol, preferably 0.01 to 0.05 mol, relative to 1 mol of the compound [III-1].

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類,碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類,三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類。此外,相對於化合物[III-1]1莫耳,鹼的使用量是0.1至10莫耳,佳者是0.1至2.0莫耳。但,有機鹼類的情況也可作為溶劑使用。 Examples of the base that can be used in this reaction include: hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide; and sodium carbonate , Potassium carbonate and other alkali metal carbonates, sodium bicarbonate, potassium bicarbonate and other alkali metal bicarbonates and other inorganic bases, triethylamine, 4-methylmorpholin, diisopropylethylamine, Organic bases such as 1,8-diazabicyclo[5.4.0]-7-undecene, pyridine, 4-N,N-dimethylaminopyridine, 2,6-lutidine, etc. In addition, the amount of the base used is 0.1 to 10 moles relative to 1 mole of compound [III-1], preferably 0.1 to 2.0 moles. However, organic bases can also be used as solvents.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0134-108
烷等醚類;苯、甲苯、二甲苯、氯 苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;丙酮、甲基乙基酮、環己酮等酮類;或此等混合溶劑等。此外,相對於化合物[III-1]1莫耳,溶劑的使用量是0.1至500公升,佳者是0.3至30公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0134-108
Ethers such as alkanes; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrole Aprotic polar solvents such as ketone, dimethyl sulfoxide, cyproterone, 1,3-dimethyl-2-imidazolidinone; alcohols such as methanol, ethanol, 2-propanol; acetonitrile, propionitrile, etc. Nitriles; ketones such as acetone, methyl ethyl ketone, cyclohexanone; or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 500 liters relative to 1 mole of compound [III-1], preferably 0.3 to 30 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應壓力是在通常大氣壓至50氣壓的範圍選擇任意的壓力即可,佳者是在1氣壓至未達10氣壓的範圍進行為佳。 The reaction pressure of this reaction may be any pressure within the range of ordinary atmospheric pressure to 50 atmospheric pressure, and it is preferably carried out in the range of 1 atmospheric pressure to less than 10 atmospheric pressure.

本反應的反應時間是隨反應溫度、反應壓力、反應基質、反應量等而有不同,通常是10分鐘至72小時。 The reaction time of this reaction varies with the reaction temperature, reaction pressure, reaction substrate, reaction amount, etc., and is usually 10 minutes to 72 hours.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[II-1]。單離的化合物[II-1]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and then the precipitated solid is filtered or extracted with an organic solvent and then concentrated to perform operations such as isolation of compound [II-1]. The isolated compound [II-1] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟1-4) (Steps 1-4)

在本反應可使用的酸、鹼、溶劑、反應溫度及反應時間係與步驟1-2相同。 The acid, base, solvent, reaction temperature and reaction time that can be used in this reaction are the same as in Step 1-2.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[II-2]。單離的化合物[II-2]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and the precipitated solid is filtered out or extracted with an organic solvent and then concentrated, thereby isolating the compound [II-2]. The isolated compound [II-2] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟1-5) (Steps 1-5)

在本反應可使用的鹼、溶劑、反應溫度及反應時間係與步驟1-3相 同。 The base, solvent, reaction temperature and reaction time that can be used in this reaction are the same as those in steps 1-3 with.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[II-2]。單離的化合物[II-2]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and the precipitated solid is filtered out or extracted with an organic solvent and then concentrated, thereby isolating the compound [II-2]. The isolated compound [II-2] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法2> <Manufacturing method 2>

本發明化合物中,通式[I-1]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-1] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0136-294
Figure 108126125-A0202-12-0136-294

(式中,L1表示鹵原子、基OC(=O)OR10、甲烷基磺醯基氧基、三氟甲烷基磺醯基氧基、苯磺醯基氧基或對甲苯磺醯基氧基,B、R1、R2、R3、R4、R5、R6、R10及n表示與前述相同的意義) (In the formula, L 1 represents a halogen atom, radical OC(=O)OR 10 , methanesulfonyloxy, trifluoromethanesulfonyloxy, benzenesulfonyloxy or p-toluenesulfonyloxy Group, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 10 and n represent the same meaning as above)

亦即,通式[I-1]表示的化合物係可以(步驟2-1)在適當的溶 劑中,適當的觸媒的存在下或不存在下,將化合物[II-2]製成屬於酸鹵化物或混合酸酐等活性衍生物的化合物[IV]之後,(步驟2-2)在適當的溶劑中,適當的鹼的存在下或不存在下,藉由與化合物[V]反應而製造。再者,通式[I-1]表示的化合物也可藉由(步驟2-3)將化合物[II-2]及化合物[V],在適當的縮合劑及適當的鹼的存在下或不存在下,在適當的溶劑中反應而製造。 That is, the compound system represented by the general formula [I-1] can (step 2-1) be dissolved in an appropriate In the agent, in the presence or absence of an appropriate catalyst, after compound [II-2] is made into compound [IV] which is an active derivative such as acid halide or mixed acid anhydride, (Step 2-2) It is produced by reacting with compound [V] in the presence of a suitable base in the presence or absence of a suitable base. Furthermore, the compound represented by the general formula [I-1] can also be obtained by (Step 2-3) the compound [II-2] and the compound [V] in the presence of a suitable condensing agent and a suitable base. In the presence, it is produced by reacting in an appropriate solvent.

(步驟2-1) (Step 2-1)

為了將化合物[II-2]變換為酸鹵化物,可使用亞硫醯氯、草醯氯或三氯氧化磷(phosphoryl chloride)等。變換為其他活性衍生物的試劑可使用:氯碳酸異丁酯、甲磺醯氯、三氟甲磺醯氯,對甲苯磺醯氯等。此外,相對於化合物[II-2]1莫耳,變換為活性衍生物的試劑的使用量係在0.5至30莫耳的範圍適當地選擇即可,佳者是0.5至6.0莫耳。 In order to convert the compound [II-2] to an acid halide, thionyl chloride, oxalyl chloride, phosphoryl chloride, or the like can be used. Reagents converted to other active derivatives can be used: isobutyl chlorocarbonate, mesyl chloride, trifluoromethanesulfonyl chloride, p-toluenesulfonyl chloride, etc. In addition, the amount of the agent converted into the active derivative is appropriately selected in the range of 0.5 to 30 moles relative to 1 mole of the compound [II-2], and preferably 0.5 to 6.0 moles.

在本反應可使用的觸媒可舉:N,N-二甲基甲醯胺等。此外,相對於化合物[II-2]1莫耳,觸媒的使用量係在0.01至1莫耳的範圍適當地選擇即可,佳者是0.01至0.1莫耳。 Examples of catalysts that can be used in this reaction include N,N-dimethylformamide and the like. In addition, the amount of the catalyst used may be appropriately selected in the range of 0.01 to 1 mole relative to 1 mole of the compound [II-2], and preferably 0.01 to 0.1 mole.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0137-107
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;或此等混合溶劑等。此外,相對於化合物[II-2]1莫耳,溶劑的使用量係使用0.1至100公升,佳者是0.3至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0137-107
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; nitriles such as acetonitrile and propionitrile; ethyl acetate , Butyl acetate, ethyl propionate and other esters; pentane, hexane, cyclohexane, heptane and other aliphatic hydrocarbons; or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mole of compound [II-2], preferably 0.3 to 10 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為 佳。 The reaction temperature of this reaction is usually any temperature in the temperature range from -30°C to the reflux temperature of the reaction system, but it is preferably carried out in the range of 0°C to 150°C. good.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後進行濃縮等操作,藉此,可單離化合物[IV]。 After the reaction is completed, concentration and the like are performed, whereby the compound [IV] can be isolated.

(步驟2-2) (Step 2-2)

相對於化合物[IV]1莫耳,本發明使用的化合物[V]的使用量通常是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.5莫耳。 The amount of the compound [V] used in the present invention is usually appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [IV], preferably 1.0 to 2.5 moles.

在本反應可使用的鹼例如可舉:三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類,氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金屬的重碳酸鹽類等的無機鹼類。此外,相對於化合物[IV]1莫耳,鹼的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至3.5莫耳。 Examples of bases that can be used in this reaction include triethylamine, 4-methylmorpholine, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]-7-undecene, Organic bases such as pyridine, 4-N,N-dimethylaminopyridine, 2,6-lutidine, and alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; calcium hydroxide , Hydroxides of alkaline earth metals such as magnesium hydroxide; carbonates of alkali metals such as sodium carbonate and potassium carbonate; inorganic alkalis such as bicarbonates of alkali metals such as sodium bicarbonate and potassium bicarbonate. In addition, the amount of the base used may be appropriately selected in the range of 1 to 5 mols relative to 1 mol of the compound [IV], preferably 1.0 to 3.5 mols.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;苯、甲苯、二甲苯、氯苯等芳香族烴類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;乙腈、丙腈等腈類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0138-106
烷等醚類等;水,或此等混合溶劑等。此外,相對於化合物[IV]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至50公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; benzene, Aromatic hydrocarbons such as toluene, xylene and chlorobenzene; esters such as ethyl acetate, butyl acetate and ethyl propionate; nitriles such as acetonitrile and propionitrile; N,N-dimethylformamide, N, Aprotic polar solvents such as N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; Diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0138-106
Ethers such as alkanes; water, or mixed solvents such as these. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mole of compound [IV], preferably 0.3 to 50 liters.

本反應因應所需可在觸媒的存在下進行,觸媒可舉:溴化四 丁基銨、氯化四丁基銨、15-冠-5、18-冠-6等。此外,相對於化合物[IV]1莫耳,觸媒的使用量再由0.001至1莫耳的範圍適當地選擇即可,佳者是0.01至0.1莫耳。 This reaction can be carried out in the presence of a catalyst as required. Butyl ammonium, tetrabutyl ammonium chloride, 15-crown-5, 18-crown-6, etc. In addition, the amount of the catalyst used may be appropriately selected from the range of 0.001 to 1 mole relative to 1 mole of the compound [IV], and preferably 0.01 to 0.1 mole.

本反應的反應溫度是在由-20℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至80℃的範圍進行為佳。 The reaction temperature of this reaction may be any temperature in the temperature range from -20°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 80°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是1分鐘至48小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 1 minute to 48 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-1]。單離的化合物[I-1]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is filtered or extracted with an organic solvent, followed by concentration, etc., whereby the compound [I-1] can be isolated. The isolated compound [I-1] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟2-3) (Step 2-3)

相對於化合物[II-2]1莫耳,本發明使用的化合物[V]的使用量是在1至3莫耳的範圍適當地選擇即可,佳者是1.0至2.6莫耳。 The use amount of the compound [V] used in the present invention is appropriately selected in the range of 1 to 3 moles relative to 1 mole of the compound [II-2], and preferably 1.0 to 2.6 moles.

在本反應可使用的縮合劑是例如可舉:1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽、1-乙基-3-(3-二甲基胺基丙基)碳二亞胺、N,N’-二環己基碳二亞胺、N,N’-二異丙基碳二亞胺,N,N’-羰基二咪唑、4-(4,6-二甲氧基-1,3,5-三

Figure 108126125-A0202-12-0139-105
-2-基)-4-甲基嗎啉氯化物、六氟磷酸1H-苯并三唑-1-基氧三(二甲胺基)鏻(phosphonium)、{{[(1-氰基-2-乙氧基-2-側氧基亞乙基)胺基]氧基}-4-嗎啉基亞甲基}二甲基銨六氟磷酸鹽、O-(7-氮雜苯并三唑-1-基)-N,N,N’,N’-四甲基脲鎓(uronium)六氟磷酸鹽、1-羥基苯并三唑或此等混合物等。 Examples of condensing agents that can be used in this reaction include 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 1-ethyl-3-(3-di Methylaminopropyl) carbodiimide, N,N'-dicyclohexylcarbodiimide, N,N'-diisopropylcarbodiimide, N,N'-carbonyldiimidazole, 4- (4,6-dimethoxy-1,3,5-tri
Figure 108126125-A0202-12-0139-105
-2-yl)-4-methylmorpholine chloride, hexafluorophosphate 1H-benzotriazol-1-yloxytris(dimethylamino)phosphonium, {{[(1-cyano- 2-ethoxy-2-pentoxyethylene)amino]oxy}-4-morpholinylmethylene}dimethylammonium hexafluorophosphate, O-(7-azabenzotris Azole-1-yl)-N,N,N',N'-tetramethyl uronium hexafluorophosphate, 1-hydroxybenzotriazole, or mixtures of these.

此外,相對於化合物[II-2]1莫耳,縮合劑的使用量是在1至3莫耳的範圍適當地選擇即可,佳者是1.0至1.2莫耳。 In addition, the amount of the condensing agent used may be appropriately selected in the range of 1 to 3 moles relative to 1 mole of the compound [II-2], preferably 1.0 to 1.2 moles.

在本反應使用鹼時,可使用的鹼例如可舉:三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類等。此外,是相對於化合物[II-2]1莫耳,鹼的使用量在0.1至5莫耳的範圍適當地選擇即可,佳者是0.1至3.0莫耳。 When a base is used in this reaction, examples of usable bases include triethylamine, 4-methylmorpholin, diisopropylethylamine, and 1,8-diazabicyclo[5.4.0]-7- Organic bases such as undecene, pyridine, 4-N,N-dimethylaminopyridine, 2,6-lutidine, etc. In addition, the amount of base used may be appropriately selected in the range of 0.1 to 5 moles relative to 1 mole of the compound [II-2], and preferably 0.1 to 3.0 moles.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;乙腈、丙腈等腈類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0140-104
烷等醚類等;或此等混合溶劑等。此外,相對於化合物[II-2]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至80公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; and ethyl acetate Esters, butyl acetate, ethyl propionate and other esters; acetonitrile, propionitrile and other nitriles; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2 -Aprotic polar solvents such as pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyl Tetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0140-104
Ethers such as alkanes; or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mole of compound [II-2], preferably 0.3 to 80 liters.

本反應因應所需可在觸媒的存在下進行,觸媒可舉:4-N,N-二甲胺基吡啶等。此外,相對於化合物[II-2]1莫耳,觸媒的使用量是在0.001至1莫耳的範圍適當地選擇即可,佳者是0.01至0.1莫耳。 This reaction can be carried out in the presence of a catalyst according to the needs. Examples of the catalyst include 4-N,N-dimethylaminopyridine and the like. In addition, the amount of the catalyst used may be appropriately selected in the range of 0.001 to 1 mol relative to 1 mol of the compound [II-2], preferably 0.01 to 0.1 mol.

本反應的反應溫度是在由-20℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至80℃的範圍進行為佳。 The reaction temperature of this reaction may be any temperature in the temperature range from -20°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 80°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是1分鐘至96小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 1 minute to 96 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-1]。單離的化合物[I-1]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is filtered or extracted with an organic solvent, followed by concentration, etc., whereby the compound [I-1] can be isolated. The isolated compound [I-1] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法3> <Manufacturing method 3>

本發明化合物中,通式[I-3]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-3] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0141-295
Figure 108126125-A0202-12-0141-295

(式中,B1表示氧原子或硫原子,L2表示鹵原子、甲烷磺醯基氧基、三氟甲烷磺醯基氧基、九氟丁烷磺醯基氧基、苯磺醯基氧基、對甲苯磺醯基氧基、甲烷磺醯基或乙烷磺醯基,Ra表示氫原子、鹵原子、基C(=O)OR10或基C(=O)NR1R2,R1、R2、R3、R4、R6及n表示與前述相同意義) (In the formula, B 1 represents an oxygen atom or a sulfur atom, L 2 represents a halogen atom, methanesulfonyloxy, trifluoromethanesulfonyloxy, nonafluorobutanesulfonyloxy, benzenesulfonyloxy Group, p-toluenesulfonyloxy, methanesulfonyl or ethanesulfonyl, R a represents a hydrogen atom, halogen atom, radical C(=O)OR 10 or radical C(=O)NR 1 R 2 , (R 1 , R 2 , R 3 , R 4 , R 6 and n represent the same meaning as above)

亦即,通式[I-3]表示的化合物是可將通式[I-2]表示的化合物及化合物[VI],在適當的鹼的存在下或不存在下,在適當的自由基起始劑的存在下或不存在下,在適當的溶劑中反應而製造。 That is, the compound represented by the general formula [I-3] is a compound represented by the general formula [I-2] and the compound [VI], in the presence or absence of an appropriate base, in the presence of an appropriate radical It is produced by reacting in an appropriate solvent in the presence or absence of the initiator.

相對於化合物[I-2]1莫耳,本發明使用的化合物[VI]的使用量是在1至100莫耳的範圍適當地選擇即可,佳者是1.0至3.3莫耳。 The amount of the compound [VI] used in the present invention may be appropriately selected in the range of 1 to 100 moles relative to 1 mole of the compound [I-2], and preferably 1.0 to 3.3 moles.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類;氫化鈉、氫化鉀等金屬氫化物類;甲氧基鈉、乙氧基鈉、第三丁氧基鉀等醇的金屬鹽類或三乙胺、N,N-二甲基苯 胺、吡啶、4-N,N-二甲胺基吡啶、1,8-二氮雜雙環[5.4.0]-7-十一烯等有機鹼類等。此外,相對於化合物[I-2]1莫耳,鹼的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.0莫耳。 Examples of the base that can be used in this reaction include: hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide; and sodium carbonate , Alkali carbonates such as potassium carbonate; inorganic alkalis such as alkali metal bicarbonate such as sodium bicarbonate and potassium bicarbonate; metal hydrides such as sodium hydride and potassium hydride; sodium methoxide and ethoxy Metal salts of alcohols such as sodium and potassium tributoxide or triethylamine, N,N-dimethylbenzene Organic bases such as amine, pyridine, 4-N,N-dimethylaminopyridine, 1,8-diazabicyclo[5.4.0]-7-undecene, etc. In addition, the amount of the base used may be appropriately selected in the range of 1 to 5 mols relative to 1 mol of the compound [I-2], preferably 1.0 to 2.0 mols.

在本反應可使用的自由基起始劑是例如可舉:亞硫酸、亞硫酸鹽、Rongalite(商品名,甲醛次硫酸氫鈉)等亞硫酸加成物等。此外,相對於化合物[I-2]1莫耳,自由基起始劑的使用量是在0.01至5莫耳的範圍適當地選擇即可,佳者是0.01至1.2莫耳。 Examples of the radical initiator that can be used in this reaction include sulfurous acid adducts such as sulfurous acid, sulfite, and Rongalite (trade name, sodium formaldehyde sulfoxylate). In addition, the amount of the radical initiator used is appropriately selected from the range of 0.01 to 5 moles relative to 1 mole of the compound [I-2], and preferably 0.01 to 1.2 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0142-103
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;吡啶、甲基吡啶等吡啶類;水或此等混合溶劑等。此外,相對於化合物[I-2]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0142-103
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; N,N-dimethylformamide, Aprotic polar solvents such as N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone Alcohols; methanol, ethanol, 2-propanol and other alcohols; acetonitrile, propionitrile and other nitriles; ethyl acetate, butyl acetate, ethyl propionate and other esters; pentane, hexane, cyclohexane, heptane Aliphatic hydrocarbons; pyridines such as pyridine and picoline; water or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mol of the compound [I-2], preferably 0.3 to 10 liters.

本反應的反應溫度是在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature in this reaction may be any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-3]。單離的化合物[I-3]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated, whereby the compound [I-3] can be isolated. The isolated compound [I-3] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法4> <Manufacturing method 4>

本發明化合物中,通式[I-5]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-5] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0143-296
Figure 108126125-A0202-12-0143-296

(式中,p表示1或2的整數,R3、R4、R5、R6、Ra及n表示與前述相同的意義) (In the formula, p represents an integer of 1 or 2, R 3, R 4, R 5, R 6, R a and n have the same meaning as above)

亦即,通式[I-5]表示的化合物是可將化合物[I-4]在適當的溶劑中,適當的觸媒的存在下或不存在下氧化反應而製造。 That is, the compound represented by the general formula [I-5] can be produced by oxidizing the compound [I-4] in an appropriate solvent in the presence or absence of an appropriate catalyst.

在本反應可使用的氧化劑例如可舉:過氧化氫、間氯過氧苯甲酸、過碘酸鈉、OXONE(E I Dupont公司商品名;過氧硫酸氫鉀含有物)、N-氯琥珀醯亞胺、N-溴琥珀醯亞胺、次氯酸第三丁酯、次氯酸鈉等。此外,氧化劑的使用量是取決於通式[I-5]表示的化合物的硫原子的氧化數p,惟,相對於化合物[I-4]1莫耳,在0.8至10莫耳的範圍適當地選擇即可,佳者是0.8至4.0莫耳。 Examples of oxidizing agents that can be used in this reaction include hydrogen peroxide, m-chloroperoxybenzoic acid, sodium periodate, OXONE (trade name of EI Dupont; potassium peroxysulfate-containing substance), N-chlorosuccinimide Amine, N-bromosuccinimide, tertiary butyl hypochlorite, sodium hypochlorite, etc. In addition, the amount of the oxidizing agent used depends on the oxidation number p of the sulfur atom of the compound represented by the general formula [I-5], but it is appropriate in the range of 0.8 to 10 mol relative to 1 mol of the compound [I-4] The local choice is sufficient. The best is 0.8 to 4.0 moles.

在本反應可使用的觸媒例如可舉:鎢酸鈉等。此外,相對於化合物[I-4]1莫耳,觸媒的使用量是在0.01至1.0莫耳的範圍適當地選擇即可,佳者是0.01至0.1莫耳。 Examples of catalysts that can be used in this reaction include sodium tungstate and the like. In addition, the amount of the catalyst used may be appropriately selected in the range of 0.01 to 1.0 moles relative to 1 mole of the compound [I-4], preferably 0.01 to 0.1 moles.

在本反應可使用的溶劑例如可舉:苯、甲苯、二甲苯、氯苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯 酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;乙酸、水或此等混合溶劑等。此外,相對於化合物[I-4]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至15公升。 Examples of solvents that can be used in this reaction include aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; N,N-dimethylformamide, N,N-dimethylacetamide, and N- Methyl-2-pyrrole Aprotic polar solvents such as ketones, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; alcohols such as methanol, ethanol, 2-propanol; dichloromethane, chloroform , 1,2-dichloroethane and other halogenated hydrocarbons; pentane, hexane, cyclohexane, heptane and other aliphatic hydrocarbons; acetic acid, water or these mixed solvents, etc. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mol of the compound [I-4], preferably 0.3 to 15 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是-10℃至100℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of -10°C to 100°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-5]。單離的化合物[I-5]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated, whereby the compound [I-5] can be isolated. The isolated compound [I-5] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法5> <Manufacturing method 5>

本發明化合物中,通式[I-8]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-8] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0145-297
Figure 108126125-A0202-12-0145-297

(式中,Rb表示C1至C6烷基或C1至C6鹵烷基,R3、R4、R6、Ra及n表示與前述相同的意義) (Wherein, R b represents a C 1 to C 6 alkyl or a C 1 to C 6 haloalkyl, R 3, R 4, R 6, R a and n have the same meaning as above)

亦即,通式[I-8]表示的化合物是可在(步驟5-1)將化合物[I-6]及化合物[VII]在適當的溶劑中反應而得到化合物[I-7]後,(步驟5-2)將化合物[I-7]在適當的溶劑中,適當的鹼的存在下或不存在下,水解反應而製造。 That is, the compound represented by the general formula [I-8] can be obtained by reacting the compound [I-6] and the compound [VII] in an appropriate solvent in (Step 5-1) to obtain the compound [I-7], (Step 5-2) The compound [I-7] is produced by hydrolysis reaction in an appropriate solvent in the presence or absence of an appropriate base.

(步驟5-1) (Step 5-1)

在本反應可使用的化合物[VII]可舉:乙酸酐或三氟乙酸酐。此外,相對於化合物[I-6]1莫耳,化合物[VII]的使用量是在1莫耳至作為溶劑使用的充分的量的範圍選擇即可,佳者是1.0至5.0莫耳。 Examples of the compound [VII] usable in this reaction include acetic anhydride or trifluoroacetic anhydride. In addition, the amount of the compound [VII] used may be selected from the range of 1 mole to a sufficient amount used as a solvent relative to 1 mole of the compound [I-6], and preferably 1.0 to 5.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0145-102
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類,甲醇、乙 醇、2-丙醇等醇類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;水或此等混合溶劑等。此外,相對於化合物[I-6]1莫耳溶劑的使用量是,0.1至100公升,佳者是0.3至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0145-102
Ethers such as alkanes; aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, and 1,2-dichloroethane; and alcohols such as methanol, ethanol, and 2-propanol ; Nitriles such as acetonitrile, propionitrile; esters such as ethyl acetate, butyl acetate, ethyl propionate; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, heptane; water or these mixed solvents, etc. . In addition, the amount of 1 mol solvent used relative to compound [I-6] is 0.1 to 100 liters, preferably 0.3 to 10 liters.

本反應的反應溫度是任一個反應中都在-10℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至50℃的溫度範圍進行為佳。 The reaction temperature in this reaction may be any temperature within a range of -10°C to the reflux temperature of the reaction system in any reaction, and it is preferably carried out in a temperature range of 0°C to 50°C.

本反應的反應時間是任一反應中都隨反應溫度、反應基質、反應量等而有不同,通常是5分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc. in any reaction, and is usually 5 minutes to 24 hours.

反應結束後將反應混合物注入至水中等,以有機溶劑萃取,進行濃縮等操作,藉此,可單離化合物[I-7]。單離的化合物[I-7]可因應所需使用管柱層析法、再結晶等而再精製。此外,化合物[I-7]是可不經過單離及精製而使用在步驟5-2。 After the reaction is completed, the reaction mixture is poured into water, etc., extracted with an organic solvent, and concentrated to perform operations such that the compound [I-7] can be isolated. The isolated compound [I-7] can be purified by using column chromatography, recrystallization, etc. as required. In addition, the compound [I-7] can be used in step 5-2 without isolation and purification.

(步驟5-2) (Step 5-2)

在本反應可使用的鹼、溶劑、反應溫度及反應時間係與製造方法1的步驟1-2相同。 The base, solvent, reaction temperature and reaction time that can be used in this reaction are the same as steps 1-2 of Production Method 1.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-8]。單離的化合物[I-8]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and then the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated to separate the compound [I-8]. The isolated compound [I-8] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法6> <Manufacturing method 6>

本發明化合物中,通式[I-9]表示的化合物是例如可使用通式[I-1]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-9] is, for example, a compound represented by the general formula [I-1] and can be produced according to the following method.

Figure 108126125-A0202-12-0147-298
Figure 108126125-A0202-12-0147-298

(式中,B、R1、R2、R3、R4、R5、R6及n表示與前述相同的意義)。亦即,通式[I-9]表示的化合物是可將化合物[I-1]及適當的硫化劑在適當的鹼的存在下或不存在下反應而製造。 (In the formula, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and n represent the same meaning as described above). That is, the compound represented by the general formula [I-9] can be produced by reacting the compound [I-1] and an appropriate vulcanizing agent in the presence or absence of an appropriate base.

在本反應可使用的硫化劑例如可舉:五硫化磷、勞森試劑(Lawesson’s Reagent:2,4-雙(4-甲氧基苯基)-1,3,2,4-二噻二磷雜丁環(thiadiphosphetane)-2,4-二硫化物)等。此外,相對於化合物[I-1]1莫耳,硫化劑的使用量是在0.5至30莫耳的範圍適當地選擇即可,佳者是0.5至5.0莫耳。 Examples of vulcanizing agents that can be used in this reaction include phosphorus pentasulfide and Lawesson's Reagent (Lawesson's Reagent: 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphos Thiadiphosphetane-2,4-disulfide) etc. In addition, the amount of the vulcanizing agent used may be appropriately selected in the range of 0.5 to 30 moles relative to 1 mole of the compound [I-1], preferably 0.5 to 5.0 moles.

本反應不一定需要添加鹼,惟,如使用鹼時,可使用的鹼是例如可舉:碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類等的無機鹼類或三乙胺、N,N-二甲基苯胺、吡啶、4-N,N-二甲胺基吡啶、1,8-二氮雜雙環[5,4,0]-7-十一烯等有機鹼類等。此外,相對於化合物[I-1]1莫耳,鹼的使用量是在0.01至10莫耳的範圍適當地選擇即可,佳者是0.1至2.0莫耳。 In this reaction, it is not necessary to add a base. However, when a base is used, the base that can be used is, for example, inorganic bases such as sodium carbonate, potassium carbonate and other alkali metal carbonates or triethylamine, N,N- Organic bases such as dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine, 1,8-diazabicyclo[5,4,0]-7-undecene, etc. In addition, the amount of the base used may be appropriately selected in the range of 0.01 to 10 moles relative to 1 mole of compound [I-1], and preferably 0.1 to 2.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0147-101
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二甲基亞碸、環丁碸等非質子性極性溶劑類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;水或此等混合溶劑等。此外,相對於化合物[I-1]1莫耳,溶劑的使用量是0.1至300公升,佳者是0.3至50公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0147-101
Ethers such as alkanes; aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aprotic polar solvents such as dimethyl sulfoxide and cyclobutane; dichloromethane, chloroform, 1,2-dichloroethane Halogenated hydrocarbons such as alkanes; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, heptane; water or these mixed solvents; In addition, the amount of the solvent used is 0.1 to 300 liters relative to 1 mol of the compound [I-1], preferably 0.3 to 50 liters.

本反應的反應溫度是通常在由-70℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -70°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中,以有機溶劑萃取,進行濃縮等操作,藉此,可單離化合物[I-9]。或者是,亦可由反應混合物濃縮溶劑而單離化合物[I-9]。單離的化合物[I-9]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, extracted with an organic solvent, and subjected to operations such as concentration, whereby the compound [I-9] can be isolated. Alternatively, the compound [I-9] may be isolated by concentrating the solvent from the reaction mixture. The isolated compound [I-9] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法7> <Manufacturing method 7>

本發明化合物中,通式[I-11]表示的化合物是例如可使用通式[I-10]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-11] is, for example, a compound represented by the general formula [I-10] and can be produced according to the following method.

Figure 108126125-A0202-12-0148-299
Figure 108126125-A0202-12-0148-299

(式中,B、R1、R2、R4、R5、R6及X1表示與前述相同的意義) (In the formula, B, R 1 , R 2 , R 4 , R 5 , R 6 and X 1 represent the same meaning as described above)

在本反應可使用的氰化物、觸媒、溶劑、反應溫度及反應時間係與製造方法1的步驟1-1相同。 The cyanide, catalyst, solvent, reaction temperature and reaction time that can be used in this reaction are the same as Step 1-1 of Production Method 1.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I- 11]。單離的化合物[I-11]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is injected into water and neutralized, and the precipitated solid is filtered or extracted with an organic solvent and then concentrated, thereby isolating the compound [I- 11]. The isolated compound [I-11] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法8> <Manufacturing method 8>

本發明化合物中,通式[I-1]表示的化合物係例如可使用通式[III-1]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-1] can be produced according to the following method using, for example, a compound represented by the general formula [III-1].

Figure 108126125-A0202-12-0149-300
Figure 108126125-A0202-12-0149-300

(式中,B、R1、R2、R3、R4、R5、R6、n及X1表示與前述相同的意義) (In the formula, B, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , n, and X 1 represent the same meaning as described above)

亦即,通式[I-1]表示的化合物是可將通式[III-1]表示的化合物及化合物[V],在適當的觸媒及適當的鹼的存在下在適當的溶劑中進行一氧化碳插入反應而製造。 That is, the compound represented by the general formula [I-1] is a compound and the compound [V] represented by the general formula [III-1] can be carried out in a suitable solvent in the presence of a suitable catalyst and a suitable base Manufactured by carbon monoxide insertion reaction.

相對於化合物[III-1]1莫耳,本發明使用的化合物[V]的使用量通常在1至5莫耳的範圍適當地選擇即可,佳者是1.0至3.0莫耳。 The amount of the compound [V] used in the present invention is usually appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [III-1], preferably 1.0 to 3.0 moles.

在本反應可使用的觸媒而言使用過度金屬錯合物或過度金屬與配位子的組合,例如可舉:過度金屬錯合物可舉:四(三苯基膦)鈀或二氯[1,1’-雙(二苯基膦基)鐵莘]鈀-二氯甲烷加成物,過度金屬可舉:氯化鈀、溴化鈀、乙酸鈀等,配位子可舉:三甲基膦、三乙基膦、三丁基膦、三苯基膦、1,3-雙二甲基膦基丙烷、1,2-雙二苯基膦基乙烷、1,3-雙二苯基膦基丙烷等。此外,相對於化合物[III-1]1莫耳,觸媒的使用量是 0.001至0.1莫耳,佳者是0.01至0.05莫耳。 For the catalyst that can be used in this reaction, a transition metal complex or a combination of a transition metal and a ligand is used. For example, the transition metal complex may be tetrakis(triphenylphosphine)palladium or dichloro[ 1,1'-bis(diphenylphosphino)ferroxin]palladium-dichloromethane adducts, transition metals can be mentioned: palladium chloride, palladium bromide, palladium acetate, etc., ligands can be mentioned: trimethyl Phosphine, triethylphosphine, tributylphosphine, triphenylphosphine, 1,3-bisdimethylphosphinopropane, 1,2-bisdiphenylphosphinoethane, 1,3-bisdiphenyl Phosphinyl propane and so on. In addition, relative to the compound [III-1] 1 mole, the amount of catalyst used is 0.001 to 0.1 mol, the better is 0.01 to 0.05 mol.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類,氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類,碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類,碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類,三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類。此外,相對於化合物[III-1]1莫耳,鹼的使用量是0.1至10莫耳,佳者是0.1至7.0莫耳。但,有機鹼類時也可當作溶劑使用。 Examples of the base usable in this reaction include hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide, hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide, and sodium carbonate , Potassium carbonate and other alkali metal carbonates, sodium bicarbonate, potassium bicarbonate and other alkali metal bicarbonates and other inorganic bases, triethylamine, 4-methylmorpholin, diisopropylethylamine, Organic bases such as 1,8-diazabicyclo[5.4.0]-7-undecene, pyridine, 4-N,N-dimethylaminopyridine, 2,6-lutidine, etc. In addition, the amount of the base used is 0.1 to 10 moles relative to 1 mole of compound [III-1], preferably 0.1 to 7.0 moles. However, organic bases can also be used as solvents.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0150-100
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;丙酮、甲基乙基酮、環己酮等酮類;或此等混合溶劑等。此外,相對於化合物[III-1]1莫耳,溶劑的使用量是0.1至500公升,佳者是0.5至30公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0150-100
Ethers such as alkanes; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrole Aprotic polar solvents such as ketone, dimethyl sulfoxide, cyproterone, 1,3-dimethyl-2-imidazolidinone; alcohols such as methanol, ethanol, 2-propanol; acetonitrile, propionitrile, etc. Nitriles; ketones such as acetone, methyl ethyl ketone, cyclohexanone; or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 500 liters relative to 1 mole of compound [III-1], preferably 0.5 to 30 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應壓力是在通常大氣壓至50氣壓的範圍選擇任意的壓力即可,佳者是1氣壓至未達10氣壓的範圍進行為佳。 The reaction pressure of this reaction may be any pressure within a range of usually atmospheric pressure to 50 atmospheres, and preferably, it is preferably carried out in a range of 1 atmosphere to less than 10 atmospheres.

本反應的反應時間是隨反應溫度、反應壓力、反應基質、反應量等而有不同,通常是10分鐘至72小時。 The reaction time of this reaction varies with the reaction temperature, reaction pressure, reaction substrate, reaction amount, etc., and is usually 10 minutes to 72 hours.

本反應結束後將反應混合物注入至水中而中和之後,濾取析 出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-1]。單離的化合物[I-1]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and after neutralization, it is filtered out The extracted solid may be extracted with an organic solvent and then subjected to operations such as concentration to isolate the compound [I-1]. The isolated compound [I-1] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法9> <Manufacturing method 9>

本發明化合物中,通式[I-12]表示的化合物是例如可使用通式[XXIII]表示的化合物及[XXIV]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-12] is, for example, a compound represented by the general formula [XXIII] and a compound represented by [XXIV], and can be produced according to the following method.

Figure 108126125-A0202-12-0151-100
Figure 108126125-A0202-12-0151-100

(式中,R11表示C1至C6烷基或C1至C6鹵烷基,R12表示氫原子、基C(=O)OR10或基C(=O)NR1R2,R1、R2、R3、R4、R6、R10、n及X1表示與前述相同意義。特別是,其中的[XXIV]表示的化合物的通式中的B表示硼原子) (In the formula, R 11 represents a C 1 to C 6 alkyl group or a C 1 to C 6 haloalkyl group, R 12 represents a hydrogen atom, a group C(=O)OR 10 or a group C(=O)NR 1 R 2 , R 1 , R 2 , R 3 , R 4 , R 6 , R 10 , n, and X 1 have the same meaning as described above. In particular, B in the general formula of the compound represented by [XXIV] represents a boron atom)

亦即,通式[I-12]表示的化合物係可將通式[XXIII]表示的化合物及化合物[XXIV],在適當的觸媒及適當的鹼的存在下,在適當的溶劑中進行鈴木宮浦耦合反應而製造。 That is, the compound represented by the general formula [I-12] can carry out the compound represented by the general formula [XXIII] and the compound [XXIV] in the presence of an appropriate catalyst and an appropriate base in an appropriate solvent. Manufactured by coupling reaction of Miyaura.

相對於化合物[XXIII]1莫耳,本發明使用的化合物[XXIV]的使用量通常在1至5莫耳的範圍適當地選擇即可,佳者是1.0至1.5莫耳。 The amount of the compound [XXIV] used in the present invention is usually appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [XXIII], preferably 1.0 to 1.5 moles.

在本反應可使用的觸媒可使用過度金屬錯合物或過度金屬與配位子的組合,例如可舉:過度金屬錯合物可舉:四(三苯基膦)鈀或二氯[1,1’-雙(二苯基膦基)鐵莘]鈀-二氯甲烷加成物,過度金屬可舉:氯化 鈀,溴化鈀,乙酸鈀等,配位子可舉:三甲基膦,三乙基膦,三丁基膦,三苯基膦,1,3-雙二甲基膦基丙烷、1,2-雙二苯基膦基乙烷、1,3-雙二苯基膦基丙烷等。此外,相對於化合物[XXIII]1莫耳,觸媒的使用量是0.001至0.2莫耳,佳者是0.01至0.15莫耳。 The catalyst that can be used in this reaction may use a transition metal complex or a combination of a transition metal and a ligand. For example, the transition metal complex may include tetrakis(triphenylphosphine)palladium or dichloro[1 ,1'-bis(diphenylphosphino)ironxin]palladium-dichloromethane adducts, transition metals include: chlorination Palladium, palladium bromide, palladium acetate, etc., ligands include trimethylphosphine, triethylphosphine, tributylphosphine, triphenylphosphine, 1,3-bisdimethylphosphinopropane, 1, 2-bisdiphenylphosphinoethane, 1,3-bisdiphenylphosphinopropane, etc. In addition, the amount of catalyst used is 0.001 to 0.2 moles relative to 1 mole of compound [XXIII], preferably 0.01 to 0.15 moles.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類,三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類。此外,相對於化合物[XXIII]1莫耳,鹼的使用量是0.1至10莫耳,佳者是0.1至4.0莫耳。 Examples of the base that can be used in this reaction include: hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide; and sodium carbonate , Potassium carbonate and other alkali metal carbonates; sodium bicarbonate, potassium bicarbonate and other alkali metal bicarbonates and other inorganic bases, triethylamine, 4-methylmorpholin, diisopropylethylamine, Organic bases such as 1,8-diazabicyclo[5.4.0]-7-undecene, pyridine, 4-N,N-dimethylaminopyridine, 2,6-lutidine, etc. In addition, the amount of the base used is 0.1 to 10 moles relative to 1 mole of compound [XXIII], and preferably 0.1 to 4.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0152-167
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;甲醇、乙醇、2-丙醇等醇類;乙腈、丙腈等腈類;丙酮、甲基乙基酮、環己酮等酮類;水或此等混合溶劑等。此外,相對於化合物[XXIII]1莫耳,溶劑的使用量是0.1至500公升,佳者是0.3至30公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0152-167
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrole Aprotic polar solvents such as ketones, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane Alcohols such as methanol, ethanol and 2-propanol; nitriles such as acetonitrile and propionitrile; ketones such as acetone, methyl ethyl ketone and cyclohexanone; water or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 500 liters relative to 1 mole of compound [XXIII], preferably 0.3 to 30 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應壓力、反應基質、反 應量等而有不同,通常是10分鐘至72小時。 The reaction time of this reaction depends on the reaction temperature, reaction pressure, reaction matrix, reaction The amount varies depending on the amount, usually 10 minutes to 72 hours.

反應結束後將反應混合物注入至水中,以有機溶劑萃取,進行濃縮等操作,藉此,可單離化合物[I-12]。或者是,亦可從反應混合物濃縮溶劑而單離化合物[I-12]。單離的化合物[I-12]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, extracted with an organic solvent, and subjected to operations such as concentration, whereby the compound [I-12] can be isolated. Alternatively, the solvent may be concentrated from the reaction mixture to isolate the compound [I-12]. The isolated compound [I-12] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法10> <Manufacturing method 10>

本發明化合物中,通式[I-14]表示的化合物是例如可使用通式[I-13]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-14] is, for example, a compound represented by the general formula [I-13] and can be produced according to the following method.

Figure 108126125-A0202-12-0153-101
Figure 108126125-A0202-12-0153-101

(式中,Re表示氫原子、鹵原子或基C(=O)NR1R2,R1、R2、R3、R4、R6、R10及n表示與前述相同意義) (In the formula, R e represents a hydrogen atom, a halogen atom or a radical C(=O)NR 1 R 2 , R 1 , R 2 , R 3 , R 4 , R 6 , R 10 and n represent the same meaning as above)

亦即,通式[I-14]表示的化合物是可在適當的溶劑中,將通式[I-13]表示的化合物在適當的酸或鹼的存在下,水解而製造。 That is, the compound represented by the general formula [I-14] can be produced by hydrolyzing the compound represented by the general formula [I-13] in the presence of an appropriate acid or base in an appropriate solvent.

在本反應可使用的溶劑、酸、鹼、反應溫度及反應時間係與製造方法1的步驟1-4相同。 The solvents, acids, bases, reaction temperature and reaction time that can be used in this reaction are the same as Steps 1-4 of Production Method 1.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-14]。單離的化合物[I-14]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated to separate the compound [I-14]. The isolated compound [I-14] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法11> <Manufacturing method 11>

本發明化合物中,通式[I-17]表示的化合物是例如可使用通式[I-15]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-17] is, for example, a compound represented by the general formula [I-15] and can be produced according to the following method.

Figure 108126125-A0202-12-0154-102
Figure 108126125-A0202-12-0154-102

(式中,R13表示氫原子或基C(=O)OR10,R1、R2、R3,R4、R6、R10、Ra及n表示與前述相同的意義) (In the formula, R 13 represents a hydrogen atom or a radical C(=O)OR 10 , R 1 , R 2 , R 3 , R 4 , R 6 , R 10 , R a and n represent the same meaning as above)

亦即,通式[I-17]表示的化合物是可在適當的溶劑中,在適當的鹼存在下,對通式[I-15]表示的化合物與二苯基磷酸疊氮化物(DPPA)反應所產生的異氰酸鹽[I-16],附加作為親核劑的化合物R10OH而製造。 That is, the compound represented by the general formula [I-17] can be used in a suitable solvent in the presence of a suitable base, the compound represented by the general formula [I-15] and diphenyl phosphate azide (DPPA) The isocyanate [I-16] produced by the reaction is produced by adding the compound R 10 OH as a nucleophile.

相對於化合物[I-15]1莫耳,在本反應可使用的DPPA的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.5莫耳。 The amount of DPPA that can be used in this reaction is appropriately selected in the range of 1 to 5 moles relative to 1 mole of compound [I-15], and preferably 1.0 to 2.5 moles.

在本反應可使用的鹼可舉:三乙胺、N,N-二甲基苯胺、吡 啶、4-N,N-二甲胺基吡啶、1,8-二氮雜雙環[5.4.0]-7-十一烯等有機鹼類,氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類,氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類,碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類,碳酸氫鈉、碳酸氫鉀等鹼金屬的重碳酸鹽類等的無機鹼類。此外,相對於化合物[I-15]1莫耳,鹼的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.5莫耳。 The bases that can be used in this reaction include triethylamine, N,N-dimethylaniline, pyridine Organic bases such as pyridine, 4-N,N-dimethylaminopyridine, 1,8-diazabicyclo[5.4.0]-7-undecene, lithium hydroxide, sodium hydroxide, potassium hydroxide, etc. Hydroxides of alkali metals, hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide, carbonates of alkali metals such as sodium carbonate and potassium carbonate, and heavy metals such as sodium bicarbonate and potassium bicarbonate Inorganic bases such as carbonates. In addition, the amount of the base used may be appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [I-15], preferably 1.0 to 2.5 moles.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;苯、甲苯、二甲苯、氯苯等芳香族烴類;甲醇、乙醇、2-丙醇等醇類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0155-168
烷等醚類等;水,或此等混合溶劑等。此外,相對於化合物[I-15]1莫耳,溶劑的使用量是0.1至300公升,佳者是0.1至100公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; benzene, Aromatic hydrocarbons such as toluene, xylene, chlorobenzene; alcohols such as methanol, ethanol, 2-propanol; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl Aprotic polar solvents such as di-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0155-168
Ethers such as alkanes; water, or mixed solvents such as these. In addition, the amount of the solvent used is 0.1 to 300 liters relative to 1 mol of the compound [I-15], preferably 0.1 to 100 liters.

在本反應可使用的親核劑例如可舉:甲醇、乙醇、2-丙醇,第三丁基醇等醇類或水等。此外,相對於化合物[I-15]1莫耳,親核劑的使用量是在1莫耳至作為溶劑使用的充分量的範圍選擇即可,佳者是1.0至100莫耳。 Nucleophilic agents usable in this reaction include, for example, alcohols such as methanol, ethanol, 2-propanol, and tert-butyl alcohol, water, and the like. In addition, the amount of the nucleophilic agent used may be selected from the range of 1 mole to a sufficient amount used as a solvent with respect to 1 mole of the compound [I-15], and preferably 1.0 to 100 moles.

本反應的反應溫度是在由-20℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至120℃的範圍進行為佳。 The reaction temperature in this reaction may be any temperature within a range from -20°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 120°C.

本反應的反應時間是隨反應溫度、反應基質、反應量而有不同,通常是1分鐘至48小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, and reaction amount, and is usually 1 minute to 48 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以 有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-17]。單離的化合物[I-17]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid or After the organic solvent is extracted, concentration and other operations are performed, whereby the compound [I-17] can be isolated. The isolated compound [I-17] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法12> <Manufacturing method 12>

本發明化合物中,通式[I-19]表示的化合物是例如可使用通式[I-18]表示的化合物且依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-19] is, for example, a compound represented by the general formula [I-18] and can be produced according to the following method.

Figure 108126125-A0202-12-0156-103
Figure 108126125-A0202-12-0156-103

(式中,X3表示氫原子、鹵原子或氰基,R3、R4、R6、Ra及n表示與前述相同的意義) (Wherein, X 3 represents a hydrogen atom, a halogen atom or a cyano, R 3, R 4, R 6, R a and n have the same meaning as above)

亦即,通式[I-19]表示的化合物是可將通式[I-18]表示的化合物在適當的溶劑中,依據Organic Synthesis,Coll.第3卷195頁(1955年)所述之方法(例如,使用鹽酸、硫酸及氫溴酸等無機酸及亞硝酸鹽或亞硝酸烷基酯的方法)成為重氮鹽(diazonium salt)之後,在鹵化銅或氰化銅的存在下或不存在下,在適當的溶劑中反應而製造。 That is, the compound represented by the general formula [I-19] is a compound represented by the general formula [I-18] in an appropriate solvent, according to Organic Synthesis, Coll. Vol. 3, page 195 (1955) After the method (for example, a method using inorganic acids such as hydrochloric acid, sulfuric acid, hydrobromic acid, and nitrite or alkyl nitrite) becomes a diazonium salt, it may or may not be in the presence of copper halide or copper cyanide In the presence, it is produced by reacting in an appropriate solvent.

在本反應可使用的鹵化銅例如可舉:氯化銅(I)、溴化銅(I)、碘化銅(I)、氯化銅(II)、溴化銅(II)等。此外,相對於化合物[I-18]1莫耳,鹵化銅或氰化銅的使用量是1至5莫耳,佳者是1.0至2.5莫耳。 Examples of the copper halide that can be used in this reaction include copper (I), copper (I) bromide, copper (I) iodide, copper (II) chloride, and copper (II) bromide. In addition, the use amount of copper halide or copper cyanide is 1 to 5 moles, preferably 1.0 to 2.5 moles relative to 1 mole of compound [I-18].

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0156-169
烷等醚類;苯、甲苯、二甲苯、氯 苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;乙腈、丙腈等腈類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;鹽酸、硫酸等無機酸類;乙酸等羧酸類;水或此等混合溶劑等。此外,相對於化合物[I-18]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0156-169
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; nitriles such as acetonitrile and propionitrile; N, N -Dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazole Aprotic polar solvents such as porphyrin; inorganic acids such as hydrochloric acid and sulfuric acid; carboxylic acids such as acetic acid; water or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mol of the compound [I-18], preferably 0.3 to 10 liters.

本反應的反應溫度是在由-70℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是-20℃至100℃的範圍進行為佳。 The reaction temperature in this reaction may be any temperature within a range from -70°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of -20°C to 100°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中而中和後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-19]。單離的化合物[I-19]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated, thereby isolating the compound [I-19]. The isolated compound [I-19] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法13> <Manufacturing method 13>

本發明化合物中,通式[I-20]表示的化合物是例如使用通式[I-13]表示的化合物可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-20] is, for example, a compound represented by the general formula [I-13] and can be produced according to the following method.

Figure 108126125-A0202-12-0157-104
Figure 108126125-A0202-12-0157-104

(式中,R3、R4、R6、R10、Re及n表示與前述相同的意義) (Wherein, R 3, R 4, R 6, R 10, R e , and n have the same meaning as above)

亦即,通式[I-20]表示的化合物是可藉由依據實驗化學講座第4版(丸 善),第26卷的「還原一般之項」,而將通式[I-13]表示的化合物還原而製造。 That is, the compound represented by the general formula [I-20] can be Good), "Reducing General Items" in Volume 26, which is produced by reducing the compound represented by the general formula [I-13].

<製造方法14> <Manufacturing method 14>

本發明化合物中,通式[I-22]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-22] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0158-105
Figure 108126125-A0202-12-0158-105

(式中,B2表示氧原子、硫原子、基-N(-R7)-,L2、R3、R4、R5、R6、R7、Re及n表示與前述相同的意義) (Wherein, B 2 represents an oxygen atom, a sulfur atom, a group -N (-R 7) -, L 2, R 3, R 4, R 5, R 6, R 7, R e and n are the same as defined above significance)

亦即,通式[1-22]表示的化合物是可以(步驟14-1)在適當的溶劑中,在適當的鹼的存在下或不存在下,將化合物[I-20]成為化合物[I-21]後,(步驟14-2)在適當的鹼的存在下或不存在下,在適當的溶劑中與化合物[XXVII]反應而製造。再者,通式[1-22]表示的化合物也可在適當的溶劑中,在偶氮二甲酸二酯(azodicarboxylate diester)及三苯基膦存在 下,將化合物[I-20]與化合物[XXVII]反應而製造。 That is, the compound represented by the general formula [1-22] may (step 14-1) convert the compound [I-20] into the compound [I in an appropriate solvent in the presence or absence of an appropriate base After -21], (Step 14-2) is produced by reacting with compound [XXVII] in an appropriate solvent in the presence or absence of an appropriate base. Furthermore, the compound represented by the general formula [1-22] may also be present in a suitable solvent in the presence of azodicarboxylate diester (azodicarboxylate diester) and triphenylphosphine Next, the compound [I-20] and the compound [XXVII] are reacted to produce.

(步驟14-1) (Step 14-1)

通式[I-21]表示的化合物是可將通式[I-20]表示的化合物,在鹵化劑或鹵化劑及三苯基膦的存在下,在適當的溶劑中反應而製造。 The compound represented by the general formula [I-21] can be produced by reacting the compound represented by the general formula [I-20] in the presence of a halogenating agent or a halogenating agent and triphenylphosphine in an appropriate solvent.

本反應所使用的鹵化劑例如可舉:亞硫醯氯(thionyl chloride)、氯、磺醯氯(sulfuryl chloride)、四氯化碳、N-氯琥珀醯亞胺(N-chlorosuccinimide)、溴、四溴化碳、N-溴琥珀醯亞胺、1,3-二溴-5,5-乙內醯脲(hydantoin)、碘、N-碘琥珀醯亞胺、1,3-二碘-5,5-乙內醯脲等。此外,相對於化合物[I-20]1莫耳,鹵化劑的使用量是在0.5至相當於溶劑量的莫耳的範圍適當地選擇即可,佳者是1.0至100莫耳。 Examples of the halogenating agent used in this reaction include: thionyl chloride, chlorine, sulfuryl chloride, carbon tetrachloride, N-chlorosuccinimide, bromine, Carbon tetrabromide, N-bromosuccinimide, 1,3-dibromo-5,5-hydantoin, iodine, N-iodosuccinimide, 1,3-diiodo-5 , 5-hydantoin, etc. In addition, the amount of the halogenating agent used may be appropriately selected from the range of 0.5 to the molar equivalent of the amount of the solvent relative to 1 mole of the compound [I-20], preferably 1.0 to 100 molar.

相對於化合物[I-20]1莫耳,本反應所使用的三苯基膦的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.5莫耳。 The use amount of triphenylphosphine used in this reaction is appropriately selected in the range of 1 to 5 moles relative to 1 mole of compound [I-20], preferably 1.0 to 2.5 moles.

又,通式[I-21]表示的化合物是可將通式[I-20]表示的化合物在假鹵化劑的存在下,在適當的溶劑中反應而製造。 In addition, the compound represented by the general formula [I-21] can be produced by reacting the compound represented by the general formula [I-20] in the presence of a pseudo halogenating agent in an appropriate solvent.

本反應所使用的擬鹵化劑可舉:三氟甲烷磺酸酐、三氟甲烷磺醯氯、對甲苯磺醯氯等。此外,相對於化合物[I-20]1莫耳,擬鹵化劑的使用量是在0.5至10莫耳的範圍適當地選擇即可,佳者是0.5至5.0莫耳。 Examples of the pseudohalogenating agent used in this reaction include trifluoromethanesulfonic anhydride, trifluoromethanesulfonyl chloride, and p-toluenesulfonyl chloride. In addition, the amount of the pseudohalogenating agent used may be appropriately selected in the range of 0.5 to 10 moles relative to 1 mole of the compound [I-20], preferably 0.5 to 5.0 moles.

在本反應使用鹼時,可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類,氫化鈉、氫化鉀等金屬氫化物類;甲氧基鈉、乙氧基鈉、第三丁氧基鉀等醇的金屬鹽類或三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4- N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類等。此外,相對於化合物[I-20]1莫耳,鹼的使用量是在0.1至20莫耳的範圍適當地選擇即可,佳者是0.5至6.0莫耳。 When a base is used in this reaction, the base that can be used includes, for example, hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide Types; alkali carbonates such as sodium carbonate and potassium carbonate; inorganic bases such as alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate; metal hydrides such as sodium hydride and potassium hydride; sodium methoxide , Sodium ethoxylate, potassium tributoxide and other metal salts of alcohol or triethylamine, 4-methylmorpholin, diisopropylethylamine, 1,8-diazabicyclo[5.4.0 ]-7-undecene, pyridine, 4- Organic bases such as N,N-dimethylaminopyridine and 2,6-lutidine. In addition, the amount of the base used may be appropriately selected in the range of 0.1 to 20 moles relative to 1 mole of the compound [I-20], preferably 0.5 to 6.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0160-170
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;或此等混合溶劑等。此外,相對於化合物[I-20]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.3至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0160-170
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; nitriles such as acetonitrile and propionitrile; ethyl acetate , Butyl acetate, ethyl propionate and other esters; pentane, hexane, cyclohexane, heptane and other aliphatic hydrocarbons; or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mol of the compound [I-20], preferably 0.3 to 10 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是10分鐘至48小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 48 hours.

反應結束後將反應混合物注入至水中,以有機溶劑萃取進行濃縮等操作,藉此,可單離化合物[I-21]。單離的化合物[I-21]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, extracted with an organic solvent, concentrated, etc., whereby the compound [I-21] can be isolated. The isolated compound [I-21] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟14-2) (Step 14-2)

相對於化合物[I-21]1莫耳,在本反應可使用的化合物[XXVII]的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至2.5莫耳。 The amount of the compound [XXVII] that can be used in this reaction is appropriately selected from the range of 1 to 5 moles relative to 1 mole of the compound [I-21], and preferably 1.0 to 2.5 moles.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金 屬重碳酸鹽類等的無機鹼類;氫化鈉、氫化鉀等金屬氫化物類;甲氧基鈉、乙氧基鈉、第三丁氧基鉀等醇的金屬鹽類;或三乙胺、4-甲基嗎福林、二異丙基乙胺、1,8-二氮雜雙環[5.4.0]-7-十一烯、吡啶、4-N,N-二甲胺基吡啶、2,6-二甲基吡啶等有機鹼類等。此外,相對於化合物[I-21]1莫耳,鹼的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至3.0莫耳。 Examples of the base that can be used in this reaction include: hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide; and sodium carbonate , Potassium carbonate and other alkali metal carbonates; sodium bicarbonate, potassium bicarbonate and other alkali gold Inorganic bases such as bicarbonates; metal hydrides such as sodium hydride and potassium hydride; metal salts of alcohols such as sodium methoxide, sodium ethoxylate, and potassium tributoxide; or triethylamine, 4-methylmorpholin, diisopropylethylamine, 1,8-diazabicyclo[5.4.0]-7-undecene, pyridine, 4-N,N-dimethylaminopyridine, 2 , 6-lutidine and other organic bases. In addition, the amount of the base used may be appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [I-21], and preferably 1.0 to 3.0 moles.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;苯、甲苯、二甲苯、氯苯等芳香族烴類;甲醇、乙醇、2-丙醇等醇類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0161-171
烷等醚類等;水,或此等混合溶劑等。此外,相對於化合物[I-21]1莫耳,溶劑的使用量是0.1至300公升,佳者是0.1至100公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; benzene, Aromatic hydrocarbons such as toluene, xylene, chlorobenzene; alcohols such as methanol, ethanol, 2-propanol; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl Aprotic polar solvents such as di-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone; diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0161-171
Ethers such as alkanes; water, or mixed solvents such as these. In addition, the amount of the solvent used is 0.1 to 300 liters relative to 1 mole of the compound [I-21], preferably 0.1 to 100 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至120℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature selected from a temperature range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 120°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常在10分鐘至48小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually from 10 minutes to 48 hours.

反應結束後將反應混合物注入至水中,以有機溶劑萃取進行濃縮等操作,藉此,可單離化合物[I-22]。單離的化合物[I-22]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, extracted with an organic solvent, concentrated, etc., whereby the compound [I-22] can be isolated. The isolated compound [I-22] can be purified by using column chromatography, recrystallization, etc. as required.

(步驟14-3) (Step 14-3)

在本反應可使用的偶氮二甲酸二酯例如可舉:偶氮二甲酸二乙酯及偶氮二甲酸二異丙酯等。此外,相對於化合物[I-20]1莫耳,偶氮二甲酸二酯的使用量是在1至10莫耳的範圍適當地選擇即可,佳者是1.0至5.0莫耳。 Examples of the azodicarboxylic acid diester that can be used in this reaction include diethyl azodicarboxylate and diisopropyl azodicarboxylate. In addition, the amount of the azodicarboxylic acid diester used is appropriately selected in the range of 1 to 10 moles relative to 1 mole of the compound [I-20], preferably 1.0 to 5.0 moles.

相對於化合物[I-20]1莫耳,在本反應可使用的三苯基膦的使用量是在1至10莫耳的範圍適當地選擇即可,佳者是1.0至5.0莫耳。 The amount of triphenylphosphine that can be used in this reaction is appropriately selected in the range of 1 to 10 moles relative to 1 mole of the compound [I-20], preferably 1.0 to 5.0 moles.

相對於化合物[I-20]1莫耳在本反應可使用的化合物[XXVII]的使用量是在1至10莫耳的範圍適當地選擇即可,佳者是1.0至5.0莫耳。 The use amount of the compound [XXVII] that can be used in this reaction with respect to the compound [I-20] 1 mol may be appropriately selected in the range of 1 to 10 mol, preferably 1.0 to 5.0 mol.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;苯、甲苯、二甲苯、氯苯等芳香族烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0162-172
烷等醚類等或此等混合溶劑等。此外,相對於化合物[I-20]1莫耳,溶劑的使用量是0.1至300公升,佳者是0.1至100公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; benzene, Toluene, xylene, chlorobenzene and other aromatic hydrocarbons; N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide , Cyclobutane, 1,3-dimethyl-2-imidazolidinone and other aprotic polar solvents; diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0162-172
Ethers such as alkanes or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 300 liters relative to 1 mole of the compound [I-20], preferably 0.1 to 100 liters.

本反應的反應溫度是通常在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至120℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature selected from a temperature range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 120°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常10分鐘至48小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 48 hours.

反應結束後將反應混合物注入至水中,以有機溶劑萃取進行濃縮等操作,藉此,可單離化合物[I-22]。單離的化合物[I-22]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, extracted with an organic solvent, concentrated, etc., whereby the compound [I-22] can be isolated. The isolated compound [I-22] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法15> <Manufacturing method 15>

本發明化合物中,通式[I-23]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-23] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0163-106
Figure 108126125-A0202-12-0163-106

(式中,L2、R3、R4、R5、R6、Re及n表示與前述相同意義) (In the formula, L 2, R 3, R 4, R 5, R 6, R e and n are the same meaning as aforementioned)

亦即,通式[I-23]表示的化合物是可將通式[I-20]表示的化合物及化合物[VI],在適當的鹼的存在下或不存在下在適當的溶劑中反應而製造。 That is, the compound represented by the general formula [I-23] is a compound and the compound [VI] represented by the general formula [I-20] can be reacted in an appropriate solvent in the presence or absence of an appropriate base manufacture.

在本反應可使用的鹼、溶劑、反應溫度及反應時間是與製造方法3相同。 The base, solvent, reaction temperature and reaction time that can be used in this reaction are the same as those in Production Method 3.

本反應結束後將反應混合物注入至水中而中和之後,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-23]。單離的化合物[I-23]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water and neutralized, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated to separate the compound [I-23]. The isolated compound [I-23] can be purified by using column chromatography, recrystallization, etc. as required.

<製造方法16> <Manufacturing method 16>

本發明化合物中,通式[I-25]表示的化合物是例如可依照下述方法製造。 Among the compounds of the present invention, the compound represented by the general formula [I-25] can be produced according to the following method, for example.

Figure 108126125-A0202-12-0164-107
Figure 108126125-A0202-12-0164-107

(式中,R14表示氫原子、基C(=O)OR10、C1至C6烷基,L2、R3、R4、R6、R7、R10、Ra及n表示與前述相同意義) (In the formula, R 14 represents a hydrogen atom, a group C(=O)OR 10 , C 1 to C 6 alkyl, L 2 , R 3 , R 4 , R 6 , R 7 , R 10 , R a and n represent (Same meaning as above)

亦即,通式[I-25]表示的化合物是可在適當的溶劑中,在適當的鹼存在下,將通式[I-24]表示的化合物及化合物XXVIII]反應而製造。 That is, the compound represented by the general formula [I-25] can be produced by reacting the compound represented by the general formula [I-24] and the compound XXVIII in an appropriate solvent in the presence of a suitable base.

相對於化合物[I-24]1莫耳,本發明使用的化合物[XXVIII]的使用量是在1至10莫耳的範圍適當地選擇即可,佳者是1.0至3.5莫耳。 The use amount of the compound [XXVIII] used in the present invention may be appropriately selected in the range of 1 to 10 moles relative to 1 mole of the compound [I-24], preferably 1.0 to 3.5 moles.

在本反應可使用的鹼例如可舉:氫氧化鋰、氫氧化鈉、氫氧化鉀等鹼金屬的氫氧化物類;氫氧化鈣、氫氧化鎂等鹼土類金屬的氫氧化物類;碳酸鈉、碳酸鉀等鹼金屬的碳酸鹽類;碳酸氫鈉、碳酸氫鉀等鹼金屬重碳酸鹽類等的無機鹼類;氫化鈉、氫化鉀等金屬氫化物類;甲氧基鈉、乙氧基鈉、第三丁氧基鉀等醇的金屬鹽類或三乙胺、N,N-二甲基苯胺、吡啶、4-N,N-二甲胺基吡啶、1,8-二氮雜雙環[5.4.0]-7-十一烯等有機鹼類等。此外,相對於化合物[I-24]1莫耳,鹼的使用量是在1至5莫耳的範圍適當地選擇即可,佳者是1.0至3.0莫耳。 Examples of the base that can be used in this reaction include: hydroxides of alkali metals such as lithium hydroxide, sodium hydroxide, and potassium hydroxide; hydroxides of alkaline earth metals such as calcium hydroxide and magnesium hydroxide; and sodium carbonate , Alkali carbonates such as potassium carbonate; inorganic alkalis such as alkali metal bicarbonate such as sodium bicarbonate and potassium bicarbonate; metal hydrides such as sodium hydride and potassium hydride; sodium methoxide and ethoxy Metal salts of alcohols such as sodium and potassium tributoxide or triethylamine, N,N-dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine, 1,8-diazabicyclo [5.4.0]-7-undecene and other organic bases. In addition, the amount of the base used may be appropriately selected in the range of 1 to 5 moles relative to 1 mole of the compound [I-24], preferably 1.0 to 3.0 moles.

在本反應可使用的溶劑例如可舉:二乙醚、環戊基甲基醚、四氫呋喃、2-甲基四氫呋喃、1,4-二

Figure 108126125-A0202-12-0164-174
烷等醚類;苯、甲苯、二甲苯、氯苯等芳香族烴類;二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮、二甲基亞碸、環丁碸、1,3-二甲基-2-咪唑啉酮等非質子性極性溶劑類;甲醇、乙醇、2-丙醇 等醇類;乙腈、丙腈等腈類;乙酸乙酯、乙酸丁酯、丙酸乙酯等酯類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;吡啶、甲基吡啶等吡啶類;水或此等混合溶劑等。此外,相對於化合物[I-24]1莫耳,溶劑的使用量是0.1至100公升,佳者是0.2至10公升。 Examples of solvents that can be used in this reaction include diethyl ether, cyclopentyl methyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-di
Figure 108126125-A0202-12-0164-174
Ethers such as alkane; aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene; halogenated hydrocarbons such as methylene chloride, chloroform, 1,2-dichloroethane; N,N-dimethylformamide, Aprotic polar solvents such as N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, cyclobutane, 1,3-dimethyl-2-imidazolidinone Alcohols; methanol, ethanol, 2-propanol and other alcohols; acetonitrile, propionitrile and other nitriles; ethyl acetate, butyl acetate, ethyl propionate and other esters; pentane, hexane, cyclohexane, heptane Aliphatic hydrocarbons; pyridines such as pyridine and picoline; water or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 100 liters relative to 1 mol of the compound [I-24], preferably 0.2 to 10 liters.

本反應的反應溫度是在由-30℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是在0℃至150℃的範圍進行為佳。 The reaction temperature in this reaction may be any temperature within a range from -30°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of 0°C to 150°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[I-25]。單離的化合物[I-25]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is filtered out or extracted with an organic solvent and then concentrated to perform operations such as isolation of the compound [I-25]. The isolated compound [I-25] can be purified by using column chromatography, recrystallization, etc. as required.

再者,屬於通式[I]或[II]表示的本發明化合物的製造中間物的化合物[III]等是可依照下述所示的製造法而製造,惟,不限定於此等方法。 In addition, the compound [III] and the like that belong to the intermediate for producing the compound of the present invention represented by the general formula [I] or [II] can be produced according to the production methods shown below, but it is not limited to these methods.

<中間物的製造方法1> <Method of Manufacturing Intermediate 1>

Figure 108126125-A0202-12-0165-108
Figure 108126125-A0202-12-0165-108

(式中,RC表示氰基或羧基,R3、R4、X1及n表示與前述相同意義) (In the formula, R C represents a cyano group or a carboxyl group, and R 3 , R 4 , X 1 and n represent the same meaning as described above)

亦即,通式[IX]表示的化合物是可在適當的溶劑中,將化合物[VIII]與鹵化劑反應而製造。 That is, the compound represented by the general formula [IX] can be produced by reacting the compound [VIII] with a halogenating agent in an appropriate solvent.

在本反應可使用的鹵化劑可舉:氯、磺醯氯、N-氯琥珀醯亞胺、溴、N-溴琥珀醯亞胺、1,3-二溴-5,5-乙內醯脲,碘、N-碘琥珀醯亞胺、1,3-二碘-5,5-乙內醯脲等。此外,相對於化合物[VIII]1莫耳,鹵化劑的使用量是在0.5至10莫耳的範圍適當地選擇即可,佳者是0.5至2.0莫耳。 Halogenating agents usable in this reaction include chlorine, sulfonyl chloride, N-chlorosuccinimide, bromine, N-bromosuccinimide, 1,3-dibromo-5,5-hydantoin , Iodine, N-iodosuccinimide, 1,3-diiodo-5,5-hydantoin, etc. In addition, the amount of halogenating agent used may be appropriately selected in the range of 0.5 to 10 moles relative to 1 mole of compound [VIII], and preferably 0.5 to 2.0 moles.

在本反應可使用的溶劑例如可舉:二氯甲烷、氯仿、1,2-二氯乙烷等鹵化烴類;戊烷、己烷、環己烷、庚烷等脂肪族烴類;乙腈、丙腈等腈類;乙酸、丙酸、三氟乙酸等羧酸類;硫酸、水,或此等混合溶劑等。此外,相對於化合物[VIII]1莫耳,溶劑的使用量是0.1至300公升,佳者是0.3至20公升。 Examples of solvents that can be used in this reaction include halogenated hydrocarbons such as dichloromethane, chloroform, and 1,2-dichloroethane; aliphatic hydrocarbons such as pentane, hexane, cyclohexane, and heptane; and acetonitrile. Nitriles such as propionitrile; carboxylic acids such as acetic acid, propionic acid, trifluoroacetic acid; sulfuric acid, water, or these mixed solvents. In addition, the amount of the solvent used is 0.1 to 300 liters relative to 1 mole of compound [VIII], preferably 0.3 to 20 liters.

本反應的反應溫度是通常在由-70℃至反應系統的迴流溫度為止的溫度範圍選擇任意的溫度即可,佳者是-20℃至100℃的範圍進行為佳。 The reaction temperature of this reaction is usually any temperature selected from a temperature range of -70°C to the reflux temperature of the reaction system, and it is preferably carried out in the range of -20°C to 100°C.

本反應的反應時間是隨反應溫度、反應基質、反應量等而有不同,通常是10分鐘至24小時。 The reaction time of this reaction varies with the reaction temperature, reaction substrate, reaction amount, etc., and is usually 10 minutes to 24 hours.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[IX]。單離的化合物[IX]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated, whereby the compound [IX] can be isolated. The isolated compound [IX] can be purified by using column chromatography, recrystallization, etc. as required.

<中間物的製造方法2> <Method of Manufacturing Intermediate 2>

Figure 108126125-A0202-12-0167-109
Figure 108126125-A0202-12-0167-109

(式中,X2表示氫原子或鹵原子,B1、R3、R4、R6及n表示與前述相同意義) (In the formula, X 2 represents a hydrogen atom or a halogen atom, and B 1 , R 3 , R 4 , R 6 and n represent the same meaning as above)

亦即,通式[XV]表示的化合物是可使用Chem.Pharm.Bull.,第23卷(第5號)955頁-966頁(1975年)或日本特開2007-308485號公報說明書所述之方法或依據其所述之方法,(步驟2’-1)在適當的溶劑中, 在適當的觸媒的存在下或不存在下,將化合物[X]使用酸鹵化劑成為化合物[XI]後,(步驟2’-2)在適當的溶劑中,在適當的鹼的存在下或不存在下,將化合物[XI]及化合物[XII]反應而得到化合物[XIII]後,(步驟2’-3)在適當的溶劑中或無溶劑,在適當的酸的存在下,將化合物[XIII]及氰酸鹽或硫氰酸鹽反應而得到化合物[XIV],(步驟2’-4)在適當的溶劑中,在適當的鹼的存在下,經環化反應而製造化合物[XIV]。 That is, the compound represented by the general formula [XV] can be used as described in Chem. Pharm. Bull., Vol. 23 (No. 5) page 955-page 966 (1975) or Japanese Patent Application Publication No. 2007-308485 Method or according to the method described (Step 2'-1) in a suitable solvent, After compound [X] is converted to compound [XI] using an acid halogenating agent in the presence or absence of a suitable catalyst, (Step 2'-2) in a suitable solvent in the presence of a suitable base or In the absence of, after compound [XI] and compound [XII] are reacted to obtain compound [XIII], (Step 2'-3) in an appropriate solvent or without solvent, in the presence of an appropriate acid, the compound [ XIII] reacts with cyanate or thiocyanate to obtain compound [XIV], (step 2'-4) in a suitable solvent in the presence of a suitable base, cyclization reaction to produce compound [XIV] .

<中間物的製造方法3> <Method of Manufacturing Intermediate 3>

Figure 108126125-A0202-12-0168-110
Figure 108126125-A0202-12-0168-110

(式中,B、R3、R4、R5、R6、X1及n表示與前述相同意義) (In the formula, B, R 3 , R 4 , R 5 , R 6 , X 1 and n represent the same meaning as above)

亦即,通式[III-1]表示的化合物是可在適當的溶劑中,將化合物[XVI]與鹵化劑反應而製造。 That is, the compound represented by the general formula [III-1] can be produced by reacting the compound [XVI] with a halogenating agent in an appropriate solvent.

在本反應使用的鹵化劑、在本反應可使用的溶劑、反應溫度及反應時間係與中間物的製造方法1相同。 The halogenating agent used in this reaction, the solvent usable in this reaction, the reaction temperature and the reaction time are the same as those of the intermediate production method 1.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[III-1]。單離的化合物[III-1]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated to separate the compound [III-1]. The isolated compound [III-1] can be purified by using column chromatography, recrystallization, etc. as required.

<中間物的製造方法4> <Method of Manufacturing Intermediate 4>

Figure 108126125-A0202-12-0169-112
Figure 108126125-A0202-12-0169-112

(式中,R5’表示C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C1至C6鹵烷基或C3至C6鹵環烷基,R6’表示C1至C6烷基,Rd表示C1至C6烷基,L3表示鹵原子,R3、R4、X1及n表示與前述相同意義) (Wherein, R 5 'represents a C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl, a C 1 to C 6 -alkyl, C 1 to C 6 haloalkyl, or C 3 to C 6 halocycloalkyl, R 6′ represents C 1 to C 6 alkyl, R d represents C 1 to C 6 alkyl, L 3 represents a halogen atom, R 3 , R 4 , X 1 and n represent (Same meaning as above)

亦即,通式[III-4]表示的化合物是可使用日本特開2007-308485號公報所述之方法或依據其所述之方法,(步驟4’-1)在適當的溶劑中或無溶劑下,醇存在下,將化合物[XVII]與氯化氫經比南(Pinner)反應而製造化合物[XVIII]的鹽酸鹽,繼而(步驟4’-2)在適當的溶劑中,在適當的鹼的存在下或不存在下,將化合物[XVIII]及聯胺反應而製造化合物[XIX],進一步(步驟4’-3)在適當的溶劑中,在適當的鹼的存在下或不存在下,將化合物[XIX]與化合物[XX]或與化合物[XXI]進行環化反應而製造化合物[III-3],最後(步驟4’-4)將化合物[III-3]與化合物[XXII]反應而製造化合物[III-4]。此時,可製造化合物[III-4’]作為副生成物。 That is, the compound represented by the general formula [III-4] can use the method described in Japanese Patent Application Publication No. 2007-308485 or the method according to it, (Step 4'-1) in an appropriate solvent or without In the presence of an alcohol, the compound [XVII] and hydrogen chloride are reacted by Pinner to produce the hydrochloride salt of the compound [XVIII], and then (step 4'-2) in an appropriate solvent in an appropriate base In the presence or absence of the compound, the compound [XVIII] and the hydrazine are reacted to produce the compound [XIX], further (step 4'-3) in an appropriate solvent in the presence or absence of an appropriate base, The compound [XIX] is reacted with the compound [XX] or with the compound [XXI] to produce the compound [III-3], and finally (step 4'-4) the compound [III-3] is reacted with the compound [XXII] And manufacture compound [III-4]. At this time, compound [III-4'] can be produced as a by-product.

<中間物的製造方法5> <Method of Manufacturing Intermediate 5>

Figure 108126125-A0202-12-0170-114
Figure 108126125-A0202-12-0170-114

(式中,R3、R4、R6、R10、X2及n表示與前述相同意義) (In the formula, R 3 , R 4 , R 6 , R 10 , X 2 and n represent the same meaning as above)

亦即,通式[III-5]表示的化合物是可使用Tetrahedron Letters,第53卷6078頁-6082頁(2012年)所述之方法或依據記載的方法,在適當的溶劑中,將化合物[XIII]與化合物[XXV]反應而製造。 That is, the compound represented by the general formula [III-5] can use the method described in Tetrahedron Letters, Vol. 53, pages 6078-6082 (2012) or according to the described method, in a suitable solvent, the compound [ XIII] is produced by reacting with compound [XXV].

<中間物的製造方法6> <Method of Manufacturing Intermediate 6>

Figure 108126125-A0202-12-0171-115
Figure 108126125-A0202-12-0171-115

(式中,R6、R11及X1表示與前述相同的意義) (In the formula, R 6 , R 11 and X 1 have the same meaning as above)

亦即,依照通式[XXIII]表示的化合物是可使用(步驟6-1)US4670448A(1987年)所述之方法或依據記載的方法,在適當的溶劑中或無溶劑,將化合物[XVIII]與化合物[XXIX]反應而製造化合物[XXX],繼而(步驟6-2)在鹵化銅的存在下在適當的溶劑中將化合物[XXX]由桑德邁爾反應(Sandmyer reaction)而可製造。 That is, the compound represented by the general formula [XXIII] is a compound [XVIII] that can be prepared by using the method described in (Step 6-1) US4670448A (1987) or according to the described method in an appropriate solvent or without a solvent The compound [XXX] is reacted with the compound [XXIX] to produce the compound [XXX], and then (Step 6-2) The compound [XXX] can be produced by Sandmyer reaction in an appropriate solvent in the presence of copper halide.

步驟6-2的反應使用的鹵化劑、可使用的溶劑、反應溫度及反應時間係與製造方法12相同。 The halogenating agent, usable solvent, reaction temperature and reaction time used in the reaction of Step 6-2 are the same as those of Production Method 12.

反應結束後將反應混合物注入至水中,濾取析出的固體或以有機溶劑萃取後進行濃縮等操作,藉此,可單離化合物[XXIII]。單離的化合物[XXIII]可因應所需使用管柱層析法、再結晶等而再精製。 After the reaction is completed, the reaction mixture is poured into water, and the precipitated solid is collected by filtration or extracted with an organic solvent and then concentrated, whereby the compound [XXIII] can be isolated. The isolated compound [XXIII] can be purified by using column chromatography, recrystallization, etc. as required.

本發明的通式[II]表示的5-(1,2,4-三唑-5-基)苯甲酸衍生物或其酯體是作為製造本發明的通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽時的中間物有用的化合物。 The 5-(1,2,4-triazol-5-yl)benzoic acid derivative represented by the general formula [II] of the present invention or its ester form is used to produce the 5-(represented by the general formula [I] of the present invention. 1,2,4-triazol-5-yl)benzamide derivatives or compounds that are useful as intermediates in agriculturally acceptable salts.

再者,本發明的通式[III]表示的5-苯基-1,2,4-三唑衍生物是作為製造本發明的通式[II]表示的5-(1,2,4-三唑-5-基)苯甲酸衍生物或其酯體時的中間物有用的化合物。 Furthermore, the 5-phenyl-1,2,4-triazole derivative represented by the general formula [III] of the present invention is a 5-(1,2,4- represented by the general formula [II] of the present invention Triazole-5-yl)benzoic acid derivatives or their esters are useful compounds as intermediates.

本發明的農藥組成物係含有本發明的通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為有效成分。 The pesticide composition of the present invention contains the 5-(1,2,4-triazol-5-yl)benzamide derivative represented by the general formula [I] of the present invention or its agriculturally acceptable salt as Active ingredients.

本發明的農藥組成物因應所需可含有在農藥製劑通常被使用的添加成分(載體)。 The agricultural chemical composition of the present invention may contain additional components (carriers) that are generally used in agricultural chemical preparations as needed.

本發明的有害生物防除劑係含有本發明的通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為有效成分。本發明的有害生物防除劑代表性的是殺蟲劑、殺蟎劑及殺線蟲劑。 The pest control agent of the present invention contains the 5-(1,2,4-triazol-5-yl)benzamide derivative represented by the general formula [I] of the present invention or its agriculturally acceptable salt As an active ingredient. The pest control agents of the present invention are representative of insecticides, acaricides and nematicides.

本發明的有害生物防除劑係因應所需可含有在農藥製劑通常被使用的添加成分(載體)。 The pest control agent of the present invention may contain additional components (carriers) that are usually used in pesticide preparations as needed.

該添加成分可舉:固體載體或液體載體等載體、界面活性劑、結合劑及賦黏劑、增黏劑、著色劑、擴展劑、展著劑、抗凍劑、抗結塊劑、崩解劑、抗分解劑等,因應其他所需時,也可使用防腐劑及植物片等作為添加成分。再者,此等添加成分是可以使用1種,再者,也可以將2種以上組合使用。 Examples of the added component include carriers such as solid carriers or liquid carriers, surfactants, binders and tackifiers, tackifiers, colorants, extenders, spreading agents, antifreeze agents, anti-caking agents, and disintegration Agents, anti-decomposition agents, etc., according to other needs, preservatives and plant tablets can also be used as additional ingredients. In addition, one type of these additional components may be used, or two or more types may be used in combination.

以下,詳細地說明上述添加成分。 Hereinafter, the above-mentioned added components will be described in detail.

固體載體例如可舉:葉蠟石黏土、高嶺黏土、矽石黏土、滑石、矽藻土、沸石、皂土、酸性白土、活性白土、鎂鋁海泡石(attapulgite)黏土、蛭石、珍珠岩、浮石、白碳(合成矽酸、合成矽酸鹽等)、二氧化鈦等礦物系載體;木質粉、玉米莖、核桃殼、果實核、稻殼、鋸木屑、麩皮、大豆粉、粉末纖維素、澱粉、糊精、糖類等植物性載體;碳酸鈣、硫酸銨、硫酸鈉、氯化鉀等無機鹽類載體;聚乙烯、聚丙烯、聚氯乙烯、聚乙酸乙烯酯、乙烯-乙酸乙烯酯共聚物、尿素-醛樹脂等高分子載體等。 Examples of solid carriers include pyrophyllite clay, kaolin clay, silica clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, activated clay, attapulgite clay, vermiculite, and perlite , Pumice, white carbon (synthetic silicic acid, synthetic silicate, etc.), titanium dioxide and other mineral-based carriers; wood flour, corn stalks, walnut shells, fruit kernels, rice husks, sawdust, bran, soy flour, powdered cellulose , Starch, dextrin, sugar and other vegetable carriers; calcium carbonate, ammonium sulfate, sodium sulfate, potassium chloride and other inorganic salt carriers; polyethylene, polypropylene, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate Polymer carriers such as copolymers and urea-aldehyde resins.

液體載體例如可舉:甲醇、乙醇、丙醇、2-丙醇、丁醇、環己醇等一元醇類;乙二醇、二乙二醇、丙二醇、己二醇、聚乙二醇、聚丙二醇、甘油等多元醇類;丙烯系二醇醚等多元醇衍生物類;丙酮、甲基乙 基酮、甲基異丁基酮、二異丁基酮、環己酮、異佛酮等酮類;乙醚、1,4-二

Figure 108126125-A0202-12-0173-175
烷、2-乙氧基乙醇(cellosolve)、二丙基醚、四氫呋喃等醚類;直鏈烷烴(normal paraffin)、環烷烴(naphthene)、異構烷烴(isoparaffin)、煤油、礦油等脂肪族烴類;甲苯、C9-C10烷基苯、二甲苯、溶劑石油腦(solvent naphtha)、烷基萘、高沸點芳香族烴等芳香族烴類;1,2-二氯乙烷、氯仿、四氯化碳等鹵化烴類;乙酸乙酯、苯二甲酸二異丙酯、苯二甲酸二丁酯、苯二甲酸二辛酯、己二酸二甲酯等酯類;γ-丁內酯之等內酯類;N,N-二甲基甲醯胺、N,N-二乙基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯酮等醯胺類;乙腈等腈類;二甲基亞碸等硫化合物類;大豆油、菜籽油、棉籽油、椰子油、蓖麻籽油等植物油;水等。 Examples of the liquid carrier include monohydric alcohols such as methanol, ethanol, propanol, 2-propanol, butanol, and cyclohexanol; ethylene glycol, diethylene glycol, propylene glycol, hexylene glycol, polyethylene glycol, and polyethylene glycol. Polyols such as propylene glycol and glycerin; polyhydric alcohol derivatives such as propylene glycol ether; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, diisobutyl ketone, cyclohexanone, and isophorone Class; ether, 1,4-di
Figure 108126125-A0202-12-0173-175
Alkanes, 2-ethoxyethanol (cellosolve), dipropyl ether, tetrahydrofuran and other ethers; linear paraffins (normal paraffin), naphthene (naphthene), isoparaffin (isoparaffin), kerosene, mineral oil and other aliphatic Hydrocarbons; aromatic hydrocarbons such as toluene, C 9 -C 10 alkylbenzene, xylene, solvent naphtha, alkyl naphthalene, high-boiling aromatic hydrocarbons; 1,2-dichloroethane, chloroform , Halogenated hydrocarbons such as carbon tetrachloride; ethyl acetate, diisopropyl phthalate, dibutyl phthalate, dioctyl phthalate, dimethyl adipate and other esters; γ-butyrolene Lactones such as esters; N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, etc. Acetamides; nitriles such as acetonitrile; sulfur compounds such as dimethyl sulfoxide; vegetable oils such as soybean oil, rapeseed oil, cottonseed oil, coconut oil, castor seed oil; water, etc.

界面活性劑沒有特別的限制,佳者是在水中顯示凝膠化、或表現膨潤性者,例如可舉:山梨醇酐脂肪酸酯、聚氧乙烯山梨醇酐脂肪酸酯、蔗糖脂肪酸酯、聚氧乙烯脂肪酸酯、聚氧乙烯樹脂酸酯、聚氧乙烯脂肪酸二酯、聚氧乙烯烷基醚、聚氧乙烯烷基苯基醚、聚氧乙烯二烷基苯基醚、聚氧乙烯烷基苯基醚福馬林縮合物、聚氧乙烯聚氧丙烯崁段共聚物、烷基聚氧乙烯聚丙烯崁段共聚物醚、聚氧乙烯烷基胺、聚氧乙烯脂肪醯胺、聚氧乙烯脂肪酸雙苯基醚、聚伸烷基苄基苯基醚、聚氧伸烷基苯乙烯基苯基醚、乙炔二醇、聚氧伸烷基加成乙炔二醇、聚氧乙烯醚型聚矽氧、酯型聚矽氧、氟系界面活性劑、聚氧乙烯蓖麻籽油、聚氧乙烯硬化蓖麻籽油等非離子性界面活性劑;烷基硫酸鹽、聚氧乙烯烷基醚硫酸鹽、聚氧乙烯烷基苯基醚硫酸鹽、聚氧乙烯苯乙烯基苯基醚硫酸鹽、烷基苯磺酸鹽、木質素磺酸鹽、烷基磺基琥珀酸鹽、萘磺酸鹽、烷基萘磺酸鹽、萘磺酸的福馬林縮合物的鹽、烷基萘磺酸的福馬林縮合物的鹽、脂肪酸鹽、聚羧酸 鹽、N-甲基-脂肪酸肌胺酸酯、樹脂酸鹽、聚氧乙烯烷基醚磷酸鹽、聚氧乙烯烷基苯基醚磷酸鹽等陰離子性界面活性劑;月桂基胺鹽酸鹽、硬脂基胺鹽酸鹽、油基胺鹽酸鹽、硬脂基胺乙酸鹽、硬脂基胺丙基胺乙酸鹽、氯化烷基三甲基銨、烷基二甲基羥基氯苯胺等烷基胺鹽等的陽離子界面活性劑;二烷基二胺基乙基甜菜鹼、烷基二甲基苄基甜菜鹼等甜菜鹼型、二烷基胺基乙基甘胺酸、烷基二甲基苄基甘胺酸等胺基酸型等的兩性界面活性劑等。 The surfactant is not particularly limited, and the one that shows gelation or swelling in water is preferred, for example: sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, Polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, polyoxyethylene fatty acid diester, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene dialkyl phenyl ether, polyoxyethylene Alkylphenyl ether formalin condensate, polyoxyethylene polyoxypropylene segment copolymer, alkyl polyoxyethylene polypropylene segment copolymer ether, polyoxyethylene alkylamine, polyoxyethylene fatty amide, polyoxyethylene Ethylene fatty acid diphenyl ether, polyalkylene benzyl phenyl ether, polyoxyalkylene styryl phenyl ether, acetylene glycol, polyoxyalkylene addition acetylene glycol, polyoxyethylene ether type poly Non-ionic surfactants such as silicone, ester-type silicone, fluorine-based surfactants, polyoxyethylene castor seed oil, polyoxyethylene hardened castor seed oil; alkyl sulfates, polyoxyethylene alkyl ethers Sulfate, polyoxyethylene alkyl phenyl ether sulfate, polyoxyethylene styryl phenyl ether sulfate, alkyl benzene sulfonate, lignin sulfonate, alkyl sulfosuccinate, naphthalene sulfonic acid Salt, alkyl naphthalene sulfonate, salt of formalin condensate of naphthalene sulfonic acid, salt of formalin condensate of alkyl naphthalene sulfonate, fatty acid salt, polycarboxylic acid Salt, N-methyl-fatty acid sarcosinate, resinate, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkyl phenyl ether phosphate and other anionic surfactants; laurylamine hydrochloride, Stearylamine hydrochloride, oleylamine hydrochloride, stearylamine acetate, stearylaminepropylamine acetate, alkyltrimethylammonium chloride, alkyldimethylhydroxychloroaniline, etc. Cationic surfactants such as alkylamine salts; betaine type such as dialkyldiaminoethyl betaine, alkyl dimethyl benzyl betaine, dialkylaminoethylglycine, alkyl di Amphoteric surfactants such as amino acid type such as methylbenzylglycine etc.

鍵結劑及賦黏劑例如可舉:羧甲基纖維素及其鹽、糊精、水溶性澱粉、黃原膠、瓜爾膠、蔗糖,聚乙烯吡咯烷酮、阿拉伯樹膠、聚乙烯醇、聚乙酸乙烯酯,聚丙烯酸鈉、平均分子量6000至20000的聚乙二醇、平均分子量10萬至500萬的聚環氧乙烷,天然磷脂質(例如,腦磷脂酸、卵磷脂等)等。 Examples of binding agents and tackifiers include carboxymethyl cellulose and its salts, dextrin, water-soluble starch, xanthan gum, guar gum, sucrose, polyvinylpyrrolidone, gum arabic, polyvinyl alcohol, and polyacetic acid Vinyl esters, sodium polyacrylate, polyethylene glycol with an average molecular weight of 6,000 to 20,000, polyethylene oxide with an average molecular weight of 100,000 to 5 million, natural phospholipids (eg, cephalinic acid, lecithin, etc.), etc.

增黏劑例如可舉:黃原膠、瓜爾膠、羧甲基纖維素、聚乙烯吡咯烷酮、羧乙烯聚合物、丙烯酸系聚合物、澱粉衍生物、多糖類等水溶性高分子;如高純度皂土,白碳的無機微粉等。 Examples of the thickener include xanthan gum, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivatives, polysaccharides, and other water-soluble polymers; such as high purity Bentonite, inorganic fine powder of white carbon, etc.

著色劑例如可舉:氧化鐵、氧化鈦、普魯士藍等無機顏料;茜素染料、偶氮染料、金屬酞花青染料等有機染料等。 Examples of the colorant include inorganic pigments such as iron oxide, titanium oxide, and Prussian blue; organic dyes such as alizarin dye, azo dye, and metal phthalocyanine dye.

擴展劑例如可舉:聚矽氧系界面活性劑、纖維素粉末、糊精、加工澱粉、聚胺基羧酸螯合物化合物、交聯聚乙烯基吡咯烷酮、順丁烯二酸及苯乙烯類、甲基丙烯酸共聚物、多元醇的聚合物與二甲酸酐的半酯、聚苯乙烯磺酸的水溶性鹽等。 Examples of the extender include polysiloxane-based surfactants, cellulose powder, dextrin, processed starch, polyaminocarboxylic acid chelate compounds, cross-linked polyvinylpyrrolidone, maleic acid, and styrenes. , Methacrylic acid copolymers, polyhydric alcohol polymers and half esters of dicarboxylic anhydride, water-soluble salts of polystyrene sulfonic acid, etc.

展著劑例如可舉:二烷基磺基琥珀酸鈉、聚氧乙烯烷基醚、聚氧乙烯烷基苯基醚、聚氧乙烯脂肪酸酯等各種界面活性劑;石蠟、萜 烯、聚醯胺樹脂、聚丙烯酸鹽、聚氧乙烯、蠟、聚乙烯基烷基醚、烷基酚福馬林縮合物、合成樹脂乳液等。 Examples of the spreading agent include various surfactants such as sodium dialkyl sulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester; paraffin, terpene Ethylene, polyamide resin, polyacrylate, polyoxyethylene, wax, polyvinyl alkyl ether, alkylphenol formalin condensate, synthetic resin emulsion, etc.

抗凍劑例如可舉:乙二醇、二乙二醇、丙二醇、甘油等多元醇類等。 Examples of antifreeze agents include polyhydric alcohols such as ethylene glycol, diethylene glycol, propylene glycol, and glycerin.

抗結塊劑例如可舉:澱粉、海藻酸、甘露糖、半乳糖等多糖類;聚乙烯吡咯烷酮、白碳、酯膠、石油樹脂等。 Examples of anti-caking agents include polysaccharides such as starch, alginic acid, mannose, and galactose; polyvinylpyrrolidone, white carbon, ester gum, petroleum resin, and the like.

崩解劑例如可舉:三聚磷酸鈉、六偏磷酸鈉、硬脂酸金屬鹽、纖維素粉末、糊精、甲基丙烯酸酯的共聚物、聚乙烯吡咯烷酮、聚胺基羧酸螯合物化合物、磺化苯乙烯/異丁烯/順丁烯二酸酐共聚物、澱粉/聚丙烯腈接枝共聚物等。 Examples of the disintegrant include sodium tripolyphosphate, sodium hexametaphosphate, metal stearate, cellulose powder, dextrin, methacrylate copolymer, polyvinylpyrrolidone, and polyaminocarboxylic acid chelate. Compounds, sulfonated styrene/isobutylene/maleic anhydride copolymer, starch/polyacrylonitrile graft copolymer, etc.

抗分解劑例如可舉:沸石、生石灰、氧化鎂等乾燥劑;酚系、胺系、硫系、磷酸系等抗氧化劑;水楊酸系、二苯基酮系等紫外線吸收劑等。 Examples of the anti-decomposition agent include desiccants such as zeolite, quicklime, and magnesium oxide; antioxidants such as phenol-based, amine-based, sulfur-based, and phosphoric acid-based; ultraviolet absorbers such as salicylic acid-based and diphenyl ketone-based.

另一方面,本發明的有害生物防除劑中,含有上述添加成分時,關於其添加比率是以質量基準,在固體載體或液體載體等載體通常是在5至95%,佳者是20至90%的範圍選用,界面活性劑通常是在0.1%至30%,佳者是0.5至10%的範圍選用,其他添加劑是在0.1至30%,佳者是0.5至10%的範圍選用。 On the other hand, when the pest control agent of the present invention contains the above-mentioned added components, the addition ratio thereof is based on mass, and it is usually 5 to 95% in a solid carrier or liquid carrier, preferably 20 to 90 It is selected in the range of %, and the surfactant is usually selected in the range of 0.1% to 30%, preferably in the range of 0.5 to 10%, and other additives are selected in the range of 0.1 to 30%, preferably in the range of 0.5 to 10%.

本發明的有害生物防除劑是製劑化成下列任意劑型的製劑使用:粉劑、粉粒劑、粒劑、水和劑、水溶劑、顆粒水和劑、錠劑、轉移(jumper agent)劑、乳劑、油劑、液劑、懸浮劑(flowable agent)、乳化劑、微乳化劑、懸浮乳劑(Suspoemulsion)、微量散布劑、微膠囊劑、薰蒸劑、煙霧劑、誘餌劑、膏狀製劑等。 The pest control agent of the present invention is a preparation formulated into any of the following dosage forms: powder, powder granule, granule, water and agent, water solvent, granular water and agent, lozenge, jumper agent, emulsion, Oils, liquids, flowable agents, emulsifiers, microemulsifiers, suspension emulsions (Suspoemulsion), micro-dispersants, microcapsules, fumigants, aerosols, bait agents, paste preparations, etc.

此等製劑在實際的使用時,可直接使用,或者是以水等烯釋劑烯釋成預定濃度使用。含有本發明的化合物之各種製劑或其烯釋物的施用係以通常一般所行之施用方法,亦即,以散布(例如,噴霧、霧化、微粒化、散粉、散粒、水面施用、箱施用等)、土壤施用(例如,混入、灌注等)、表面施用(例如,塗布、粉衣、被覆等)、種子處理(例如,塗抹、粉衣處理等)、浸漬、毒餌、薰蒸施用等施用。再者,也可將前述有效成分在飼料中混合而給予家畜,兒防除在其排泄物中的有害蟲,特別是有害昆蟲的產生、成長。 When these preparations are actually used, they can be used directly, or they can be released to a predetermined concentration with a release agent such as water. The application of various preparations containing the compound of the present invention or its alkenes is by the usual general application method, that is, by spraying (for example, spraying, atomizing, micronizing, loose powder, loose granules, water surface application, tank Application, etc.), soil application (eg, mixing, infusion, etc.), surface application (eg, coating, powder coating, coating, etc.), seed treatment (eg, painting, powder coating treatment, etc.), dipping, poison bait, fumigation application, etc. Apply. In addition, the aforementioned active ingredients may be mixed in feed and given to livestock to prevent harmful insects in their excrement, especially the generation and growth of harmful insects.

本發明的有害生物的防除方法,係藉由在前述的施用方法中使用本發明的通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽的有效成分量而實施。 The pest control method of the present invention is derived by using 5-(1,2,4-triazol-5-yl)benzamide represented by the general formula [I] of the present invention in the aforementioned application method The amount of the active ingredient of the substance or its agriculturally acceptable salt is implemented.

關於本發明的有害生物防除劑的有效成分的調配比率(質量%)可因應所需而適當地選擇。例如,製成粉劑、粉粒劑、微粒劑等時是在0.01至20%,佳者是0.05至10%的範圍適當地選擇為佳,製成粒劑等時是在0.1至30%,佳者是在0.5至20%的範圍適當地選擇為佳,製成水和劑、顆粒水和劑等時是在1至70%,佳者是在5至50%的範圍適當地選擇為佳,製成水溶劑、液劑等時是在1至95%,佳者是在10至80%的範圍適當地選擇為佳,製成乳劑等時是在5至90%,佳者是在10至80%的範圍適當地選擇為佳,製成油劑等時是在1至50%,佳者是在5至30%的範圍適當地選擇為佳,製成懸浮劑等時是在5至60%,佳者是在10至50%的範圍適當地選擇為佳,製成乳化劑、微乳化劑、懸浮乳劑等時是在5至70%,佳者是在10至60%的範圍適當地選擇為佳,製成錠劑、誘餌劑、膏狀製劑等時在1至80%,佳者是在5至50%的範圍適當地選擇為佳,製成薰蒸劑等時在0.1至 50%,佳者是在1至30%的範圍適當地選擇為佳,製成煙霧劑等時在0.05至20%,佳者是在0.1至10%的範圍適當地選擇為佳。 The compounding ratio (mass %) of the active ingredient of the pest control agent of the present invention can be appropriately selected according to needs. For example, when it is made into powders, granules, granules, etc., it is in the range of 0.01 to 20%, preferably in the range of 0.05 to 10%, and it is preferably selected in the range of 0.05 to 10%. It is preferably selected in the range of 0.5 to 20%, and it is preferably in the range of 1 to 70% when it is made into water and agent, granular water and agent, etc. It is preferably selected in the range of 5 to 50%. When it is made into water solvent, liquid agent, etc., it is in the range of 1 to 95%, preferably in the range of 10 to 80%. It is preferably selected in the range of 10 to 80%. The range of 80% is preferably selected appropriately, when it is made into an oil agent, etc., it is 1 to 50%, and the case is preferably selected within a range of 5 to 30%, when it is made into a suspension agent, etc., it is 5 to 60. %, the better is appropriately selected in the range of 10 to 50%, preferably 5 to 70% when made into emulsifiers, microemulsifiers, suspending emulsions, etc., preferably in the range of 10 to 60% It is better to choose from 1 to 80% when making lozenges, baits, paste preparations, etc. It is better to choose properly from 5 to 50%, and from 0.1 to 80% when making fumigants etc. 50%, the better is properly selected in the range of 1 to 30%, 0.05 to 20% when made into aerosol, etc., the better is appropriately selected in the range of 0.1 to 10%.

此等製劑是烯釋成適當的濃度而散布或直接施用。 These formulations are released or applied directly to the appropriate concentration.

本發明的有害生物防除劑的施用係以烯釋劑烯釋使用時,通常以0.1至5000ppm的有效成分濃度進行。將製劑直接使用時的每單位面積的施用量,以有效成分化合物而言,每1ha使用0.1至5000g,惟,不限定於此等。 The application of the pest control agent of the present invention is usually carried out at an active ingredient concentration of 0.1 to 5000 ppm when it is used as a release agent. When the preparation is directly used, the application amount per unit area is 0.1 to 5000 g per 1ha for the active ingredient compound, but it is not limited thereto.

此外,本發明的有害生物防除劑不僅是將本發明的化合物單獨作為有效成分也充分有效,因應所需也可與其他肥料、農藥,例如,殺蟲劑、殺蟎劑、殺線蟲劑、增效劑、殺菌劑、抗病毒劑、誘引劑、除草劑、植物生長調整劑等混用、併用,此時也有表現更進一步優異的效果的情況。 In addition, the pest control agent of the present invention is not only effective when the compound of the present invention is used alone as an active ingredient, but can also be combined with other fertilizers and pesticides, such as insecticides, acaricides, nematicides, Effective agents, fungicides, antiviral agents, attractants, herbicides, plant growth regulators, etc. are mixed and used together, and in this case, even further excellent effects may be exhibited.

其次,例示可以混合或併用的公知殺蟲劑、殺蟎劑、殺線蟲劑、增效劑化合物。 Next, exemplified well-known insecticides, acaricides, nematicides, and synergist compounds that can be mixed or used together.

殺蟲活性成分: Insecticidal active ingredients:

阿納寧(acrinathrin)、印楝素(azadirachtin)、甲基吡啶磷(azamethiphos)、acynonapyr(通用名)、乙基谷速松(azinphos-ethyl)、甲基谷速松(azinphos-methyl)、亞醌蟎(acequinocyl)、亞滅培(acetamiprid)、乙醯蟲腈(acetoprole)、毆殺松(acephate)、亞環鍚(azocyclotin)、阿巴汀(abamectin)、雙丙環蟲酯(afidopyropen)、阿弗索拉納(afoxolaner)、磺胺蟎酯(amidoflumet)、三亞蟎(amitraz)、棉鈴威(alanycarb)、得滅克(aldicarb)、涕滅威(aldoxycarb)、亞烈寧(allethrin)[包含d-順式-反式-體,d-反式-體]、 依殺松(isazophos)、氯唑磷(isamidofos)、水胺硫磷(isocarbophos)、加福松(isoxathion)、isocycloseram(通用名)、甲基異柳磷(isofenphos-methyl)、滅必蝨(isoprocarb)、ε-甲氧芐氟菊酯單體(epsilon-metofluthrin)、ε-甲氧芐氟菊酯單體(epsilon-momfluorothrin)、伊維菌素(ivermectin)、滅線蟲松(imicyafos)、益達胺(imidacloprid)、依普寧(imiprothrin)、因得克(indoxacarb)、益化利(esfenvalerate)、愛芬克(ethiofencarb)、愛殺松(ethion)、益斯普(ethiprole)、二溴乙烯(ethylene dibromide)、依殺蟎(etoxazole)、依芬寧(etofenprox)、普伏松(ethoprophos)、益多松(etrimfos)、因滅汀(emamectin)、因滅汀(emamectin benzoate)、安殺番(endosulfan)、益避寧(empenthrin)、oxazosulfyl(通用名)、歐殺滅(oxamyl)、滅多松(oxydemeton-methyl)、異亞碸磷(oxydeprofos)、歐滅松(omethoate)、克線丹(cadusafos)、κ-七氟菊酯(κ-tefluthrin)、κ-畢芬寧(κ-bifenthrin)、水黃皮素(karanjin)、培丹(cartap)、加保利(carbaryl)、丁基加保扶(carbosulfan)、加保扶(carbofuran)、γ-BHC(gamma-BHC)、滅爾蝨(xylylcarb)、拜裕松(quinalphos)、烯蟲炔酯(kinoprene)、蟎離丹(chinomethionat)、蠅毒磷(coumaphos)、冰晶石(cryolite)、可尼丁(clothianidin)、克芬蟎(clofentezine)、可芬諾(chromafenozide)、剋安勃(chlorantraniliprole)、氯氧磷(chlorethoxyfos)、氯丹(chlordane)、氯化苦(chloropicrin)、陶斯松(chlorpyrifos)、甲基陶斯松(chlorpyrifos-methyl)、克凡派(chlorfenapyr)、氯芬松(chlorfenvinphos)、克福隆 (chlorfluazuron)、氯甲磷(chlormephos)、右旋反式氯丙炔菊酯(chloroprallethrin)、溴氰蟲醯胺(cyazypyr)、氰乃松(cyanophos)、汰芬隆(diafenthiuron)、除線特(diamidafos)、氰蟲醯胺(cyantraniliprole)、得氯蟎(dienochlor)、唑蟎氰(cyenopyrafen)、殺力松(dioxabenzofos)、苯蟲醚(diofenolan)、環溴蟲醯胺(cyclaniliprole)、環氧蟲啶(cycloxaprid)、雙特松(dicrotophos)、除線磷(dichlofenthion)、乙氰菊酯(cycloprothrin)、二氯松(dichlorvos)、dicloromezotiaz(通用名)、大克蟎(dicofol)、環蟲腈(dicyclanil)、二硫松(disulfoton)、達特南(dinotefuran)、敌蟎通(dinobuton)、氯氟氰蟲醯胺(cyhalodiamide)、賽洛寧(cyhalothrin)[包含γ-體,λ-體]、賽芬寧(cyphenothrin)[包含(1R)-反式-體]、賽扶寧(cyfluthrin)[包含β-體]、二福隆(diflubenzuron)、賽芬蟎(cyflumetofen)、氟蟎

Figure 108126125-A0202-12-0179-176
(diflovidazin)、錫滿丹(cyhexatin)、亞滅寧(cypermethrin)[包含α-體、β-體、θ-體、ζ-體]、dimpropyridaz(通用名)、二甲基-2,2,2-三氯-1-羥乙基膦酸酯(DEP)、甲基毒蟲畏(dimethylvinphos)、大滅松(dimethoate)、四氟甲醚菊酯(dimefluthrin)、矽護芬(silafluofen)、賽滅淨(cyromazine)、賜諾特(spinetoram)、賜諾殺(spinosad)、賜派芬(spirodiclofen)、賜滅派(spirotetramat)、spiropidion(通用名)、賜滅芬(spiromesifen)、速克吩鈉鹽(sulcofuron-sodium)、氟蟲胺(sulfluramid)、碸蟲啶(sulfoxaflor)、治螟磷(sulfotep)、大利松(diazinon)、賽果培(thiacloprid)、賽速安(thiamethoxam)、tioxazafen(通用名)、硫敵克(thiodicarb)、硫賜安(thiocyclam)、殺蟲雙(thiosultap)、硫磷
Figure 108126125-A0202-12-0179-177
(thionazin)、硫伐隆(thiofanox)、硫滅松(thiometon)、tyclopyrazoflor(通用名)、四剋安勃(tetrachlorantraniliprole)、樂本松(tetrachlorvinphos)、得脫蟎(tetradifon)、氟氰蟲醯胺(tetraniliprole)、四氟醚菊酯(tetramethylfluthrin)、治滅寧(tetramethrin)、丁基嘧啶磷(tebupirimfos)、得芬諾(tebufenozide)、得芬瑞(tebufenpyrad)、汰福寧(tefluthrin)、得福隆(teflubenzuron)、滅賜松(demeton-S-methyl)、雙硫磷(temephos)、第滅寧(deltamethrin)、托福松(terbufos)、泰滅寧(tralomethrin)、拜富寧(transfluthrin)、唑蚜威(triazamate)、三落松(triazophos)、三氯松(trichlorfon)、殺蟲隆(triflumuron)、三氟苯嘧啶(triflumezopyrim)、混殺威(trimethacarb)、脫芬瑞(tolfenpyrad)、乃力松(naled)、尼古丁(nicotine)、烯啶蟲胺(nitenpyram)、尼莫克汀(nemadectin)、諾伐隆(novaluron)、諾福隆(noviflumuron)、臘蚧輪刺抱菌(Verticillium lecanii)、烯蟲乙酯(hydroprene)、液化澱粉芽孢桿菌(Bacillus amyloliquefaciens)、堅強芽孢桿菌(Bacillus firmus)、球形芽孢桿菌(Bacillus sphaericus)、枯草桿菌(Bacillus subtillis)、蘇力菌(Bacillus thuringiensis)、蘇力菌(Bacillus thuringiensis)生產的昆蟲毒素、蘇力菌相澤氏亞種(Bacillus thuringiensis subsp.Aizawai)、蘇力菌以色列亞種(Bacillus thuringiensis subsp.Israelensis)、蘇力菌庫斯克亞種(Bacillus thuringiensis subsp.Kurstaki)、蘇力菌擬步行亞種(Bacillus thuringiensis subsp.Tenebrionis)、日本甲蟲芽孢桿菌(Bacillus popilliae)、巴斯德穿刺桿菌胞子(Pasteuriapenetrans spore)、繁米松(vamidothion)、巴拉松 (parathion)、甲基巴拉松(parathion-methyl)、合芬寧(halfenprox)、合芬隆(halofenozide)、二丙烯除蟲菊酯(bioallethrin)、S-環戊烯基二丙烯除蟲菊酯(bioallethrinS-cyclopentenyl)、苄呋菊酯(bioresmethrin)、雙-(2-氯-1-甲基乙基)醚(DCIP)、雙三氟蟲脲(bistrifluron)、愛美松(hydramethylnon)必芬蟎(bifenazate)、畢芬寧(bifenthrin)、氟他胺(pyflubumide)、協力精(piperonyl butoxide)、派滅淨(pymetrozine)、白克松(pyraclofos)、派福若(pyrafluprole)、必芬松(pyridaphenthion)、畢達本(pyridaben)、三氟甲吡醚(pyridalyl)、哌氟喹腙(pyrifluquinazon)、吡普若(pyriprole)、百利普芬(pyriproxyfen)、比加普(pirimicarb)、畢汰芬(pyrimidifen)、嘧蟎胺(pyriminostrobin)、甲基亞特松(pirimiphos-methyl)、除蟲菊素(pyrethrine)、氨磺磷(famphur)、芬普尼(fipronil)、芬殺蟎(fenazaquin)、芬滅松(fenamiphos)、撲滅松(fenitrothion)、芬諾克(fenoxycarb)、芬硫克(fenothiocarb)、酚丁滅蝨(phenothrin)[包含(1R)-反式-體]、丁基滅必蝨(fenobucarb)、芬殺松(fenthion)、賽達松(phenthoate)、芬化利(fenvalerate)、芬普蟎(fenpyroximate)、芬佈賜(fenbutatin oxide)、芬普寧(fenpropathrin)、大福松(fonofos)、磺醯氟(sulfuryl fluoride)、佈嘉信(butocarboxim)、丁酮碸威(butoxycarboxim)、布芬淨(buprofezin)、呋線威(furathiocarb)、普亞列寧(prallethrin)、嘧蟎酯(fluacrypyrim)、三氟咪啶醯胺(fluazaindolizine)、克福隆(fluazuron)、氟速芬(fluensulfone)、福拜倫(fluopyram)、氟乙酸鈉鹽(sodium fluoroacetate)、fluxametamide(fluxametamide)、氟環脲 (flucycloxuron)、護賽寧(flucythrinate)、氟硫滅(flusulfamide)、賽扶寧(fluthrin)、氟胺氰菊酯(fluvalinate)[包含τ-體]、氟吡呋喃酮(flupyradifurone)、吡氟硫磷(flupyrazofos)、flupyrimin(通用名)、丁蟲腈(flufiprole)、嘧蟲胺(flufenerim)、氟菌螨酯(flufenoxystrobin)、氟芬隆(flufenoxuron)、菲殺碸(fluhexafon)、氟大滅(flubendiamide)、氟氯苯菊酯(flumethrin)、弗雷拉納(fluralaner)、氟蟲芬(flurimfen)、茉莉酮(jasmone)、順式-茉莉酮(cis-jasmone)、普硫松(prothiofos)、羅芬布(protrifenbute)、氟尼胺(flonicamid)、加護松(propaphos)、毆蟎多(propargite)、佈飛松(profenofos)、溴蟲氟苯雙醯胺(broflanilide)、四氟苯甲菊酯(profluthrin)、撲達松(propetamphos)、安丹(propoxur)、弗洛梅托昆(flometoquin)、新殺蟎(bromopropylate)、合賽多(hexythiazox)、六伏隆(hexaflumuron)、細腳擬青黴(Pacilimyces tenuipes)、玫煙色擬青黴(Paecilomyces fumosoroceus)、淡紫擬青黴菌(Paecilomyces lilacinus)、右旋七氟甲醚菊酯(heptafluthrin)、飛達松(heptenophos)、百滅寧(permethrin)、benclothiaz(benclothiaz)、benzpyrimoxan(通用名)、免速達(bensultap)、苯蟎特(benzoximate)、免敵克(bendiocarb)、免扶克(benfuracarb)、纖細白僵菌(Beauveria tenella)、巴氏蠶白僵菌(Beauveria bassiana)、布氏白僵菌(Beauveria brongniartii)、巴賽松(phoxim)、裕必松(phosalone)、福賽絕(fosthiazate)、丁硫環磷(fosthietan)、福賜米松(phosphamidon)、益滅松(phosmet)、抗蟎素複合體(polynactins)、覆滅璊(formetanate)、福瑞松(phorate)、機油 (machine oil)、馬拉松(malathion)、密滅汀(milbemectin)、滅加松(mecarbam)、倍硫磷亞碸(mesulfenfos)、納乃得(methomyl)、聚乙醛(metaldehyde)、美氟綜(metaflumizone)、達馬松(methamidophos)、威百畝(metham)、滅賜克(methiocarb)、滅大松(methidathion)、異硫氰酸甲酯(methyl isothiocyanate)、溴化甲烷(methyl bromide)、甲氧氯(methoxychlor)、滅芬諾(methoxyfenozide)、對甲氧基甲基菊酯(methothrin)、美特寧(metofluthrin)、美賜平(methoprene)、治滅蝨(metolcarb)、美文松(mevinphos)、氯氟醚菊酯(meperfluthrin)、瘤捕單頂孢菌(Monacrosporium phymatophagum)、亞素靈(monocrotophos)、沒氟菊酯(momfluorothrin)、哈氏木黴菌(Trichoderma harzianum)、夜蛾誘劑A(litlure-A)、夜蛾誘劑B(litlure-B)、磷化鋁(aluminium phosphide)、磷化鋅(zinc phosphide)、磷化氫(phosphine)、祿芬隆(lufenuron)、rescalure(紅圓蚧引誘劑)、列滅寧(resmethrin)、雷皮菌素(lepimectin)、魚藤精(rotenone)、核多角體病病毒包埋體、芬佈賜(fenbutatin oxide)、氰化鈣(calcium cyanide)、有機錫化合物(organotins)、硫酸尼古丁(nicotine-sulfate)、(Z)-11-十四烯基=乙酸酯、(Z)-11-十六碳烯醇、(Z)-11-十六碳烯基=乙酸酯、(Z)-9,12-十四碳二烯基=乙酸酯、(Z)-9-十四碳烯-1-醇、(Z,E)-9,11-十四碳二烯基=乙酸酯、(Z,E)-9,12-十四碳二烯基=乙酸酯、1,1,1-三氯-2,2-雙(4-氯苯基)乙烷(DDT)、1,3-二氯丙烯(1,3-dichloropropene)、2-氯-4-氟-5-[(5-三氟甲基硫基)戊基氧]苯基2,2,2-三氟乙基亞碸(化學名,CAS登錄號碼:1472050-04-6)、2,4-二氯-5- {2-[4-(三氟甲基)苯基]乙氧基}苯基2,2,2-三氟乙基亞碸(化學名,CAS登錄號碼:1472052-11-1)、2,4-二甲基-5-[6-(三氟甲基硫基)己氧基]苯基-2,2,2-三氟乙基亞碸(化學名,CAS登錄號碼:1472050-34-2)、2-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯氧基}-5-(三氟甲基)吡啶(化學名,CAS登錄號碼:1448758-62-0)、3-氯-2-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯氧基}-5-(三氟甲基)吡啶(化學名,CAS登錄號碼:1448761-28-1)、4,6-二硝基-o-甲酚(DNOC)、4-氟-2-甲基-5-(5,5-二甲基己氧基]苯基2,2,2-三氟乙基亞碸(化學名,CAS登錄號碼:1472047-71-4)、Bt蛋白質(Cry1Ab、Cry1Ac、Cry1Fa、Cry2Ab、mCry3A、Cry3Ab、Cry3Bb、Cry34/35Ab1)、CL900167(編碼序號)、NA-85(編碼序號)、NI-30(編碼序號)、O,O-二乙基-O-[4-(二甲基胺磺醯基)苯基]-硫代磷酸酯(DSP)、O-乙基-O-4-(硝基苯基)苯基硫代臉酸酯(EPN)、RU15525(編碼序號)、XMC(XMC)、Z-13-二十碳烯-10-酮、ZXI8901(編碼序號)、F4260(編碼序號)。 Anacrinthrin, azadirachtin, azamethiphos, acynonapyr (common name), azinphos-ethyl, azinphos-methyl, azinphos-methyl, Acequinocyl, acetamiprid, acetoprole, acephate, azocyclotin, abamectin, afidopyropen , Afoxolaner, amidoflumet, amitraz, alanycarb, aldicarb, aldoxycarb, allethrin [ Contains d-cis-trans-body, d-trans-body], isazophos, isamidofos, isocarbophos, isoxathion, isocycloseram (general purpose Name), isofenphos-methyl, isoprocarb, epsilon-metofluthrin, epsilon-metofluthrin (epsilon- momfluorothrin), ivermectin, imicyafos, imidacloprid, imiprothrin, indoxacarb, esfenvalerate, ethiofencarb ), ethion, ethiprole, ethylene dibromide, etoxazole, etofenprox, ethoprophos, etrimfos ), emamectin, emamectin benzoate, endosulfan, empenthrin, oxazosulfyl (common name), oxamyl, oxydemeton-methyl ), oxydeprofos, omethoate, cadusafos, κ-tefluthrin, κ-bifenthr in), karanjin, cartap, carbaryl, carbosulfan, carbofuran, γ-BHC (gamma-BHC), methall Lice (xylylcarb), quinalphos, kinoprene, chinomethionat, coumaphos, cryolite, clothianidin, kefir mite (clofentezine), chromafenozide, chlorantraniliprole, chlorethoxyfos, chlordane, chloropicrin, chlorpyrifos, chlorpyrifos-methyl ), chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chloroprallethrin, cyazypyr ), cyanophos, diafenthiuron, diamidafos, cyantraniliprole, dienochlor, cyenopyrafen, dioxabenzofos ), diofenolan, cyclaniliprole, cycloxaprid, dicrotophos, dichlofenthion, cycloprothrin, dichloro Pine (dichlorvos), dicloromezotiaz (common name), dicofol, dicyclanil, disulfoton, dinotefuran, dinobuton, chlorofluorocyanide Cyhalodiamide, cyhalothrin [containing γ-body, λ-body], cyphenothrin [containing (1R)-trans-body], cyfluthrin [containing β -Body], diflubenzuron, cyflumetofen, fluoromite
Figure 108126125-A0202-12-0179-176
(diflovidazin), cyhexatin, cypermethrin [including α-body, β-body, θ-body, ζ-body], dimpropyridaz (common name), dimethyl-2,2, 2-trichloro-1-hydroxyethylphosphonate (DEP), dimethylvinphos, dimethoate, dimefluthrin, silafluofen, Cyromazine, spinotoram, spinosad, spirodiclofen, spirotetramat, spiropidion (common name), spiromesifen, speed Sulcofuron-sodium, sulfluramid, sulfoxaflor, sulfotep, diazinon, thiacloprid, thiamethoxam, tioxazafen (common name), thiodicarb, thiocyclam, thiosultap, thiophosphor
Figure 108126125-A0202-12-0179-177
(thionazin), thiofanox, thiometon, tyclopyrazoflor (general name), tetrachlorantraniliprole, tetrachlorantraniliprole, tetrachlorvinphos, tetradifon, chlorfenapyr Amine (tetraniliprole), tetramethylfluthrin, tetramethrin, tetramethrin, tebupirimfos, tebufenozide, tebufenpyrad, tefluthrin, Teflubenzuron, demeton-S-methyl, temephos, deltamethrin, terbufos, tralomethrin, transfluthrin ), triazamate, triazophos, trichlorfon, triflumuron, triflumezopyrim, trimethacarb, tolfenpyrad ), naled, nicotine, nitenpyram, nemadectin, novaluron, noviflumuron, and Pseudoceras (Verticillium lecanii), hydroprene, Bacillus amyloliquefaciens, Bacillus firmus, Bacillus sphaericus, Bacillus subtillis, Bacillus thuringiensis), insect toxin produced by Bacillus thuringiensis, Bacillus thuringiensis subsp.Aizawai, Bacillus thuringiensis subsp.Israelensis, Sullicus cusca Species (Bacillus thuringiensis subsp. Kurstaki), Bacillus turingiensis subsp. (Bacillus t huringiensis subsp.Tenebrionis), Bacillus popilliae, Pasteuriapenetrans spore, vamidothion, parathion, parathion-methyl, Halfenprox, halofenozide, bioallethrin, S-cyclopentenyl dipropenyl pyrethroid (bioallethrinS-cyclopentenyl), bioresmethrin, Bis-(2-chloro-1-methylethyl) ether (DCIP), bistrifluron (bistrifluron), hydramethylnon (bifenazate), bifenthrin (bifenthrin), flutamide (pyflubumide) ), piperonyl butoxide, pymetrozine, pyraclofos, pyrafluprole, pyridaphenthion, pyridaben, pyridalyl , Pyrifluquinazon (pyrifluquinazon), pyriprole (pyriprole), pyriproxyfen (pyriproxyfen), bigipa (pirimicarb), bififen (pyrimidifen), pyrimidin (pyriminostrobin), methyl atson (pirimiphos-methyl), pyrethrine (pyrethrine), famphur, fipronil, fenazaquin, fenamiphos, fenitrothion, fenno (Fenoxycarb), fenthiocarb (fenothiocarb), phenothrin (containing (1R)-trans-body), butyl fenbicarb (fenobucarb), fenthion (fenthion), cydarson (phenthoate), fenvalerate, fenpyroximate, fenbutatin oxide, fenpropathrin, fenpropathrin, fonofos, sulfuryl fluoride, butocarboxim ), butoxycarboxi m), buprofezin, furathiocarb, prallethrin, fluacrypyrim, fluazaindolizine, fluazuron, fluazuron Fluensulfone, Fluopyram, sodium fluoroacetate, fluxametamide (fluxametamide), flucycloxuron, flucythrinate, flusulfamide, flusulfamide, and safinin (fluthrin), fluvalinate [containing τ-body], flupyradifurone, flupyrazofos, flupyrimin (common name), flufiprole, pyrimidine Flufenerim, flufenoxystrobin, flufenoxuron, fluhexafon, flubendiamide, flumethrin, fluralaner , Flurimfen, jasmone, cis-jasmone, prothiofos, protrifenbute, flonicamid, propaphos ), propargite, profenofos, broflanilide, profluthrin, propetamphos, propoxur, propofol Flometoquin, bromopropylate, hexythiazox, hexaflumuron, Pacilimyces tenuipes, Paecilomyces fumosoroceus, lilac Paecilomyces lilacinus, heptafluthrin, heptenophos, permethrin, benclothiaz (benclothiaz), benzpyrimoxan (common name), bensultap ), benzoximate, bendiocarb, benfuracarb, Beauveria tenella, Beauveria bassiana, Beauveria brongniartii), phoxim, phosalone, fosthiazate, fosthietan, phosphamidon, phosmet, anti-mite complex Polynactins, formetanate, phorate, machine oil, marathon, milbemectin, mecarbam, mesulfenfos , Metomyl, metaldehyde, metaflumizone, methamidophos, metham, methiocarb, methidathion, different Methyl thiocyanate (methyl isothiocyanate), methyl bromide, methoxychlor, methoxyfenozide, methothrin, metofluthrin , Metoprene, metolcarb, mevinphos, meperfluthrin, Monacrosporium phymatophagum, monocrotophos, fluorinated Momfluorothrin, Trichoderma harzianum, Litworm A (litlure-A), Litworm B (litlure-B), aluminum phosphide, zinc phosphide (zinc) phosphide, phosphine, lufenuron, rescalure (red scale attractant), resmethrin, lepimectin, rotenone, nuclear polygon Embryo of body disease virus, fenbutatin oxide, calcium cyanid e), organotins, nicotine-sulfate, (Z)-11-tetradecenyl=acetate, (Z)-11-hexadecenol, (Z)-11 -Hexadecenyl=acetate, (Z)-9,12-tetradecadienyl=acetate, (Z)-9-tetradecen-1-ol, (Z,E) -9,11-tetradecadienyl=acetate, (Z,E)-9,12-tetradecadienyl=acetate, 1,1,1-trichloro-2,2- Bis(4-chlorophenyl)ethane (DDT), 1,3-dichloropropene (1,3-dichloropropene), 2-chloro-4-fluoro-5-[(5-trifluoromethylthio) Amyloxy]phenyl 2,2,2-trifluoroethyl sulfoxide (chemical name, CAS registration number: 1472050-04-6), 2,4-dichloro-5- {2-[4-(tri (Fluoromethyl)phenyl]ethoxy}phenyl 2,2,2-trifluoroethyl sulfoxide (chemical name, CAS registration number: 1472052-11-1), 2,4-dimethyl-5- [6-(trifluoromethylthio)hexyloxy]phenyl-2,2,2-trifluoroethyl sulfoxide (chemical name, CAS registration number: 1472050-34-2), 2-{2- Fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenoxy}-5-(trifluoromethyl)pyridine (chemical name, CAS registration number: 1448758 -62-0), 3-chloro-2-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenoxy}-5-( Trifluoromethyl)pyridine (chemical name, CAS registration number: 1448761-28-1), 4,6-dinitro-o-cresol (DNOC), 4-fluoro-2-methyl-5-(5 ,5-dimethylhexyloxy]phenyl 2,2,2-trifluoroethyl sulfoxide (chemical name, CAS registration number: 1472047-71-4), Bt protein (Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1), CL900167 (coding serial number), NA-85 (coding serial number), NI-30 (coding serial number), O,O-diethyl-O-(4-(dimethyl Sulfamoyl)phenyl]-thiophosphoric acid ester (DSP), O-ethyl-O-4-(nitrophenyl) phenyl thiophosphonate (EPN), RU15525 (coding number), XMC (XMC), Z-13-eicosene-10-one, ZXI8901 (coding serial number), F4260 (coding serial number).

其次,例示可以混合或併用的公知的殺菌劑或病害防除劑化合物。 Next, exemplified well-known fungicides or disease control compound compounds that can be mixed or used together.

殺菌活性成分: Bactericidal active ingredients:

阿扎康唑(azaconazole)、噻二唑素-S-甲基(acibenzolar-S-methyl)、亞托敏(azoxystrobin)、敵菌靈(anilazine)、安美速(amisulbrom)、aminopyrifen(通用名)、滅脫定(ametoctradin)、艾迪嗎林(aldimorph)、亞汰尼(isotianil)、益拜若(isopyrazam)、艾索非他滅(isofetamid)、異丙噻菌胺(isoflucypram)、亞賜圃(isoprothiolane)、種菌唑(ipconazole)、ipflufenoquin(通用名)、 ipfentrifluconazole(通用名)、依普同(iprodione)、丙森辛(iprovalicarb)、丙基喜樂松(iprobenfos)、依滅列(imazalil)、雙胍辛胺烷苯磺酸鹽(iminoctadine-albesilate)、雙胍辛胺乙酸鹽(iminoctadine-triacetate)、易胺座(imibenconazole)、inpyrfluxam(通用名)、imprimatin A(植物免疫引發化合物)、imprimatin B(植物免疫引發化合物)、護粒松(edifenphos)、乙環唑(etaconazole)、噻唑菌胺(ethaboxam)、依瑞莫(ethirimol)、乙氧基喹因(ethoxyquin)、依得利(etridiazole)、烯肟菌酯(enestroburin)、烯肟菌酯(enoxastrobin)、依普座(epoxiconazole)、有機油(organic oils)、歐殺斯(oxadixyl)、噁嗪拉唑(oxazinylazole)、奧賽普林(oxathiapiprolin)、嘉保信(oxycarboxin)、快得寧(oxine-copper)、土黴素(oxytetracycline)、

Figure 108126125-A0202-12-0185-178
咪唑反丁烯二酸鹽(oxpoconazole-fumarate)、歐索林酸(oxolinic acid)、二辛酸銅(copper dioctanoate)、辛異噻啉酮(octhilinone)、呋醯胺(ofurace)、肟醚菌胺(orysastrobin)、鄰苯基苯酚(o-phenylphenol)、嘉賜黴素(kasugamycin)、四氯丹(captafol)、加普胺(carpropamid)、加保扶(carbendazim)、嘉保信(carboxin)、香旱芹酮(carvone)、快諾芬(quinoxyfen)、quinofumelin(通用名)、蟎離丹(chinomethionat)、蓋普丹(captan)、喹康唑(quinconazole)、五氯硝苯(quintozene)、雙胍鹽(guazatine)、銅合浦單劑(cufraneb)、甲香菌酯(coumethoxystrobin)、丁香菌酯.(coumoxystrobin)、克收欣(kresoxim-methyl)、抑霉胺(clozylacon)、克氯得(chlozolinate)、四氯異苯腈(chlorothalonil)、地茂散(chloroneb)、賽座滅 (cyazofamid)、乙霉威(diethofencarb)、雙氯氰菌胺(diclocymet)、益發靈(dichlofluanid)、diehlobentiazox(通用名)、達滅淨(diclomezine)、大克爛(dicloran)、雙氯酚(dichlorophen)、二氰蒽醌(dithianon)、達克利(diniconazole)、達克利-M(diniconazole-M)、鋅乃浦(zineb)、白粉克(dinocap)、dipymetitrone(dipymetitrone)、二苯基胺(diphenylamine)、二待克利(difenoconazole)、賽芬胺(cyflufenamid)、二氟林(diflumetorim)、環克座(cyproconazole)、賽普洛(cyprodinil)、硅氟唑(simeconazole)、二甲嘧酚(dimethirimol)、二硫二甲烷(dimethyl disulfide)、達滅芬(dimethomorph)、克絕(cymoxanil)、醚菌胺(dimoxystrobin)、霍氏假單胞菌HAI-0804(Pseudomonas rhodesiae HAI-0804)、吉闌(ziram)、硅噻菌胺(silthiofam)、鏈黴素(streptomycin)、螺環菌胺(spiroxamine)、先正達(sedaxane)、座賽胺(zoxamide)、苯並烯氟菌唑(solatenol)、邁隆(dazomet)、黃藍狀菌(Talaromyces flavus)、噻醯菌胺(tiadinil)、腐絕(thiabendazole)、福美雙(thiram)、多保淨(thiophanate)、甲基多保淨(thiophanate-methyl)、賽氟滅(thifluzamide)、福美雙(thiram)、四氯硝基苯(tecnazene)、克枯爛(tecloftalam)、四克利(tetraeonazole)、咪菌威(debacarb)、得克利(tebuconazole)、氟硅唑(tebufloquin)、療黴舒(terbinafine)、多寧(dodine)、嗎菌靈(dodemorph)、三泰隆(triadimenol)、三泰芬(triadimefon)、咪唑
Figure 108126125-A0202-12-0186-180
(triazoxide)、水楊菌胺(trichlamide)、氯啶菌酯(triclopyricarb)、深綠木霉(Trichoderma atroviride)、三賽唑(tricyclazole)、滅菌唑 (triticonazole)、三得芬(tridemorph)、賽福座(triflumizole)三氟敏(trifloxystrobin)、賽福寧(triforine)、甲基益發靈(tolylfluanid)、脫克松(tolclofos-methyl)、甲磺菌胺(tolnifanide)、托普洛卡(tolprocarb)、代森鈉(nabam)、納他黴素(natamycin)、萘替芬(naftifine)、氯草定(nitrapyrin)、酞菌酯(nitrothal-isopropyl)、尼瑞莫(nuarimol)、壬基酚磺酸銅(copper nonyl phenol sulphonate)、枯草桿菌(Bacillus subtilis)(菌株:Q ST 713)、維利黴素(validamycin)、伐利芬(valifenalate)、皮卡布西(picarbutrazox)、聯苯吡菌胺(bixafen)、啶氧菌酯(picoxystrobin)、pydiflumetofen(通用名)、比多農(bitertanol)、樂殺蟎(binapacryl)、β-檜酚酮(hinokitiol)、聯苯(biphenyl)、哌丙靈(piperalin)、殺紋寧(hymexazol)、唑菌酯(pyraoxystrobin)、百克敏(pyraclostrobin)、pyraziflumid(通用名)、白粉松(pyrazophos)、pyrapropoyne(通用名)、唑胺菌酯(pyrametostrobin)、pyriofenone(通用名)、啶菌
Figure 108126125-A0202-12-0187-181
唑(pyrisoxazole)、氟醚菌醯胺(pyridachlometyl)、比芬諾(pyrifenox)、稗草畏(pyributicarb)、吡菌苯威(pyribencarb)、派美尼(pyrimethanil)、百快隆(pyroquilon)、免克寧(vinclozolin)、福美鐵(ferbam)、凡殺同(famoxadone)、吩
Figure 108126125-A0202-12-0187-182
氧化物(phenazine oxide)、咪唑菌酮(fenamidone)、烯肟菌胺(fenaminstrobin)、芬瑞莫(fenarimol)、芬諾尼(fenoxanil)、富米綜(ferimzone)、拌種咯(fenpiclonil)、fenpicoxamid(通用名)、胺苯吡菌酮(fenpyrazamine)、芬克座(fenbuconazole)、甲呋醯胺(fenfuram)、苯銹啶(fenpropidin)、芬普福(fenpropimorph)、環菌胺 (fenhexamid)、福爾培(folpet)、熱必斯(phthalide)、布瑞莫(bupirimate)、麥穗靈(fuberidazole)、滅瘟素-S(blasticidin-S)、福拉比(furametpyr)、呋霜靈(furalaxyl)、呋喃羧酸(furancarboxylic acid)、呋霜靈(fluazinam)、氟茚唑菌胺(fluindapyr)、氟嘧菌酯(fluoxastrobin)、fluoxapiprolin(通用名)、氟比來(fluopicolide)、氟醚菌醯胺(fluopimomide)、福拜倫(fluopyram)、氟氯菌核利(fluoroimide)、福賽斯(fluxapyroxad)、氟喹唑(fluquinconazole)、氟康唑(furconazole)、順式氟康唑(furconazole-cis)、護汰寧(fludioxonil)、護矽得(flusilazole)、氟硫滅(flusulfamide)、氟噻唑(flutianil)、福多寧(flutolanil)、護汰芬(flutriafol)、氟菌蟎酯(flufenoxystrobin)、氟醯菌胺(flumetover)、氟嗎啉(flumorph)、普快淨(proquinazid)、撲克拉(prochloraz)、撲滅寧(procymidone)、硫菌威(prothiocarb)、丙硫菌唑(prothioconazole)、溴硝丙二醇(bronopol)、普拔克鹽酸鹽(propamocarb-hydrochloride)、普克利(propiconazole)、丙森鋅(propineb)、撲殺熱(probenazole)、溴克座(bromuconazole)、氟美多喹(flometoquin)、florylpicoxamid(通用名)、菲克利(hexaconazole)、本達樂(benalaxyl)、本達樂M(benalaxyl-M)、麥銹靈(benodanil)、苯菌靈(benomyl)、披扶座(pefurazoate)、平克座(penconazole)、賓克隆(pencycuron)、苯并烯氟菌唑(benzovindiflupyr)、佈生(benthiazole)、苯噻菌胺(benthiavalicarb-isopropyl)、吡噻菌胺(penthiopyrad)、平氟芬(penflufen)、白克列(boscalid)、福賽得(fosetyl)(alminium,calcium,sodium)、多抗霉素(polyoxin)、福代鋅(polycarbamate)、 波爾多液(Bordeaux mixture)、代森錳銅(mancopper)、鋅錳乃浦(mancozeb)、曼普胺(mandipropamid)、滿得賓(mandestrobin)、錳乃浦(maneb)、邁克尼(myclobutanil)、礦油(mineral oils)、米多霉素(mildiomycin)、滅速克(methasulfocarb)、威百畝(metam)、右滅達樂(metalaxyl)、右滅達樂M(metalaxyl-M)、代森聯(metiram)、metyltetraprole(通用名,苯基吡唑類)、滅特座(metconazole)、苯氧菌胺(metominostrobin)、滅芬農(metrafenone)、滅派林(mepanipyrim)、氯氟醚菌唑(mefentrifluconazole)、敵蟎普(meptyldinocap)、滅普寧(mepronil)、碘克(iodocarb)、海帶多醣(laminarin)、葡萄根瘤菌(Rhizobium vitis)、亞磷酸及鹽(phosphorous acid and salts)、鹼性氯化銅(copper oxychloride)、銀(silver)、氧化亞銅(cuprous oxide)、氫氧化銅(copper hydroxide)、碳酸氫鉀(potassium bicarbonate)、碳酸氫鈉(sodium bicarbonate)、硫(sulfur)、硫酸羥基喹啉(oxyquinoline sulfate)、硫酸銅(copper sulfate)、(3,4-二氯異噻唑-5-基)甲基4-(第三丁基)苯甲酸酯(化學名,CAS登錄號碼:1231214-23-5)、BAF-045(編碼序號)、BAG-010(編碼序號)、UK-2A(編碼序號)、十二烷基苯磺酸雙乙烯二胺銅錯鹽[II](DBEDC)、MIF-1002(編碼序號)、NF-180(編碼序號)、乙酸三苯基錫(TPTA)、三苯基氯化錫(TPTC)、氫氧化三苯基錫(TPTH)、非病原性Erwinia carotovora,F9650(編碼序號)。 Azaconazole, acibenzolar-S-methyl, azoxystrobin, anilazine, anisulbrom, aminopyrifen (common name) , Ametoctradin, aldimorph, isotianil, isopyrazam, isofetamid, isoflucypram, and aci Isoprothiolane, ipconazole, ipflufenoquin (common name), ipfentrifluconazole (common name), iprodione, iprovalicarb, iprobenfos, iprobenfos, imazalil ), iminoctadine-albesilate, iminoctadine-triacetate, imibenconazole, inpyrfluxam (common name), imprimatin A (plant immune inducing compound), imprimatin B (plant immune triggering compound), edifenphos, etaconazole, ethaboxam, ethirimol, ethoxyquin, and etridiazole ), enestroburin, enoxastrobin, epoxiconazole, organic oils, oxadixyl, oxazinylazole, oxseprine (oxathiapiprolin), oxycarboxin, oxine-copper, oxytetracycline,
Figure 108126125-A0202-12-0185-178
Oxpoconazole-fumarate, oxolinic acid, copper dioctanoate, octhilinone, octhilinone, ofurace, and oxamid (orysastrobin), o-phenylphenol, kasugamycin, captafol, carpropamid, carbendazim, carboxin, incense Carvone, quinoxyfen, quinofumelin (common name), chinomethionat, captan, quinconazole, quintozene, biguanide (guazatine), cufraneb, coumethoxystrobin, syringamate (coumoxystrobin), kresoxim-methyl, clozylacon, chlozolinate , Chlorothalonil, chloroneb, cyazofamid, diethofencarb, diclocymet, dichlofluanid, diehlobentiazox (common name) ), diclomezine, dicloran, dichlorophen, dithianon, diniconazole, diniconazole-M, zinc naipura (zineb), dinocap, dipymetitrone (dipymetitrone), diphenylamine (diphenylamine), diphennoconazole (difenoconazole), cyflufenamid, diflumetorim, cyproconazole , Cyprodinil, simeconazole, dimethirimol, dimethyl disulfide, dimethomorph, cymoxanil, dimoxystrobin ), Pseudomonas holsteinii HAI -0804 (Pseudomonas rhodesiae HAI-0804), ziram, silthiofam, streptomycin, spiroxamine, sedaxane, zetoxamine ( zoxamide), solatenol, dazomet, Talaromyces flavus, tiadinil, thiabendazole, thiram, and polyphenol Thiophanate, thiophanate-methyl, thifluzamide, thiram, thiram, tecnazene, tecloftalam, tetraeonazole , Debacarb, tebuconazole, tebufloquin, terbinafine, dodine, dodemorph, triadimenol, tritaifen (triadimefon), imidazole
Figure 108126125-A0202-12-0186-180
(triazoxide), trichlamide, triclopyricarb, Trichoderma atroviride, tricyclazole, trigononazole, tridmorph Triflumizole trifloxystrobin, triforine, tolylfluanid, tolclofos-methyl, tolnifanide, tolprocarb ), nabam, natamycin, naftifine, nitrapyrin, nitrothal-isopropyl, nuarimol, nonylphenol Copper nonyl phenol sulphonate, Bacillus subtilis (strain: Q ST 713), viridamycin, valifenalate, picarbutrazox, bifenpyr Bixafen, picoxystrobin, pydiflumetofen (common name), bitertanol, binapacryl, β-hinokitiol, biphenyl, piperapron Piperalin, hymexazol, pyraoxystrobin, pyraclostrobin, pyraziflumid (common name), pyrazophos, pyrapropoyne (common name), pyramethostrobin (pyrametostrobin) , Pyriofenone (common name), cyprodin
Figure 108126125-A0202-12-0187-181
Pyrisoxazole, pyridachlometyl, pyrifenox, pyributicarb, pyrribencarb, pyrimethanil, pyroquilon, Vinclozolin, ferbam, famoxadone, phen
Figure 108126125-A0202-12-0187-182
Oxide (phenazine oxide), fenamidone, fenaminstrobin, fenarimol, fenoxanil, ferimzone, fenpiclonil, fenpicoxamid (common name), fenpyrazamine, fenbuconazole, fenfuram, fenpropidin, fenpropimorph, fenhexamid , Folpet, phthalide, bupirimate, fuberidazole, blasticidin-S, furametpyr, furaxyl (furalaxyl), furancarboxylic acid, fluazinam, fluindapyr, fluoxastrobin, fluoxapiprolin (common name), fluopicolide, fluorine Fluopimomide, fluopyram, fluoroimide, fluxapyroxad, fluquinconazole, fluconconazole, cisfluconazole (furconazole-cis), fludioxonil, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fludioxol Flufenoxystrobin, flumetover, flumorph, proquinazid, prochloraz, procymidone, prothiocarb, prothioconazole (prothioconazole), bronopol, propamocarb-hydrochloride, propiconazole, propineb, probenazole, bromuconazole, fluorine Flometoquin, florylpicox amid (common name), hexaconazole, benalaxyl, benalaxyl-M, benodanil, benomyl, pefurazoate, Penconazole, pencycuron, benzovindiflupyr, benthiazole, benthiavalicarb-isopropyl, penthiopyrad, penflufen (penflufen), boscalid, fosetyl (alminium, calcium, sodium), polyoxin, polycarbamate, Bordeaux mixture, mancozeb Copper, mancozeb, mancozeb, mandipropamid, mandestrobin, maneb, myclobutanil, mineral oils, and mildew Mildiomycin, methasulfocarb, metam, metalaxyl, metalaxyl-M, metiram, metyltetraprole (common name, (Phenylpyrazoles), metconazole, metominostrobin, metrafenone, mepanipyrim, mefentrifluconazole, mepteridinocap ), mepronil, iodocarb, laminin, Rhizobium vitis, phosphorous acid and salts, copper oxychloride, silver (silver), cuprous oxide, copper hydroxide, potassium bicarbonate, sodium bicarbonate, sulfur, oxyquinoline sulfate, Copper sulfa te), (3,4-dichloroisothiazol-5-yl)methyl 4-(third butyl)benzoate (chemical name, CAS registration number: 1231214-23-5), BAF-045( (Code No.), BAG-010 (Code No.), UK-2A (Code No.), dodecylbenzenesulfonic acid diethylenediamine copper salt [II] (DBEDC), MIF-1002 (Code No.), NF -180 (coding number), triphenyltin acetate (TPTA), triphenyltin chloride (TPTC), triphenyltin hydroxide (TPTH), non-pathogenic Erwinia carotovora, F9650 (coding number).

其次,將可以混合或併用的公知的除草劑化合物、植物生長調整劑化合物例示如下述。 Next, the known herbicide compounds and plant growth regulator compounds that can be mixed or used together are exemplified as follows.

除草活性成分: Herbicidal active ingredients:

碘草腈(ioxynil)、苯草醚(aclonifen)、丙烯醛(acrolein)、草芬定(azafenidin)、亞喜芬(acifluorfen)(包含鈉等鹽)、四唑嘧磺隆(azimsulfuron)、亞速爛(asulam)、乙草胺(acetochlor)、草脫淨(atrazine)、莎稗磷(anilofos)、胺唑草酮(amicarbazone)、醯嘧磺隆(amidosulfuron)、滅草強(amitrole)、氯丙嘧啶酸(aminocyclopyrachlor)、氯胺吡啶酸(aminopyralid)、甲基胺草磷(amiprofos-methyl)、愛落殺(ametryn)、拉草(alachlor)、亞汰草(alloxydim)、環丙嘧啶醇(ancymidol)、愛速隆(isouron)、異

Figure 108126125-A0202-12-0190-183
氯草酮(isoxachlortole)、異
Figure 108126125-A0202-12-0190-184
唑草酮(isoxaflutole)、伊索本(isoxaben)、異癸醇乙氧基化物(Isodecylalkoholethoxylate)、異丙隆(isoproturon)、三唑醯草胺(ipfencarbazone)、滅草喹(imazaquin)、甲基咪草煙(imazapic)(包含胺等鹽)、依滅草(imazapyr)(包含異丙胺等鹽)、甲基咪草酸(imazamethabenz-methyl)、甲氧咪草煙(imazamox)、咪草烟(imazethapyr)、依速隆(imazosulfuron)、茚
Figure 108126125-A0202-12-0190-185
氟草胺(indaziflam)、茚草酮(indanofan)、甘草津(eglinazine-ethyl)、禾草畏(esprocarb)、甲磺隆(ethametsulfuro正methyl)、乙丁烯氟靈(ethalfluralin)、磺噻隆(ethidimuron)、亞速隆(ethoxysulfuron)、氯氟草醚乙酯(ethoxyfen-ethyl)、益覆滅(ethofumesate)、乙氧苯草胺(etobenzanid)、草藻滅(endothal-disodium)、樂滅草(oxadiazon)、丙炔
Figure 108126125-A0202-12-0190-186
草酮(oxadiargyl)、
Figure 108126125-A0202-12-0190-187
草酮(oxaziclomefone)、環氧嘧磺隆(oxasulfuron)、復祿芬(oxyfluorfen)、歐拉靈(oryzalin)、嘧苯胺磺隆(orthosulfamuron)、坪草丹(orbencarb)、油酸(oleic acid)、苯酮唑 (cafenstrole)、乙基克繁草(carfentrazone-ethyl)、特胺靈(karbutilate)、卡草胺(carbetamide)、快伏草(quizalofop)、快伏草(quizalofop-ethyl)、快伏草(quizalofop-P-ethyl)、喹禾糠酯(quizalofop-P-tefuryl)、莫克草(quinoclamine)、二氯喹啉酸(quinclorac)、氯甲喹啉酸(quinmerac)、苄草隆(cumyluron)、氯醯草膦(clacyfos)、嘉磷塞(glyphosate)(包含鈉、鉀、胺、丙基胺、異丙胺、二甲基胺或三甲基硫等鹽)、固殺草(glufosinate)(胺或鈉等鹽包含)、固殺草P(glufosinate-P)、固殺草P鈉鹽(glufosinate-P-sodium)、剋草同(clethodim)、clodinafop-炔丙基(clodinafop-propargyl)、畢克草(clopyralid)、可滅蹤(clomazone)、甲氧基護谷(chlomethoxyfen)、克普草(clomeprop)、氯酯磺草胺(cloransulam-methyl)、草滅平(chloramben)、殺草敏(chloridazon)、氯嘧磺隆(chlorimuron-ethyl)、氯磺隆(chlorsulfuron)、氯酸二甲酯(chlorthal-dimethyl)、草克樂(chlorthiamid)、氯醯亞胺(chlorphthalim)、整形素(chlorflurenol-methyl)、克普芬(chlorpropham)、氯溴隆(chlorbromuron)、枯草隆(chloroxuron)、綠麥隆(chlorotoluron)、ketospiradox(ketospiradox)(包含鈉、鈣或銨等鹽)、苯嘧磺草胺(saflufenacil)、假蒟亭鹼(sarmentine)、氰乃淨(cyanazine)、氰胺(cyanamide)、達有龍(diuron)、乙醯甲草胺(diethatyl-ethyl)、麥草畏(dicamba)(包含胺、二乙胺、異丙胺、二甘醇胺、鈉或鋰等鹽)、草滅特(cycloate)、環殺草(cycloxydim)、雙氯磺草安(diclosulam)、環磺隆(cyclosulfamuron)、cyclopyranil(通用名,吡唑類除草劑)、cyclopyrimorate(通用名)、敵草腈(dichlobenil)、禾草 靈(diclofop-P-methyl)、禾草靈(diclofop-methyl)、2,4滴丙酸鹽(dichlorprop)、2,4滴丙酸鹽-P(dichlorprop-P)、敵草快(diquat)、汰硫草(dithiopyr)、環草隆(siduron)、達乃安(dinitramine)、吲哚酮草酯(cinidon-ethyl)、醚磺隆(西速隆)(cinosulfuron)、達諾殺(dinoseb)、特垃酚(dinoterb)、氰氟草酯(cyhalofop-butyl)、大芬滅(diphenamid)、野燕枯(difenzoquat)、吡氟草胺(diflufenican)、二氟吡隆(diflufenzopyr)、草滅淨(simazine)、莫多草(dimethachlor)、愛落殺(dimethametryn)、汰草滅(dimethenamid)、汰草滅P(dimethenamid-P)、西草淨(simetryn)、哌草丹(dimepiperate)、
Figure 108126125-A0202-12-0192-188
唑隆(dimefuron)、環庚草醚(cinmethylin)、滅草靈(swep)、磺草酮(sulcotrione)、甲磺草胺(sulfentrazone)、草硫膦(sulfosate)、磺醯磺隆(sulfosulfuron)、甲嘧磺隆(sulfometuron-methyl)、西殺草(sethoxydim)、特草定(terbacil)、汰草龍(daimuron)、thaxtomin A(通用名)、茅草枯(dalapon)、噻草定(thiazopyr)、氟丙嘧草酯(tiafenacil)、噻酮磺隆(thiencarbazone)(包含鈉鹽、甲基酯等)、仲草(tiocarbazil)、禾草丹(thiobencarb)、噻苯隆(thidiazimin)、噻苯隆(thidiazuron)、甲基噻吩磺隆(thifensulfuron-methyl)、甜菜胺(desmedipham)、敵草淨(desmetryne)、tetflupyrolimet(通用名)、欣克草(thenylchlor)、牧草胺(tebutam)、特丁噻草隆(tebuthiuron)、得殺草(tepraloxydim)、特糠酯酮(tefuryltrione)、特丁津(terbuthylazine)、去草淨(terbutryn)、特丁通(terbumeton)、環磺酮(tembotrione)、苯唑草酮(topramezone)、肟草酮(tralkoxydim)、三
Figure 108126125-A0202-12-0193-189
氟草胺(triaziflam)、醚苯磺隆(triasulfuron)、氟酮磺草胺(triafamone)、野麥畏(tri-allate)、草達津(trietazine)、綠草定(triclopyr)、三氯比(triclopyr-butotyl)、三氟甲磺隆(tritosulfuron)、trifludimoxazin(通用名)、氟胺磺隆(triflusulfuron-methyl)、氟樂靈(trifluralin)、三氟啶磺隆鈉鹽(trifloxysulfuron-sodium)、苯磺隆(tribenuron-methyl)、tolpyralate(tolpyralate)、鈉得爛(naptalam)(包含鈉等鹽)、萘丙胺(naproanilide)、敵草胺(napropamide)、滅落脫(napropamide-M)、烟嘧磺隆(nicosulfuron)、草不隆(neburon)、氟草敏(norflurazon)、滅草猛(vernolate)、巴拉刈二氯鹽(paraquat dichloride)、氟氯吡啶酯(halauxifen-benzyl)、氟氯吡啶酯(halauxifen-methyl)、甲基合氯氟(haloxyfop)、甲基合氯氟(haloxyfop-P)、吡氟甲禾靈(haloxyfop-etotyl)、氟硝磺醯胺(halosafen)、氯吡嘧磺隆(halosulfuron-methyl)、bixlozone(bixlozone)、畢克爛(picloram)、氟吡醯草胺(picolinafen)、氟吡草酮(bicyclopyrone)、雙草醚(bispyribac-sodium)、唑啉草酯(pinoxaden)、必芬諾(bifenox)、哌草磷(piperophos)、雙唑草腈(pyraclonil)、磺醯草吡唑(pyrasulfotole)、芐草唑(pyrazoxyfen)、百速隆(pyrazosulfuron-ethyl)、苄草唑(pyrazolynate)、雙丙胺磷(bilanafos)、派芬草(pyraflufen-ethyl)、氯苯噠醇(pyridafol)、嘧硫草醚(pyrithiobac-sodium)、必汰草(pyridate)、環酯草醚(pyriftalid)、稗草畏(pyributicarb)、嘧啶肟草醚(pyribenzoxim)、pyrimisulfan(pyrimisulfan)、甲基嘧草醚(pyriminobac-methyl)、碸吡草唑(pyroxasulfone)、甲氧磺草胺 (pyroxsulam)、棉胺寧(phenisopham)、非草隆(fenuron)、fenoxasulfone(通用名)、
Figure 108126125-A0202-12-0194-190
唑禾草靈(fenoxaprop)(包含甲基、乙基、異丙基酯)、精
Figure 108126125-A0202-12-0194-191
唑禾草靈(fenoxaprop-P)(包含甲基、乙基、異丙基酯)、fenquinotrione(通用名)、噻唑禾草靈(fenthiaprop-ethyl)、四唑醯草胺(fentrazamide)、甜菜寧(phenmedipham)、丁基拉草(butachlor)、布芬草(butafenacil)、丁胺磷(butamifos)、丁酸酯(butylate)、丁烯草胺(butenachlor)、比達寧(butralin)、丁苯草酮(butroxydim)、伏速隆(flazasulfuron)、麥草氟(flamprop)(包含甲基、乙基、異丙基酯)、麥草氟M(flamprop-M)(包含甲基、乙基、異丙基酯)、甲基氟嘧磺隆(primisulfuro正methyl)、伏寄普(fluazifop-butyl)、伏寄普(fluazifop-P-butyl)、異丙吡草酯(fluazolate)、伏草隆(fluometuron)、乙羧氟草醚(fluoroglycofe正ethyl)、氟酮磺隆鈉鹽(flucarbazone-sodium)、氟消草(fluchloralin)、氟吡磺隆(flucetosulfuron)、
Figure 108126125-A0202-12-0194-192
草酸甲酯(fluthiacet-methyl)、氟啶嘧磺隆(flupyrsulfuro正methyl)(包含鈉、鈣或銨等鹽)、氟噻草胺(flufenacet)、氟嗒
Figure 108126125-A0202-12-0194-193
草酯(flufenpyr-ethyl)、氟丙酸酯(flupropanate)、氟洛普塞(flupoxame)、丙炔氟草胺(flumioxazin)、氟烯草酸(flumiclorac-pentyl)、唑嘧磺草胺(flumetsulam)、氟啶草酮(fluridone)、呋草酮(flurtamone)、氟氯比(fluroxypyr)(包含丁基甲酯、甲基庚酯等酯體,鈉、鈣或銨等鹽)、氟咯草酮(flurochloridone)、普拉草(pretilachlor)、甲基苄肼鈉鹽(procarbazone-sodium)、胺氟樂靈(prodiamine)、氟磺隆(prosulfuron)、芐草丹(prosulfocarb)、普拔草(propaquizafop)、毒 草安(propachlor)、普拔根(propazine)、除草靈(propanil)、拿草特(propyzamide)、異丙草胺(propisochlor)、丙
Figure 108126125-A0202-12-0195-194
嘧磺隆(propyrisulfuron)、苯胺靈(propham)、氟唑草胺(profluazol)、調環酸鈣(prohexadione-calcium)、丙苯磺隆(propoxycarbazone)、丙苯磺隆(propoxycarbazone-sodium)、環苯草酮(profoxydim)、除草定(bromacil)、溴殺草敏(brompyrazon)、撲草淨(prometryn)、撲滅通(prometon)、溴苯腈(bromoxynil)(包含丁酸、辛酸或庚酸等酯體)、殺草全(bromofenoxim)、溴芬諾(bromobutide)、雙氟磺草胺(florasulam)、氯氟吡啶酯(florpyrauxifen)、氯氟吡啶酯(florpyrauxifen-benzyl)、菲殺淨(hexazinone)烯草胺(pethoxamid)、草除靈(benazolin)、平速爛(penoxsulam)、heptamaloxyloglucan(heptamaloxyloglucan)、氟丁醯草胺(beflubutamid)、氟丁醯草胺-M(beflubutamid-M)、丁烯酸苯酯(pebulate)、壬酸(pelargonic acid)、茚蟲威(bencarbazone)、施得圃(pendimethalin)、雙苯嘧草酮(benzfendizone)、地散磷(bensulide)、免速隆(bensulfuron-methyl)、苯并雙環酮(benzobicyclon)、吡草酮(benzofenap)、滅草松(bentazone)、蔬草滅(pentanochlor)、環戊惡草酮(pentoxazone)、倍尼芬(benfluralin)、呋草黃(benfuresate)、殺木膦(fosamine)、氟磺胺草醚(fomesafen)、甲醯胺磺隆(foramsulfuron)、氯吡苯脲(forchlorfenuron)、2-甲基-4氯丙酸(mecoprop)(包含鈉、鉀、異丙胺、三乙醇胺、二甲基胺等鹽)、高甲氯丙酸鉀鹽(mecoprop-P-potassium)、甲磺胺磺窿(mesosulfuron)(包含甲酯等酯體)、硝磺草酮(mesotrione)、滅草胺(metazachlor)、
Figure 108126125-A0202-12-0195-195
吡嘧磺隆(metazosulfuron)、噻唑隆(methabenzthiazuron)、苯
Figure 108126125-A0202-12-0196-196
草酮(metamitron)、
Figure 108126125-A0202-12-0196-197
唑醯草胺(metamifop)、威百畝(metam)、甲基砷酸二鈉(DSMA)、methiozolin(通用名)、滅草隆(methyldymuron)、甲氧隆(metoxuron)、磺草唑胺(metosulam)、甲磺隆(metsulfuron-methyl)、撲奪草(metobromuron)、甲氧苯草隆(metobenzuron)、莫多草(metolachlor)、滅必淨(metribuzin)、縮節胺(mepiquat chloride)、滅芬草(mefenacet)、單嘧磺隆(monosulfuron)(包含甲基、乙基、異丙基酯)、氯谷隆(monolinuron)、禾草敵(molinate)、碘磺隆(iodosulfuron)、甲基二磺隆鈉鹽(iodosulfulon-methyl-sodium)、iofensulfuron(iofensulfuron)、鵬橫隆-乙基鈉(iofensulfuron-sodium)、乳氟禾草靈(lactofen)、lancotrione(通用名)、理有龍(linuron)、碸嘧磺隆(rimsulfuron)、環草定(lenacil)、2,2,2-三氯乙酸(TCA)(包含鈉、鈣或銨等鹽)、2,3,6-三氯苯甲酸(2,3,6-TBA)、2,4,5-三氯苯氧基乙酸(2,4,5-T)、2,4-二氯苯氧基乙酸(2,4-D)(包含胺、二乙胺、三乙醇胺、異丙胺、鈉或鋰等鹽)、2-胺基-3-氯-1,4-萘醌(ACN)、2-甲基-4-氯苯氧基乙酸(MCPA)(包含鈉鹽、乙基酯等)、2-甲基-4-氯苯氧基丁酸(MCPB)(包含鈉鹽、乙基酯等)、4-(2,4-二氯苯氧基)丁酸(2,4-DB)、4,6-二硝基-O-甲酚(DNOC)(包含胺或鈉等鹽)、AE-F-150944(編碼序號)、IR-6396(編碼序號)、MCPA硫基乙基(MCPA-thioethyl)、SYP-298(編碼序號)、SYP-300(編碼序號)、S-乙基二丙基硫基胺甲酸酯(EPTC)、S-莫多草(S-metolachlor)、S-9750(編碼序號)、MSMA(MSMA)、HW-02(編碼序號)、NC-653(編碼序號)、S-523(編碼序號)、SL-1201(編碼序號)。 Ioxynil, aclonifen, acrolein, azafenidin, acifluorfen (including sodium and other salts), azimsulfuron, azimsulfuron, Asulam, acetochlor, atrazine, anilofos, amicarbazone, amidosulfuron, amtrole, Aminocyclopyrachlor, aminopyralid, amiprofos-methyl, ametryn, alachlor, alloxydim, cypropyrimidine Alcohol (ancymidol), isouron, different
Figure 108126125-A0202-12-0190-183
Chlorfenone (isoxachlortole), iso
Figure 108126125-A0202-12-0190-184
Isoxaflutole, isoxaben, Isodecylalkoholethoxylate, isoproturon, ipfencarbazone, imazaquin, methyl Imazapic (containing salts such as amine), imazapyr (containing salts such as isopropylamine), imazamethabenz-methyl, imazamox, imazamox (imazamox) imazethapyr), imazosulfuron, indene
Figure 108126125-A0202-12-0190-185
Indaziflam, indanofan, eglinazine-ethyl, esprocarb, ethametsulfuro-methyl, ethalfluralin, sulfathion (ethidimuron), ethoxysulfuron, ethoxyfen-ethyl, ethofumesate, etobenzanid, endothal-disodium, lemethamate (oxadiazon), propyne
Figure 108126125-A0202-12-0190-186
Oxadiargyl,
Figure 108126125-A0202-12-0190-187
Oxaziclomefone, oxasulfuron, oxyfluorfen, oryzalin, orthosulfamuron, orbencarb, oleic acid , Cafenstrole, carfentrazone-ethyl, carbutilate, carbetamide, carbetamide, quizalofop, quizalofop-ethyl, fast Quizalofop-P-ethyl, quizalofop-P-tefuryl, quinoclamine, quinclorac, quinmerac, bensulfuron-methyl (quinmerac) cumyluron), clacyfos, glyphosate (containing sodium, potassium, amine, propylamine, isopropylamine, dimethylamine or trimethylsulfide), glufosinate ) (Including salts such as amine or sodium), glufosinate-P, glufosinate-P-sodium, clethodim, clodinafop-propargyl ), clopyralid, clomazone, chlomethoxyfen, clomeprop, cloransulam-methyl, chloramben, Chloridazon, chlorimuron-ethyl, chlorsulfuron, chlorthal-dimethyl, chlorthiamid, chlorphthalim, Chlorflurenol-methyl, chlorpropham, chlorbromuron, chloroxuron, chlorotoluron, ketospiradox (ketospiradox) (including salts such as sodium, calcium or ammonium), Saflufenacil, sarmentine, cyanazine, cyanamide, diuron, acetochlor (d iethatyl-ethyl), dicamba (containing amine, diethylamine, isopropylamine, diglycolamine, sodium or lithium, etc.), cycloate, cycloxydim, dichlorosulfonate Diclosulam, cyclosulfamuron, cyclopyranil (common name, pyrazole herbicide), cyclopyrimorate (common name), dichlobenil, diclofop-P-methyl, he Diclofop-methyl, 2,4 drops of propionate (dichlorprop), 2,4 drops of propionate-P (dichlorprop-P), diquat (diquat), dithiopyr (dithiopyr), cyclic grass Siduron, dinitramine, cinidon-ethyl, cinosulfuron, dinoseb, dinoterb, cyanogen Cyhalofop-butyl, diphenamid, difenzoquat, diflufenican, diflufenzopyr, simazine, madochlor ( dimethachlor), dimethametryn, dimethenamid, dimethenamid-P, dimethenamid-P, simetryn, dimepiperate,
Figure 108126125-A0202-12-0192-188
Dimefuron, cinmethylin, swip, sulcotrione, sulfentrazone, sulfosate, sulfosulfuron , Sulfometuron-methyl, sethoxydim, terbacil, daimuron, thaxtomin A (common name), dalapon, thiazopyr ), tiafenacil, thiencarbazone (including sodium salts, methyl esters, etc.), tiocarbazil, thiobencarb, thidiazimin, thiophene Thidiazuron, thifensulfuron-methyl, desmedipham, desmetryne, tetflupyrolimet (common name), thenylchlor, thenylchlor, tebutam, special Tebuthiuron, tepraloxydim, tefuryltrione, terbuthylazine, terbutryn, terbumeton, tembotrione , Topramezone (topramezone), oxachlor (tralkoxydim), three
Figure 108126125-A0202-12-0193-189
Triaziflam, triasulfuron, triafamone, tri-allate, trietazine, triclopyr, triclosan (triclopyr-butotyl), tritosulfuron (tritosulfuron), trifludimoxazin (common name), triflusulfuron-methyl (triflusulfuron-methyl), trifluralin (trifluralin), trifloxysulfuron-sodium , Tribenuron-methyl, tolpyralate (tolpyralate), sodium naptalam (including sodium and other salts), naproanilide, napropamide, napropamide, napropamide-M, Nicosulfuron, neburon, norflurazon, vernolate, paraquat dichloride, halauxifen-benzyl, Haloxyifen-methyl, haloxyfop, haloxyfop-P, haloxyfop-etotyl, halosafen, Halosulfuron-methyl, bixlozone (bixlozone), picloram, picolinafen, bicyclopyrone, bispyribac-sodium, azole Pinoxaden, bifenox, piperophos, pyraclonil, pyrasulfotole, pyrazoxyfen, pyrazosulfuron -ethyl), pyrazolynate, pyranafos, pyraflufen-ethyl, pyridafol, pyrithiobac-sodium, pyridate ), pyriftalid, pyributicarb, pyribenzoxim , Pyrimsulfan (pyrimisulfan), pyriminobac-methyl, pyroxasulfone, pyroxasulfone, pyroxsulam, phenisopham, fenuron, fenoxasulfone ( common name),
Figure 108126125-A0202-12-0194-190
Fenoxaprop (containing methyl, ethyl, isopropyl ester), refined
Figure 108126125-A0202-12-0194-191
Fenoxaprop-P (containing methyl, ethyl, isopropyl ester), fenquinotrione (common name), fenthiaprop-ethyl, fenthiaprop-ethyl, fentrazamide, beetin (phenmedipham), butachlor, butafenacil, butamifos, butylate, butenachlor, butralin, butylene Butroxydim, flazasulfuron, flamprop (containing methyl, ethyl, isopropyl ester), flamprop-M (including methyl, ethyl, isopropyl Ester), primisulfuromethyl (primisulfuro-n-methyl), fluazifop-butyl, fluazifop-P-butyl, fluazifop-P-butyl, fluazolate, fluazolate, fluometuron ), fluoroglycofe orthoethyl, flucarbazone-sodium, fluchloralin, flucetosulfuron,
Figure 108126125-A0202-12-0194-192
Fluthiacet-methyl, flupyrsulfuro-n-methyl (containing sodium, calcium, or ammonium salts), flufenacet, and flufenacet
Figure 108126125-A0202-12-0194-193
Flufenpyr-ethyl, flupropanate, flupoxame, flumioxazin, flumiclorac-pentyl, flumetsulam , Fluridone, flurtamone, fluroxypyr (including butyl methyl ester, methyl heptyl ester and other esters, sodium, calcium or ammonium and other salts), flurochloridone (flurochloridone ), pretilachlor, procarbazone-sodium, prodiamine, prodiuron, prosulfuron, prosulfocarb, propaquizafop, Propachlor, propazine, propanil, propyzamide, propisochlor, propionate
Figure 108126125-A0202-12-0195-194
Propyrisulfuron, Propham, Profluazol, Prohexadione-calcium, Propoxycarbazone, Propoxycarbazone-sodium, Ring Profoxydim, bromacil, brompyrazon, prometryn, prometon, bromoxynil (including butyric acid, caprylic acid or enanthic acid, etc.) (Ester), bromofenoxim, bromobutide, flosulam, florpyrauxifen, florpyrauxifen-benzyl, hexazinone ) Penthoxamid, benazolin, penoxsulam, heptamaloxyloglucan (heptamaloxyloglucan), beflubutamid, beflubutamid-M, butene Pebulate, pelargonic acid, bencarbazone, pendimethalin, benzfendizone, bensulide, bensulfuron-methyl ), benzobicyclon, benzofenap, bentazone, pentanochlor, pentoxazone, benfluralin, furfur yellow (benfuresate), fosamine, fomesafen, foramsulfuron, forchlorfenuron, 2-methyl-4 chloropropionic acid (mecoprop) (including (Sodium, potassium, isopropylamine, triethanolamine, dimethylamine and other salts), mecoprop-P-potassium, mesosulfuron (including methyl esters and other esters), nitrate Mesotrione, metazachlor,
Figure 108126125-A0202-12-0195-195
Pyrazosulfuron (metazosulfuron), thiazolone (methabenzthiazuron), benzene
Figure 108126125-A0202-12-0196-196
Metamitron,
Figure 108126125-A0202-12-0196-197
Metamifop, metam, disodium methyl arsenate (DSMA), metiozolin (common name), methyldymuron, metoxuron, sulfoxazone (metoxuron) metosulam), metsulfuron-methyl, metobromuron, metobenzuron, metolachlor, metribuzin, mepiquat chloride, Mefenacet, monosulfuron (containing methyl, ethyl, and isopropyl esters), monolinuron, molinate, iodosulfuron, and formazan Iodosulfulon-methyl-sodium, iofensulfuron (iofensulfuron), iofensulfuron-sodium, iofensulfuron-sodium, lactofen, lancotrione (common name), and liyoulong (linuron), rimsulfuron, lenacil, 2,2,2-trichloroacetic acid (TCA) (including sodium, calcium or ammonium salts), 2,3,6-trichloro Benzoic acid (2,3,6-TBA), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), 2,4-dichlorophenoxyacetic acid (2,4-D ) (Including amine, diethylamine, triethanolamine, isopropylamine, sodium or lithium and other salts), 2-amino-3-chloro-1,4-naphthoquinone (ACN), 2-methyl-4-chlorobenzene Oxyacetic acid (MCPA) (including sodium salt, ethyl ester, etc.), 2-methyl-4-chlorophenoxybutyric acid (MCPB) (including sodium salt, ethyl ester, etc.), 4-(2,4 -Dichlorophenoxy)butyric acid (2,4-DB), 4,6-dinitro-O-cresol (DNOC) (including salts such as amine or sodium), AE-F-150944 (coding serial number) , IR-6396 (coding serial number), MCPA-thioethyl (MCPA-thioethyl), SYP-298 (coding serial number), SYP-300 (coding serial number), S-ethyldipropylthiocarbamate ( EPTC), S-metolachlor, S-9750 (coding serial number), MSMA (MSMA), HW-02 (coding serial number), NC-653 (coding serial number), S-523 (coding serial number) , SL-1201 (coding serial number).

植物生長調節劑: Plant Growth Regulator:

1-萘基乙醯胺(1-naphthylacetamide)、1-甲基環丙烯(1-methylcyclopropene)、2,6-二異丙基萘(2,6-diisopropylnaphthalene)、4-側氧基-4-(2-苯基乙基)胺基丁酸(化學名,CAS登錄號碼:1083-55-2)、4-氯苯氧基乙酸(4-CPA)、正癸醇(n-decanol)、艾維激素(aviglycine)、嘧啶醇(ancymidol)、離層酸(abscisic acid)、依鈉素(inabenfide)、吲哚乙酸(indole acetic acid)、吲哚丁酸(indole butyric acid)、單克素(uniconazole)、單克素-P(uniconazole-P)、Ecolyst(Ecolyst)、吲熟酯(ethychlozate)、益收生長素(ethephon)、丙醯芸苔素內酯(epocholeone)、奧辛硫酸鹽(oxine-sulfate)、香旱芹酮(carvone)、甲酸鈣(calcium formate)、坐果酸(cloxyfonac)、坐果酸鉀鹽(cloxyfonac-potassium)、坐果安(cloprop)、克美素(chlormequat)、膽鹼(choline)、細胞分裂素(cytokinins)、環丙草胺(cyclanilide)、敵草克(dikegulac)、赤黴酸(gibberellin acid)、穫萎得(dimethipin)、殺雄啉(sintofen)、丁醯肼(daminozide)、噻苯隆(thidiazuron)、三十烷醇(triacontanol)、抗倒酯(trinexapac-ethyl)、巴克素(paclobutrazol)、石蠟(paraffin)、氟節胺(flumetralin)、呋嘧醇(flurprimidol)、抑草丁(flurenol)、pronitridine(通用名)、茉莉酸丙酯(prohydrojasmon)、調環酸鈣鹽(prohexadione-calcium)、heptamaloxyloglucan(通用名)、苄胺嘌呤(benzylaminopurine)、氯吡苯脲(forchlorfenuron)、順丁烯二醯肼(maleic hydrazide)、缩節胺(mepiquat chloride)、氟磺醯草胺(mefluidide)、過氧化鈣。 1-naphthylacetamide, 1-methylcyclopropene, 2,6-diisopropylnaphthalene, 4-oxo-4- (2-Phenylethyl)aminobutyric acid (chemical name, CAS registration number: 1083-55-2), 4-chlorophenoxyacetic acid (4-CPA), n-decanol (n-decanol), Ai Aviglycine, ancymidol, abscisic acid, inabenfide, indole acetic acid, indole butyric acid, monogram ( uniconazole), monoiconazole-P (uniconazole-P), Ecolyst (Ecolyst), indyl ester (ethychlozate), ethephon, eprophon, epocholeone, oxin sulfate ( oxine-sulfate, carvone, calcium formate, cloxyfonac, cloxyfonac-potassium, cloprop, chlormequat, choline (choline), cytokinins, cyclanilide, dikegulac, gibberellin acid, dimethipin, sintofen, dingyin Hydrazine (daminozide), thidiazuron, triacontanol, trinexapac-ethyl, paclobutrazol, paraffin, flumetralin, furimidine (flurprimidol), flurenol, pronitridine (generic name), propyl jasmonate (prohydrojasmon), prohexadione-calcium, heptamaloxyloglucan (generic name), benzylaminopurine (benzylaminopurine), chlorine Forchlorfenuron, maleic hydrazide, mepiquat chloride, mefluid ide), calcium peroxide.

其次,將可以混合或併用的公知的藥害減輕化合物例示如 下。 Secondly, examples of well-known phytotoxicity-reducing compounds that can be mixed or used together are exemplified as under.

雙苯

Figure 108126125-A0202-12-0198-198
唑酸(isoxadifen)、雙苯
Figure 108126125-A0202-12-0198-199
唑酸乙酯(isoxadifen-ethyl)、解草腈(oxabetrinil)、解毒喹(cloquintcet-mexyl)、增效磷(dietholate)、解草胺腈(cyometrinil)、二氯丙烯胺(dichlormid)、二環酮(dicyclonone)、環丙磺醯胺(cyprosulfamide)、1,8-萘二甲酸酐(1,8-Naphthalic Anhydride)、解草唑(fenchlorazole-O-ethyl)、解草啶(fenclorim)、解草
Figure 108126125-A0202-12-0198-200
唑(furilazole)、氟草肟(fluxofenim)、解草胺(flurazole)、解草酮(benoxacor)、mephenate(通用名)、吡唑解草酸(mefenpyr)、吡唑解草酸乙酯(mefenpyr-ethyl)、吡唑解草酸二乙酯(mefenpyr-diethyl)、低級烷基取代苯甲酸、2,2-二氯-N-(1,3-二
Figure 108126125-A0202-12-0198-201
烷-2-基甲基)-N-(2-丙烯基)乙醯胺(PPG-1292)、2-二氯甲基-2-甲基-1,3-二
Figure 108126125-A0202-12-0198-202
烷(MG-191)、3-二氯乙醯基-2,2,5-三甲基-1,3-
Figure 108126125-A0202-12-0198-203
唑烷(R-29148)、4-二氯乙醯基-1-氧雜-4-氮雜螺環[4.5]癸烷(AD-67)、MON4660(編碼序號)、metcamifen(通用名)、N1,N2-二烯丙基-N2-二氯乙醯基甘胺醯胺(DKA-24)、TI-35(編碼序號)。 Bisbenzene
Figure 108126125-A0202-12-0198-198
Izodic acid (isoxadifen), bisbenzene
Figure 108126125-A0202-12-0198-199
Isoxadifen-ethyl, oxabetrinil, cloquintcet-mexyl, dietholate, cyometrinil, dichlormid, dicyclo Dicyclonone, cyprosulfamide, 1,8-Naphthalic Anhydride, fenchlorazole-O-ethyl, fenclorim, fenclorim grass
Figure 108126125-A0202-12-0198-200
Furilazole, fluxofenim, flurazole, benoxacor, mephenate (common name), mefenpyr, mefenpyr-ethyl ), mefenpyr-diethyl pyrazolate (mefenpyr-diethyl), lower alkyl substituted benzoic acid, 2,2-dichloro-N-(1,3-di
Figure 108126125-A0202-12-0198-201
Alkan-2-ylmethyl)-N-(2-propenyl)acetamide (PPG-1292), 2-dichloromethyl-2-methyl-1,3-di
Figure 108126125-A0202-12-0198-202
Alkane (MG-191), 3-dichloroacetyl-2,2,5-trimethyl-1,3-
Figure 108126125-A0202-12-0198-203
Oxazolidine (R-29148), 4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane (AD-67), MON4660 (coding number), metcamifen (common name), N1,N2-diallyl-N2-dichloroacetamideglycamine (DKA-24), TI-35 (coding number).

按照上述所構成的本發明之有害生物防除劑,對於直翅目害蟲、纓翅目害蟲、半翅目害蟲、鞘翅目害蟲、雙翅目害蟲、鱗翅目害蟲、膜翅目害蟲、彈尾目害蟲、衣魚目害蟲、蜚蠊目害蟲、囓蟲目害蟲、食毛目害蟲、蝨目害蟲、植物寄生性蟎類、植物寄生性線蟲類、植物寄生性軟體動物、其他有害動物、令人不舒服的動物、衛生害蟲、寄生蟲等有害生物顯示優異之防除效果。如此的有害生物可例示如下述之生物種。 The pest control agent of the present invention constituted as described above is suitable for orthoptera pests, Thysanoptera pests, hemiptera pests, Coleoptera pests, Diptera pests, Lepidoptera pests, Hymenoptera pests, and Pteroceras pests. , Chlamydomonas pests, Blattidae pests, Rodentes pests, Trichoderma pests, Liceles pests, plant parasitic mites, plant parasitic nematodes, plant parasitic mollusks, other harmful animals, unpleasant Comfortable animals, sanitary pests, parasites and other harmful organisms show excellent control effect. Such pests can be exemplified by the following biological species.

直翅目害蟲例如可舉:螽蟖科之黑頸鉤額螽(Ruspolia lineosa)等;蟋蟀科之閻魔蟋蟀(Teleogryllus emma)、梨片蟋(Truljalia hibinonis)等;螻蛄科之螻蛄(Gryllotalpa orientalis)、蝗蟲科之小翅蝗蟲(Oxya hyla intricate)、東亞飛蝗(Locusta migratoria)、血黑蝗(Melanoplus sanguinipes)、異黑蝗(Melanoplus differentialis)、赤脛黑蝗(Melanoplus femurrubrum)等;背負蝗科之背負蝗(Atractomorpha lata);松蟲科之茅蟋蟀(Euscyrtus japonicus);蚤蝗蟲科之日本蚤蝗蟲(Xya japonicus)等。 Orthoptera pests include, for example: Ruspolia lineosa (Ceramidae) and others; Teleogryllus emma (Truljalia) and Cricket (Truljalia) hibinonis), etc.; Griflotalpa orientalis, Oxya hyla intricate, Locusta migratoria, Melanoplus sanguinipes, Melanoplus differentialis, red shank Black locust (Melanoplus femurrubrum), etc.; Atractomorpha lata carrying the locust family; Euscyrtus japonicus; Xya japonicus such as the flea locust family.

纓翅目害蟲例如可舉:薊馬科之台灣薊馬(Frankliniella intonsa)、西方薊馬(Frankliniella occidentalis)、小黃薊馬(Scirtothrips dorsalis)、南黃薊馬(Thrips palmi)、蔥薊馬(Thrips tabaci)、日本煙草薊馬(Thrips setosus)、變葉木薊馬(Heliothrips haemorrhoidalis)、稻薊馬(Stenchaetothrips biformis)等;管薊馬科之柿管薊馬(Ponticulothrips diospyrosi)、芥辣管薊馬(Liothrips wasabiae)、稻管薊馬(Haplothrips aculeatus)等。 Examples of the Thysanoptera pests are: Thrips Taiwan thrips (Frankliniella intonsa), Western thrips (Frankliniella occidentalis), Small yellow thrips (Scirtothrips dorsalis), Southern yellow thrips (Thrips palmi), Onion thrips (Thrips palmi) Thrips tabaci), Japanese tobacco thrips (Thrips setosus), leaf thrips (Heliothrips haemorrhoidalis), rice thrips (Stenchaetothrips biformis), etc.; persimmon thrips (Ponticulothrips diospyrosi), mustard tube thrips (Liothrips wasabiae), rice tube thrips (Haplothrips aculeatus), etc.

半翅目害蟲例如可舉:蟬科之姬草蟬(Mogannia minuta)等;沫蟬科(Cercopidae)之白帶尖胸沫蟬(Aphrophora intermedia)、甘蔗沬蟬(Mahanarva fimbriolata)等;角蟬科之褐角蟬(Machaerotypus sibiricus)等;葉蟬科之葡萄葉蟬(Arboridia apicalis)、茶小綠葉蟬(Empoasca onukii)、偽黑尾葉蟬(Nephotettix cincticeps)、馬來亞黑尾葉蟬(Nephotettix malayanus)、台灣黑尾葉蟬(Nephotettix virescens)、黑條黑尾葉蟬(Nephotettix nigropictus)、電光紋葉蟬(Recilia dorsalis)、二點小綠葉蟬(Amrasca biguttula)、檬果褐葉蟬(Idioscopus nitidulus、Idioscopus clypealis、Amritodus atkinsoni)、馬鈴薯葉蟬(Empoasca fabae)、玉米葉蟬 (Dalbulus maidis)等;菱飛蝨科之菱飛蝨(Pentastiridius apicalis)等;稻蝨科之斑飛蝨(Laodelphax striatellus)、褐飛蝨(Nilaparvata lugens)、白背飛蝨(Sogatella furcifera)、玉米飛蝨(Peregrinus maidis)等;縞飛蝨科之縞飛蝨(Nisia nervosa)等;長翅飛蝨科之砂糖斑長飛蝨(Kamendaka saccharivora)等;小頭飛蝨科之紅黴菌飛蝨(Achilus flammeus)等;廣翅蠟蟬科之鼈甲廣翅蠟蟬(Orosanga japonicus)等;青翅飛蝨科之禾草褐蛾蠟蟬(Mimophantia maritima)等;木蝨科之梨木蝨(Cacopsylla pyrisuga)、柑橘木蝨(Diaphorina citri)等;榕木蝨科之芒果木蝨(Calophya mangiferae)等;根瘤蚜科之葡萄根瘤蚜(Daktulosphaira vitifoliae)等;球蚜科之落葉松球蚜(Adelges laricis)、鐵杉球蚜(Adelges tsugae)等;蚜科之豌豆蚜(Acyrthosiphon pisum)、棉蚜(Aphis gossypii)、橘捲葉蚜(Aphis spiraecola)、偽菜蚜(Lipaphis erysimi)、菜蚜(Brevicoryne brassicae)、桃紅蚜(Myzus persicae)、麥綠蚜(Schizaphis graminum)、稻麥蚜(Rhopalosiphum padi)、小橘蚜(Toxoptera aurantii)、馬鈴薯長鬚蚜(Aulacorthum solani)、馬鈴薯網管蚜(Macrosiphum euphorbiae)、萵苣衲長管蚜(Nasonovia ribisnigri)、麥長管蚜(Sitobion avenae)、大豆蚜(Aphis glycines)等;粉蝨科之茶刺粉蝨(Aleurocanthus camelliae)、柑桔黑刺粉蝨(Aleurocanthus spiniferus)、煙草粉蝨(Bemisia tabaci)、銀葉粉蝨(Bemisia argentifolii)、溫室粉蝨(Trialeurodes vaporariorum)等;碩介殼蟲科之草履介殼蟲(Drosicha corpulenta)、吹綿介殼蟲(Icerya purchasi)等;粉介殼蟲之鳳梨嫡粉介殼蟲(Dysmicoccus brevipes)、柑桔粉介殼蟲(Planococcus citri)、桑粉介殼蟲(Pseudococcus comstocki) 等;介殼蟲科之角蠟介殼蟲(Ceroplastes ceriferus)、紅蠟介殼蟲(Ceroplastes rubens)等;仁介殼蟲科之甘蔗仁介殼蟲(Aclerda takahashii)等;盾介殼蟲科之橘紅腎圓盾介殼蟲(Aonidiella aurantii)、梨齒盾介殼蟲(Diaspidiotus perniciosus)、桑白盾介殼蟲(Pseudaulacaspis pentagona)、矢尖盾介殼蟲(Unaspis yanonensis)等;盲椿象科之美國牧草盲椿象(Lygus lineolaris)、紅鬚細綠盲椿象(Trigonotylus caelestialium)、綠盲椿象(Apolygus lucorum)、煙草盲椿象(Nesidiocoris tenuis)、庭園盲椿象(Halticus bractatus)等;軍配蟲科之杜鵑軍配蟲(Stephanitis pyrioides)、梨軍配蟲(Stephanitis nashi)等;椿象科之皺紋菜椿象(Eurydema rugosum)、大二星椿象(Eysarcoris lewisi)、二星椿象(Eysarcoris aeneus)、稻椿象(Lagynotomus elongatus)、南方綠椿象(Nezara viridula)、珀椿象(Plautia crossota)、東方稻綠椿象(Nezara antennata)、褐椿象(Euschistus heros)、紅帶月椿象(Piezodorus guildini)、稻椿象(Tibraca limbativentris)、綠每椿象(Dichelops furcatus)等;圓椿象科之台灣圓椿象(Megacopta cribraria)等;異尾椿象科之

Figure 108126125-A0202-12-0201-204
梨椿象(Urochela luteovoria)等;長椿象科之甘蔗小翅長椿象(Cavelerius saccharivorus)等;突眼長椿象科之豆突眼長椿象(Malcus japonicus)等;紅椿象科之離斑棉紅椿象(Dysdercus cingulatus)等;蛛緣椿象科之禾蛛緣椿象(Leptocorisa acuta)、中華稻緣椿象(Leptocorisa chinensis)等;緣椿象科之紋鬚同緣椿象(Anacanthocoris striicornis)等;姬緣椿象科之赤姬緣椿象(Rhopalus maculatus)等;土椿象科之褐土椿象(Scaptocoris castanea)等;臭蟲科之溫帶臭蟲(Cimex lectularis)等。 Hemiptera pests include, for example: Mogannia minuta and the like; Aphrophora intermedia of Cercopidae, Acanophora intermedia, Mahanarva fimbriolata, etc.; Brown-horned cicada (Machaerotypus sibiricus), etc.; grape leaf cicada (Arboridia apicalis), tea small green leaf cicada (Empoasca onukii), pseudo black-tailed cicada (Nephotettix cincticeps), Malayan black-tailed cicada (Nephotettix malayanus) ), Taiwan black-tailed leafhopper (Nephotettix virescens), black-striped blacktail leafhopper (Nephotettix nigropictus), electro-optic leafhopper (Recilia dorsalis), two-pointed green leafhopper (Amrasca biguttula), lemon fruit brown leafhopper (Idioscopus nitidulus) , Idioscopus clypealis, Amritodus atkinsoni), potato leafhopper (Empoasca fabae), corn leafhopper (Dalbulus maidis), etc.; Pentastiridius apicalis, etc.; Laodelphax striatellus , Brown planthopper (Nilaparvata lugens), white-backed planthopper (Sogatella furcifera), corn planthopper (Peregrinus maidis), etc.; the brown planthopper (Nisia nervosa) of the onion plant family (Nisia nervosa), etc.; (Kamendaka saccharivora), etc.; Achilus flammeus, etc.; Ochianga japonicus, etc.; Grass brown brown moth wax of the blue-winged planthopper. Cicada (Mimophantia maritima), etc.; Cacopsylla pyrisuga, Diaphorina citri, etc.; Mango psyllium (Calophya mangiferae) of Ficus plutidae; Calophya mangiferae, etc.; Daktulosphaira vitifoliae), etc.; Adelges laricis, Adelges tsugae, etc.; Acyrthosiphon pisum, Aphis g. ossypii), Aphis spiraecola, Lipaphis erysimi, vegetable aphid (Brevicoryne brassicae), pink aphid (Myzus persicae), wheat green aphid (Schizaphis graminum), rice wheat aphid (Rhopalosiphum padi), Toxoptera aurantii, Aulacorthum solani, Macrosiphum euphorbiae, Nasonovia ribisnigri, Sitobion avenae, Aphis glycines Etc.; Aleurocanthus camelliae, Aleurocanthus spiniferus, Bemisia tabaci, Bemisia argentifolii, Greenhouse mealworm (Trialeurodes vaporariorum) Etc.; Drosicha corpulenta, Icerya purchasi, etc.; Dysmicoccus brevipes, Planococcus citri, mulberry Pseudococcus comstocki, etc.; Ceroplastes ceriferus, Ceroplastes rubens, etc.; Aclerda takahashii, etc.; Shield scale insects Aonidiella aurantii, Diaspidiotus perniciosus, Pseudaulacaspis pentagona, Unaspis yanonensis, etc.; American forage Lygus lineolaris, Trigonotylus caelestialium, Apolygus lucorum, Nesidiocoris tenuis, Halticus bractatus, etc.; Rhododendron armyworm (Stephanitis pyrioi des), Stephanitis nashi, etc.; Eurydema rugosum, Eysarcoris lewisi, Eysarcoris aeneus, Lagynotomus elongatus, southern green stink bug (Nezara) viridula), Plautia crossota, Nezara antennata, Euchistus heros, Piezodorus guildini, Tibraca limbativentris, Dichelops furcatus, etc. ; Taiwan round stink bug (Megacopta cribraria), etc.;
Figure 108126125-A0202-12-0201-204
Pear stink bug (Urochela luteovoria), etc.; sugarcane small-winged stink bug (Cavelerius saccharivorus), etc.; pieropsis stink bug (Malcus japonicus), etc.; spotted cotton red stink bug of the red stink bug ( Dysdercus cingulatus); Leptocorisa acuta, Leptocorisa chinensis, etc.; Anacanthocoris striicornis etc. Rhopalus maculatus, etc.; Scaptocoris castanea, etc.; Cimex lectularis, etc.

鞘翅目害蟲例如可舉:金龜子科之銅色麗金龜(Anomara cuprea)、紅銅麗金龜(Anomara rufocuprea)、豆金龜(Popillia japonica)、小青花金龜(Oxycetonia jucunda)、櫻桃小麗金龜(Anomala geniculata)、椰子犀角金龜(Oryctes rhinoceros)、茶色長金龜(Heptophylla picea)、六月金龜(Phyllophaga cuyabana)等;叩頭蟲科之鳶色細胸叩頭蟲(Agriotes ogurae)、直條叩頭蟲(Agriotes lineatus)、暗色叩頭蟲(Agriotes obscurus)、沖繩梳爪叩頭蟲(Melanotus okinawensis)、圓首梳爪叩頭蟲(Melanotus fortnumi)等;鰹節蟲科之姬圓鰹節蟲(Anthrenus verbasci)等;長蠹蟲科之二突異翅長蠹蟲(Heterobostrychus hamatipennis)等;食骸蟲科之藥材甲蟲(Stegobium paniceum)等;蛛甲科之棕蛛甲(Pitinus clavipes)等;穀盜蟲科之大穀盜(Tenebroides mauritanicus)等;郭公蟲科之赤足郭金蟲(Necrobia rufipes);出尾蟲科之黃斑露尾甲(Carpophilus hemipterus)、油菜花露尾甲(Meligethes seneus)等;細扁蟲科之背圓粉扁蟲(Ahasverus advena)等;姬扁蟲科之角胸粉扁蟲(Cryptolestes ferrugineus)等;瓢蟲科之墨西哥豆瓢蟲(Epilachna varivestis)、茄二十八星瓢蟲(Henosepilachna vigintioctopunctata)等;擬步行蟲科之黃粉蟲(Tenebrio molitor)、擬穀盜(Tribolium castaneum)等;芫菁科之豆莞菁(Epicauta gorhami)等;天牛科之光肩星天牛(Anoplophora glabripennis)、葡萄虎天牛(Xylotrechus pyrrhoderus)、松斑天牛(Monochamus alternatus)、大豆黑光天牛(Dectes texanus)等;豆象科之綠豆象(Callosobruchus chinensis)等;金花蟲科之科羅拉多金花蟲(Leptinotarsa decemlineata)、西方玉米根蟲(Diabrotica virgifera virgifera)、北方玉米根蟲(Diabrotica barberi)、南方玉米根蟲(Diabrotica undecimpunctata howardi)、黃守瓜(Aulacophora femoralis)、甘藍金花蟲(Phaedon brassicae)、甜菜大龜甲(Cassida nebulosa)、水稻負泥蟲(Oulema oryzae)、墨西哥大豆瓢蟲(Epilachna varivestis)、黃條葉蚤(Phyllotreta striolata)、茶肖葉甲(Demotina fasciculata)、油菜金頭跳甲(Psylliodes chrysocephala)、菜豆黃跳甲(Cerotoma trifurcate)、葡萄肖跳甲(Colaspis brunnea)、愛荷華肖跳甲(Colaspis crinnicornis)、大豆跳甲(Odontota horni)、玉米跳甲(Chaetocnema pulicaria)、帶斑黃瓜葉甲(Diabrotica balteata)等;三維象蟲科之甘藷蟻象(Cylas formicarius)等;象鼻蟲科之苜蓿葉象鼻蟲(Hypera postica)、蔬菜象蟲(Listroderes costirostris)、甘藷象鼻蟲(Euscepes postfasciatus)、栗象鼻蟲(Curculio sikkimensis)、墨西哥棉鈴象鼻蟲(Anthonomus grandis)、豆莖象鼻蟲(Sternechus subsignatus)等;稻象鼻蟲科之二星稻象(Echinocnemus bipunctatus)、稻根象鼻蟲(Lissorhoptrus oryzophilus)、南美稻象鼻蟲(Oryzophagus oryzae)等;椰象鼻蟲科之玉米象鼻蟲(Sitophilus zeamais)、芝隱喙象鼻蟲(Sphenophorus venatus)、甘蔗象鼻蟲(Sphenophorus levis)等;木蠹蟲科之縱坑切梢小蠹(Tomicus piniperda)等;長小蠹蟲科之臺日截尾長小蠹(Crossotarsus niponicus)等;粉蠹科之褐粉蠹(Lyctus brunneus)等。 Coleoptera pests include, for example: Anomara cuprea (Anomara cuprea), red copper beetle (Anomara rufocuprea), bean chafer (Popillia japonica), blue-and-white chafer (Oxycetonia jucunda), cherry chamomile (Anomala geniculata) ), coconut rhinoceros chafer (Oryctes rhinoceros), brown chafer (Heptophylla picea), June chafer (Phyllophaga cuyabana), etc.; Agriotes ogurae, Agriotes ogurae, Agriotes lineatus, Dark color beetle (Agriotes obscurus), Okinawa comb claw beetle (Melanotus okinawensis), round head comb claw beetle (Melanotus fortnumi), etc.; Anthrenus verbasci, etc.; two outbursts of the long beetle family Heterobostrychus hamatipennis, etc.; Stegobium paniceum, etc.; Pitinus clavipes, etc.; Tenebroides mauritanicus, etc.; Necrobia rufipes of the family Guogongidae; Carpophilus hemipterus and Meligethes seneus, etc.; A. versicolor flatworms (Ahasverus) advena); etc.; Cryptolestes ferrugineus, etc.; Epilachna varivestis, Henosepilachna vigintioctopunctata, etc.; Psedidae Tenebrio molitor, Tribolium castaneum, etc.; Epicauta gorhami, etc.; Anoplophora glabripennis, Xylotrechus pyrrhoderus, Monochamus alternatus, Soybean black beetle (Dectes texanus), etc.; Mung bean elephant of the legume family (Callosobruchus chinensis) Etc.; Colorado golden bug (Leptinotarsa decemlineata) and western corn rootworm (Diabrotica virgifera) virgifera), northern corn rootworm (Diabrotica barberi), southern corn rootworm (Diabrotica undecimpunctata howardi), yellow guard melon (Aulacophora femoralis), cabbage flower bug (Phaedon brassicae), beet beetle (Cassida nebulosa), rice negative mud Insects (Oulema oryzae), Mexican soybean ladybug (Epilachna varivestis), yellow leaf fleas (Phyllotreta striolata), tea Xiao leaf beetle (Demotina fasciculata), rapeseed golden beetle (Psylliodes chrysocephala), kidney bean yellow beetle (Cerotoma trifurcate) ), Colaspis brunnea, Colaspis crinnicornis, Odontota horni, Chaetocnema pulicaria, Diabrotica balteata, etc.; The sweet potato ant elephant (Cylas formicarius) of the weevil family; the alfalfa leaf weevil (Hypera postica), the vegetable weevil (Listroderes costirostris), the sweet potato weevil (Euscepes postfasciatus), the chestnut weevil ( Curculio sikkimensis), Mexican cotton boll weevil (Anthonomus grandis), bean stem weevil (Sternechus subsignatus), etc.; two-star rice elephant (Echinocnemus bipunctatus), rice root weevil (Lissorhoptrus oryzophilus), South America Rice weevil (Oryzophagus oryzae), etc.; corn weevil (Sitophilus zeamais), coccinus weevil (Sphenophorus venatus), sugarcane weevil (Sphenophorus levis), etc.; Longitudinal pit-cutting bark beetle (Tomicus piniperda), etc.; Long-tailed bark beetle family (Crossotarsus niponicus), etc.; Powdered beetle family (Lyctus brunneus), etc.

雙翅目害蟲例如可舉:大蚊科之切蛀大蚊(Tipula aino)等;毛蚋科之毛蚋(Plecia nearctica)等;蕈蚋科之香菇蚋(Exechia shiitakevora)等;黑翅蕈蚋科之馬鈴薯黑翅蕈蚋(Pnyxia scabiei)、矮黑翅蕈蚋(Bradysia agrestis)等;癭蚋科之大豆莢癭蚋(Asphondylia yushimai)、小麥癭蚋(Mayetiola destructor)、藍莓癭蚋(Dasineura oxycoccana)等;蚊科之埃及斑蚊(Aedes aegypti)、淡色庫蚊(Culex pipiens pallens)等;蚋科之牛蚋(Simulium takahashii)等;搖蚊科之稻搖蚊(Chironomus oryzae)等;虻科之合瘤斑虻(Chrysops suavis)、牛虻(Tabanus trigonus)等;Syrphidae之灰條球蚜蠅(Eumerus strigatus)等;果實蠅科之東方果實蠅(Bactrocera dorsalis)、日本櫻桃果實蠅(Euphranta japonica)、地中海果實蠅(Ceratitis capitata)等;潛葉蠅科之非洲菊斑潛葉蠅(Liriomyza trifolii)、蔬菜斑潛葉蠅(Liriomyza sativae)、稻潛葉蠅(Agromyza oryzae)、茄斑潛葉蠅(Liriomyza bryoniae)、韭菜葉蠅(Chromatomyia horticola)、蔥潛葉蠅(Liriomyza chinensis)、南美斑潛蠅(Liriomyza trifolii)等;杆蠅科之麥杆蠅(Meromyza nigriventris)等;果蠅科之斑翅果蠅(Drosophila suzukii)、黑腹果蠅(Drosophila melanogaster)等;水蠅科之稻小潛葉蠅(Hydrellia griseola)等;蝨蠅科之馬蝨蠅(Hippobosca equina)等;糞蠅科之笹川糞蠅(Parallelpmma sasakawae)等;花蠅科之蔥地種蠅(Delia antiqua)、灰地種蠅(Delia platura)等;廁蠅科之廁蠅(Fannia canicularis)等;家蠅科之家蠅(Musca domestica)、螫蠅(Stomoxys calcitrans)等;肉蠅科之肉蠅(Sarcophaga peregrina)等;馬蠅科之馬蠅(Gasterophilus intestinalis)等;牛蠅科之牛蠅(紋皮蠅)(Hypoderma lineatum)等;羊蠅科之羊蠅(Oestrus ovis)等。 Diptera pests include, for example: Tipula aino, etc.; Plecia nearctica, etc.; Exechia shiitakevora, etc.; Black-winged fungus Potato black-winged fungus (Pnyxia scabiei), dwarf black-fed fungus (Bradysia agrestis), etc.; Soybean pod gallflies (Asphondylia) yushimai), wheat gallet (Mayetiola destructor), blueberry gallet (Dasineura oxycoccana), etc.; Aedes aegypti, Culex pipiens pallens, etc.; Simulium takahashii Chironomus oryzae, etc.; Chrysops suavis, Tabanus trigonus, etc.; Eumerus strigatus, Syrphidae, etc.; fruit fly family Eastern fruit fly (Bactrocera dorsalis), Japanese cherry fruit fly (Euphranta japonica), Mediterranean fruit fly (Ceratitis capitata), etc.; Liriomyza trifolii, Liriomyza trifolii sativae), Agromyza oryzae, Liriomyza bryoniae, Chromatomyia horticola, Liriomyza chinensis, Liriomyza trifolii, etc.; Meromyza nigriventris, etc.; Drosophila suzukii, Drosophila melanogaster, etc.; Hydrellia griseola, etc.; Hippobosca equina, etc.; Parallelpmma sasakawae, etc.; Delia antiqua, Delia platura, etc.; Toilet Fannia canicularis, etc.; Musca domestica, Stomoxys calcitrans, etc.; Sarcophaga peregrina, etc.; Gasterophilus intestinalis), etc.; Bovine fly (Hypoderma lineatum) of Bovidae (Hypoderma lineatum), etc.; Oestrus ovis (Oestrus ovis), etc.

鱗翅目害蟲例如可舉:蝠蛾科之淡緣蝠蛾(Endoclita excrescens)等;艷小蛾科之葡萄艷小蛾(Antispila ampelopsia)等;木蠹蛾科之六星黑點蠹蛾(Zeuzera leuconotum)、姬木蠹蛾(Cossus insularis)等;捲葉蛾科之角紋黃捲葉蛾(Archips fuscocupreanus)、蘋果角紋黃捲葉蛾(Adoxophyes orana fasciata)、梨小喰心蟲(Grapholitha molesta)、茶捲葉蛾(Homona magnanima)、大豆喰心蟲(Leguminivora glycinivorella)、蘋果蠹蛾(Cydia pomonella)、葡萄花翅小捲蛾(Lobesia botrana)等;細葉捲蛾科之葡萄細葉捲蛾(Eupoecilia ambiguella)等;蓑蛾科之黑艷蓑蛾(Bambalina sp.)、微型大蓑蛾(Eumeta minuscula)等;蕈蛾科之穀蛾(Nemapogon granella)、衣蛾(Tinea translucens)等;稜巢蛾科之梨矮蛾(Bucculatrix pyrivorella)等;潛葉蛾科之桃潛葉蛾(Lyonetia clerkella)、銀紋潛葉蛾(Lyonetiaprunifoliella malinella)等;細蛾科之茶細蛾(Caloptilia theivora)、金紋細蛾(Phyllonorycter ringoniella)等;小潛葉蛾科之柑橘潛葉蛾(Phyllocnistis citrella)等;偽菜蛾科之蔥葉蛾(Acrolepiopsis sapporensis)等;菜蛾科之小菜蛾(Plutella xylostella);巢蛾科之蘋果巢蛾(Yponomeuta orientalis)等;銀蛾科之蘋果銀蛾(Argyresthia conjugella)等;透翅蛾科之葡萄透翅蛾(Nokona regalis)、蘋果透翅蛾(Synanthedon hector)等;旋蛾科之馬鈴薯麥蛾(Phthorimaea operculella)、麥蛾(Sitotroga cerealella)、棉紅鈴麥蛾(Pectinophora gossypiella)、番茄葉牙蛾(Tuta absoluta)等;果蛀蛾科之桃蛀果蛾(Carposina sasakii)等;斑蛾科之梨葉斑蛾(Illiberis pruni)等;刺蛾科之黃刺蛾(Monema flavescens)等;草螟科之日本巢草螟(Ancylolomia japonica)、二化螟(Chilo suppressalis)、稻緃卷葉野螟(Cnaphalocrocis medinalis)、亞洲玉米蛾(Ostrinia furnacalis)、菜心蛾(Hellulla undalis)、桃胡麻斑野螟蛾(Conogethes punctiferlis)、瓜絹野螟 (Diaphania indica)、早熟禾擬睛草螟(Parapediasia teterrella)、歐洲玉米螟(Ostrinia nubilalis)等;甘蔗桿草螟(Diatraea saccharalis)、螟蛾科之粉斑螟蛾(Cadra cautella)、蠟螟(Galleria mellonella)等;羽蛾科之葡萄羽蛾(Nippoptilia vitis)等;鳳蝶科之柑橘鳳蝶(Papilio xuthus)等;粉蝶科之白紋蝶(Pieris rapae)等;弄蝶科之稻弄蝶(Parnara guttata)等;尺蛾科之腎斑尺蛾(Ascotis selenaria)等;枯葉蛾科之赤松毛蟲(Dendrolimus spectabilis)、帶枯葉蛾(Malacosoma neustrium testaceum)等;天蛾科之蝦殼天蛾(Agrius convolvuli)等;毒蛾科之茶毒蛾(Arna pseudoconspersa)、小白蚊毒蛾(Orygia recens approximans)、舞毒蛾(Lymantria dispar)等;燈蛾科之美國白蛾(Hyphantria cunea)等;夜蛾科之小地老虎(Agrotis ipsilon)、黃地老虎(Agrotis segetum)、黑點銀紋夜蛾(Autographa nigrisigna)、棉鈴實夜蛾(Helicoverpa armigera)、玉米蛾(Helicoverpa zea)、煙草芽夜蛾(Heliothis virescens)、甜菜斜紋夜蛾(Spodoptera exigua)、斜紋夜蛾(Spodoptera litura)、大豆尺蠖(Chrysodeix includens)、草地夜蛾(Spodoptera frugiperda)、銅色切夜蛾(Nephelodes minians)等。 For example, Lepidoptera pests include: Endoclita excrescens of the family Helicopteridae; Antispila ampelopsia, etc.; Six-star black spot moth (Zeuzera leuconotum) ), Colesus moth (Cossus insularis), etc.; Archips fuscocupreanus, Adoxophyes orana fasciata, Grapholitha molesta, Homona magnanima, Leguminivora glycinivorella), apple codling moth (Cydia pomonella), grape flower winged small moth (Lobesia botrana), etc.; grape leaf moth (Eupoecilia ambiguella), etc.; black moth (Bambalina) sp.), Eumeta minuscula, etc.; Nemapogon granella, Tinea translucens, etc.; Bucculatrix pyrivorella, etc.; leaf moth Peach leaf moth (Lyonetia clerkella), silver leaf moth (Lyonetia prunifoliella malinella), etc.; tea moth (Caloptilia theivora), gold moth (Phyllonorycter ringoniella), etc.; citrus in the leaf moth family Leaf moth (Phyllocnistis citrella), etc.; Acrolepiopsis sapporensis, etc.; Plutella xylostella; Plutella xylostella; Apple nest moth (Yponomeuta orientalis), etc.; Silver moth Apple silver moth (Argyresthia conjugella), etc.; Nokona regalis, Synanthedon hector, etc.; Potato wheat moth (Phthorimaea operculella), wheat moth (Sitotroga) cerealella), cotton red bell moth (Pectinophora gossypiella), tomato leaf tooth moth (Tuta absoluta), etc.; fruit moth moth family Peach borer moth (Carposina sasakii), etc.; moth family Moth family pear leaf spot moth (Illiberis pruni) Etc.; Monema flavescens, etc.; Ancylolomia japonica, Chilo suppressalis, Chilo suppressalis, Cnaphalocrocis medinalis, Asian corn moth (Ostrinia furnacalis), cabbage moth (Hellulla undalis), peach flax moth (Conogethes punctiferlis), melon silk moth (Diaphania indica), bluegrass borer (Parapediasia teterrella), European corn borer (Ostrinia nubilalis), etc.; sugarcane stem borer (Diatraea saccharalis), meal moth (Cadra cautella), wax borer ( Galleria mellonella), etc.; Nippoptilia vitis, etc.; Papilio xuthus, Papilio xuthus, etc.; Pieris rapae, Pieridae; etc. (Parnara guttata), etc.; Ascotis selenaria, etc.; Dendrolimus spectabilis, Malacosoma neustrium testaceum, etc. Agrius convolvuli), etc.; Arna pseudoconspersa, Orygia recens approximans, Lymantria dispar, etc.; American white moth (Hyphantria cunea), etc.; Agrotis ipsilon, Agrotis segetum, Autographa nigrisigna, Helicoverpa armigera, Corn moth (Helicoverpa zea), Heliothis virescens ), Spodoptera exigua, Spodoptera litura, Chrysodeix includens, Spodoptera frugiperda, Nephelodes minians, etc.

膜翅目例如可舉:三節葉蜂科之玫瑰三節葉蜂(Arge pagana)等;葉蜂科之栗葉蜂(Apethymus kuri)、蕪菁葉蜂(Athalia rosae ruficornis)等;癭蜂科之板栗癭蜂(Dryocosmus kuriphilus)等;胡蜂科之黃色胡蜂(Vespa simillima xanthoptera)等;蟻科之入侵紅火蟻(Solenopsis invicta)、阿根廷蟻(Linepithema humile)等;切葉蟻科之薔薇切葉蟻(Megachile nipponica)等。 Examples of Hymenoptera include: Arge pagana and other three species: Apethymus kuri, Athalia rosae ruficornis, etc.; Chestnut gall in the family Meloididae Bees (Dryocosmus kuriphilus), etc.; Vespa simillima xanthoptera, etc.; Solenopsis invicta, Linepithema humile, etc.; Megachile nipponica )Wait.

彈尾目害蟲例如可舉:圓跳蟲科之黃星圓跳蟲 (Bourletiella hortensis)等。 Examples of Pterocephalid pests are the yellow star roundworm (Bourletiella hortensis) and so on.

纓尾目害蟲例如可舉:衣魚科之衣魚(Lepisma saccharina)、絨毛衣魚(Ctenolepisma villosa)等。 Examples of the tassel-tailed pests include Lepisma saccharina and Ctenolepisma villosa.

蜚蠊目害蟲例如可舉:蜚蠊科之美洲家蠊(Periplaneta americana);姬蜚蠊科之德國姬蜚蠊(Blattella germanica);白蟻科之台灣白蟻(Odontotermes formosanus);木白蟻科科之小楹白蟻(Incisitermes minor)、截頭堆砂白蟻(Cryptotermes domesticus);溝頭白蟻科之家白蟻(Coptotermes formosanus)、大和白蟻(Reticulitermes speratus)等。 Examples of pests in the order Blattella include: Periplaneta americana in the family Blattella; Blattella germanica in the family Blattella germanica; Odontotermes formosanus in the termite family; Incisitermes minor, Cryptotermes domesticus; Coptotermes formosanus, Reticulitermes speratus, etc.

囓蟲目害蟲例如可舉:節嚙蟲科之粉茶柱蟲(Trogium pulsatorium)等;書蝨科之淡黑書蝨(Liposcelis corrodens)等。 Pests of the order Rodentia include, for example, Trogium pulsatorium of the family Rodentia; Liposcelis corrodens of the family Leptidae.

革翅目害蟲例如可舉:大蠼螋蟲科之大蠼螋蟲(Labodura riparia)等。 Examples of the pests of the order Lepidoptera include Labodura riparia and the like.

食毛目害蟲例如可舉:短角鳥蝨科之雞長羽蝨(Menopon pallidum)等;畜翅蝨科之牛羽蝨(Damalinia bovis)等。 Examples of the insects of the order Trichophyta include: Menopon pallidum of the short-horned bird lice family; Damalia bovis of the family Lepidoptera.

蝨目害蟲例如可舉:畜蝨科之豬血蝨(Haematopinus suis)等;人蝨科之人蝨(Pediculus humanus)等;畜毛蝨科之犬毛蝨(Linognathus setosus)等;毛蝨科之陰蝨(Pthirus pubis)等。 Examples of lice-order pests include: Haematopinus suis, etc.; Pediculus humanus, etc.; Linognathus setosus, etc.; Pthirus pubis, etc.

壁蝨目害蟲例如可舉:走蟎科之麥大背肚蟎(Penthaleus major)等;塵蟎科之仙克來塵蟎(Phytonemus pallidus)、茶塵蟎(Polyphagotarsonemus latus)等;蒲蟎科之一種蒲蟎(Siteroptes sp.)等;偽葉蟎科之葡萄短鬚蟎(Brevipalpus lewisi)等;杜克葉蟎科之孔雀杜克葉蟎(Tuckerella pavoniformis)等;葉蟎科之杏葉蟎(Eotetranychus boreus)、柑橘葉蟎(柑桔紅蜘蛛)(Panonychus citri)、蘋果葉蟎(Panonychus ulmi)、二點葉蟎(Tetranychus urticae)、神澤葉蟎(Tetranychus kanzawai)等;納氏癭蟎科之松三毛癭蟎(Trisetacus pini)等;節蜱科之桔刺皮節蜱(Aculops pelekassi)、梨銹蜱(Epitrimerus pyri)、柑桔皺葉刺節蜱(Phyllocoptruta oleivora)、番茄刺皮癟蟎(Aculops lycopersici)等;双羽爪節蜱科之假黃楊節蜱(Diptacus crenatae)等;粉蟎科之橢圓食粉蟎(Aleuroglyphus ovatus)、腐食酪蟎(Tyrophagus putrescentiae)、羅賓根蟎(Rhizoglyphus robini);瓦蟎科之蜜蜂蟹蟎(Varroa jacobsoni)等;皮刺蟎科之雞皮刺蟎(Dermanyssus gallinae)等;巨刺蟎科之林禽刺蟎(Ornithonyssus sylvialum)等;硬蜱科之微小牛蜱(Boophilus microplus)、血紅扇頭蜱(Rhipicephalus sanguineus)、長角血蜱(Haemaphysalis longicornis)等;疥蟎科之疥蟎(Sarcoptes scabiei)等。 Examples of tick insects include: Penthaleus major, etc.; Phytonemus pallidus, Polyphagotarsonemus latus, etc.; one of the family Acaridae Siteroptes sp., etc.; Brevipalpus lewisi, etc.; Tuckerella pavoniformis, etc.; Eotetranychus, Tetranychus boreus), Citrus spider mite (Panonychus citri), Apple spider mite (Panonychus ulmi), Tetranychus urticae, Tetranychus urticae, Tetranychus kanzawai, etc.; Trisetacus pini, etc.; Aculops pelekassi, Epitrimerus pyri, Phyllocoptruta oleivora, tomato acarops (Aculops) lycopersici), etc.; Diptacus crenatae, etc.; Aleuroglyphus ovatus, Tyrophagus putrescentiae, Rhizoglyphus robini ; Varroa jacobsoni, etc.; Dermanyssus gallinae, etc.; Ornithonyssus sylvialum, etc.; Ornithonyssus sylvialum, etc. (Boophilus microplus), Rhipicephalus sanguineus, Haemaphysalis longicornis, etc.; Sarcoptes scabiei, etc.

植物寄生性線蟲類例如可舉:長囊亞科(Longidorinae)之劍線蟲(Xiphinema index)等;毛刺科毛刺線蟲屬(Trichodorus)的之較小擬毛刺線蟲(Paratrichodorus minor)等;小桿科(Rhabditidae)小桿線蟲屬之一種等;墊刃科(Tylenchidae)之一種野外墊刃屬(Aglenchus sp.)等;錐墊刃科(Tylodoridae)之一種頭刃線蟲屬(Cephalenchus sp.)等;粒線蟲(Anguina)科之草每芽線蟲(Nothotylenchus acris)、馬鈴薯腐敗線蟲(Ditylenchus destructor)等;腎形線蟲紐帶科(Hoplolaimidae)科之腎形腎臟線蟲(Rotylenchulus reniformis)、雙宮螺旋線蟲(Helicotylenchus dihystera)等;針線蟲科(Paratylenchus)之彎曲短體線蟲(Paratylenchus curvitatus)等;根瘤線蟲科(Meloidogyneae)之南方根瘤線蟲 (Meloidogyne incognita)、北方根瘤線蟲(Meloidogyne hapla)、瓜哇根瘤線蟲(Meloidogyne javanica)、哥倫比亞根瘤線蟲(Meloidogyne chitwoodi)、偽哥倫比亞根瘤線虫(Meloidogyne fallax)等;異皮科(Heteroderidae)之馬鈴薯黃金線蟲(Globodera rostochiensis)、馬鈴薯胞囊線蟲(Globodera pallida)、大豆胞囊線蟲(Heterodera glycines)、甜菜胞囊線蟲(Heterodera Schachtii)等;矮化線蟲屬(Terotylenchus)之矮化線蟲(Tylenchorhynchus claytoni)等;平滑墊刃屬(Psilenchus)之平滑墊刃線蟲之一種(Psilenchus sp.)等;環狀線蟲(Chriconemella)科之環紋線蟲的一種(Criconemoides sp.)等;墊刃線蟲科(Tylenchulidiae)之柑桔根線蟲(Tylenchulus semipenetrans)等;球形線蟲(Spharonema)科之山茶球形線蟲(Sphaeronema camelliae)等;短體科(Pratylenchidae)的柑桔潛根線蟲(Radopholus citrophilus)、香蕉潛根線蟲(Radopholus similis)、偽根腐線蟲(Nacobbus aberrans)、北方根腐線蟲(Pratylenchus penetrans)、南方根腐線蟲(Pratylenchus coffeae)、玉米根腐線蟲(Pratylenchus zeae)、鳳梨根腐線蟲(Pratylenchus brachyurus)等;小齒科(Iotonchidae)之鮑魚菇厚皮病線蟲(Iotonchium ungulatum)等;滑刃科(Aphelenchus)之燕麥真滑刃線蟲(Aphelenchus avenae)等;滑刃總科(Aphelenchoidae)之稻心枯線蟲(Aphelenchoides besseyi)、草每線蟲(Aphelenchoides fragariae)等;寄生滑刃科(Parasitaphelenchidae)之松材線蟲(Bursaphelenchus xylophilus)等。 Examples of plant parasitic nematodes include: Longiporinae (Xiphinema index), etc.; Trichodidae (Prichrichodorus minor) of the genus Trichodidae (Paratrichodorus minor), etc.; Rhabditidae), a species of C. elegans, etc.; Tylenchidae, Aglenchus sp., etc.; Tylodoridae, Cephalenchus sp., etc.; grains Nothotylenchus acris and Ditylenchus destructor in the family Anguina; Rotyllenchulus reniformis and Helicotylenchus dihystera in the Neploididae family (Hoplolaimidae) ) Etc.; Paratylenchus curvitatus (Paratylenchus) etc.; Meloidogyneae (Meloidogyneae) southern rhizobia (Meloidogyne incognita), Meloidogyne hapla, Meloidogyne javanica, Meloidogyne chitwoodi, Meloidogyne fallax, etc.; potato gold of Heteroderidae Nematode (Globodera rostochiensis), potato cyst nematode (Globodera pallida), soybean cyst nematode (Heterodera glycines), beet cyst nematode (Heterodera Schachtii), etc.; dwarf nematode (Terotylenchus) (Tylenchorhynchus claytoni), etc. ; One of the smooth pad blade nematodes (Psilenchus sp.) of the Psilenchus genus (Psilenchus sp.), etc.; one of the ringworm nematodes (Criconemoides sp.) of the Chriconemella family, etc.; the ones of the Tylenchulidiae family (Tylenchulidiae) Citrus root nematode (Tylenchulus semipenetrans), etc.; Sphaeronema camelliae, etc.; Radopholus citrophilus, Radopholus similis of the Bratylenchidae family ), pseudo-root rot nematode (Nacobbus aberrans), northern root rot nematode (Pratylenchus penetrans), southern root rot nematode (Pratylenchus coffeae), corn root rot nematode (Pratylenchus zeae), pineapple root rot nematode (Pratylenchus brachyurus), etc.; small teeth Iotonchium ungulatum, Iotonchidae, etc.; Aphelenchus avenae, Aphelenchus, etc.; Aphelenchoides besseyi, Aphelenchoidae, Aphelenchoidae ), Aphelenchoides fragariae, etc.; Parasitaphelenchidae pine wood nematode (Bursaphelenchus xylophilus), etc.

植物寄生性軟體動物例如可舉:蘋果螺科之福壽螺(Pomacea canaliculata)等;皺足蛞蝓科之皺足蛞蝓(Leavicaulis alte)等;非洲大蝸牛科之非洲大蝸牛(Achatina fulica)等;黏液蛞蝓科之雙線 蛞蝓(Meghimatium bilineatum)等;陸地粗貝科之陸地粗貝(Succinea lauta)等;圓盤蝸牛科(Discidae)之淺圓盤螺(Discus pauper)等;琥珀貝科之蝦夷琥珀貝(Zonitoides yessoensis)等;蛞蝓科之黃蛞蝓(Limax flavus)、瓦侖西亞列蛞蝓(Lehmannia valentiana)、網紋野蛞蝓(Deroceras reticulatum)等;鼈甲蝸牛科之播磨蝸牛(Parakaliella harimensis)等;扁蝸牛科之琉球球蝸牛(Acusta despecta sieboldiana)、扁蝸牛(Bradybaena similaris)等。 Examples of plant-parasitic mollusks include: Pomacea canaliculata of the apple snail family; Leavicaulis alte of the sauropoda family; Leavicaulis alte, etc.; Achatina fulica of the African snail family; mucus slugs Branch of Double Slugs (Meghimatium bilineatum), etc.; Succinea lauta, etc.; Discidae, Disc pauper, etc.; Zonitoides yessoensis Etc.; Limax flavus, Lehmannia valentiana, Deroceras reticulatum, etc.; Paracariella harimensis, etc. (Acusta despecta sieboldiana), flat snail (Bradybaena similaris), etc.

其他有害動物、令人不舒服的動物、衛生害蟲、家畜害蟲、寄生蟲等之有害生物例如可舉:美國蜊蛄科之美國蜊蛄(Procambarus clarkii)等;等足目(Isopoda)的鼠婦科(Porcellionidae)之糙瓷鼠婦(Porcellio scaber)等;卷殼蟲科之鼠婦(Armadillidium vulgare)等;蚰蜓目(Scutigeromorpha)蚰蜓科(Scutigeridae)的蚰蜓及蜈蚣目之模棘蜈蚣(Scolopendra subspinipes)等之蜈蚣害蟲目;帶馬陸目(Polydesmoidea)奇馬陸科(Paradoxosomatidae)的高雅酸帶馬陸(Oxidus gracilis)等之倍足綱(Diplopoda)害蟲;蜘蛛目姬蜘蛛科之紅背蜘蛛(Theridiidae hasseltii)等;蜘蛛目袋蜘蛛科之日本美女蜘蛛(Chiracanthium japonicum)等、蠍目之土耳其黑肥尾蝎(Androctonus crassicauda)等;線形動物體內寄生蟲之蛔蟲類蛔蟲(Ascaris lumbricoides)等;蟯蟲類(Syphacia sp.)等;絲蟲類班氏絲蟲(Wuchereria bancrofti)等;扁形動物體內寄生蟲之肝吸蟲(Distomum sp.)、衛氏肺吸蟲(Paragonimus westermanii)、橫川肺吸蟲(Metagonimus yokokawai)、日本住血吸蟲(Schistosoma japonicum)、有鉤條蟲(Taenia solium)、無鉤條蟲(Taeniarhynchus saginatus)、包生 條蟲屬(Echinococcus sp.)、廣節裂頭條蟲(Diphyllobothrium latum)等。 Other harmful animals, uncomfortable animals, sanitary pests, domestic animal pests, parasites and other harmful organisms can be exemplified by: Procambarus clarkii, etc.; Isopoda's gynecology (Porcellionidae), Porcellio scaber, etc.; Armadillidium vulgare, etc.; Scutigeromorpha, Scutigeridae, and Stenigeridae. Scolopendra subspinipes and other centipedes pest orders; Polydesmoidea, Polydesmoidea, Paradoxosomatidae, elegant acid, Oxipus gracilis, Diplopoda, and other insects; Spider order, red spider Theridiidae hasseltii), etc.; Chiracanthium japonicum, and other Turkish black fat tail scorpions (Androctonus crassicauda), etc.; Ascaris lumbricoides, etc.; Insects (Syphacia sp.), etc.; filarias (Wuchereria bancrofti), etc.; flatworm endoparasites such as liver flukes (Distomum sp.), Weisi lung fluke (Paragonimus westermanii), Yokogawa lung Flukes (Metagonimus yokokawai), Schistosoma japonicum, Taenia solium, Taeniarhynchus saginatus, encapsulated Echinococcus sp., Diphyllobothrium latum, etc.

本發明的有害生物防除劑是對既有的有害生物防除劑獲得抵抗性的,前述例示的有害生物等也表現防除效果。再者,本發明的有害生物防除劑也可對經過基因重組、人工交配等而獲得抗害蟲性、抗病害性、抗除草劑性等特性的植物使用。 The pest control agent of the present invention is resistant to existing pest control agents, and the pests exemplified above also exhibit a control effect. In addition, the pest control agent of the present invention can also be used for plants that have acquired characteristics such as insect resistance, disease resistance, and herbicide resistance through genetic recombination and artificial mating.

本發明的「藉由育種法或基因重組技術而賦有抗性的植物」意指不僅包含以古典的品種交配而賦予抗性、以基因重組技術而賦予抗性,亦包含藉由在至今為止的交配技術中組合分子生物學手法的新育種技術(New Plant Breeding Techniques,NBTs)而賦有抗性的植物。新育種技術(NBTs)記載於書籍「來理解新植物育種技術吧」(國際文獻公司,大澤良,江面浩著作)、評論文章「Genome Editing Tools in Plants」(Genes 2017,8,399,Tapan Kumar Mohanta,Tufail Bashir,Abeer Hashem,Elsayed Fathi Abd_Allah and Hanhong Bae著)等。 The term "plants endowed with resistance by breeding methods or gene recombination technology" in the present invention means not only the resistance given by mating of classical varieties, but also the resistance given by genetic recombination technology, as well as New plant breeding techniques (NBTs) combined with molecular biology techniques in mating techniques confer resistance to plants. New breeding techniques (NBTs) are recorded in the book "Let's understand the new plant breeding techniques" (International Literature Corporation, Ozawa Liang, Jiang Mianhao works), the review article "Genome Editing Tools in Plants" (Genes 2017, 8,399, Tapan Kumar Mohanta, Tufail Bashir, Abeer Hashem, Elsayed Fathi Abd_Allah and Hanhong Bae) etc.

其次,將本發明化合物的製造方法、製劑方法以及用途在下述的實施例詳細地說明,惟,本發明不受此等實施例的任何限制。此外,本發明化合物的物性值的熔點係利用YANACO製之MP-500V微量熔點測定裝置測定。折射率係使用ATAGO製之ABBE折射計測定。1H NMR譜係使用日本電子製JNM-LA400(400MHz)、JNM-LA300(300MHz)或JNM-ECS300(300MHz),以四甲基矽烷(TMS)作為內部標準而測定。高分解能質量分析譜(HRMS)係使用Thermo Fisher Scientific製之Q Exactive Focus Hybrid Quadrupole-Orbitrap LC-MS/MS System(ESI,positive mode)測定。 Next, the production method, preparation method, and use of the compound of the present invention will be described in detail in the following examples, but the present invention is not limited by these examples. In addition, the melting point of the physical property value of the compound of the present invention was measured using an MP-500V trace melting point measuring device manufactured by YANACO. The refractive index was measured using an ABBE refractometer manufactured by ATAGO. The 1 H NMR spectrum was measured using JNM-LA400 (400 MHz), JNM-LA300 (300 MHz) or JNM-ECS300 (300 MHz) manufactured by JEOL Ltd., using tetramethylsilane (TMS) as an internal standard. The high resolution energy mass analysis spectrum (HRMS) was measured using a Q Exactive Focus Hybrid Quadrupole-Orbitrap LC-MS/MS System (ESI, positive mode) manufactured by Thermo Fisher Scientific.

再者,亦一併記載本發明化合物的製造中間物的製造例。 In addition, examples of production of intermediates for producing compounds of the present invention are also described.

[實施例] [Example]

[實施例1] [Example 1]

4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0022)的製造 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(2,2,2 -Production of trifluoroethyl) benzamide (the compound number of the present invention: A-0022)

(1)2-氟-5-碘-4-甲基苯甲亞胺酸乙酯鹽酸鹽的製造 (1) Manufacture of ethyl 2-fluoro-5-iodo-4-methylbenzimidate hydrochloride

在冰冷下,對2-氟-5-碘-4-甲基苯甲腈5.00g(19.2mmol)、乙醇1.32g(28.7mmol)、1,4-二

Figure 108126125-A0202-12-0212-205
烷20mL的混合物吹進氯化氫,在室溫下攪拌4日。反應結束後,在減壓下濃縮。所得的殘渣以乙酸乙酯清洗,得到粗製的目標物4.40g(產率67%)。 Under ice cooling, p-2-fluoro-5-iodo-4-methylbenzonitrile 5.00g (19.2mmol), ethanol 1.32g (28.7mmol), 1,4-bis
Figure 108126125-A0202-12-0212-205
A mixture of 20 mL of alkane was blown into hydrogen chloride, and stirred at room temperature for 4 days. After the reaction was completed, it was concentrated under reduced pressure. The obtained residue was washed with ethyl acetate to obtain 4.40 g of crude target substance (yield 67%).

1H-NMR數據(400MHz,DMSO-d6/TMS δ(ppm)):8.26(1H,d),7.55(1H,d),4.62(2H,q),2.45(3H,s),1.44(3H,t) 1 H-NMR data (400 MHz, DMSO-d 6 /TMS δ (ppm)): 8.26 (1H, d), 7.55 (1H, d), 4.62 (2H, q), 2.45 (3H, s), 1.44 ( 3H,t)

(2)2-氟-5-碘-4-甲基苯甲醯亞胺醯肼鹽酸鹽的製造 (2) Manufacture of 2-fluoro-5-iodo-4-methylbenzimidimide hydrazide hydrochloride

在冰冷下,在聯胺一水合物0.73g(14.6mmol)、乙醇15mL的混合物中添加2-氟-5-碘-4-甲基苯甲亞胺酸乙酯鹽酸鹽5.00g(14.6mmol),在室溫攪拌5小時。反應結束後,將溶劑在減壓下餾去,得到粗製的目標物。不經精製直接用於下一步驟。 Under ice cooling, to a mixture of 0.73 g (14.6 mmol) of hydrazine monohydrate and 15 mL of ethanol was added 5.00 g (14.6 mmol of ethyl 2-fluoro-5-iodo-4-methylbenzimidate hydrochloride ), stirred at room temperature for 5 hours. After the reaction, the solvent was distilled off under reduced pressure to obtain a crude target. Used directly in the next step without purification.

(3)5-(2-氟-5-碘-4-甲基苯基)-3-(三氟甲基)-1H-1,2,4-三唑(本發明的化合物號碼:J-0002)的製造 (3) 5-(2-fluoro-5-iodo-4-methylphenyl)-3-(trifluoromethyl)-1H-1,2,4-triazole (Compound No. of the present invention: J- 0002) manufacturing

在85℃,將上述(2)所得的粗製的2-氟-5-碘-4-甲基苯甲醯亞胺醯肼鹽酸鹽(14.6mmol)、三氟乙酸酐20mL的混合物在封管內攪拌2小時。反應結束後,添加水以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,所得的殘渣以正己烷清洗,得到 粗製的目標物4.69g(產率87%)。 At 85° C., a mixture of the crude 2-fluoro-5-iodo-4-methylbenzimidimide hydrazide hydrochloride (14.6 mmol) and trifluoroacetic anhydride 20 mL obtained in (2) above was sealed in a tube Stir for 2 hours. After the reaction was completed, water was added and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was washed with n-hexane to obtain Crude target 4.69g (yield 87%).

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):8.69(1H,d),7.17(1H,d),4.70(1H,s),2.50(3H,s) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 8.69 (1H, d), 7.17 (1H, d), 4.70 (1H, s), 2.50 (3H, s)

(4)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-(三氟甲基)-1H-1,2,4-三唑(本發明的化合物號碼:J-0001)的製造 (4) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole (inventive Compound number: J-0001)

在冰冷下,在5-(2-氟-5-碘-4-甲基苯基)-3-(三氟甲基)-1H-1,2,4-三唑2.50g(6.74mmol)、N,N-二甲基甲醯胺7mL的混合物中,添加碳酸鉀1.21g(8.76mmol)、碘甲烷1.05g(7.40mmol),在室溫攪拌一夜。反應結束後,添加水以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=10:1)精製,得到目標物0.79g(產率30%)及作為副生成物的3-(2-氟-5-碘-4-甲基苯基)-1-甲基-5-(三氟甲基)-1H-1,2,4-三唑0.54g(產率21%)。 Under ice cooling, in 5-(2-fluoro-5-iodo-4-methylphenyl)-3-(trifluoromethyl)-1H-1,2,4-triazole 2.50g (6.74mmol), To a mixture of 7 mL of N,N-dimethylformamide, 1.21 g (8.76 mmol) of potassium carbonate and 1.05 g (7.40 mmol) of methyl iodide were added, and the mixture was stirred overnight at room temperature. After the reaction was completed, water was added and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 10: 1) to obtain 0.79 g of the target product (yield 30%) and as a vice The product of 3-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-1,2,4-triazole 0.54g (product Rate 21%).

目標物1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):8.06(1H,d),7.16(1H,d),3.91(3H,s),2.51(3H,s) Target 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 8.06 (1H, d), 7.16 (1H, d), 3.91 (3H, s), 2.51 (3H, s)

副生成物1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):8.46(1H,d),7.09(1H,d),4.12(3H,s),2.45(3H,s) By-product 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 8.46 (1H, d), 7.09 (1H, d), 4.12 (3H, s), 2.45 (3H, s)

(5)4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]苯甲腈(本發明的化合物號碼:H-0001)的製造 (5) 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]benzonitrile (present invention Compound number: H-0001)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-(三氟甲基)-1H-1,2,4-三唑0.79g(2.1mmol)、氰化鋅(II)0.31g(2.6mmol)、四(三苯基膦)鈀0.47g(0.41mmol)、N,N-二甲基甲醯胺10mL的混合物,在80℃攪拌4小時。反應結束後,添加水以乙酸乙酯萃取,所得的有機層以飽和食鹽水清 洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=2:1)精製,得到目標物0.58g(產率100%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole 0.79g (2.1mmol) A mixture of 0.31 g (2.6 mmol) of zinc (II) cyanide, 0.47 g (0.41 mmol) of tetrakis(triphenylphosphine) palladium, and 10 mL of N,N-dimethylformamide was stirred at 80° C. for 4 hours. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine Wash and dry with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 2: 1) to obtain 0.58 g of the target product (yield 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.96(1H,d),7.26(1H,d),3.94(3H,s),2.70(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.96 (1H, d), 7.26 (1H, d), 3.94 (3H, s), 2.70 (3H, s)

(6)4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]苯甲酸(本發明的化合物號碼:G-0001)的製造 (6) 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]benzoic acid (of the present invention) Compound number: G-0001)

在4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]苯甲腈0.58g(2.0mmol)、1,4-二

Figure 108126125-A0202-12-0214-206
烷10mL的混合物,添加60%硫酸水溶液10mL而加熱迴流5小時。反應結束後,添加水以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,所得的殘渣以正己烷清洗,得到粗製的目標物0.56g(產率91%)。 In 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]benzonitrile 0.58g (2.0mmol ), 1,4-two
Figure 108126125-A0202-12-0214-206
A mixture of 10 mL of alkane was added with 10 mL of 60% sulfuric acid aqueous solution and heated to reflux for 5 hours. After the reaction was completed, water was added and extracted with ethyl acetate. The resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was washed with n-hexane to obtain 0.56 g of crude target product (yield 91%).

1H-NMR數據(400MHz,DMSO-d6/TMS δ(ppm)):13.24(1H,s),8.15(1H,d),7.51(1H,d),3.91(3H,s),2.64(3H,s) 1 H-NMR data (400 MHz, DMSO-d 6 /TMS δ (ppm)): 13.24 (1H, s), 8.15 (1H, d), 7.51 (1H, d), 3.91 (3H, s), 2.64 ( 3H,s)

(7)4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0022)的製造 (7) 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(2, Production of 2,2-trifluoroethyl)benzamide (the compound number of the present invention: A-0022)

在冰冷下,在4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]苯甲酸0.44g(1.5mmol)、2,2,2-三氟乙胺0.17g(1.7mmol)、1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽0.33g(1.7mmol)、1-羥基苯并三唑一水合物0.20g(1.3mmol)、二氯甲烷2mL的混合物中,添加三乙胺0.35g(3.5mmol),在室溫攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減 壓下餾去,所得的殘渣以正己烷清洗,得到粗製的目標物0.47g(產率84%)。 Under ice cooling, in 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]benzoic acid 0.44g (1.5mmol), 2,2,2-trifluoroethylamine 0.17g (1.7mmol), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 0.33g ( 1.7 mmol), 1-hydroxybenzotriazole monohydrate 0.20 g (1.3 mmol), and dichloromethane 2 mL, triethylamine 0.35 g (3.5 mmol) was added, and the mixture was stirred overnight at room temperature. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. Reduce the solvent The residue was distilled off under reduced pressure, and the resulting residue was washed with n-hexane to obtain 0.47 g (yield 84%) of the crude target product.

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):7.70(1H,d),7.16(1H,d),6.70(1H,s),4.08(2H,sext),3.92(3H,d),2.55(3H,s) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 7.70 (1H, d), 7.16 (1H, d), 6.70 (1H, s), 4.08 (2H, sext), 3.92 (3H, d), 2.55(3H,s)

[實施例2] [Example 2]

4-氰基-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(環丙基)苯甲醯胺(本發明的化合物號碼:A-0077)的製造 4-cyano-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(cyclopropyl) Production of benzamide (the compound number of the present invention: A-0077)

(1)4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(環丙基)苯甲醯胺(本發明的化合物號碼:A-0008)的製造 (1) 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(cyclopropyl Base) benzamide (the compound number of the present invention: A-0008)

將4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]苯甲酸1.00g(3.30mmol)、草醯氯0.54g(4.3mmol)、N,N-二甲基甲醯胺數滴,氯仿3.3mL的混合物在室溫下攪拌2小時後,減壓下濃縮。將所得的濃縮物,在冰冷下,添加於環丙胺0.23g(4.0mmol)、三乙胺0.40g(3.95mmol)的氯仿溶液3.3mL,在室溫攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,所得的殘渣以正己烷清洗,得到目標物0.99g(產率88%)。 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]benzoic acid 1.00g (3.30mmol) A few drops of 0.54 g (4.3 mmol) of oxalyl chloride, N,N-dimethylformamide, and a mixture of 3.3 mL of chloroform were stirred at room temperature for 2 hours, and then concentrated under reduced pressure. The resulting concentrate was added to a chloroform solution 3.3 mL of 0.23 g (4.0 mmol) of cyclopropylamine and 0.40 g (3.95 mmol) of triethylamine under ice cooling, and stirred at room temperature overnight. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was washed with n-hexane to obtain 0.99 g of the target substance (yield 88%).

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):0.62(2H,q),0.88(2H,q),2.55(3H,s),2.73(1H,m),3.90(3H,s),6.13(1H,s),7.12(1H,d),7.59(1H,d) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 0.62 (2H, q), 0.88 (2H, q), 2.55 (3H, s), 2.73 (1H, m), 3.90 (3H, s), 6.13 (1H, s), 7.12 (1H, d), 7.59 (1H, d)

(2)4-氰基-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(環丙基)苯甲醯胺(本發明的化合物號碼:A-0077)的製造 (2) 4-cyano-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(ring Propyl) Benzoamide (Compound No. of the Invention: A-0077)

將4-氟-2-甲基-5-[1-甲基-3-(三氟甲基)-1H-1,2,4-三唑-5-基]-N-(環 丙基)苯甲醯胺0.64g(1.9mmol)、氰化鈉0.36g(7.4mmol)、二甲基亞碸2mL的混合物在130℃下攪拌5小時。反應結束後,添加水並以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:2)精製,得到目標物0.33g(產率51%)。 4-fluoro-2-methyl-5-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl]-N-(ring A mixture of 0.64 g (1.9 mmol) of propyl)benzamide, 0.36 g (7.4 mmol) of sodium cyanide and 2 mL of dimethyl sulfoxide was stirred at 130° C. for 5 hours. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1: 2) to obtain 0.33 g of the target product (yield 51%).

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):7.70(1H,s),7.61(1H,s),6.18(1H,s),3.97(3H,s),2.90(1H,m),2.56(3H,s),0.91(2H,q),0.63(2H,q) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 7.70 (1H, s), 7.61 (1H, s), 6.18 (1H, s), 3.97 (3H, s), 2.90 (1H, m), 2.56 (3H, s), 0.91 (2H, q), 0.63 (2H, q)

[實施例3] [Example 3]

5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0583)的製造 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2,2 -Production of trifluoroethyl) benzamide (compound number of the present invention: B-0583)

(1)2-氟5-碘-4-甲基苯甲酸的製造 (1) Manufacture of 2-fluoro 5-iodo-4-methylbenzoic acid

2-氟-4-甲基苯甲酸50.00g(324.4mmol)溶解於濃硫酸350mL,在冰冷下,添加N-碘琥珀醯亞胺58.90g(261.8mmol),一邊保持相同溫度一邊攪持30分鐘後,在室溫下攪拌2小時。反應結束後,在冰水中注入反應溶液,以乙酸乙酯萃取,將所得的有機層以硫代硫酸鈉溶液、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物。不經精製,直接用於下一步驟。 50.00g (324.4mmol) of 2-fluoro-4-methylbenzoic acid was dissolved in 350mL of concentrated sulfuric acid. Under ice cooling, 58.90g (261.8mmol) of N-iodosuccinimide was added, and the mixture was stirred for 30 minutes while maintaining the same temperature. After that, it was stirred at room temperature for 2 hours. After the reaction was completed, the reaction solution was poured into ice water, extracted with ethyl acetate, and the resulting organic layer was washed with sodium thiosulfate solution and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain a crude target. It is used directly in the next step without purification.

(2)2-氟-5-碘-N,4-二甲基苯并醯肼的製造 (2) Manufacture of 2-fluoro-5-iodo-N,4-dimethyl benzohydrazide

將粗製的2-氟-5-碘-4-甲基苯甲酸100.0g(357.1mmol)懸浮於氯仿600mL,並添加N,N-二甲基甲醯胺0.3mL(6.15mmol)後,在冰冷下,在0至5℃將草醯氯67.90g(535.0mmol)緩緩滴下,再在室溫下攪拌1.5小時。將反應混合物在減壓下濃縮後,溶解於氯仿200mL。將所得的粗製物的氯 仿溶液200mL,在冰冷下,滴入於甲基聯胺41.10g(892.1mmol)的氯仿溶液500mL,在室溫下攪拌17小時。反應結束後,添加水,以氯仿萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=2:1至1:1)精製,得到目標物117.3g(產率100%)。 After suspending 100.0 g (357.1 mmol) of crude 2-fluoro-5-iodo-4-methylbenzoic acid in 600 mL of chloroform, and adding 0.3 mL (6.15 mmol) of N,N-dimethylformamide, it was cooled in ice Next, 67.90 g (535.0 mmol) of oxalyl chloride was slowly dropped at 0 to 5°C, and then stirred at room temperature for 1.5 hours. After the reaction mixture was concentrated under reduced pressure, it was dissolved in 200 mL of chloroform. The resulting crude 200 mL of the imitation solution was added dropwise to 500 mL of a chloroform solution of 41.10 g (892.1 mmol) of methyl hydrazine under ice cooling, and the mixture was stirred at room temperature for 17 hours. After the reaction was completed, water was added and extracted with chloroform. The resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 2: 1 to 1:1) to obtain 117.3 g of the target product (yield 100%) ).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):7.85(0.35H,d),7.68(0.65H,d),7.37(0.35H,d),7.21(0.65H,d),3.10(1.95H,s),2.97(1.05H,s),2.39(1.05H,s),2.35(1.95H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 7.85 (0.35H, d), 7.68 (0.65H, d), 7.37 (0.35H, d), 7.21 (0.65H, d ), 3.10 (1.95H, s), 2.97 (1.05H, s), 2.39 (1.05H, s), 2.35 (1.95H, s)

(3)2-(2-氟-5-碘-4-甲基苯甲醯基)-2-甲基聯胺-1-硫代甲醯胺的製造 (3) Production of 2-(2-fluoro-5-iodo-4-methylbenzyl)-2-methyldiamine-1-thioformamide

將2-氟5-碘-N,4-二甲基苯并醯肼110.0g(357.0mmol)、硫氰酸鉀63.10g(649.3mmol)、2M鹽酸170mL的混合物加熱迴流3小時。在室溫下放冷後,在反應混合物添加飽和碳酸氫鈉水溶液成為鹼性,使固體析出。將固體過濾、水洗、乾燥,得到粗製的目標物113.2g(產率86%)。 A mixture of 110.0 g (357.0 mmol) of 2-fluoro5-iodo-N,4-dimethylbenzoylhydrazine, 63.10 g (649.3 mmol) of potassium thiocyanate, and 170 mL of 2M hydrochloric acid was heated to reflux for 3 hours. After leaving to cool at room temperature, a saturated sodium bicarbonate aqueous solution was added to the reaction mixture to make it alkaline, and a solid was precipitated. The solid was filtered, washed with water, and dried to obtain 113.2 g of crude target product (yield 86%).

(4)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-硫醇(本發明的化合物號碼:J-0003)的製造 (4) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-thiol (the compound number of the present invention: J -0003) manufacturing

將2-(2-氟-5-碘-4-甲基苯甲醯基)-2-甲基聯胺-1-硫代甲醯胺101.0g(275.1mmol)、氫氧化鈉22.00g(550.0mmol)、水500mL的混合物加熱迴流4.5小時。在室溫下放冷後,在反應混合物添加10%檸檬酸水溶液使反應混合物成為酸性,使固體析出。將固體過濾、水洗、乾燥,得到粗製的目標物61.0g(產率64%)。 2-(2-fluoro-5-iodo-4-methylbenzyl)-2-methyldiamine-1-thioformamide 101.0g (275.1mmol), sodium hydroxide 22.00g (550.0 mmol) and 500 mL of water were heated to reflux for 4.5 hours. After leaving to cool at room temperature, a 10% citric acid aqueous solution was added to the reaction mixture to make the reaction mixture acidic, and a solid was precipitated. The solid was filtered, washed with water, and dried to obtain 61.0 g of crude target product (yield: 64%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):8.17(1H,d),7.57(1H,d),3.65(3H,d),2.46(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 8.17 (1H, d), 7.57 (1H, d), 3.65 (3H, d), 2.46 (3H, s)

(5)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-(甲基硫基)-1H-1,2,4-三唑(本發明的化合物號碼:J-0012)的製造 (5) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-(methylthio)-1H-1,2,4-triazole (inventive Compound number: J-0012)

在5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-硫醇25.0g(71.6mmol)、Rongalite 10.1g(65.5mmol)、碳酸鉀14.8g(107mmol)、N,N-二甲基甲醯胺150mL的混合物添加碘甲烷12.2g(86.0mmol),在室溫下攪拌6.5小時。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,所得的粗生成物以正己烷及乙酸乙酯的混合溶劑(正己烷:乙酸乙酯=10:1)清洗,得到目標物23.4g(產率90%)。 In 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-thiol 25.0g (71.6mmol), Rongalite 10.1g (65.5 mmol), potassium carbonate 14.8 g (107 mmol), and a mixture of 150 mL of N,N-dimethylformamide added 12.2 g (86.0 mmol) of methyl iodide, and stirred at room temperature for 6.5 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude product was washed with a mixed solvent of n-hexane and ethyl acetate (n-hexane: ethyl acetate = 10: 1) to obtain 23.4 g of the target product (yield 90%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.03(1H,d),7.12(1H,d),3.79(3H,s),2.62(3H,s),2.49(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.03 (1H, d), 7.12 (1H, d), 3.79 (3H, s), 2.62 (3H, s), 2.49 (3H, s)

(6)4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲腈(本發明的化合物號碼:H-0002)的製造 (6) 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzonitrile (present invention Compound number: H-0002)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-(甲基硫基)-1H-1,2,4-三唑23.4g(64.4mmol)、氰化銅17.3g(193mmol)、1,3-二甲基-2-咪唑啉酮150mL的混合物在110℃加熱攪拌6.5小時。在室溫下放冷後,在反應混合物添加氨水溶液以乙酸乙酯萃取,將所得的有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:1)精製,所得的固體以己烷清洗,得到目標物14.0g(產率83%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-(methylthio)-1H-1,2,4-triazole 23.4g (64.4mmol) A mixture of 17.3 g (193 mmol) of copper cyanide and 150 mL of 1,3-dimethyl-2-imidazolidinone was heated and stirred at 110° C. for 6.5 hours. After leaving to cool at room temperature, an ammonia aqueous solution was added to the reaction mixture and extracted with ethyl acetate. The obtained organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:1), and the resulting solid was washed with hexane to obtain 14.0 g of the target substance ( Yield 83%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.91(1H,d),7.21(1H,d),3.80(3H,d),2.64(3H,s),2.62(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.91 (1H, d), 7.21 (1H, d), 3.80 (3H, d), 2.64 (3H, s), 2.62 (3H, s)

(7)4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑- 5-基]苯甲酸(本發明的化合物號碼:G-0283)的製造 (7) 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazole- Production of 5-yl]benzoic acid (Compound No. of the present invention: G-0283)

將4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲腈14.0g(53.4mmol)及50%硫酸水溶液300mL的混合物加熱迴流27小時。在室溫下放冷後,添加乙酸乙酯及飽和碳酸氫鈉水溶液。在所得的水層添加鹽酸成為酸性後,以乙酸乙酯萃取。將所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物14.3g(產率95%)。 4-Fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzonitrile 14.0g (53.4mmol ) And 300 mL of 50% sulfuric acid aqueous solution were heated to reflux for 27 hours. After cooling at room temperature, ethyl acetate and saturated aqueous sodium bicarbonate were added. After adding hydrochloric acid to the resulting aqueous layer to make it acidic, it was extracted with ethyl acetate. The obtained organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 14.3 g of the target product (yield 95%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.44(1H,d),7.12(1H,d),3.83(3H,d),2.70(3H,s),2.65(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.44 (1H, d), 7.12 (1H, d), 3.83 (3H, d), 2.70 (3H, s), 2.65 (3H, s)

(8)4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲酸甲酯(本發明的化合物號碼:F-0290)的製造 (8) 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzoic acid methyl ester (this Invention compound number: F-0290)

在4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲酸14.3g(50.8mmol)、碳酸鉀12.6g(91.2mmol)、N,N-二甲基甲醯胺200mL的混合物添加碘甲烷10.8g(76.1mmol),在室溫下攪拌2小時。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將所得的粗生成物以正己烷清洗,得到目標物14.3g(產率95%)。 In 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzoic acid 14.3g (50.8mmol) A mixture of 12.6 g (91.2 mmol) of potassium carbonate and 200 mL of N,N-dimethylformamide was added iodomethane 10.8 g (76.1 mmol) and stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crude product was washed with n-hexane to obtain 14.3 g of the target product (yield 95%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.23(1H,d),7.12(1H,d),3.89(3H,s),3.80(3H,d),2.69(3H,s),2.63(s,3H) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.23 (1H, d), 7.12 (1H, d), 3.89 (3H, s), 3.80 (3H, d), 2.69 (3H, s), 2.63 (s, 3H)

(9)4-氟-2-甲基-5-[1-甲基-3-(甲基亞磺醯基)-1H-1,2,4-三唑-5-基]苯甲酸甲酯(本發明的化合物號碼:F-0292)的製造 (9) 4-fluoro-2-methyl-5-[1-methyl-3-(methylsulfinyl)-1H-1,2,4-triazol-5-yl]benzoic acid methyl ester (Compound No. of the present invention: F-0292)

在4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲酸甲酯14.3g(48.4mmol)的氯仿溶液200mL在冰冷下,0至5℃下緩緩添加間 氯過氧苯甲酸12.2g(46.0mmol,作為換算純度65%),在冰冷下攪拌1小時。反應結束後,添加氯仿及飽和硫代硫酸鈉水溶液,將有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:3)精製,得到目標物13.4g(產率89%)。 In 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzoic acid methyl ester 14.3g (48.4 mmol) of chloroform solution 200mL under ice cooling, slowly add between 0 to 5 ℃ Chloroperoxybenzoic acid 12.2 g (46.0 mmol, 65% as converted purity) was stirred under ice cooling for 1 hour. After the reaction was completed, chloroform and a saturated sodium thiosulfate aqueous solution were added, and the organic layer was washed with a saturated sodium bicarbonate aqueous solution, water, and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1: 3) to obtain 13.4 g of the target product (yield 89%).

(10)4-氟-2-甲基-5-(1-甲基-3-{[(2,2,2-三氟乙醯氧基)甲基]硫}-1H-1,2,4-三唑-5-基)苯甲酸甲酯(本發明的化合物號碼:F-0215)的製造 (10) 4-fluoro-2-methyl-5-(1-methyl-3-{[(2,2,2-trifluoroacetoxy)methyl]sulfur)-1H-1,2, Production of methyl 4-triazol-5-yl)benzoate (Compound No. of the present invention: F-0215)

在4-氟-2-甲基-5-[1-甲基-3-(甲基亞磺醯基)-1H-1,2,4-三唑-5-基]苯甲酸甲酯13.4g(43.0mmol)的氯仿溶液200mL添加三氟乙酸酐45.2g(215.2mmol),在室溫下攪拌2小時後,再在50℃下加熱攪拌2小時。在室溫下放冷後,將溶劑在減壓下餾去,得到粗製的目標物。不經精製,直接用於下一步驟。 13.4-g methyl 4-fluoro-2-methyl-5-[1-methyl-3-(methylsulfinyl)-1H-1,2,4-triazol-5-yl]benzoate To 200 mL of (43.0 mmol) chloroform solution, 45.2 g (215.2 mmol) of trifluoroacetic anhydride was added, and after stirring at room temperature for 2 hours, it was further heated and stirred at 50°C for 2 hours. After cooling at room temperature, the solvent was distilled off under reduced pressure to obtain a crude target. It is used directly in the next step without purification.

(11)4-氟-5-(3-巰基-1-甲基-1H-1,2,4-三唑-5-基)-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0283)的製造 (11) 4-fluoro-5-(3-mercapto-1-methyl-1H-1,2,4-triazol-5-yl)-2-methylbenzoic acid methyl ester (the compound number of the present invention: F-0283)

將上述(10)所得的粗製的4-氟-2-甲基-5-(1-甲基-3-{[(2,2,2-三氟乙醯氧基)甲基]硫}-1H-1,2,4-三唑-5-基)苯甲酸甲、碳酸鉀17.8g(129mmol)、甲醇120mL的混合物在室溫下攪拌2個半小時。反應結束後,添加乙酸乙酯,再添加10%檸檬酸水溶液使反應混合物成為酸性,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物16.7g(產率100%)。 The crude 4-fluoro-2-methyl-5-(1-methyl-3-{[(2,2,2-trifluoroethoxycarbonyl)methyl]sulfur]- A mixture of 1H-1,2,4-triazol-5-yl)benzoic acid methyl ester, potassium carbonate 17.8 g (129 mmol), and methanol 120 mL was stirred at room temperature for 2.5 hours. After the reaction was completed, ethyl acetate was added, and then a 10% citric acid aqueous solution was added to make the reaction mixture acidic, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 16.7 g of a crude target product (yield: 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.21(1H,d),7.17(1H,d),3.90(3H,s),3.85(3H,d),2.72(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.21 (1H, d), 7.17 (1H, d), 3.90 (3H, s), 3.85 (3H, d), 2.72 (3H, s)

(12)5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0312)的製造 (12) 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid methyl ester (this Invention compound number: F-0312)

在粗製的4-氟-5-(3-巰基-1-甲基-1H-1,2,4-三唑-5-基)-2-甲基苯甲酸甲酯0.80g(2.8mmol)、碳酸鉀0.59g(4.3mmol)、Rongalite 0.17g(1.1mmol)、N,N-二甲基甲醯胺14mL的混合物添加碘乙烷0.53g(3.4mmol),在室溫下攪拌1小時半。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=4:1)精製,得到目標物0.51g(產率58%)。 0.80 g (2.8 mmol) of crude 4-fluoro-5-(3-mercapto-1-methyl-1H-1,2,4-triazol-5-yl)-2-methylbenzoic acid methyl ester, To a mixture of potassium carbonate 0.59 g (4.3 mmol), Rongalite 0.17 g (1.1 mmol) and N,N-dimethylformamide 14 mL, 0.53 g (3.4 mmol) of ethyl iodide was added, and the mixture was stirred at room temperature for 1 hour and a half. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 4: 1) to obtain 0.51 g of the target product (yield 58%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.23(1H,d),7.12(1H,d),3.89(3H,s),3.79(3H,d),3.16(2H,q),2.69(3H,s),1.42(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.23 (1H, d), 7.12 (1H, d), 3.89 (3H, s), 3.79 (3H, d), 3.16 (2H, q), 2.69(3H,s), 1.42(3H,t)

(13)5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸(本發明的化合物號碼:G-0305)的製造 (13) 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid (inventive Compound number: G-0305)

在5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸甲酯1.40g(4.53mmol)、四氫呋喃4mL、甲醇4mL、水4mL的混合物添加氫氧化鋰一水合物0.57g(14mmol),在室溫下攪拌15小時。反應結束後,添加乙酸乙酯。在所得的水層添加10%檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物1.27g(產率95%)。 Methyl 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoate 1.40g (4.53 0.57 g (14 mmol) of lithium hydroxide monohydrate was added to a mixture of 4 mmol), 4 mL of tetrahydrofuran, 4 mL of methanol, and 4 mL of water, and the mixture was stirred at room temperature for 15 hours. After the reaction was completed, ethyl acetate was added. After adding a 10% citric acid aqueous solution to the resulting aqueous layer to make it acidic, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 1.27 g of the target product (yield 95%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.43(1H,d),7.12(1H,d),3.83(3H,d),3.18(2H,q),2.70(3H,s),1.43(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.43 (1H, d), 7.12 (1H, d), 3.83 (3H, d), 3.18 (2H, q), 2.70 (3H, s),1.43(3H,t)

(14)5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0583) 的製造 (14) 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2, 2,2-trifluoroethyl)benzamide (Compound No. of the invention: B-0583) Manufacturing

在5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸0.30g(1.0mmol)、N,N-二甲基甲醯胺數滴、氯仿5mL的混合物,在冰冷下,添加草醯氯0.19g(1.5mmol),保持同一溫度下攪拌1小時。將所得的反應混合物在減壓下濃縮後,將殘渣溶解於氯仿5mL,在冰冷下,滴入於2,2,2-三氟乙胺0.25g(2.5mmol)、三乙胺0.31g(3.1mmol)、氯仿5mL的混合物,將反應混合物在室溫下攪拌5小時。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將所得的固體以正己烷清洗,得到目標物0.34g(產率89%)。 In 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid 0.30g (1.0mmol) A mixture of several drops of N,N-dimethylformamide and 5 mL of chloroform. Under ice cooling, 0.19 g (1.5 mmol) of oxalyl chloride was added, and the mixture was stirred at the same temperature for 1 hour. After the resulting reaction mixture was concentrated under reduced pressure, the residue was dissolved in 5 mL of chloroform, and added dropwise to 0.25 g (2.5 mmol) of 2,2,2-trifluoroethylamine and 0.31 g (3.1 mmol of triethylamine) under ice cooling (3.1 mmol) and 5 mL of chloroform, and the reaction mixture was stirred at room temperature for 5 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained solid was washed with n-hexane to obtain 0.34 g of the target product (yield 89%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.67(1H,d),7.12(1H,d),6.46(1H,t),4.16-4.01(2H,m),3.79(3H,d),3.15(2H,q),2.54(3H,s),1.42(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.67 (1H, d), 7.12 (1H, d), 6.46 (1H, t), 4.16-4.01 (2H, m), 3.79 ( 3H, d), 3.15 (2H, q), 2.54 (3H, s), 1.42 (3H, t)

[實施例4] [Example 4]

5-{3-[(氰基乙基)硫]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0879)的製造 5-{3-[(cyanoethyl)sulfur]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl-N-(2, Production of 2,2-trifluoroethyl)benzamide (Compound No. of the present invention: B-0879)

(1)4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0529)的製造 (1) 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]-N-(2, Production of 2,2-trifluoroethyl)benzamide (Compound No. of the present invention: B-0529)

在4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]苯甲酸3.80g(13.5mmol)、N,N-二甲基甲醯胺數滴,氯仿50mL的混合物,在冰冷下,添加草醯氯3.09g(24.4mmol),一邊保持相同溫度一邊攪拌1小時。將所得的反應混合物在減壓下濃縮後,將殘渣溶解於氯仿10mL,在冰冷下,滴入於2,2,2-三氟乙胺2.68g(27.1mmol)、三乙胺3.01g(29.8mmol)、氯仿30mL的混合物,將反應混合物在室溫下攪拌30分 鐘。反應結束後,添加乙酸乙酯,將有機層以10%檸檬酸水溶液、飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將所得的固體以正己烷清洗,得到目標物4.56g(產率93%)。 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]benzoic acid 3.80g (13.5mmol) A few drops of N,N-dimethylformamide and 50 mL of chloroform. Under ice cooling, 3.09 g (24.4 mmol) of oxalyl chloride was added, and the mixture was stirred for 1 hour while maintaining the same temperature. After the resulting reaction mixture was concentrated under reduced pressure, the residue was dissolved in 10 mL of chloroform, and under ice cooling, 2.68 g (27.1 mmol) of 2,2,2-trifluoroethylamine and 3.01 g (29.8 of triethylamine) were added dropwise mmol) and chloroform 30mL, the reaction mixture was stirred at room temperature for 30 minutes bell. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with 10% citric acid aqueous solution, saturated sodium bicarbonate aqueous solution, water, and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained solid was washed with n-hexane to obtain 4.56 g of the target product (yield 93%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.66(1H,d),7.12(1H,d),6.46(1H,t),4.16-4.01(2H,m),3.79(3H,d),2.62(3H,s),2.53(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.66 (1H, d), 7.12 (1H, d), 6.46 (1H, t), 4.16-4.01 (2H, m), 3.79 ( 3H, d), 2.62 (3H, s), 2.53 (3H, s)

(2)4-氟-2-甲基-5-[1-甲基-3-(甲基亞磺醯基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0530)的製造 (2) 4-fluoro-2-methyl-5-[1-methyl-3-(methylsulfinyl)-1H-1,2,4-triazol-5-yl]-N-( Production of 2,2,2-trifluoroethyl)benzamide (Compound No. of the present invention: B-0530)

在4-氟-2-甲基-5-[1-甲基-3-(甲基硫基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺4.56g(12.6mmol)的氯仿溶液60mL在冰冷下,在0至5℃緩緩添加間氯過氧苯甲酸3.01g(11.3mmol,作為純度65%換算),在冰冷下攪拌4小時。反應結束後,添加氯仿及飽和硫代硫酸鈉水溶液,將有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:1至1:3)精製,得到目標物5.10g(產率100%)。 In 4-fluoro-2-methyl-5-[1-methyl-3-(methylthio)-1H-1,2,4-triazol-5-yl]-N-(2,2, 2-trifluoroethyl)benzamide 4.56g (12.6mmol) in 60mL of chloroform solution Under ice cooling, slowly add 3.01g (11.3mmol of m-chloroperoxybenzoic acid at 0 to 5°C, converted to 65% purity ), stirring under ice cooling for 4 hours. After the reaction was completed, chloroform and a saturated sodium thiosulfate aqueous solution were added, and the organic layer was washed with a saturated sodium bicarbonate aqueous solution, water, and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1:1 to 1:3) to obtain 5.10 g of the target product (yield 100%) ).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.73(1H,d),7.15(1H,d),6.94(1H,t),4.14-4.04(2H,m),3.90(3H,d),3.02(3H,s),2.56(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.73 (1H, d), 7.15 (1H, d), 6.94 (1H, t), 4.14-4.04 (2H, m), 3.90 ( 3H, d), 3.02 (3H, s), 2.56 (3H, s)

(3)2,2,2-三氟乙酸[(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)硫]甲酯(本發明的化合物號碼:B-0377)的製造 (3) 2,2,2-trifluoroacetic acid [(5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamide]phenyl)- Production of 1-methyl-1H-1,2,4-triazol-3-yl)thio]methyl ester (Compound No. of the present invention: B-0377)

在4-氟-2-甲基-5-(1-甲基-3-(甲基亞磺醯基)-1H-1,2,4-三唑-5-基)-N-(2,2,2-三氟乙基)苯甲醯胺4.76g(12.6mmol)的氯仿溶液60mL添加三 氟乙酸酐13.2g(62.9mmol),在50℃下加熱攪拌4小時。在室溫下放冷後,將溶劑在減壓下餾去,得到粗製的目標物。不經精製,直接用於下一步驟。 In 4-fluoro-2-methyl-5-(1-methyl-3-(methylsulfinyl)-1H-1,2,4-triazol-5-yl)-N-(2, 2,2-trifluoroethyl)benzamide 4.76g (12.6mmol) in chloroform solution 60mL added three 13.2 g (62.9 mmol) of fluoroacetic anhydride was heated and stirred at 50°C for 4 hours. After cooling at room temperature, the solvent was distilled off under reduced pressure to obtain a crude target. It is used directly in the next step without purification.

(4)4-氟-5-(3-巰基-1-甲基-1H-1,2,4-三唑-5-基)-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0504)的製造 (4) 4-fluoro-5-(3-mercapto-1-methyl-1H-1,2,4-triazol-5-yl)-2-methyl-N-(2,2,2-tri Production of fluoroethyl) benzamide (compound number of the present invention: B-0504)

將粗製的2,2,2-三氟乙酸[(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)硫]甲酯、碳酸鉀5.22g(37.8mmol)、甲醇60mL的混合物在室溫下攪拌2小時。反應結束後,添加乙酸乙酯,再添加10%檸檬酸水溶液使反應混合物成為酸性,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物3.82g(產率87%)。 The crude 2,2,2-trifluoroacetic acid [(5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamide]phenyl}- A mixture of 1-methyl-1H-1,2,4-triazol-3-yl)thio]methyl ester, potassium carbonate 5.22 g (37.8 mmol), and methanol 60 mL was stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate was added, and then a 10% citric acid aqueous solution was added to make the reaction mixture acidic, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 3.82 g of crude target product (yield 87%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.63(1H,d),7.14(1H,d),6.54(1H,t),4.16-4.04(2H,m),3.81(3H,d),2.54(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.63 (1H, d), 7.14 (1H, d), 6.54 (1H, t), 4.16-4.04 (2H, m), 3.81 ( 3H, d), 2.54 (3H, s)

(5)5-{3-[(2-氰基乙基)硫]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0879)的製造 (5) 5-{3-[(2-cyanoethyl)sulfur]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl- Production of N-(2,2,2-trifluoroethyl)benzamide (Compound No. of the present invention: B-0879)

在粗製的4-氟-5-(3-巰基-1-甲基-1H-1,2,4-三唑-5-基)-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺1.00g(2.87mmol)、碳酸鉀0.60g(4.34mmol)、Rongalite 0.41g(2.66mmol)、N,N-二甲基甲醯胺26mL的混合物添加3-溴丙腈0.46g(3.43mmol),在室溫下攪拌2小時。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:1)精製,得到目標物0.93g(產率81%)。 In crude 4-fluoro-5-(3-mercapto-1-methyl-1H-1,2,4-triazol-5-yl)-2-methyl-N-(2,2,2-tri Fluoroethyl) benzamide 1.00g (2.87mmol), potassium carbonate 0.60g (4.34mmol), Rongalite 0.41g (2.66mmol), N,N- dimethylformamide 26mL mixture was added 3-bromopropane Nitrile 0.46 g (3.43 mmol) was stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1:1) to obtain 0.93 g of the target product (yield 81%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.68(1H,d),7.15(1H,d),6.36(1H,t),4.17-4.03(2H,m),3.81(3H,d),3.37(2H,t),2.94(2H,t),2.55(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.68 (1H, d), 7.15 (1H, d), 6.36 (1H, t), 4.17-4.03 (2H, m), 3.81 ( 3H, d), 3.37 (2H, t), 2.94 (2H, t), 2.55 (3H, s)

[實施例5] [Example 5]

5-[3-(乙基亞磺醯基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0584)的製造 5-[3-(ethylsulfinyl)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2 ,2-trifluoroethyl)benzamide (Compound No. of the present invention: B-0584)

在5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺0.20g(0.53mmol)的氯仿溶液5mL在冰冷下,在0至5℃緩緩添加間氯過氧苯甲酸0.12g(0.45mmol,換算為純度65%),在冰冷下攪拌1小時。反應結束後,添加飽和硫代硫酸鈉水溶液,以氯仿萃取,將有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:3)精製,得到目標物0.15g(產率72%)。 In 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2, 2-trifluoroethyl) benzamide 0.20g (0.53mmol) in chloroform solution 5mL under ice cooling, slowly add m-chloroperoxybenzoic acid 0.12g (0.45mmol, converted to 65% purity) at 0 to 5 ℃ ), stirring for 1 hour under ice cooling. After the reaction was completed, a saturated sodium thiosulfate aqueous solution was added, extracted with chloroform, and the organic layer was washed with a saturated sodium bicarbonate aqueous solution, water, and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1: 3) to obtain 0.15 g of the target product (yield 72%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.74(1H,d),7.16(1H,d),6.46(1H,t),4.17-4.03(2H,m),3.92(3H,d),3.30-3.19(2H,m),2.56(3H,s),1.35(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.74 (1H, d), 7.16 (1H, d), 6.46 (1H, t), 4.17-4.03 (2H, m), 3.92 ( 3H, d), 3.30-3.19 (2H, m), 2.56 (3H, s), 1.35 (3H, t)

[實施例6] [Example 6]

5-[3-(乙基磺醯基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0585)的製造 5-[3-(Ethylsulfonyl)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2, 2-Trifluoroethyl) Benzoamide (Compound No. of the Invention: B-0585)

在5-[3-(乙基硫基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺0.23g(0.61mmol)的氯仿溶液5mL添加間氯過氧苯甲酸0.32g(1.2mmol,換算為純度65%),在室溫下攪拌15分 鐘後,再添加間氯過氧苯甲酸0.32g(1.2mmol,換算為純度65%),在室溫下攪拌14小時。反應結束後,添加飽和硫代硫酸鈉水溶液,以氯仿萃取,將有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:3)精製,得到目標物0.21g(產率84%)。 In 5-[3-(ethylthio)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2, 2-trifluoroethyl)benzamide 0.23g (0.61mmol) in chloroform solution 5mL added m-chloroperoxybenzoic acid 0.32g (1.2mmol, converted to purity 65%), stirred at room temperature for 15 minutes After 2 minutes, 0.32 g (1.2 mmol, converted to 65% purity) of m-chloroperoxybenzoic acid was added, and the mixture was stirred at room temperature for 14 hours. After the reaction was completed, a saturated sodium thiosulfate aqueous solution was added, extracted with chloroform, and the organic layer was washed with a saturated sodium bicarbonate aqueous solution, water, and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1: 3) to obtain 0.21 g of the target product (yield 84%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.75(1H,d),7.18(1H,d),6.32(1H,t),4.18-4.03(2H,m),3.97(3H,d),3.42(2H,q),2.57(3H,s),1.44(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.75 (1H, d), 7.18 (1H, d), 6.32 (1H, t), 4.18-4.03 (2H, m), 3.97 ( 3H, d), 3.42 (2H, q), 2.57 (3H, s), 1.44 (3H, t)

[實施例7] [Example 7]

4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0027)的製造 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazol-5-yl} -Production of -N-(2,2,2-trifluoroethyl)benzamide (the compound number of the present invention: B-0027)

(1)5-(2-氟-5-碘-4-甲基苯基)-1H-1,2,4-三唑-3-硫醇(本發明的化合物號碼:J-0005)的製造 (1) Production of 5-(2-fluoro-5-iodo-4-methylphenyl)-1H-1,2,4-triazole-3-thiol (the compound number of the present invention: J-0005)

將2-氟-5-碘-4-甲基苯甲酸3.48g(12.4mmol)、草醯氯1.89g(14.9mmol)、N,N-二甲基甲醯胺數滴、氯仿13mL的混合物在50℃下攪拌2小時,在減壓下濃縮。將所得的濃縮物在冰冷下,添加於胺基硫脲(thiosemicarbazide)1.13g(12.4mmol)的吡啶溶液13mL,在室溫下攪拌一夜。反應結束後,將所得的反應混合物在減壓下濃縮,添加飽和碳酸氫鈉水溶液13mL,在加熱迴流下攪拌3小時。在室溫下放冷後,添加2M鹽酸使反應混合物成為酸性,添加正己烷。過濾析出的固體,以水及二異丙基醚清洗,乾燥,得到粗製的目標物3.53g(產率85%)。 A mixture of 3.48 g (12.4 mmol) of 2-fluoro-5-iodo-4-methylbenzoic acid, 1.89 g (14.9 mmol) of oxalyl chloride, N,N-dimethylformamide and 13 mL of chloroform Stir at 50°C for 2 hours and concentrate under reduced pressure. The obtained concentrate was added to 13 mL of a pyridine solution of 1.13 g (12.4 mmol) of thiosemicarbazide under ice cooling, and stirred at room temperature overnight. After the reaction was completed, the resulting reaction mixture was concentrated under reduced pressure, 13 mL of a saturated sodium bicarbonate aqueous solution was added, and stirred under heating and reflux for 3 hours. After cooling at room temperature, 2M hydrochloric acid was added to make the reaction mixture acidic, and n-hexane was added. The precipitated solid was filtered, washed with water and diisopropyl ether, and dried to obtain 3.53 g of crude target product (yield 85%).

1H-NMR數據(400MHz,DMSO-d6/TMS δ(ppm)):13.8(1H,s),13.7 (1H,s),8.24(1H,d),7.45(1H,d),2.41(3H,s) 1 H-NMR data (400 MHz, DMSO-d 6 /TMS δ (ppm)): 13.8 (1H, s), 13.7 (1H, s), 8.24 (1H, d), 7.45 (1H, d), 2.41 ( 3H,s)

(2)5-(2-氟-5-碘-4-甲基苯基)-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑(本發明的化合物號碼:J-0018)的製造 (2) 5-(2-fluoro-5-iodo-4-methylphenyl)-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole (Compound No. of the present invention: J-0018)

在冰冷下,在5-(2-氟-5-碘-4-甲基苯基)-1H-1,2,4-三唑-3-硫醇3.03g(9.04mmol)、碳酸鉀1.37g(9.91mmol)、Rongalite 0.98g(6.36mmol)、N,N-二甲基甲醯胺9mL的混合物中,添加三氟甲磺酸2,2,2-三氟乙酯2.20g(9.48mmol),在室溫下攪拌3小時。反應結束後,添加水並以乙酸乙酯萃取,將所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=4:1)精製,得到目標物1.37g(產率36%)。 Under ice cooling, 5-(2-fluoro-5-iodo-4-methylphenyl)-1H-1,2,4-triazole-3-thiol 3.03g (9.04mmol), potassium carbonate 1.37g (9.91mmol), Rongalite 0.98g (6.36mmol), N,N-dimethylformamide 9mL mixture, add 2,20,2-trifluoroethyl trifluoromethanesulfonate 2,20g (9.48mmol) , Stir at room temperature for 3 hours. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 4:1) to obtain 1.37 g of the target product (yield 36%).

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):11.16(1H,s),8.63(1H,d),7.13(1H,d),3.91(2H,q),2.49(3H,s) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 11.16 (1H, s), 8.63 (1H, d), 7.13 (1H, d), 3.91 (2H, q), 2.49 (3H, s)

(3)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑(本發明的化合物號碼:J-0019)的製造 (3) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2 , 4-Triazole (Compound No. of the Invention: J-0019)

在5-(2-氟-5-碘-4-甲基苯基)-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑1.37g(3.28mmol)、碳酸鉀0.50g(3.62mmol)、N,N-二甲基甲醯胺3.5mL的混合物,在冰冷下,添加碘甲烷0.51g(3.59mmol),在室溫下攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=8:1)精製,得到目標物0.61g(產率43.1%)及作為副生成物得到3-(2-氟-5-碘-4-甲基苯基)-1-甲基-5-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑0.69g(產率49%)。 In 5-(2-fluoro-5-iodo-4-methylphenyl)-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole 1.37g (3.28 mmol), a mixture of 0.50 g (3.62 mmol) of potassium carbonate and 3.5 mL of N,N-dimethylformamide, under ice cooling, 0.51 g (3.59 mmol) of methyl iodide was added, and the mixture was stirred overnight at room temperature. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 8: 1) to obtain the target substance 0.61g (yield 43.1%) and used as an auxiliary The product gives 3-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-5-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2 , 4-triazole 0.69g (yield 49%).

目標物1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):8.01(1H,d), 7.13(1H,d),3.86(2H,q),3.79(3H,s),2.50(3H,s) Target 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 8.01 (1H, d), 7.13 (1H, d), 3.86 (2H, q), 3.79 (3H, s), 2.50 ( 3H,s)

副生成物1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):8.44(1H,d),7.08(1H,d),3.95(2H,q),3.91(3H,s),2.45(3H,s) By-product 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 8.44 (1H, d), 7.08 (1H, d), 3.95 (2H, q), 3.91 (3H, s), 2.45 (3H,s)

(4)4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲腈(本發明的化合物號碼:H-0008)的製造 (4) 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole-5 -Base} Benzonitrile (Compound No. of the present invention: H-0008)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑28.4g(65.9mmol)、氰化銅(I)20.6g(230mmol)、1,3-二甲基-2-咪唑啉酮100mL的混合物,在100℃下攪拌7小時。反應結束後,添加水及乙酸乙酯以矽藻土(celite)過濾,將所得的濾液以乙酸乙酯萃取,以氨水及飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物19.9g(產率92%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4 -A mixture of 28.4 g (65.9 mmol) of triazole, 20.6 g (230 mmol) of copper (I) cyanide, and 100 mL of 1,3-dimethyl-2-imidazolidinone, and stirred at 100° C. for 7 hours. After the reaction was completed, water and ethyl acetate were added, and the mixture was filtered through celite. The obtained filtrate was extracted with ethyl acetate, washed with ammonia water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 19.9 g of crude target product (yield 92%).

1H-NMR數據(400MHz,CDCl3/TMS δ(ppm)):7.90(1H,d),7.23(1H,d),3.85(2H,sext),3.81(3H,d),2.65(3H,s) 1 H-NMR data (400 MHz, CDCl 3 /TMS δ (ppm)): 7.90 (1H, d), 7.23 (1H, d), 3.85 (2H, sext), 3.81 (3H, d), 2.65 (3H, s)

(5)4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲酸(本發明的化合物號碼:G-0153)的製造 (5) 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole-5 -Group} benzoic acid (the compound number of the present invention: G-0153)

在4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲腈19.9g(60.3mmol)、1,4-二

Figure 108126125-A0202-12-0228-207
烷20mL的混合物,添加60%硫酸水溶液120mL而加熱迴流3.5小時。反應結束後,將所得的反應混合物注入於冰水,使固體析出。將固體過濾、水洗、乾燥,得到粗製的目標物19.8g(產率94%)。 In 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazol-5-yl } Benzonitrile 19.9g (60.3mmol), 1,4-di
Figure 108126125-A0202-12-0228-207
A mixture of 20 mL of alkane, 120 mL of a 60% sulfuric acid aqueous solution was added, and the mixture was heated to reflux for 3.5 hours. After the reaction was completed, the resulting reaction mixture was poured into ice water to precipitate a solid. The solid was filtered, washed with water, and dried to obtain 19.8 g of crude target product (yield 94%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.36(1H,d),7.15(1H,d),3.95-3.80(5H,m),2.73(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.36 (1H, d), 7.15 (1H, d), 3.95-3.80 (5H, m), 2.73 (3H, s)

(6)2-氟-N,4-二甲基苯并醯肼的製造 (6) Manufacture of 2-fluoro-N,4-dimethyl benzohydrazide

將2-氟-4-甲基苯甲酸60.00g(389.3mmol)懸浮於氯仿500mL,添加N,N-二甲基甲醯胺0.5mL後,在冰冷下,在0至5℃緩緩滴下草醯氯88.90g(700.4mmol),在室溫下攪拌3小時。將反應混合物在減壓下濃縮後,將殘渣溶解於氯仿100mL,在冰冷下,在0至5℃滴入於甲基聯胺71.7g(1.56mol)的氯仿溶液500mL,在室溫下攪拌22小時。反應結束後,添加水,以氯仿萃取,將將所得的有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物。不經精製,直接用於下一步驟。 After suspending 60.00 g (389.3 mmol) of 2-fluoro-4-methylbenzoic acid in 500 mL of chloroform and adding 0.5 mL of N,N-dimethylformamide, the grass was slowly dropped at 0 to 5°C under ice cooling 88.90 g (700.4 mmol) of acetyl chloride was stirred at room temperature for 3 hours. After the reaction mixture was concentrated under reduced pressure, the residue was dissolved in 100 mL of chloroform. Under ice cooling, 500 mL of a chloroform solution of 71.7 g (1.56 mol) of methyl benzamine was dropped at 0 to 5°C, and stirred at room temperature for 22 hour. After the reaction was completed, water was added, extracted with chloroform, and the resulting organic layer was washed with saturated aqueous sodium bicarbonate solution, water, and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain a crude target. It is used directly in the next step without purification.

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.38-7.26(1H,m),7.01(1H,d),6.95-6.88(1H,m),4.66(1.4H,d),3.98(0.6H,s),3.35(0.9H,s),3.13(2.1H,s),2.38(3H,s) 1 H-NMR data (300MHz, CDCl 3 /TMS δ (ppm)): 7.38-7.26 (1H, m), 7.01 (1H, d), 6.95-6.88 (1H, m), 4.66 (1.4H, d) , 3.98 (0.6H, s), 3.35 (0.9H, s), 3.13 (2.1H, s), 2.38 (3H, s)

(7)2-(2-氟-4-甲基苯甲醯基)-2-甲基聯胺-1-硫代甲醯胺的製造 (7) Production of 2-(2-fluoro-4-methylbenzyl)-2-methyldiamine-1-thioformamide

將在上述(6)所得的粗製的2-氟-N,4-二甲基苯并醯肼、硫氰酸鉀75.7g(779mmol)、2M鹽酸400mL的混合物加熱迴流5小時。在室溫下放冷後,在反應混合物添加飽和碳酸氫鈉水溶液成為鹼性,使固體析出。將固體過濾、水洗,以正己烷清洗,乾燥,得到粗製的目標物94.3g(產率100%)。 A mixture of crude 2-fluoro-N,4-dimethylbenzoylhydrazine obtained in the above (6), 75.7 g (779 mmol) of potassium thiocyanate, and 400 mL of 2M hydrochloric acid was heated to reflux for 5 hours. After leaving to cool at room temperature, a saturated sodium bicarbonate aqueous solution was added to the reaction mixture to make it alkaline, and a solid was precipitated. The solid was filtered, washed with water, washed with n-hexane, and dried to obtain 94.3 g of a crude target product (yield: 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.38-7.26(1H,m),7.01(1H,d),6.95-6.88(1H,m),4.66(1.4H,d),3.98(0.6H,s),3.35(0.9H,s),3.13(2.1H,s),2.38(3H,s) 1 H-NMR data (300MHz, CDCl 3 /TMS δ (ppm)): 7.38-7.26 (1H, m), 7.01 (1H, d), 6.95-6.88 (1H, m), 4.66 (1.4H, d) , 3.98 (0.6H, s), 3.35 (0.9H, s), 3.13 (2.1H, s), 2.38 (3H, s)

(8)5-(2-氟-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-硫醇(本發明的化合物號碼:J-0036)的製造 (8) 5-(2-fluoro-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-thiol (the compound number of the present invention: J-0036) manufacture

將2-(2-氟-5-碘-4-甲基苯甲醯基)-2-甲基聯胺-1-硫代甲醯胺94.30g(390.8mmol)、氫氧化鈉31.30g(782.6mmol)、水500mL的混合物加熱迴流5小時。在室溫下放冷後,在反應混合物添加1M鹽酸使反應混合物成為酸性,使固體析出。將固體過濾、水洗、以正己烷清洗、乾燥,得到粗製的目標物68.9g(產率79%)。 2-(2-fluoro-5-iodo-4-methylbenzyl)-2-methyldiamine-1-thioformamide 94.30g (390.8mmol), sodium hydroxide 31.30g (782.6 mmol) and 500 mL of water were heated to reflux for 5 hours. After leaving to cool at room temperature, 1M hydrochloric acid was added to the reaction mixture to make the reaction mixture acidic, and a solid was precipitated. The solid was filtered, washed with water, washed with n-hexane, and dried to obtain 68.9 g of crude target product (yield 79%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):7.60(1H,t),7.36(1H,d),7.26(1H,d),3.64(3H,d),2.41(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 7.60 (1H, t), 7.36 (1H, d), 7.26 (1H, d), 3.64 (3H, d), 2.41 ( 3H,s)

(9)5-(2-氟-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑(本發明的化合物號碼:J-0035)的製造 (9) 5-(2-fluoro-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-tri Production of azole (Compound No. of the present invention: J-0035)

在5-(2-氟-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-硫醇30.00g(134.4mmol)、Rongalite 15.90g(103.2mmol)、碳酸鉀33.40g(241.7mmol)、N,N-二甲基甲醯胺350mL的混合物添加三氟甲磺酸2,2,2-三氟乙酯37.4g(161.1mmol),在室溫下攪拌2小時。 In 5-(2-fluoro-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-thiol 30.00g (134.4mmol), Rongalite 15.90g (103.2mmol) , Potassium carbonate 33.40g (241.7mmol), N,N-dimethylformamide 350mL mixture was added trifluoromethanesulfonic acid 2,2,2-trifluoroethyl 37.4g (161.1mmol), at room temperature Stir for 2 hours.

反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=8:1至3:1)精製,得到目標物32.5g(產率79%)。 After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 8: 1 to 3: 1) to obtain 32.5 g of the target product (yield 79%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.46(1H,t),7.11(1H,dd),7.04(1H,d),3.93-3.79(5H,m),2.44(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.46 (1H, t), 7.11 (1H, dd), 7.04 (1H, d), 3.93-3.79 (5H, m), 2.44 ( 3H,s)

(10)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑(本發明的化合物號碼:J-0019)的製造 (10) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2 , 4-Triazole (Compound No. of the Invention: J-0019)

將5-(2-氟-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑20.0g(65.5mmol)溶解於濃硫酸400mL,在冰冷下,添加N-碘琥珀 醯亞胺15.5g(68.9mmol),在室溫下攪拌3小時。反應結束後,在冰水注入反應溶液,以乙酸乙酯萃取,將所得的有機層以硫代硫酸鈉溶液、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=5:1)精製,得到目標物28.3g(產率100%)。 5-(2-fluoro-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole 20.0 g (65.5mmol) was dissolved in concentrated sulfuric acid 400mL, under ice cooling, add N-iodine amber Acetimide 15.5 g (68.9 mmol) was stirred at room temperature for 3 hours. After the reaction was completed, the reaction solution was poured into ice water, extracted with ethyl acetate, and the resulting organic layer was washed with sodium thiosulfate solution and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 5: 1) to obtain 28.3 g of the target product (yield 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.01(1H,d),7.13(1H,d),3.92-3.76(5H,m),2.50(3H,s) 1 H-NMR data (300MHz, CDCl 3 /TMS δ (ppm)): 8.01 (1H, d), 7.13 (1H, d), 3.92-3.76 (5H, m), 2.50 (3H, s)

(11)4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲酸甲酯(本發明的化合物號碼:F-0160)的製造 (11) 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole-5 -Methyl}benzoic acid methyl ester (Compound No. of the present invention: F-0160)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑0.32g(0.74mmol)、二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物11.4mg(0.014mmol)、三乙胺0.14g(1.38mmol)、甲醇1.5mL的混合物在一氧化碳環境下(9.0kg/cm2)、在100℃下加熱攪拌24小時。在室溫下放冷後,添加乙酸乙酯,將不溶物以過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:1)精製,得到目標物0.25g(產率93%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4 -Triazole 0.32g (0.74mmol), dichloride [1,1'-bis(diphenylphosphino)ironxin] palladium (II) dichloromethane adduct 11.4mg (0.014mmol), triethylamine A mixture of 0.14 g (1.38 mmol) and 1.5 mL of methanol was heated and stirred at 100° C. for 24 hours under a carbon monoxide environment (9.0 kg/cm 2 ). After cooling at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:1) to obtain 0.25 g of the target product (yield 93%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.21(1H,d),7.13(1H,d),3.95-3.75(8H,m),2.70(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.21 (1H, d), 7.13 (1H, d), 3.95-3.75 (8H, m), 2.70 (3H, s)

(12)4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲酸(本發明的化合物號碼:G-0153)的製造 (12) 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole-5 -Group} benzoic acid (the compound number of the present invention: G-0153)

在4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲酸甲酯2.15g(5.92mmol)、四氫呋喃10mL、乙醇10mL、水10mL的混合物添加氫氧化鋰一水合物0.74g(18mmol),在室溫下攪拌2 小時。反應結束後,添加乙酸乙酯及水,在所得的水層添加10%檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物2.12g(產率100%)。 In 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazol-5-yl }Methyl benzoate 2.15g (5.92mmol), tetrahydrofuran 10mL, ethanol 10mL, water 10mL mixture was added lithium hydroxide monohydrate 0.74g (18mmol), stirred at room temperature 2 hour. After the reaction was completed, ethyl acetate and water were added, and a 10% citric acid aqueous solution was added to the resulting aqueous layer to make it acidic, followed by extraction with ethyl acetate, and the organic layer was washed with water and saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 2.12 g of the target product (yield: 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.36(1H,d),7.15(1H,d),3.95-3.80(5H,m),2.73(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.36 (1H, d), 7.15 (1H, d), 3.95-3.80 (5H, m), 2.73 (3H, s)

(13)4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:B-0027)的製造 (13) 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole-5 -Yl}-N-(2,2,2-trifluoroethyl)benzamide (the compound number of the present invention: B-0027)

在冰冷下,在4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫]-1H-1,2,4-三唑-5-基}苯甲酸0.42g(1.2mmol)、2,2,2-三氟乙胺0.14g(1.4mmol)、二氯甲烷5mL的混合物中,添加1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽0.28g(1.5mmol),在室溫下攪拌2小時。反應結束後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:1)精製,得到目標物0.37g(產率72%)。 Under ice cooling, in 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)sulfur]-1H-1,2,4-triazole 5-ethyl}benzoic acid 0.42g (1.2mmol), 2,2,2-trifluoroethylamine 0.14g (1.4mmol), dichloromethane 5mL mixture, 1-ethyl-3-(3- 0.28 g (1.5 mmol) of dimethylaminopropyl)carbodiimide hydrochloride was stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1:1) to obtain 0.37 g of the target product (yield 72%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.67(1H,d),7.14(1H,d),6.42(1H,t),4.16-4.03(2H,m),3.90-3.76(5H,m),2.55(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.67 (1H, d), 7.14 (1H, d), 6.42 (1H, t), 4.16-4.03 (2H, m), 3.90- 3.76(5H,m),2.55(3H,s)

[實施例8] [Example 8]

4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫基〕]-1H-1,2,4-三唑-5-基}-N-(2,2,2-三氟乙基)硫代苯甲醯胺(本發明的化合物號碼:B-0489)的製造 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)thio]]-1H-1,2,4-triazole-5- Radical}-N-(2,2,2-trifluoroethyl)thiobenzamide (Compound No. of the present invention: B-0489)

將4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫基〕]-1H- 1,2,4-三唑-5-基}-N-(2,2,2-三氟乙基)苯甲醯胺0.28g(0.65mmol)、勞森試劑0.18g(0.45mmol)、甲苯4mL的混合物加熱迴流3小時。在室溫下放冷後,將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:1至1:1)精製,將所得的固體以正己烷及二異丙基醚的混合溶劑(正己烷:二異丙基醚=1:1)清洗,得到目標物0.25g(產率86%)。 4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)thio]]-1H- 1,2,4-triazol-5-yl)-N-(2,2,2-trifluoroethyl)benzamide 0.28g (0.65mmol), Lawson reagent 0.18g (0.45mmol), toluene The 4 mL mixture was heated to reflux for 3 hours. After cooling at room temperature, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:1 to 1:1), and The obtained solid was washed with a mixed solvent of n-hexane and diisopropyl ether (n-hexane: diisopropyl ether = 1:1) to obtain 0.25 g of the target product (yield 86%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):11.0(1H,t),7.47-7.37(2H,m),4.77-4.61(2H,m),4.13(2H,q),3.77(3H,d),2.33(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 11.0 (1H, t), 7.47-7.37 (2H, m), 4.77-4.61 (2H, m), 4.13 (2H, q ), 3.77(3H,d), 2.33(3H,s)

[實施例9] [Example 9]

5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:C-0029)的製造 5-[3-(cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-(2,2 , 2-Trifluoroethyl) Benzoamide (Compound No. of the Invention: C-0029)

(1)2-(2-氟-5-碘-4-甲基苯甲醯基)-2-甲基聯胺-1-羧醯胺的製造 (1) Production of 2-(2-fluoro-5-iodo-4-methylbenzyl)-2-methyldiamine-1-carboxamide

將2-氟5-碘-N,4-二甲基苯并醯肼6.50g(21.1mmol)、氰酸鈉1.78g(27.4mmol)、乙酸25mL、水25mL的混合物加熱迴流2小時半。在室溫下放冷後,過濾析出的白色固體,以正己烷清洗、乾燥,得到目標物4.45g(產率60%)。 A mixture of 2-fluoro5-iodo-N,4-dimethylbenzoylhydrazine 6.50 g (21.1 mmol), sodium cyanate 1.78 g (27.4 mmol), acetic acid 25 mL, and water 25 mL was heated to reflux for 2.5 hours. After leaving to cool at room temperature, the precipitated white solid was filtered, washed with n-hexane and dried to obtain 4.45 g of the target substance (yield 60%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):8.43(1H,s),7.72(1H,d),7.25(1H,d),6.08(2H,s),3.07(3H,s),2.35(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 8.43 (1H, s), 7.72 (1H, d), 7.25 (1H, d), 6.08 (2H, s), 3.07 ( 3H,s), 2.35(3H,s)

(2)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-醇(本發明的化合物號碼:J-0031)的製造 (2) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-ol (Compound No. of the present invention: J- 0031) Manufacturing

將2-(2-氟-5-碘-4-甲基苯甲醯基)-2-甲基聯胺-1-羧醯胺4.45g(12.7mmol)、氫氧化鈉0.51g(12.8mmol)、水10mL的混合物加熱迴流 1小時。在室溫下放冷後,在反應混合物添加10%檸檬酸水溶液使反應混合物成為酸性,使固體析出。將固體過濾、水洗、己烷清洗、乾燥,得到目標物3.92g(產率93%)。 Combine 2-(2-fluoro-5-iodo-4-methylbenzyl)-2-methyldiamine-1-carboxamide 4.45g (12.7mmol) and sodium hydroxide 0.51g (12.8mmol) , 10mL water mixture is heated to reflux 1 hour. After leaving to cool at room temperature, a 10% citric acid aqueous solution was added to the reaction mixture to make the reaction mixture acidic, and a solid was precipitated. The solid was filtered, washed with water, washed with hexane, and dried to obtain 3.92 g of the target product (yield 93%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):11.1(1H,s),7.97(1H,d),7.46(1H,d),3.56(3H,d),2.43(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 11.1 (1H, s), 7.97 (1H, d), 7.46 (1H, d), 3.56 (3H, d), 2.43 ( 3H,s)

(3)3-(環丙基甲氧基)-5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑(本發明的化合物號碼:J-0034)的製造 (3) 3-(cyclopropylmethoxy)-5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole (this Invention compound number: J-0034)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-醇1.20g(3.60mmol)、碳酸鉀0.90g(6.5mmol)、N,N-二甲基甲醯胺20mL的混合物在80℃加熱5分鐘後,添加1-(溴甲基)環丙烷0.58g(4.3mmol),在同溫度下加熱攪拌2小時。在室溫下放冷後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:1至1:1)精製,得到目標物1.36g(產率98%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-ol 1.20g (3.60mmol), potassium carbonate 0.90g (6.5mmol), a mixture of 20mL of N,N-dimethylformamide was heated at 80°C for 5 minutes, 0.58g (4.3mmol) of 1-(bromomethyl)cyclopropane was added, and the mixture was heated and stirred at the same temperature 2 hour. After cooling at room temperature, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3: 1 to 1:1) to obtain 1.36 g of the target product (yield 98%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.02(1H,d),7.10(1H,d),4.11(2H,d),3.69(3H,d),2.48(3H,s),1.40-1.25(1H,m),0.65-0.57(2H,m),0.41-0.34(2H,m) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.02 (1H, d), 7.10 (1H, d), 4.11 (2H, d), 3.69 (3H, d), 2.48 (3H, s),1.40-1.25(1H,m),0.65-0.57(2H,m),0.41-0.34(2H,m)

(4)5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0593)的製造 (4) 5-[3-(Cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid methyl ester (Compound No. of the present invention: F-0593)

將3-(環丙基甲氧基)-5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑1.28g(3.31mmol)、二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物54mg(0.066mmol)、三乙胺0.67g(6.6mmol)、甲醇3mL的混合物在一氧化碳環境下(9.0kg/cm2)、在100℃下加熱攪拌5小 時。在室溫下放冷後,添加乙酸乙酯,將不溶物以過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=8:1至3:1)精製,得到目標物0.75g(產率71%)。 3-(Cyclopropylmethoxy)-5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole 1.28g (3.31 mmol), dichlorinated [1,1'-bis(diphenylphosphino)ironxin] palladium (II) dichloromethane adduct 54mg (0.066mmol), triethylamine 0.67g (6.6mmol), methanol The 3 mL mixture was heated and stirred at 100° C. for 5 hours under a carbon monoxide environment (9.0 kg/cm 2 ). After cooling at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 8:1 to 3:1) to obtain 0.75 g of the target product (yield 71%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.23(1H,d),7.10(1H,d),4.12(2H,d),3.89(3H,s),3.70(3H,d),2.68(3H,s),1.40-1.25(1H,m),0.66-0.57(2H,m),0.41-0.34(2H,m) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.23 (1H, d), 7.10 (1H, d), 4.12 (2H, d), 3.89 (3H, s), 3.70 (3H, d), 2.68 (3H, s), 1.40-1.25 (1H, m), 0.66-0.57 (2H, m), 0.41-0.34 (2H, m)

(5)5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸(本發明的化合物號碼:G-0586)的製造 (5) 5-[3-(cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid (this Invention compound number: G-0586)

在5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸甲酯0.73g(2.3mmol)、四氫呋喃4mL、甲醇4mL、水4mL的混合物添加氫氧化鋰一水合物0.29g(6.9mmol),在室溫下攪拌2小時。反應結束後,添加乙酸乙酯及水。在所得的水層添加10%檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物0.68g(產率97%)。 0.73-g methyl 5-[3-(cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoate To a mixture of (2.3 mmol), 4 mL of tetrahydrofuran, 4 mL of methanol, and 4 mL of water, 0.29 g (6.9 mmol) of lithium hydroxide monohydrate was added, and the mixture was stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate and water were added. After adding a 10% citric acid aqueous solution to the resulting aqueous layer to make it acidic, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 0.68 g of the target product (yield 97%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.38(1H,d),7.10(1H,d),4.14(2H,d),3.73(3H,d),2.69(3H,s),1.40-1.30(1H,m),0.65-0.57(2H,m),0.43-0.35(2H,m) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.38 (1H, d), 7.10 (1H, d), 4.14 (2H, d), 3.73 (3H, d), 2.69 (3H, s),1.40-1.30(1H,m),0.65-0.57(2H,m),0.43-0.35(2H,m)

(6)5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:C-0029)的製造 (6) 5-[3-(cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methyl-N-( Production of 2,2,2-trifluoroethyl)benzamide (Compound No. of the present invention: C-0029)

在5-[3-(環丙基甲氧基)-1-甲基-1H-1,2,4-三唑-5-基]-4-氟-2-甲基苯甲酸0.21g(0.69mmol)、N,N-二甲基甲醯胺數滴、氯仿5mL的混合物,在冰冷下,添加草醯氯0.16g(1.3mmol),一邊保持相同溫度一邊攪拌1 小時。將所得的反應混合物在減壓下濃縮後,將殘渣溶解於氯仿5mL,在冰冷下,滴入於2,2,2-三氟乙胺0.14g(1.4mmol)、三乙胺0.17g(1.7mmol)、氯仿5mL的混合物,將反應混合物在室溫下攪拌2小時。反應結束後,添加乙酸乙酯,將有機層以10%檸檬酸水溶液、飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,所得的固體以正己烷清洗,得到目標物0.21g(產率79%)。 In 5-[3-(cyclopropylmethoxy)-1-methyl-1H-1,2,4-triazol-5-yl]-4-fluoro-2-methylbenzoic acid 0.21g (0.69 mmol), a few drops of N,N-dimethylformamide, and 5 mL of chloroform. Under ice cooling, add 0.16 g (1.3 mmol) of oxalyl chloride and stir while maintaining the same temperature. 1 hour. After the resulting reaction mixture was concentrated under reduced pressure, the residue was dissolved in 5 mL of chloroform, and dropwise added to 2,2,2-trifluoroethylamine 0.14 g (1.4 mmol) and triethylamine 0.17 g (1.7 mmol) and 5 mL of chloroform, and the reaction mixture was stirred at room temperature for 2 hours. After the reaction was completed, ethyl acetate was added, and the organic layer was washed with 10% citric acid aqueous solution, saturated sodium bicarbonate aqueous solution, water, and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting solid was washed with n-hexane to obtain 0.21 g of the target product (yield 79%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.63(1H,d),7.08(1H,d),6.80(1H,t),4.17-4.03(4H,m),3.69(2H,d),2.53(3H,d),2.69(3H,s),1.39-1.28(1H,m),0.67-0.58(2H,m),0.42-0.34(2H,m) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.63 (1H, d), 7.08 (1H, d), 6.80 (1H, t), 4.17-4.03 (4H, m), 3.69 ( 2H, d), 2.53 (3H, d), 2.69 (3H, s), 1.39-1.28 (1H, m), 0.67-0.58 (2H, m), 0.42-0.34 (2H, m)

[實施例10] [Example 10]

N-乙基-4-氟-2-甲基-5-{1-甲基-3-[(2,2,2-三氟乙基)硫基〕]-1H-1,2,4-三唑-5-基}苯甲醯胺(本發明的化合物號碼:B-0003)的製造 N-ethyl-4-fluoro-2-methyl-5-{1-methyl-3-[(2,2,2-trifluoroethyl)thio]]-1H-1,2,4- Production of triazol-5-yl}benzamide (compound number of the present invention: B-0003)

將5-(2-氟-5-碘-4-甲基苯基)-1-甲基-3-[(2,2,2-三氟乙基)硫基〕]-1H-1,2,4-三唑0.35g(0.81mmol)、二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物13.3mg(0.016mmol)、乙胺鹽酸鹽0.16g(2.0mmol)、三乙胺0.53g(5.2mmol)、1,4-二

Figure 108126125-A0202-12-0236-208
烷4.0mL的混合物在一氧化碳環境下(9.0kg/cm2)、在110℃下加熱攪拌8小時。在室溫下放冷後,添加乙酸乙酯,將不溶物以過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=5:1至2:1)精製,得到目標物0.21g(產率69%)。 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-3-[(2,2,2-trifluoroethyl)thio]]-1H-1,2 ,4-triazole 0.35g (0.81mmol), [1,1'-bis(diphenylphosphino)ironxin]palladium (II) dichloromethane adduct 13.3mg (0.016mmol), ethyl Amine hydrochloride 0.16g (2.0mmol), triethylamine 0.53g (5.2mmol), 1,4-di
Figure 108126125-A0202-12-0236-208
The 4.0 mL mixture of alkane was heated and stirred at 110° C. for 8 hours under a carbon monoxide environment (9.0 kg/cm 2 ). After cooling at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 5: 1 to 2: 1) to obtain 0.21 g of the target product (yield 69%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.60(1H,d),7.10(1H,d),5.87(1H,s),3.85(2H,q),3.79(3H,d),3.54-3.41(2H,m),2.54(3H,s),1.25(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.60 (1H, d), 7.10 (1H, d), 5.87 (1H, s), 3.85 (2H, q), 3.79 (3H, d), 3.54-3.41 (2H, m), 2.54 (3H, s), 1.25 (3H, t)

[實施例11] [Example 11]

4-氟-2-甲基-5-[1-甲基-3-(五氟乙基)-1H-1,2,4-三唑-5-基]苯甲酸乙酯(本發明的化合物號碼:F-0078)的製造 4-fluoro-2-methyl-5-[1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazol-5-yl]benzoic acid ethyl ester (the compound of the present invention) Number: F-0078)

(1)1-甲基-3-(五氟乙基)-1H-1,2,4-三唑-5-胺的製造 (1) Production of 1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazole-5-amine

將1-胺基-1-甲基胍硫酸鹽5.00g(36.5mmol)及全氟丙酸6.58g(40.1mmol)的混合物在110℃下加熱攪拌9小時。在室溫下放冷後,添加飽和碳酸氫鈉水溶液調整為pH8,以乙酸乙酯萃取,將所得的有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物4.86g(產率62%)。不經精製,直接用於下一步驟。 A mixture of 5.00 g (36.5 mmol) of 1-amino-1-methylguanidine sulfate and 6.58 g (40.1 mmol) of perfluoropropionic acid was heated and stirred at 110° C. for 9 hours. After leaving to cool at room temperature, a saturated sodium bicarbonate aqueous solution was added to adjust to pH 8, extracted with ethyl acetate, and the resulting organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 4.86 g of crude target product (yield 62%). It is used directly in the next step without purification.

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):4.92(2H,s),3.71(3H,s) 1 H-NMR data (300MHz, CDCl 3 /TMS δ(ppm)): 4.92(2H,s), 3.71(3H,s)

(2)5-溴-1-甲基-3-(五氟乙基)-1H-1,2,4-三唑的製造 (2) Production of 5-bromo-1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazole

在1-甲基-3-(五氟乙基)-1H-1,2,4-三唑-5-胺3.00g(13.9mmmol)、溴化銅(II)6.20g(27.8mmmol)、乙腈25.0mL的混合物在冰冷下,添加亞硝酸第三丁酯2.88g(27.9mmol)後,在60℃下加熱攪拌3小時。在室溫下放冷後,添加乙酸乙酯,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:1)精製,得到目標物2.31g(產率59%)。 In 1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazol-5-amine 3.00g (13.9mmmol), copper (II) bromide 6.20g (27.8mmmol), acetonitrile Under ice-cooling, 25.0 mL of the mixture was added with 2.88 g (27.9 mmol) of tributyl nitrite, followed by heating and stirring at 60° C. for 3 hours. After cooling at room temperature, ethyl acetate was added, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:1) to obtain 2.31 g of the target product (yield 59%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):4.00(3H,s) 1 H-NMR data (300MHz, CDCl 3 /TMS δ(ppm)): 4.00(3H,s)

(3)4-氟-2-甲基-5-[1-甲基-3-(五氟乙基)-1H-1,2,4-三唑-5-基]苯甲酸乙酯(本發明的化合物號碼:F-0078)的製造 (3) 4-fluoro-2-methyl-5-[1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazol-5-yl]benzoic acid ethyl ester (this Invention compound number: F-0078)

在5-溴-1-甲基-3-(五氟乙基)-1H-1,2,4-三唑2.30g(8.21mmol)、碳酸鉀3.41g(24.7mmol)、1,4-二

Figure 108126125-A0202-12-0237-209
烷11.0mL、水1.6mL的混合物,在氮環 境下,添加二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物0.67g(0.82mmol)及5-乙氧基羰基-2-氟-4-甲基苯基硼酸2.50g(11.1mmol),在70℃下加熱攪拌3.5小時。在室溫下放冷後,添加乙酸乙酯,將不溶物以過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=9:1)精製,得到目標物1.04g(產率33%)。 In 5-bromo-1-methyl-3-(pentafluoroethyl)-1H-1,2,4-triazole 2.30g (8.21mmol), potassium carbonate 3.41g (24.7mmol), 1,4-di
Figure 108126125-A0202-12-0237-209
A mixture of 11.0 mL of alkane and 1.6 mL of water is added under a nitrogen atmosphere [1,1′-bis(diphenylphosphino)ferroxa]palladium (II) dichloromethane adduct 0.67 g (0.82 mmol) and 5-ethoxycarbonyl-2-fluoro-4-methylphenylboronic acid 2.50 g (11.1 mmol), heated and stirred at 70° C. for 3.5 hours. After cooling at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 9: 1) to obtain 1.04 g of the target product (yield 33%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.23(1H,d),7.15(1H,d),4.37(2H,q),3.94(3H,d),2.71(3H,s),1.39(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.23 (1H, d), 7.15 (1H, d), 4.37 (2H, q), 3.94 (3H, d), 2.71 (3H, s), 1.39 (3H, t)

[實施例12] [Example 12]

(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)(甲基)胺甲酸第三丁酯(本發明的化合物號碼:D-00XX)的製造 (5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamide]phenyl)-1-methyl-1H-1,2,4- Production of tributyl-3-yl) (methyl) carbamic acid third butyl ester (the compound number of the present invention: D-00XX)

(1)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-羧酸乙酯(本發明的化合物號碼:J-0042)的製造 (1) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-carboxylic acid ethyl ester (the compound number of the present invention) : Manufacturing of J-0042)

在2-氟-5-碘-N,4-二甲基苯并醯肼31.59g(102.5mmol)及甲苯220mL的混合物,添加乙酸13.55g(225.6mmol)及硫代草醯胺酸乙酯15.02g(112.8mmol),加熱迴流6小時。在室溫下放冷,餾去溶劑後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:2)精製,得到目標物25.88g(產率65%)。 To a mixture of 31.59 g (102.5 mmol) of 2-fluoro-5-iodo-N,4-dimethylbenzoylhydrazine and 220 mL of toluene, add 13.55 g (225.6 mmol) of acetic acid and ethyl thioglufolate 15.02 g (112.8mmol), heated to reflux for 6 hours. After cooling at room temperature, the solvent was distilled off, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:2) to obtain 25.88 g of the target product (yield 65%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.10(1H,d),7.13(1H,d),4.51(2H,q),3.93(3H,d),2.51(3H,s),1.45(3H,t) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.10 (1H, d), 7.13 (1H, d), 4.51 (2H, q), 3.93 (3H, d), 2.51 (3H, s), 1.45 (3H, t)

(2)5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-羧 酸(本發明的化合物號碼:J-0043)的製造 (2) 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-carboxy Production of acid (Compound No. of the present invention: J-0043)

在5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-羧酸乙酯10.00g(25.70mmol)、四氫呋喃40mL、乙醇20mL、水20mL的混合物添加氫氧化鋰一水合物3.23g(76.98mmol),在室溫下攪拌23小時。反應結束後,添加乙酸乙酯。分液後在所得的水層添加10%檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物7.12g(產率77%)。 In 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-carboxylic acid ethyl ester 10.00g (25.70mmol), tetrahydrofuran A mixture of 40 mL, 20 mL of ethanol, and 20 mL of water was added with 3.23 g (76.98 mmol) of lithium hydroxide monohydrate, and stirred at room temperature for 23 hours. After the reaction was completed, ethyl acetate was added. After liquid separation, a 10% citric acid aqueous solution was added to the resulting aqueous layer to make it acidic, followed by extraction with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 7.12 g of the target product (yield 77%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.10(1H,d),7.16(1H,d),3.96(3H,d),2.52(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.10 (1H, d), 7.16 (1H, d), 3.96 (3H, d), 2.52 (3H, s)

(3)[5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-基]胺甲酸第三丁酯(本發明的化合物號碼:J-0049)的製造 (3) [5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-yl]carbamic acid tert-butyl ester ( Production of the compound number of the present invention: J-0049)

在5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-羧酸7.12g(19.7mmol)、三乙胺2.39g(23.6mmol)、第三丁醇100mL的混合物在室溫下添加二苯基磷酸疊氮化物6.51g(23.6mmol)後,加熱迴流4小時。在室溫下放冷後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=7:3至3:2)精製,得到目標物5.94g(產率70%)。 In 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-carboxylic acid 7.12g (19.7mmol), triethylamine After a mixture of 2.39 g (23.6 mmol) and 100 mL of third butanol was added 6.51 g (23.6 mmol) of diphenylphosphoryl azide at room temperature, the mixture was heated under reflux for 4 hours. After cooling at room temperature, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 7: 3 to 3: 2) to obtain 5.94 g of the target product (yield) 70%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.98(1H,d),7.11(1H,d),7.08(1H,s),3.79(3H,d),2.49(3H,s),1.53(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.98 (1H, d), 7.11 (1H, d), 7.08 (1H, s), 3.79 (3H, d), 2.49 (3H, s),1.53(9H,s)

(4)5-{3-[(第三丁氧基羰基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0661)的製造 (4) 5-{3-[(third butoxycarbonyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl Production of methyl benzoate (Compound No. of the present invention: F-0661)

將[5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-基]胺甲酸第三丁酯5.94g(13.74mmol)、二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物0.11g(0.13mmol)、三乙胺2.78g(27.5mmol)、甲醇60mL的混合物在一氧化碳環境下(9.0kg/cm2)、在100℃下加熱攪拌5小時。在室溫下放冷後,添加乙酸乙酯,將不溶物過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:2至1:1)精製,得到目標物4.36g(產率87%)。 The third butyl [5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-yl]carbamic acid 5.94g ( 13.74mmol), [1,1'-bis(diphenylphosphino)ironxin] palladium (II) dichloromethane adduct 0.11g (0.13mmol), triethylamine 2.78g (27.5mmol) A mixture of 60 mL of methanol was heated and stirred at 100° C. for 5 hours under a carbon monoxide environment (9.0 kg/cm 2 ). After leaving to cool at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3: 2 to 1:1) to obtain 4.36 g of the target product (yield 87%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.19(1H,d),7.12(1H,d),7.06(1H,s),3.89(3H,s),3.80(3H,d),2.69(3H,s),1.53(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.19 (1H, d), 7.12 (1H, d), 7.06 (1H, s), 3.89 (3H, s), 3.80 (3H, d), 2.69(3H,s), 1.53(9H,s)

(5)5-{3-[(第三丁氧基羰基)(甲基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0662)的製造 (5) 5-{3-[(third butoxycarbonyl)(methyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro- Production of methyl 2-methylbenzoate (the compound number of the present invention: F-0662)

在5-{3-[(第三丁氧基羰基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯0.98g(2.7mmol)、碘甲烷0.76g(5.4mmol)、N,N-二甲基甲醯胺10.8mL的混合物在室溫下添加氫化鈉0.12g(3.0mmol,作為純度60%換算),在同溫度下攪拌3小時。在反應混合物添加水後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物1.10g(產率100%)。 In 5-{3-[(third butoxycarbonyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid A mixture of 0.98 g (2.7 mmol) of methyl ester, 0.76 g (5.4 mmol) of methyl iodide and 10.8 mL of N,N-dimethylformamide was added 0.12 g (3.0 mmol of sodium hydride) at room temperature, converted to 60% purity ), stirring at the same temperature for 3 hours. After adding water to the reaction mixture, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 1.10 g of crude target product (yield: 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.22(1H,d),7.11(1H,d),3.89(3H,s),3.80(3H,d),3.36(3H,s),2.69(3H,s),1.53(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.22 (1H, d), 7.11 (1H, d), 3.89 (3H, s), 3.80 (3H, d), 3.36 (3H, s), 2.69(3H,s), 1.53(9H,s)

(6)5-{3-[(第三丁氧基羰基)(甲基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸(本發明的化合物號碼:G-0655)的製造 (6) 5-{3-[(third butoxycarbonyl)(methyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro- Production of 2-methylbenzoic acid (the compound number of the present invention: G-0655)

在粗製的5-{3-[(第三丁氧基羰基)(甲基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯1.10g(作為2.7mmol計算)、四氫呋喃10mL、乙醇5mL、水5mL的混合物添加氫氧化鋰一水合物0.34g(8.1mmol),在室溫下攪拌4小時。反應結束後,將溶劑在減壓下餾去,添加10%檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物0.98g(產率100%)。 In crude 5-{3-[(third butoxycarbonyl)(methyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro- A mixture of 1.10 g (calculated as 2.7 mmol) of methyl 2-methylbenzoate, 10 mL of tetrahydrofuran, 5 mL of ethanol, and 5 mL of water was added with 0.34 g (8.1 mmol) of lithium hydroxide monohydrate, and stirred at room temperature for 4 hours. After the reaction was completed, the solvent was distilled off under reduced pressure. After adding a 10% citric acid aqueous solution to make it acidic, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 0.98 g of the target product (yield: 100%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):8.07(1H,d),7.47(1H,d),3.75(3H,d),3.19(3H,s),2.63(3H,s),1.42(9H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 8.07 (1H, d), 7.47 (1H, d), 3.75 (3H, d), 3.19 (3H, s), 2.63 ( 3H,s),1.42(9H,s)

(7)(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)(甲基)胺甲酸第三丁酯(本發明的化合物號碼:D-0011)的製造 (7) (5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamido]phenyl}-1-methyl-1H-1,2 , 4-triazol-3-yl) (methyl) carbamic acid third butyl ester (Compound No. of the present invention: D-0011)

在5-{3-[(第三丁氧基羰基)(甲基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸0.98g(2.7mmol)、四氫呋喃10mL、氯仿10mL的混合物添加1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽0.62g(3.2mmol)、1-羥基苯并三唑一水合物0.44g(2.9mmol)、2,2,2-三氟乙胺0.62g(6.3mmol),在室溫下攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,將所得的有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:2至1:1)精製,得到目標物0.96g(產率80%)。 In 5-{3-[(third butoxycarbonyl)(methyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2- To a mixture of 0.98 g (2.7 mmol) of toluic acid, 10 mL of tetrahydrofuran, and 10 mL of chloroform, add 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 0.62 g (3.2 mmol) 1. 0.44 g (2.9 mmol) of 1-hydroxybenzotriazole monohydrate and 0.62 g (6.3 mmol) of 2,2,2-trifluoroethylamine were stirred overnight at room temperature. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated aqueous sodium bicarbonate solution, water, and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3: 2 to 1:1) to obtain 0.96 g of the target product (yield) 80%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.70(1H,d),7.11(1H,d),6.63(1H,t),4.19-4.00(2H,m),3.80(3H,d),3.35(3H,s),2.54(3H,s), 1.53(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.70 (1H, d), 7.11 (1H, d), 6.63 (1H, t), 4.19-4.00 (2H, m), 3.80 ( 3H,d), 3.35(3H,s), 2.54(3H,s), 1.53(9H,s)

[實施例13] [Example 13]

5-(3-氰基-1-甲基-1H-1,2,4-三唑-5-基)-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0374)的製造 5-(3-cyano-1-methyl-1H-1,2,4-triazol-5-yl)-4-fluoro-2-methyl-N-(2,2,2-trifluoroethane Base) benzamide (the compound number of the present invention: A-0374)

(1)5-{3-[(第三丁氧基羰基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸(本發明的化合物號碼:G-0654)的製造 (1) 5-{3-[(third butoxycarbonyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl Production of benzoic acid (Compound No. of the present invention: G-0654)

在5-{3-[(第三丁氧基羰基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯3.28g(9.00mmol)、四氫呋喃30mL、乙醇15mL、水15mL的混合物添加氫氧化鋰一水合物1.13g(26.9mmol),在室溫下攪拌4小時。反應結束後,將溶劑在減壓下餾去,添加1M檸檬酸水溶液成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物3.15g(產率100%)。 In 5-{3-[(third butoxycarbonyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid A mixture of 3.28 g (9.00 mmol) of methyl ester, 30 mL of tetrahydrofuran, 15 mL of ethanol, and 15 mL of water was added with 1.13 g (26.9 mmol) of lithium hydroxide monohydrate, and stirred at room temperature for 4 hours. After the reaction was completed, the solvent was distilled off under reduced pressure. After adding 1 M citric acid aqueous solution to make it acidic, it was extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 3.15 g of the target product (yield: 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):9.18(1H,s),8.71(1H,d),7.14(1H,d),3.92(3H,d),2.78(3H,s),1.58(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 9.18 (1H, s), 8.71 (1H, d), 7.14 (1H, d), 3.92 (3H, d), 2.78 (3H, s),1.58(9H,s)

(2)(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)胺甲酸第三丁酯(本發明的化合物號碼:D-0008)的製造 (2)(5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamido]phenyl}-1-methyl-1H-1,2 , 4-triazol-3-yl) carbamic acid third butyl ester (the compound number of the present invention: D-0008)

在5-{3-[(第三丁氧基羰基)胺基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸3.15g(8.99mmol)、四氫呋喃50mL、氯仿30mL的混合物添加1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽2.07g(10.8mmol)、1-羥基苯并三唑一水合物1.45g(9.47mmol)、2,2,2-三氟乙胺2.27g(22.9mmol),在室溫下攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,將所得的有機層以飽和碳酸氫鈉水溶液,水、飽和食鹽水清洗,以無 水硫酸鎂乾燥。將溶劑在減壓下餾去,得到粗製的目標物3.82g(產率98%)。 In 5-{3-[(third butoxycarbonyl)amino]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid 3.15g (8.99mmol), tetrahydrofuran 50mL, chloroform 30mL mixture was added 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 2.07g (10.8mmol), 1-hydroxyl Benzotriazole monohydrate 1.45 g (9.47 mmol) and 2,2,2-trifluoroethylamine 2.27 g (22.9 mmol) were stirred at room temperature overnight. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated aqueous sodium bicarbonate solution, water, and saturated brine to remove Water magnesium sulfate drying. The solvent was distilled off under reduced pressure to obtain 3.82 g of crude target product (yield 98%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.68(1H,d),7.17(1H,s),7.12(1H,d),6.53(1H,s),4.16-4.01(2H,m),3.79(3H,d),2.54(3H,s),1.53(9H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.68 (1H, d), 7.17 (1H, s), 7.12 (1H, d), 6.53 (1H, s), 4.16-4.01 ( 2H, m), 3.79 (3H, d), 2.54 (3H, s), 1.53 (9H, s)

(3)5-(3-胺基-1-甲基-1H-1,2,4-三唑-5-基)-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:D-0001)的製造 (3) 5-(3-amino-1-methyl-1H-1,2,4-triazol-5-yl)-4-fluoro-2-methyl-N-(2,2,2- Production of trifluoroethyl) benzamide (compound number of the present invention: D-0001)

在(5-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)胺甲醯基]苯基}-1-甲基-1H-1,2,4-三唑-3-基)胺甲酸第三丁酯3.85g(8.92mmol)的氯仿(35mL)溶液添加三氟乙酸3.0mL(39mmol),加熱迴流3小時。在室溫下放冷,餾去溶劑後,以氯仿萃取,將有機層以飽和碳酸氫鈉水溶液、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,得到目標物2.54g(產率86%)。 In (5-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)aminecarboxamide]phenyl}-1-methyl-1H-1,2,4 -A solution of 3.85 g (8.92 mmol) of tributyl-3-yl)carbamate in chloroform (35 mL) was added with 3.0 mL (39 mmol) of trifluoroacetic acid and heated to reflux for 3 hours. After cooling at room temperature, the solvent was distilled off, followed by extraction with chloroform, and the organic layer was washed with saturated aqueous sodium bicarbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 2.54 g of the target product (yield 86%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):9.12(1H,t),7.52(1H,d),7.39(1H,d),5.39(2H,s),4.17-3.97(2H,m),3.55(3H,d),2.41(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 9.12 (1H, t), 7.52 (1H, d), 7.39 (1H, d), 5.39 (2H, s), 4.17- 3.97(2H,m), 3.55(3H,d), 2.41(3H,s)

(4)5-(3-氰基-1-甲基-1H-1,2,4-三唑-5-基)-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0374)的製造 (4) 5-(3-cyano-1-methyl-1H-1,2,4-triazol-5-yl)-4-fluoro-2-methyl-N-(2,2,2- Production of trifluoroethyl) benzamide (compound number of the present invention: A-0374)

在5-(3-胺基-1-甲基-1H-1,2,4-三唑-5-基)-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺0.20g(0.60mmol)、氰化銅0.11g(1.2mmol)、乙腈3.0mL的混合物在室溫下添加亞硝酸第三丁酯0.18g(1.7mmol)後,在60℃下加熱攪拌3小時。在室溫下放冷後,添加水並以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去, 將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:1至1:2)精製,得到目標物59.1mg(產率29%)。 In 5-(3-amino-1-methyl-1H-1,2,4-triazol-5-yl)-4-fluoro-2-methyl-N-(2,2,2-trifluoro Ethyl) benzamide 0.20g (0.60mmol), copper cyanide 0.11g (1.2mmol), acetonitrile 3.0mL mixture was added at room temperature third nitrite 0.18g (1.7mmol), in 60 Heat and stir at ℃ for 3 hours. After cooling at room temperature, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. Distill off the solvent under reduced pressure, The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1:1 to 1:2) to obtain 59.1 mg of the target product (yield 29%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.67(1H,d),7.19(1H,d),6.28(1H,s),4.18-4.03(2H,m),3.94(3H,d),2.56(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.67 (1H, d), 7.19 (1H, d), 6.28 (1H, s), 4.18-4.03 (2H, m), 3.94 ( 3H, d), 2.56 (3H, s)

[實施例14] [Example 14]

5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0415)的製造 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl-N-(2 , 2,2-Trifluoroethyl) Benzoamide (Compound No. of the Invention: A-0415)

(1)[5-(2-氟-5-碘-4-甲基苯基]-1-甲基-1H-1,2,4-三唑-3-基)甲醇(本發明的化合物號碼:J-0044)的製造 (1) [5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-yl)methanol (the compound number of the present invention) : J-0044) manufacturing

在5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑-3-羧酸乙酯5.40g(13.9mmol)、四氫呋喃47mL、乙醇35mL的混合物添加氫化硼鈉0.53g(13.9mmol),在室溫下攪拌20小時。在反應混合物添加檸檬酸水溶液後,以乙酸乙酯萃取,所得的有機層以飽和食鹽水清洗,以無水硫酸鎂乾燥,將溶劑在減壓下餾去,得到粗製的目標物4.21g(產率87%)。 In 5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole-3-carboxylic acid ethyl ester 5.40g (13.9mmol), tetrahydrofuran A mixture of 47 mL and 35 mL of ethanol was added with 0.53 g (13.9 mmol) of sodium boron hydride, and stirred at room temperature for 20 hours. After adding a citric acid aqueous solution to the reaction mixture, it was extracted with ethyl acetate, and the resulting organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 4.21 g of crude target product (yield) 87%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.03(1H,d),7.13(1H,d),4.79(2H,s),3.82(3H,d),2.50(3H,s),2.35(1H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.03 (1H, d), 7.13 (1H, d), 4.79 (2H, s), 3.82 (3H, d), 2.50 (3H, s), 2.35(1H, s)

(2)3-[(苄基氧基)甲基]-5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑(本發明的化合物號碼:J-0045)的製造 (2) 3-[(benzyloxy)methyl]-5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole (Compound No. of the present invention: J-0045)

在[5-(2-氟-5-碘-4-甲基苯基]-1-甲基-1H-1,2,4-三唑-3-基)甲醇3.21g(9.25mmol)、溴化苄基1.66g(9.71mmol)、N,N-二甲基甲醯胺10mL的混合物在冰冷下,添加氫化鈉0.39g(9.8mmol,換算為純度60%),在室溫下攪拌1小時半。在反應混合物添加水後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘 渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=4:1至7:3)精製,得到目標物2.80g(產率69%)。 In [5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazol-3-yl)methanol 3.21g (9.25mmol), bromine A mixture of 1.66 g (9.71 mmol) of benzyl group and 10 mL of N,N-dimethylformamide was added under ice-cooling 0.39 g (9.8 mmol, converted to 60% purity) of sodium hydride, and stirred at room temperature for 1 hour half. After adding water to the reaction mixture, it was extracted with ethyl acetate, and the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residual The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 4: 1 to 7: 3) to obtain 2.80 g of the target product (yield 69%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.05(1H,d),7.43-7.28(5H,m),7.12(1H,d),4.71(2H,s),4.63(2H,s),3.83(3H,d),2.49(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.05 (1H, d), 7.43-7.28 (5H, m), 7.12 (1H, d), 4.71 (2H, s), 4.63 ( 2H,s), 3.83(3H,d), 2.49(3H,s)

(3)5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯(本發明的化合物號碼:F-0131)的製造 (3) 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid Production of methyl ester (Compound No. of the present invention: F-0131)

將3-[(苄基氧基)甲基]-5-(2-氟-5-碘-4-甲基苯基)-1-甲基-1H-1,2,4-三唑2.80g(6.40mmol)、二氯化[1,1’-雙(二苯基膦基)鐵莘]鈀(II)二氯甲烷加成物52.3mg(0.0640mmol)、三乙胺1.30g(12.8mmol)、甲醇40mL的混合物在一氧化碳環境下(9.0kg/cm2)、在100℃下加熱攪拌5小時。在室溫下放冷後,添加乙酸乙酯,將不溶物過濾除去,將溶劑在減壓下餾去。將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:2)精製,得到目標物2.36g(產率100%)。 3-[(Benzyloxy)methyl]-5-(2-fluoro-5-iodo-4-methylphenyl)-1-methyl-1H-1,2,4-triazole 2.80g (6.40mmol), [1,1'-bis(diphenylphosphino)ironxin] palladium (II) dichloromethane adduct 52.3mg (0.0640mmol), triethylamine 1.30g (12.8mmol) ), a mixture of 40 mL of methanol is heated and stirred at 100° C. for 5 hours under a carbon monoxide environment (9.0 kg/cm 2 ). After leaving to cool at room temperature, ethyl acetate was added to remove insoluble materials by filtration, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3:2) to obtain 2.36 g of the target product (yield 100%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):8.25(1H,d),7.47-7.26(5H,m),7.12(1H,d),4.71(2H,s),4.65(2H,s),3.89(3H,s),3.84(3H,d),2.69(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 8.25 (1H, d), 7.47-7.26 (5H, m), 7.12 (1H, d), 4.71 (2H, s), 4.65 ( 2H,s), 3.89(3H,s), 3.84(3H,d), 2.69(3H,s)

(4)5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸(本發明的化合物號碼:G-0128)的製造 (4) 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid (Compound No. of the present invention: G-0128)

在5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸甲酯2.20g(5.96mmol)、四氫呋喃10mL、乙醇5mL、水5mL的混合物添加氫氧化鋰一水合物0.75g(18mmol),在室溫下攪拌1小時。反應結束後,將溶劑在減壓下餾去,添加1M鹽酸成為酸性後,以乙酸乙酯萃取,將有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減 壓下餾去,得到目標物1.94g(產率92%)。 Methyl 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoate A mixture of 2.20 g (5.96 mmol), 10 mL of tetrahydrofuran, 5 mL of ethanol, and 5 mL of water was added with 0.75 g (18 mmol) of lithium hydroxide monohydrate, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, 1M hydrochloric acid was added to make it acidic, extracted with ethyl acetate, the organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. Reduce the solvent Distillation was carried out under reduced pressure to obtain 1.94 g of the target product (yield 92%).

1H-NMR數據(300MHz,DMSO-d6/TMS δ(ppm)):8.09(1H,d),7.47(1H,d),7.40-7.25(5H,m),4.60(2H,s),4.54(2H,s),3.79(3H,d),2.64(3H,s) 1 H-NMR data (300 MHz, DMSO-d 6 /TMS δ (ppm)): 8.09 (1H, d), 7.47 (1H, d), 7.40-7.25 (5H, m), 4.60 (2H, s), 4.54(2H,s), 3.79(3H,d), 2.64(3H,s)

(5)5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0415)的製造 (5) 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl-N -Production of (2,2,2-trifluoroethyl)benzamide (Compound No. of the present invention: A-0415)

在5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基苯甲酸1.80g(5.07mmol)、四氫呋喃20mL、氯仿10mL的混合物添加1-乙基-3-(3-二甲基胺基丙基)碳二亞胺鹽酸鹽1.17g(6.10mmol)、1-羥基苯并三唑一水合物0.82g(5.4mmol)、2,2,2-三氟乙胺1.28g(12.9mmol),在室溫下攪拌一夜。反應結束後,添加水並以乙酸乙酯萃取,將所得的有機層以飽和碳酸氫鈉水溶液、水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=3:2至3:7)精製,得到目標物2.04g(產率92%)。 In 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methylbenzoic acid 1.80g (5.07mmol), tetrahydrofuran 20mL, chloroform 10mL mixture was added 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 1.17g (6.10mmol), 1-hydroxybenzo Triazole monohydrate 0.82g (5.4mmol) and 2,2,2-trifluoroethylamine 1.28g (12.9mmol) were stirred at room temperature overnight. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with saturated aqueous sodium bicarbonate solution, water, and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 3: 2 to 3: 7) to obtain 2.04 g of the target product (yield) 92%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.69(1H,d),7.43-7.26(5H,m),7.11(1H,d),6.58(1H,t),4.69(2H,s),4.62(2H,s),4.16-4.00(2H,m),3.82(3H,d),2.54(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.69 (1H, d), 7.43-7.26 (5H, m), 7.11 (1H, d), 6.58 (1H, t), 4.69 ( 2H,s),4.62(2H,s),4.16-4.00(2H,m),3.82(3H,d),2.54(3H,s)

[實施例15] [Example 15]

4-氟-2-甲基-5-[1-甲基-3-(苯氧基甲基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0413)的製造 4-fluoro-2-methyl-5-[1-methyl-3-(phenoxymethyl)-1H-1,2,4-triazol-5-yl]-N-(2,2, 2-Trifluoroethyl) Benzoamide (Compound No. of the Invention: A-0413)

(1)4-氟-5-[3-(羥甲基)-1-甲基-1H-1,2,4-三唑-5-基]-2-甲 基-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0408)的製造 (1) 4-fluoro-5-[3-(hydroxymethyl)-1-methyl-1H-1,2,4-triazol-5-yl]-2-methyl -N-(2,2,2-trifluoroethyl)benzamide (Compound No. of the present invention: A-0408)

將5-{3-[(苄基氧基)甲基]-1-甲基-1H-1,2,4-三唑-5-基}-4-氟-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺0.32g(0.73mmol)、10%Pd/C0.03g、乙醇10mL的混合物在氫環境下(常壓)、在室溫下攪拌15小時。反應結束後,以矽藻土(celite)過濾,將溶劑在減壓下餾去,得到目標物0.24g(產率95%)。 5-{3-[(benzyloxy)methyl]-1-methyl-1H-1,2,4-triazol-5-yl}-4-fluoro-2-methyl-N-( 2,2,2-trifluoroethyl)benzamide 0.32g (0.73mmol), 10% Pd/C0.03g, and a mixture of 10mL of ethanol under a hydrogen atmosphere (atmospheric pressure) and stirred at room temperature for 15 hours . After the reaction was completed, it was filtered through celite, and the solvent was distilled off under reduced pressure to obtain 0.24 g of the target product (yield 95%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.79(1H,d),7.57(1H,t),7.10(1H,d),5.98(1H,t),4.71(2H,d),4.19-3.99(2H,m),3.86(3H,d),2.57(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.79 (1H, d), 7.57 (1H, t), 7.10 (1H, d), 5.98 (1H, t), 4.71 (2H, d), 4.19-3.99 (2H, m), 3.86 (3H, d), 2.57 (3H, s)

(2)4-氟-2-甲基-5-[1-甲基-3-(苯氧基甲基)-1H-1,2,4-三唑-5-基]-N-(2,2,2-三氟乙基)苯甲醯胺(本發明的化合物號碼:A-0413)的製造 (2) 4-fluoro-2-methyl-5-[1-methyl-3-(phenoxymethyl)-1H-1,2,4-triazol-5-yl]-N-(2 , 2,2-Trifluoroethyl) Benzoamide (Compound No. of the Invention: A-0413)

在4-氟-5-[3-(羥甲基)-1-甲基-1H-1,2,4-三唑-5-基]-2-甲基-N-(2,2,2-三氟乙基)苯甲醯胺0.20g(0.58mmol)、三苯基膦0.23g(0.88mmol)、酚0.08g(0.9mmol)、四氫呋喃3.0mL的混合物,在冰冷下,添加偶氮二甲酸二異丙基0.18g(0.89mmol)後,在室溫下攪拌18小時。反應結束後,添加水並以乙酸乙酯萃取,將所得的有機層以水、飽和食鹽水清洗,以無水硫酸鎂乾燥。將溶劑在減壓下餾去,將殘渣以氧化矽凝膠管柱層析法(展開溶劑,正己烷:乙酸乙酯=1:1)精製,得到目標物0.18g(產率74%)。 In 4-fluoro-5-[3-(hydroxymethyl)-1-methyl-1H-1,2,4-triazol-5-yl]-2-methyl-N-(2,2,2 -A mixture of 0.20 g (0.58 mmol) of trifluoroethyl)benzamide, 0.23 g (0.88 mmol) of triphenylphosphine, 0.08 g (0.9 mmol) of phenol, and 3.0 mL of tetrahydrofuran. Under ice cooling, add azobis After 0.18 g (0.89 mmol) of diisopropyl formate, it was stirred at room temperature for 18 hours. After the reaction was completed, water was added and extracted with ethyl acetate, and the resulting organic layer was washed with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent, n-hexane: ethyl acetate = 1:1) to obtain 0.18 g of the target product (yield 74%).

1H-NMR數據(300MHz,CDCl3/TMS δ(ppm)):7.69(1H,d),7.30(2H,t),7.16-6.95(4H,m),6.44(1H,t),5.16(2H,s),4.17-4.01(2H,m),3.85(3H, d),2.54(3H,s) 1 H-NMR data (300 MHz, CDCl 3 /TMS δ (ppm)): 7.69 (1H, d), 7.30 (2H, t), 7.16-6.95 (4H, m), 6.44 (1H, t), 5.16 ( 2H,s), 4.17-4.01(2H,m), 3.85(3H, d), 2.54(3H,s)

將依據前述實施例合成的本發明化合物[I]的物性值包含前述實施例中的值在內示於下述第78表至第93表,將本發明化合物[II]的物性值同樣示於第94表至第104表,將本發明化合物[III]的物性值同樣示於第105表至第110表。此外,表中的化合物號碼及記號表示與前述同樣的意義。 The physical property values of the compound [I] of the present invention synthesized according to the foregoing examples are shown in Tables 78 to 93 below including the values in the foregoing examples, and the physical property values of the compound [II] of the present invention are also shown in In Table 94 to Table 104, the physical property values of the compound [III] of the present invention are also shown in Table 105 to Table 110. In addition, the compound numbers and symbols in the table have the same meaning as described above.

Figure 108126125-A0202-12-0249-116
Figure 108126125-A0202-12-0249-116

Figure 108126125-A0202-12-0250-117
Figure 108126125-A0202-12-0250-117

Figure 108126125-A0202-12-0251-118
Figure 108126125-A0202-12-0251-118

Figure 108126125-A0202-12-0252-119
Figure 108126125-A0202-12-0252-119

Figure 108126125-A0202-12-0253-120
Figure 108126125-A0202-12-0253-120

Figure 108126125-A0202-12-0254-121
Figure 108126125-A0202-12-0254-121

Figure 108126125-A0202-12-0255-122
Figure 108126125-A0202-12-0255-122

Figure 108126125-A0202-12-0256-123
Figure 108126125-A0202-12-0256-123

Figure 108126125-A0202-12-0257-124
Figure 108126125-A0202-12-0257-124

Figure 108126125-A0202-12-0258-125
Figure 108126125-A0202-12-0258-125

Figure 108126125-A0202-12-0259-127
Figure 108126125-A0202-12-0259-127

Figure 108126125-A0202-12-0260-128
Figure 108126125-A0202-12-0260-128

Figure 108126125-A0202-12-0261-129
Figure 108126125-A0202-12-0261-129

Figure 108126125-A0202-12-0262-130
Figure 108126125-A0202-12-0262-130

Figure 108126125-A0202-12-0262-131
Figure 108126125-A0202-12-0262-131

Figure 108126125-A0202-12-0262-132
Figure 108126125-A0202-12-0262-132

Figure 108126125-A0202-12-0263-133
Figure 108126125-A0202-12-0263-133

Figure 108126125-A0202-12-0264-134
Figure 108126125-A0202-12-0264-134

Figure 108126125-A0202-12-0265-135
Figure 108126125-A0202-12-0265-135

Figure 108126125-A0202-12-0266-136
Figure 108126125-A0202-12-0266-136

Figure 108126125-A0202-12-0267-137
Figure 108126125-A0202-12-0267-137

Figure 108126125-A0202-12-0268-138
Figure 108126125-A0202-12-0268-138

Figure 108126125-A0202-12-0269-139
Figure 108126125-A0202-12-0269-139

Figure 108126125-A0202-12-0270-140
Figure 108126125-A0202-12-0270-140

Figure 108126125-A0202-12-0271-141
Figure 108126125-A0202-12-0271-141

Figure 108126125-A0202-12-0272-142
Figure 108126125-A0202-12-0272-142

Figure 108126125-A0202-12-0273-144
Figure 108126125-A0202-12-0273-144

Figure 108126125-A0202-12-0274-145
Figure 108126125-A0202-12-0274-145

Figure 108126125-A0202-12-0275-146
Figure 108126125-A0202-12-0275-146

Figure 108126125-A0202-12-0276-147
Figure 108126125-A0202-12-0276-147

Figure 108126125-A0202-12-0277-148
Figure 108126125-A0202-12-0277-148

Figure 108126125-A0202-12-0278-150
Figure 108126125-A0202-12-0278-150

Figure 108126125-A0202-12-0279-151
Figure 108126125-A0202-12-0279-151

其次,具體地說明本發明的有害生物防除劑的製劑例,該有害生物防除劑使用如上述製造的本發明的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽。惟,化合物、添加劑的種類及調配比率是不限定於此等,可在廣泛的範圍內變更。再者,下述說明中「份」表示質量份。 Next, specific examples of the preparation of the pest control agent of the present invention will be described. The pest control agent is derived from the 5-(1,2,4-triazol-5-yl)benzamide of the present invention manufactured as described above. Thing or its agriculturally acceptable salt. However, the types and compounding ratios of compounds and additives are not limited to these, and can be changed within a wide range. In addition, in the following description, "part" means a mass part.

[製劑例1]乳劑 [Formulation Example 1] Emulsion

Figure 108126125-A0202-12-0280-153
Figure 108126125-A0202-12-0280-153

將以上均勻地溶解成為乳劑。 Dissolve the above uniformly into an emulsion.

[製劑例2]水和劑 [Formulation Example 2] Water and agent

Figure 108126125-A0202-12-0280-154
Figure 108126125-A0202-12-0280-154

將以上均勻地混合粉碎成為水和劑。 The above is uniformly mixed and pulverized into water and agent.

[製劑例3]粉劑 [Formulation Example 3] Powder

Figure 108126125-A0202-12-0280-155
Figure 108126125-A0202-12-0280-155

將以上均勻地混合粉碎成為粉劑。 The above is uniformly mixed and pulverized into a powder.

[製劑例4]粒劑 [Formulation Example 4] Granules

Figure 108126125-A0202-12-0281-156
Figure 108126125-A0202-12-0281-156

將以上均勻地混合粉碎。在此混合物中添加水20份相當量而捏合,使 用擠壓式造粒機加工成14至32網目的粒狀後,乾燥成為粒劑。 Mix and crush the above uniformly. Add 20 parts of water to this mixture and knead so that After being processed into 14 to 32 mesh granules with an extrusion granulator, it is dried into granules.

[製劑例5]懸浮劑 [Formulation Example 5] Suspension

Figure 108126125-A0202-12-0281-157
Figure 108126125-A0202-12-0281-157

以上以高速攪拌機混合30分鐘後,以濕式粉碎機粉碎成為懸浮劑。 After mixing the above with a high-speed mixer for 30 minutes, it is pulverized with a wet pulverizer to form a suspending agent.

[製劑例6]顆粒水和劑 [Formulation Example 6] Granule water and agent

Figure 108126125-A0202-12-0281-158
Figure 108126125-A0202-12-0281-158

Figure 108126125-A0202-12-0282-159
Figure 108126125-A0202-12-0282-159

將以上混合捏押造粒。將所得的粒狀物以流動層乾燥機乾燥,得到顆粒水和劑。 The above mixture is kneaded and granulated. The obtained granules were dried with a fluidized bed dryer to obtain granule water and agent.

其次以試驗例說明本發明的有害生物防除劑的效果。 Next, the effect of the pest control agent of the present invention will be described with test examples.

[試驗例1]小菜蛾(Plutella xylostella)殺蟲活性試驗 [Experiment example 1] Plutella xylostella insecticidal activity test

將依據製劑例2調製而成的水和劑以水烯釋成有效成分為500ppm的濃度。在此藥液浸漬甘藍葉,風乾後,放入於塑膠杯。在其中釋放小菜蛾(Plutella xylostella)2齡幼蟲10隻,加蓋。其後,放置於25℃的恆溫室,在6日後調查死蟲數,以數1的計算式求死蟲率。試驗是以1系列實施。 The water and the agent prepared according to Formulation Example 2 were released to a concentration of 500 ppm with methene to the active ingredient. Soak the cabbage leaves in this medicine, air dry, and put in a plastic cup. Ten second-instar larvae of Plutella xylostella (Plutella xylostella) were released and capped. After that, it was placed in a constant temperature room at 25°C, and the number of dead insects was checked 6 days later, and the dead insect rate was determined by the calculation formula of number 1. The test is conducted in 1 series.

【數1】

Figure 108126125-A0202-12-0282-160
【Number 1】
Figure 108126125-A0202-12-0282-160

由此試驗表示死蟲率90%以上的化合物的化合物號碼列舉如下。 From this test, the compound numbers of compounds with a death rate of 90% or more are listed below.

A-0003、A-0022、A-0400、A-0441、A-0478、A-0524、B-0036、B-0039、B-0040、B-0125、B-0396、B-0402、B-0408、B-0548、B-0560、B-0562、B-0567、B-0574、B-0610、B-0688、B-0742、B-0744、B-0754、B-0760、B-0766、B-0767、B-0768、B-0771、B-0777、B-0784、B-0801、B-0805、B-0806、B-0829、B-0830、B-0831、B-0860、B-0900、B-0909、B-0924、B-0927、B-0930、B-0969、B-0972、B-0975、B-1004、B-1009、B-1010、B-1012、B-1017、B-1032、B-1036、B-1042、B-1044、B-1056、B-1065、B-1066、B-1070、C-0038、D-0008、E-0001、E-0008、E-0015、F- 0160、F-0368、F-0373、F-0382、F-0393、G-0248、G-0314、H-0003、H-0004、H-0007、H-0008、J-0017、J-0023 A-0003, A-0022, A-0400, A-0441, A-0478, A-0524, B-0036, B-0039, B-0040, B-0125, B-0396, B-0402, B- 0408, B-0548, B-0560, B-0562, B-0567, B-0574, B-0610, B-0688, B-0742, B-0744, B-0754, B-0760, B-0766, B-0767, B-0768, B-0771, B-0777, B-0784, B-0801, B-0805, B-0806, B-0829, B-0830, B-0831, B-0860, B- 0900, B-0909, B-0924, B-0927, B-0930, B-0969, B-0972, B-0975, B-1004, B-1009, B-1010, B-1012, B-1017, B-1032, B-1036, B-1042, B-1044, B-1056, B-1065, B-1066, B-1070, C-0038, D-0008, E-0001, E-0008, E- 0015, F- 0160, F-0368, F-0373, F-0382, F-0393, G-0248, G-0314, H-0003, H-0004, H-0007, H-0008, J-0017, J-0023

[試驗例2]褐飛蝨(Nilaparvata lugens stal)殺蟲活性試驗 [Test Example 2] Nilaparvata lugens stal insecticidal activity test

將依據製劑例2調製而成的水和劑以水烯釋成有效成分為500ppm的濃度。在其藥液,浸漬發芽的稻谷,放入於塑膠杯中。在此塑膠杯釋放褐飛蝨(Nilaparvata lugens stal)2齡幼蟲10隻,加蓋。其後,放置於25℃的恆溫室,在6日後調查死蟲數,由數1的計算式求得死蟲率。試驗是以1系列實施。 The water and the agent prepared according to Formulation Example 2 were released to a concentration of 500 ppm with methene to the active ingredient. In its liquid medicine, the germinated rice is impregnated and put in a plastic cup. In this plastic cup, 10 second-instar larvae of brown planthopper (Nilaparvata lugens stal) were released and covered. After that, it was placed in a constant temperature room at 25°C, and the number of dead insects was checked 6 days later, and the dead insect rate was obtained from the calculation formula of number 1. The test is conducted in 1 series.

使用國際公開第2015/150442號記載的化合物號碼Ibh-8作為比較化合物,實施與上述同樣的試驗。比較化合物的結構如下。 Using the compound number Ibh-8 described in International Publication No. 2015/150442 as a comparative compound, the same test as above was carried out. The structure of the comparative compound is as follows.

國際公開第2015/150442號 International Publication No. 2015/150442

Figure 108126125-A0202-12-0283-161
Figure 108126125-A0202-12-0283-161

將由此試驗表示死蟲率90%以上的化合物的化合物號碼列舉如下。 The compound numbers of the compounds whose death rate is 90% or more by this test are listed below.

A-0003、A-0008、A-0022、A-0077、A-0254、A-0255、A-0256、A-0263、A-0264、A-0265、A-0286、A-0345、A-0346、A-0360、A-0400、A-0402、A-0410、A-0419、A-0422、A-0423、A-0446、B-0002、B- 0003、B-0012、B-0018、B-0021、B-0025、B-0027、B-0033、B-0036、B-0055、B-0084、B-0125、B-0200、B-0209、B-0223、B-0298、B-0391、B-0400、B-0401、B-0402、B-0405、B-0435、B-0436、B-0487、B-0523、B-0526、B-0560、B-0577、B-0580、B-0584、B-0592、B-0601、B-0604、B-0607、B-0610、B-0616、B-0632、B-0633、B-0635、B-0638、B-0639、B-0651、B-0654、B-0655、B-0656、B-0673、B-0676、B-0688、B-0691、B-0694、B-0697、B-0700、B-0703、B-0706、B-0718、B-0721、B-0727、B-0730、B-0733、B-0741、B-0748、B-0754、B-0757、B-0760、B-0765、B-0766、B-0767、B-0768、B-0771、B-0784、B-0785、B-0788、B-0799、B-0800、B-0801、B-0805、B-0806、B-0823、B-0838、B-0857、B-0873、B-0879、B-0900、B-0906、B-0909、B-0912、B-0924、B-0927、B-0972、B-0975、B-1006、B-1015、B-1017、B-1019、B-1022、B-1044、B-1054、B-1056、B-1060、C-0007、C-0017、C-0023、C-0027、C-0028、D-0011、D-0012、E-0001、E-0008、E-0015、F-0056、F-0355、F-0368、F-0373、F-0393、F-0423、F-0429、F-0504、F-0524、G-0076、G-0290、G-0366、G-0386、H-0004、J-0020、J-0023、J-0027、J-0035、J-0050、J-0053 A-0003, A-0008, A-0022, A-0077, A-0254, A-0255, A-0256, A-0263, A-0264, A-0265, A-0286, A-0345, A- 0346, A-0360, A-0400, A-0402, A-0410, A-0419, A-0422, A-0423, A-0446, B-0002, B- 0003, B-0012, B-0018, B-0021, B-0025, B-0027, B-0033, B-0036, B-0055, B-0084, B-0125, B-0200, B-0209, B-0223, B-0298, B-0391, B-0400, B-0401, B-0402, B-0405, B-0435, B-0436, B-0487, B-0523, B-0526, B- 0560, B-0577, B-0580, B-0584, B-0592, B-0601, B-0604, B-0607, B-0610, B-0616, B-0632, B-0633, B-0635, B-0638, B-0639, B-0651, B-0654, B-0655, B-0656, B-0673, B-0676, B-0688, B-0691, B-0694, B-0697, B- 0700, B-0703, B-0706, B-0718, B-0721, B-0727, B-0730, B-0733, B-0741, B-0748, B-0754, B-0757, B-0760, B-0765, B-0766, B-0767, B-0768, B-0771, B-0784, B-0785, B-0788, B-0799, B-0800, B-0801, B-0805, B- 0806, B-0823, B-0838, B-0857, B-0873, B-0879, B-0900, B-0906, B-0909, B-0912, B-0924, B-0927, B-0972, B-0975, B-1006, B-1015, B-1017, B-1019, B-1022, B-1044, B-1054, B-1056, B-1060, C-0007, C-0017, C- 0023, C-0027, C-0028, D-0011, D-0012, E-0001, E-0008, E-0015, F-0056, F-0355, F-0368, F-0373, F-0393, F-0423, F-0429, F-0504, F-0524, G-0076, G-0290, G-0366, G-0386, H-0004, J-0020, J-0023, J-0027, J- 0035, J-0050, J-0053

另一方面,比較化合物的Ibh-8(記載於國際公開第2015/150442號)是在50ppm的濃度下沒有顯示出活性。 On the other hand, the comparative compound Ibh-8 (described in International Publication No. 2015/150442) showed no activity at a concentration of 50 ppm.

[試驗例3]二點葉蟎防除效果試驗 [Test Example 3] Experiment on the control effect of Tetranychus urticae

將依據製劑例2調製水和劑以水烯釋成有效成分為500ppm的濃度。在其藥液,浸漬預先接種二點葉蟎雌成蟲35隻的大豆苗,風乾。將處理後的大豆苗放置於25℃的恆溫室,在13日後調查雌成蟲的生存蟲數,由數2的計算式求得防除價。試驗是以1系列實施。 According to the preparation example 2, the water and the agent were prepared so that methene was released to a concentration of 500 ppm as the active ingredient. In its liquid medicine, the soybean seedlings inoculated with 35 female adults of Tetranychus urticae in advance were dipped and air-dried. The treated soybean seedlings were placed in a constant temperature room at 25°C, and the number of surviving insects of female adults was checked 13 days later, and the control price was obtained from the calculation formula of number 2. The test is conducted in 1 series.

【數2】

Figure 108126125-A0202-12-0285-162
【Number 2】
Figure 108126125-A0202-12-0285-162

使用國際公開第2015/150442號記載的化合物號碼Ibh-8作為比較化合物,實施與上述同樣的試驗。 Using the compound number Ibh-8 described in International Publication No. 2015/150442 as a comparative compound, the same test as above was carried out.

由此試驗將表示防除價90以上的化合物的化合物號碼列舉如下。 From this test, the compound numbers indicating the compounds with a control value of 90 or more are listed below.

A-0003、A-0008、A-0022、A-0077、A-0254、A-0255、A-0256、A-0286、A-0331、A-0345、A-0346、A-0359、A-0360、A-0361、A-0397、A-0402、A-0410、A-0419、A-0422、A-0446、A-0496、A-0498、B-0003、B-0012、B-0017、B-0018、B-0021、B-0024、B-0025、B-0027、B-0028、B-0032、B-0033、B-0036、B-0044、B-0046、B-0078、B-0091、B-0124、B-0125、B-0200、B-0209、B-0223、B-0289、B-0298、B-0312、B-0395、B-0396、B-0399、B-0400、B-0401、B-0402、B-0403、B-0404、B-0405、B-0408、B-0440、B-0443、B-0487、B-0488、B-0489、B-0523、B-0526、B-0545、B-0548、B-0550、B-0559、B-0577、B-0580、B-0583、B-0584、B-0585、B-0592、B-0601、B-0604、B-0607、B-0610、B-0616、B-0631、B-0632、B-0634、B-0635、B-0636、B-0638、B-0639、B-0654、B-0655、B-0656、B-0663、B-0673、B-0676、B-0679、B-0688、B-0691、B-0694、B-0697、B-0700、B-0703、B-0706、B-0718、B-0721、B-0724、B-0727、B-0730、B-0733、B-0741、B-0742、B-0743、B-0745、B-0748、B-0754、B-0757、B-0760、B-0765、B-0766、B-0767、B-0768、B-0771、B- 0783、B-0784、B-0785、B-0788、B-0799、B-0800、B-0805、B-0806、B-0820、B-0823、B-0826、B-0829、B-0830、B-0838、B-0855、B-0856、B-0857、B-0858、B-0860、B-0876、B-0879、B-0897、B-0900、B-0903、B-0924、B-0927、B-0930、B-0972、B-0975、B-0978、B-1001、B-1004、B-1007、B-1008、B-1012、B-1013、B-1014、B-1015、B-1016、B-1017、B-1019、B-1020、B-1022、B-1056、B-1064、B-1065、B-1070、B-1074、B-1075、B-1086、B-1088、C-0007、C-0017、C-0027、C-0028、C-0039、D-0001、D-0008、D-0009、D-0010、D-0012、E-0001、E-0008、E-0015、G-0076、G-0290、G-0392、J-0023 A-0003, A-0008, A-0022, A-0077, A-0254, A-0255, A-0256, A-0286, A-0331, A-0345, A-0346, A-0359, A- 0360, A-0361, A-0397, A-0402, A-0410, A-0419, A-0422, A-0446, A-0496, A-0498, B-0003, B-0012, B-0017, B-0018, B-0021, B-0024, B-0025, B-0027, B-0028, B-0032, B-0033, B-0036, B-0044, B-0046, B-0078, B- 0091, B-0124, B-0125, B-0200, B-0209, B-0223, B-0289, B-0298, B-0312, B-0395, B-0396, B-0399, B-0400, B-0401, B-0402, B-0403, B-0404, B-0405, B-0408, B-0440, B-0443, B-0487, B-0488, B-0489, B-0523, B- 0526, B-0545, B-0548, B-0550, B-0559, B-0577, B-0580, B-0583, B-0584, B-0585, B-0592, B-0601, B-0604, B-0607, B-0610, B-0616, B-0631, B-0632, B-0634, B-0635, B-0636, B-0638, B-0639, B-0654, B-0655, B- 0656, B-0663, B-0673, B-0676, B-0679, B-0688, B-0691, B-0694, B-0697, B-0700, B-0703, B-0706, B-0718, B-0721, B-0724, B-0727, B-0730, B-0733, B-0741, B-0742, B-0743, B-0745, B-0748, B-0754, B-0757, B- 0760, B-0765, B-0766, B-0767, B-0768, B-0771, B- 0783, B-0784, B-0785, B-0788, B-0799, B-0800, B-0805, B-0806, B-0820, B-0823, B-0826, B-0829, B-0830, B-0838, B-0855, B-0856, B-0857, B-0858, B-0860, B-0876, B-0879, B-0897, B-0900, B-0903, B-0924, B- 0927, B-0930, B-0972, B-0975, B-0978, B-1001, B-1004, B-1007, B-1008, B-1012, B-1013, B-1014, B-1015, B-1016, B-1017, B-1019, B-1020, B-1022, B-1056, B-1064, B-1065, B-1070, B-1074, B-1075, B-1086, B- 1088, C-0007, C-0017, C-0027, C-0028, C-0039, D-0001, D-0008, D-0009, D-0010, D-0012, E-0001, E-0008, E-0015, G-0076, G-0290, G-0392, J-0023

另一方面,比較化合物的Ibh-8(國際公開第2015/150442號記載)是在50ppm的濃度下沒有顯示出活性。 On the other hand, the comparative compound Ibh-8 (described in International Publication No. 2015/150442) showed no activity at a concentration of 50 ppm.

[試驗例4]假根瘤線蟲(Nacobbus aberrans)抑制線蟲活性試驗 [Test Example 4] Nacobbus aberrans (Nacobbus aberrans) inhibition of nematode activity test

將供試化合物以含有1%的tween20的N,N-二甲基甲醯胺溶解,將此溶液以水烯釋成有效成分為20ppm的濃度。將其藥液0.5ml與含有假根瘤線蟲(Nacobbus aberrans)第二期幼蟲約30頭的懸浮液0.5ml混合成有效成分為10ppm的濃度,在25℃的恆溫室放置。在5日後在顯微鏡下計數生存線蟲數,由數3的計算式求得抑制線蟲活性。試驗是以2系列實施。 The test compound was dissolved in N,N-dimethylformamide containing 1% of tween20, and the solution was released into a concentration of 20 ppm of the active ingredient with methene. 0.5 ml of the drug solution was mixed with 0.5 ml of the suspension containing approximately 30 larvae of the second stage of pseudo-rhizobia (Nacobbus aberrans) to a concentration of 10 ppm of the active ingredient, and placed in a constant temperature room at 25°C. After 5 days, the number of viable nematodes was counted under a microscope, and the nematode-inhibiting activity was determined from the calculation formula of number 3. The test is conducted in 2 series.

【數3】

Figure 108126125-A0202-12-0286-163
【Number 3】
Figure 108126125-A0202-12-0286-163

使用國際公開第2015/150442號記載的化合物號碼Ibh-8作為 比較化合物,實施與上述同樣的試驗。 Use the compound number Ibh-8 described in International Publication No. 2015/150442 as The compounds were compared and the same test as above was carried out.

由此試驗表示抑制線蟲率90%以上的化合物的化合物號碼列舉如下。 From this test, the compound numbers of compounds that inhibited nematode rate by 90% or more are listed below.

A-0003、A-0008、A-0022、A-0077、A-0254、A-0255、A-0256、A-0263、A-0268、A-0286、A-0301、A-0331、A-0344、A-0345、A-0346、A-0359、A-0360、A-0361、A-0374、A-0385、A-0402、A-0410、A-0419、A-0422、A-0435、A-0460、B-0002、B-0003、B-0012、B-0017、B-0018、B-0021、B-0022、B-0027、B-0028、B-0032、B-0033、B-0034、B-0035、B-0036、B-0044、B-0055、B-0060、B-0084、B-0091、B-0109、B-0200、B-0209、B-0223、B-0298、B-0312、B-0390、B-0391、B-0392、B-0399、B-0400、B-0401、B-0402、B-0403、B-0404、B-0405、B-0408、B-0435、B-0439、B-0440、B-0441、B-0442、B-0443、B-0487、B-0488、B-0489、B-0523、B-0526、B-0529、B-0545、B-0560、B-0562、B-0574、B-0577、B-0580、B-0583、B-0585、B-0592、B-0604、B-0607、B-0610、B-0633、B-0638、B-0639、B-0653、B-0654、B-0655、B-0656、B-0673、B-0676、B-0679、B-0688、B-0691、B-0694、B-0697、B-0700、B-0703、B-0706、B-0718、B-0721、B-0724、B-0730、B-0733、B-0741、B-0742、B-0743、B-0744、B-0745、B-0748、B-0751、B-0754、B-0757、B-0760、B-0765、B-0766、B-0767、B-0768、B-0774、B-0783、B-0784、B-0796、B-0801、B-0805、B-0806、B-0815、B-0826、B-0829、B-0830、B-0831、B-0855、B-0856、B-0857、B-0873、B-0879、B-0903、B-0909、B-0912、B-0924、B-0927、B-0930、B-0975、B-0978、B-1001、B-1004、B-1007、B-1009、B-1010、B-1012、B-1013、B-1014、B-1015、B-1018、B-1019、B- 1020、B-1022、B-1024、B-1032、B-1042、B-1044、B-1054、B-1056、B-1058、B-1064、B-1065、B-1066、B-1070、B-1075、B-1078、B-1085、B-1086、B-1087、B-1088、C-0007、C-0017、C-0023、C-0028、C-0029、C-0037、C-0038、C-0039、D-0012、E-0008、E-0015 A-0003, A-0008, A-0022, A-0077, A-0254, A-0255, A-0256, A-0263, A-0268, A-0286, A-0301, A-0331, A- 0344, A-0345, A-0346, A-0359, A-0360, A-0361, A-0374, A-0385, A-0402, A-0410, A-0419, A-0422, A-0435, A-0460, B-0002, B-0003, B-0012, B-0017, B-0018, B-0021, B-0022, B-0027, B-0028, B-0032, B-0033, B- 0034, B-0035, B-0036, B-0044, B-0055, B-0060, B-0084, B-0091, B-0109, B-0200, B-0209, B-0223, B-0298, B-0312, B-0390, B-0391, B-0392, B-0399, B-0400, B-0401, B-0402, B-0403, B-0404, B-0405, B-0408, B- 0435, B-0439, B-0440, B-0441, B-0442, B-0443, B-0487, B-0488, B-0489, B-0523, B-0526, B-0529, B-0545, B-0560, B-0562, B-0574, B-0577, B-0580, B-0583, B-0585, B-0592, B-0604, B-0607, B-0610, B-0633, B- 0638, B-0639, B-0653, B-0654, B-0655, B-0656, B-0673, B-0676, B-0679, B-0688, B-0691, B-0694, B-0697, B-0700, B-0703, B-0706, B-0718, B-0721, B-0724, B-0730, B-0733, B-0741, B-0742, B-0743, B-0744, B- 0745, B-0748, B-0751, B-0754, B-0757, B-0760, B-0765, B-0766, B-0767, B-0768, B-0774, B-0783, B-0784, B-0796, B-0801, B-0805, B-0806, B-0815, B-0826, B-0829, B-0830, B-0831, B-0855, B-0856, B-0857, B- 0873, B-0879, B-0903, B-0909, B-0912, B-0924 , B-0927, B-0930, B-0975, B-0978, B-1001, B-1004, B-1007, B-1009, B-1010, B-1012, B-1013, B-1014, B -1015, B-1018, B-1019, B- 1020, B-1022, B-1024, B-1032, B-1042, B-1044, B-1054, B-1056, B-1058, B-1064, B-1065, B-1066, B-1070, B-1075, B-1078, B-1085, B-1086, B-1087, B-1088, C-0007, C-0017, C-0023, C-0028, C-0029, C-0037, C- 0038, C-0039, D-0012, E-0008, E-0015

另一方面,比較化合物的Ibh-8(國際公開第2015/150442號記載)是在10ppm的濃度下沒有顯示出活性。 On the other hand, the comparative compound Ibh-8 (described in International Publication No. 2015/150442) showed no activity at a concentration of 10 ppm.

[產業上的可利用性] [Industry availability]

本發明提供一種具有優異的殺蟲活性的新穎的化合物及其製造中間物,在農藥領域、農業領域中有用,在產業上有可利用性。 The present invention provides a novel compound with excellent insecticidal activity and an intermediate for its production, which is useful in the field of pesticides and agriculture and has industrial applicability.

Figure 108126125-A0202-11-0003-212
Figure 108126125-A0202-11-0003-212

Claims (14)

一種下述通式[I]表示的5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽, A 5-(1,2,4-triazol-5-yl)benzamide derivative represented by the following general formula [I] or its agriculturally acceptable salt,
Figure 108126125-A0202-13-0001-303
Figure 108126125-A0202-13-0001-303
式中, In the formula, n表示0、1、或2的整數, n represents an integer of 0, 1, or 2, m表示0、1、或2的整數, m represents an integer of 0, 1, or 2, A表示是氧原子或硫原子, A means oxygen atom or sulfur atom, B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, radical -O-, radical -S(=O) m -or radical -N(-R 7 )-, R1及R2各自獨立地表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6炔基、C2至C6烯基、C2至C6鹵炔基、C2至C6鹵烯基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、氰基、氰基C1至C6烷基、氰基C3至C6環烷基、C1至C6烷氧基羰基C3至C6環烷基、羥基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、甲醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、C1至C6烷基羰基、C1至C6烷氧基C1至C6烷基羰 基、C3至C6環烷基羰基、C3至C6環烷基C1至C6烷基羰基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、二(C1至C6烷基)胺基羰基、C1至C6烷氧基羰基C1至C6烷基胺基、單(C1至C6烷氧基羰基)胺基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基、(C1至C6烷基硫基)羰基、(C1至C6烷基)硫基羰基、(C1至C6烷氧基)硫基羰基、胺硫甲醯基、單(C1至C6烷基)胺基硫基羰基、二(C1至C6烷基)胺基硫基羰基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺磺醯基、單(C1至C6烷基)胺基磺醯基、二(C1至C6烷基)胺基磺醯基、C1至C6烷氧基羰基C1至C6烷基、胺基羰基C1至C6烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、C1至C6鹵烷基羰基C1至C6烷基、羥基亞胺基、C1至C6烷氧基亞胺基、羥基亞胺基C1至C6烷基、C1至C6烷氧基亞胺基C1至C6烷基、C1至C6鹵烷氧基亞胺基C1至C6烷基、雜環烷基、或雜環烷基C1至C6烷基、再者,R1及R2亦可與該等所鍵結之氮原子共同形成3至8員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至8員的雜環,該雜環亦可經鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基、C1至C6鹵烷基或側氧基取代, R 1 and R 2 each independently represent a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 Alkynyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkynyl, C 2 to C 6 haloalkenyl, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 To C 6 haloalkyl, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, unsubstituted or monosubstituted by substituent group α Or polysubstituted phenyl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α Monosubstituted or polysubstituted heteroaryl, unsubstituted or selected via substituent group α, monosubstituted or polysubstituted heteroaryl C 1 to C 3 alkyl, cyano, cyano C 1 to C 6 alkyl, cyano C 3 to C 6 cycloalkyl, C 1 to C 6 alkoxycarbonyl C 3 to C 6 cycloalkyl, hydroxy, hydroxy C 1 to C 6 alkyl, C 1 to C 6 Alkoxy C 1 to C 6 alkyl, methyl amide, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, C 1 to C 6 alkyl Carbonyl, C 1 to C 6 alkoxy C 1 to C 6 alkylcarbonyl, C 3 to C 6 cycloalkylcarbonyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, aminecarboxamide, mono(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, C 1 to C 6 alkoxycarbonyl C 1 to C 6 alkylamino groups, mono (C 1 to C 6 alkoxycarbonyl) amine groups, unsubstituted or substituted groups selected through substituent group α, mono- or poly-substituted phenylcarbonyl groups, (C 1 to C 6 alkylthio) carbonyl, (C 1 to C 6 alkyl) thiocarbonyl, (C 1 to C 6 alkoxy) thiocarbonyl, amine thiocarboxamide, mono (C 1 to C 6 alkyl)aminothiocarbonyl, di(C 1 to C 6 alkyl)aminothiocarbonyl, C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine Sulfonyl, mono(C 1 to C 6 alkyl)aminosulfonyl, di(C 1 to C 6 alkyl)aminosulfonyl, C 1 to C 6 alkoxycarbonyl C 1 to C 6 Alkyl, aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylcarbonyl C 1 to C 6 alkyl, hydroxyimino group, C 1 to C 6 alkoxyimino group, Hydroxyimino group C 1 To C 6 alkyl, C 1 to C 6 alkoxyimino C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy imino C 1 to C 6 alkyl, heterocycloalkyl, Or heterocycloalkyl C 1 to C 6 alkyl, and R 1 and R 2 may also form a 3 to 8 membered heterocyclic ring together with the nitrogen atoms to which they are bonded, or have 1 to 4 selected from Heterocyclic ring of 3 to 8 members of hetero atom of oxygen atom, sulfur atom and nitrogen atom, the heterocyclic ring can also be halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group Group, C 1 to C 6 haloalkyl or pendant oxygen substitution, R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl, R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷 基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl, R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1 至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3 烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基,再者,R5及R7也可以與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl) amino C 1 to C 6 alkyl, N-(C 1 to C 6 alkylsulfonate Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α Substituent Mono- or poly-substituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkane Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfonate Acyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, unsubstituted Phenylthio C 1 to C3 alkyl substituted by the substituent selected by the substituent group α, unsubstituted or substituted by the substituent selected by the substituent group α Sulfenyl C 1 to C 3 alkyl, unsubstituted or substituted by the substituent group α, mono- or polysubstituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted or Heteroarylthio C 1 to C3 alkyl substituted by substituents selected through substituent group α, unsubstituted or substituted monosubstituted or polysubstituted heteroaromatic groups selected through substituent group α Sulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Or mono- or poly-substituted phenyl C 1 to C 3 alkylthio C 1 to C3 alkyl, unsubstituted or selected by substituent group α Substituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α, mono- or poly-substituted phenyl C 1 To C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted heteroaryl C 1 to C 3 alkylthio C 1 To C3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl selected from the substituents selected through the substituent group α, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted phenylcarbonyl C 1 to C 3 alkyl , Unsubstituted or selected via substituent group α, mono- or poly-substituted heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy Alkylcarbonyl C 1 to C 3 alkyl, mono(C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 Alkyl, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di( C 1 to C 6 alkyl) Aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 To C 3 alkyl, nitro, amine, methyl acetyl, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine methyl, mono(C 1 to C 6 alkyl Group) aminocarbonyl, mono(C 1 to C 6 haloalkyl) aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, Or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, in addition, R 5 and R 7 may also form together with these bonded nitrogen atoms 3 Heterocycle to 6 members, or 3 to 6 member heterocycle having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom, R6表示氫原子或C1至C6烷基, R 6 represents a hydrogen atom or a C 1 to C 6 alkyl group, R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷 基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl , 取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.
一種農藥組成物,該農藥組成物係含有申請專利範圍第1項所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或含有其在農業上可容許的鹽作為有效成分。 A pesticide composition containing the 5-(1,2,4-triazol-5-yl)benzamide derivative described in item 1 of the scope of the patent application or containing it in agriculture Salt as an active ingredient. 如申請專利範圍第2項所述之農藥組成物,其中,該農藥組成物更含有界面活性劑。 The pesticide composition as described in item 2 of the patent application scope, wherein the pesticide composition further contains a surfactant. 一種有害生物防除劑,該有害生物防除劑係含有申請專利範圍第1項所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為活性成分。 A pest control agent, which contains the 5-(1,2,4-triazol-5-yl)benzamide derivative described in item 1 of the scope of the patent application or its agricultural application Allowable salts are used as active ingredients. 如申請專利範圍第4項所述之有害生物防除劑,其中,該有害生物防除劑係殺蟲劑、殺線蟲劑及殺蟎劑。 The pest control agent as described in item 4 of the patent application scope, wherein the pest control agent is an insecticide, nematicide and acaricide. 如申請專利範圍第5項所述之有害生物防除劑,該有害生物防除劑係對栽培農園藝用植物的水田、旱田、草地、果樹園、非農耕地、溫室、育苗設施、或植物工廠的有害生物具有防除效力。 The pest control agent as described in item 5 of the patent application scope, the pest control agent is for paddy fields, dry fields, grasslands, orchards, non-agricultural land, greenhouses, nursery facilities, or plant factories where agricultural and horticultural plants are cultivated. Pests have the control effect. 如申請專利範圍第6項所述之有害生物防除劑,其中,農園藝用植物係藉由育種法或基因重組技術而賦有抗性的植物。 The pest control agent as described in item 6 of the patent application scope, wherein the plants for agricultural and horticultural purposes are plants conferred resistance by breeding methods or genetic recombination techniques. 一種有害生物的防除方法,該防除方法係使用申請專利範圍第1項所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽的有效成分量。 A pest control method using the 5-(1,2,4-triazol-5-yl)benzamide derivative described in item 1 of the patent application scope or its agricultural tolerance The amount of active ingredients in the salt. 一種有害生物的防除方法,該防除方法係將含有申請專利範圍第1項所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽作為有效成分的農藥組成物,同時或分批施用於農園藝用作物或者是欲栽培或正栽培農園藝用作物的場所。 A method for controlling harmful organisms, which contains 5-(1,2,4-triazol-5-yl)benzamide derivatives described in item 1 of the scope of patent application or its agriculturally acceptable The permissible salt as an active ingredient of the pesticide composition is applied simultaneously or in batches to the agricultural or horticultural use or the place where the agricultural or horticultural use is to be cultivated or being cultivated. 如申請專利範圍第8項或第9項所述之有害生物的防除方法,其中,施用有害生物防除劑的場所係水田、旱田、草地、果樹園、非農耕地、溫室、育苗設施、或植物工廠。 The pest control method as described in item 8 or item 9 of the patent application scope, wherein the place where the pest control agent is applied is paddy field, dry field, grassland, orchard, non-agricultural land, greenhouse, nursery facility, or plant factory. 如申請專利範圍第8項至第10項中之任一項所述之有害生物的防除方法,其中,係將申請專利範圍第1項所述之5-(1,2,4-三唑-5-基)苯甲醯胺衍生物或其在農業上可容許的鹽使用為殺蟲劑、殺線蟲劑及殺蟎劑。 The pest control method as described in any one of the 8th to 10th items of the patent application scope, wherein the 5-(1,2,4-triazole- 5-yl) benzamide derivatives or their agriculturally acceptable salts are used as insecticides, nematicides and acaricides. 一種有害生物防除劑的使用方法,該使用方法係將申請專利範圍第4項至第7項中之任一項所述之有害生物防除劑使用於防除農園藝用作物的有害生物。 A method for using a pest control agent, which uses the pest control agent described in any one of items 4 to 7 of the patent application range to control pests for agricultural and horticultural use. 一種下述通式[II]表示的5-(1,2,4-三唑-5-基)苯甲酸衍生物或其鹽, A 5-(1,2,4-triazol-5-yl)benzoic acid derivative represented by the following general formula [II] or a salt thereof,
Figure 108126125-A0202-13-0008-304
Figure 108126125-A0202-13-0008-304
式中, In the formula, m表示0、1、或2的整數, m represents an integer of 0, 1, or 2, n表示0、1、或2的整數, n represents an integer of 0, 1, or 2, B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, base-O-, base-S(=O)m- or base-N(-R 7 )-, R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl, R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl, R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6 烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯 基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、 羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基,再者,R5及R7也可與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl) amino C 1 to C 6 alkyl, N-(C 1 to C 6 alkylsulfonate Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α Substituent Mono- or poly-substituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkane Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfonate Acyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, unsubstituted Phenylthio C 1 to C3 alkyl substituted by the substituent selected by the substituent group α, unsubstituted or substituted by the substituent selected by the substituent group α Sulfenyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted or Heteroarylthio C 1 to C3 alkyl substituted by substituents selected through substituent group α, unsubstituted or substituted monosubstituted or polysubstituted heteroaromatic groups selected through substituent group α Sulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Or mono- or poly-substituted phenyl C 1 to C 3 alkylthio C 1 to C 3 alkyl, unsubstituted or selected by substituent group α Substituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α, mono- or poly-substituted phenyl C 1 To C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted heteroaryl C 1 to C 3 alkylthio C 1 To C3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl selected from the substituents selected through the substituent group α, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted by a substituent group α, mono- or polysubstituted phenylcarbonyl C 1 to C 3 alkyl, Heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy, unsubstituted or selected via substituent group α Carbonyl C 1 to C 3 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 to C 3 alkyl, nitro, amine, carboxamide, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine carboxamide, mono (C 1 to C 6 alkyl )Aminocarbonyl, mono(C 1 to C 6 haloalkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, in addition, R 5 and R 7 can also form 3 to 3 together with the nitrogen atoms to which they are bonded 6-membered heterocyclic ring, or 3 to 6-membered heterocyclic ring having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom, R6及R8是各自獨立地表示氫原子或C1至C6烷基, R 6 and R 8 each independently represent a hydrogen atom or a C 1 to C 6 alkyl group, R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl , 取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.
一種下述通式[III]表示的5-苯基-1,2,4-三唑衍生物或其鹽, A 5-phenyl-1,2,4-triazole derivative represented by the following general formula [III] or a salt thereof,
Figure 108126125-A0202-13-0012-305
Figure 108126125-A0202-13-0012-305
式中, In the formula, m表示0、1、或2的整數, m represents an integer of 0, 1, or 2, n表示0、1、或2的整數, n represents an integer of 0, 1, or 2, B表示單鍵、基-O-、基-S(=O)m-或基-N(-R7)-, B represents a single bond, base-O-, base-S(=O)m- or base-N(-R 7 )-, R3表示鹵原子、氰基、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 3 represents a halogen atom, cyano group, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 alkylthio group, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine Formyl or thiocarbamoyl, R4表示鹵原子、氰基、硝基、C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、氰基C1至C6烷基、C1至C6鹵烷基、C3至C6環烷基、C3至C6鹵環烷基、C2至C6烯基、C2至C6鹵烯基、C2至C6炔基、C2至C6鹵炔基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、C1至C6烷基硫基、C1至C6烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基硫基、C1至C6鹵烷基亞磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、胺甲醯基或胺硫甲醯基, R 4 represents a halogen atom, cyano group, nitro group, C 1 to C 6 alkyl group, C 1 to C 6 alkoxy group C 1 to C 6 alkyl group, C 1 to C 6 alkylthio group C 1 to C 6 Alkyl, cyano C 1 to C 6 alkyl, C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 halocycloalkyl, C 2 to C 6 alkenyl, C 2 to C 6 haloalkenyl, C 2 to C 6 alkynyl, C 2 to C 6 haloalkynyl, hydroxy, C 1 to C 6 alkoxy, C 1 to C 6 haloalkoxy, C 1 to C 6 alkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylthio, C 1 to C 6 haloalkylsulfinyl Acyl, C 1 to C 6 haloalkyl sulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) amine, amine formyl or amine Thiomethyl, R5表示氫原子、鹵原子、氰基、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C3至C6環烷基C2至C6烯基、C2至C6炔基、C3至C6環烷基C2至C6炔基、C1至C6鹵烷基、C3至C6鹵環烷基、C3至C6 鹵環烷基C1至C6烷基、C2至C6鹵烯基、C2至C6鹵炔基、羥基、胺基C1至C6烷基、單(C1至C6烷基羰基)胺基C1至C6烷基、單(C1至C6鹵烷基羰基)胺基C1至C6烷基、單(C3至C6環烷基羰基)胺基C1至C6烷基、單(C1至C6烷氧基羰基)胺基C1至C6烷基、單(C1至C6烷基)胺基羰基胺基C1至C6烷基、二(C1至C6烷基)胺基羰基胺基C1至C6烷基、單(C1至C6烷基磺醯基)胺基C1至C6烷基、單(C1至C6鹵烷基磺醯基)胺基C1至C6烷基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、N-(C1至C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基C1至C6烷基、羥基C1至C6烷基、C1至C6烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6烷基、C1至C6鹵烷氧基C1至C6鹵烷基、C3至C6環烷氧基C1至C6烷基、C3至C6鹵環烷氧基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3鹵烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3鹵烷基、氰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷氧基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷氧基C1至C3烷基、巰基C1至C6烷基、C1至C6烷基硫基C1至C6烷基、C1至C6烷基亞磺醯基C1至C6烷基、C1至C6烷基 磺醯基C1至C6烷基、C1至C6鹵烷基硫基C1至C6烷基、C1至C6鹵烷基亞磺醯基C1至C6烷基、C1至C6鹵烷基磺醯基C1至C6烷基、C3至C6環烷基硫基C1至C6烷基、C3至C6環烷基亞磺醯基C1至C6烷基、C3至C6環烷基磺醯基C1至C6烷基、C3至C6鹵環烷基硫基C1至C6烷基、C3至C6鹵環烷基亞磺醯基C1至C6烷基、C3至C6鹵環烷基磺醯基C1至C6烷基、C1至C6烷基磺醯基氧基C1至C6烷基、C1至C6烷基羰基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基C1至C3烷基磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基硫基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基亞磺醯基C1至C3烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的雜芳基C1至C3烷基磺醯基C1至C3烷基、雜環烷基C1至C6烷基、C1至C6烷基羰基C1至C6烷基、無取代的或經由取代基群組α選出的取代基單取代或多取代的苯基羰基C1至C3烷基、無取代的或經 由取代基群組α選出的取代基單取代或多取代的雜芳基羰基C1至C3烷基、羥基羰基C1至C6烷基、C1至C6烷氧基羰基C1至C3烷基、單(C1至C6烷基)胺基羰基C1至C6烷基、單(C1至C6鹵烷基)胺基羰基C1至C6烷基、單(C3至C6環烷基)胺基羰基C1至C6烷基、單(C3至C6鹵環烷基)胺基羰基C1至C6烷基、二(C1至C6烷基)胺基羰基C1至C6烷基、C1至C6烷基羰基氧基C1至C3烷基、C1至C6鹵烷基羰基氧基C1至C3烷基、硝基、胺基、甲醯基、C1至C6烷基羰基、羧基、C1至C6烷氧基羰基、胺甲醯基、單(C1至C6烷基)胺基羰基、單(C1至C6鹵烷基)胺基羰基、二(C1至C6烷基)胺基羰基、二(C1至C6鹵烷基)胺基羰基、或(1,3-二側氧基異二氫吲哚-2-基)C1至C3烷基,再者,R5及R7亦可與該等所鍵結之氮原子共同形成3至6員的雜環、或具有1至4個選自氧原子、硫原子及氮原子之雜原子的3至6員的雜環, R 5 represents a hydrogen atom, halogen atom, cyano group, C 1 to C 6 alkyl group, C 3 to C 6 cycloalkyl group, C 3 to C 6 cycloalkyl group C 1 to C 6 alkyl group, C 2 to C 6 Alkenyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, C 3 to C 6 cycloalkyl C 2 to C 6 alkynyl, C 1 to C 6 haloalkane Group, C 3 to C 6 halocycloalkyl, C 3 to C 6 halocycloalkyl C 1 to C 6 alkyl, C 2 to C 6 haloalkenyl, C 2 to C 6 haloalkynyl, hydroxyl, amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkylcarbonyl) amine C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkylcarbonyl) amine C 1 to C 6 alkyl, mono (C 1 to C 6 alkoxycarbonyl) amine C 1 to C 6 alkyl, mono (C 1 To C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, di(C 1 to C 6 alkyl)aminocarbonylamino C 1 to C 6 alkyl, mono (C 1 to C 6 alkyl) Sulfosulfonyl)amino C 1 to C 6 alkyl, mono(C 1 to C 6 haloalkylsulfonyl) amino C 1 to C 6 alkyl, N-(C 1 to C 6 alkylsulfonate Acyl)-N-(C 1 to C 6 alkyl)amine C 1 to C 6 alkyl, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl Group) amine group C 1 to C 6 alkyl, hydroxy C 1 to C 6 alkyl, C 1 to C 6 alkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 alkyl, C 1 to C 6 haloalkoxy C 1 to C 6 haloalkyl, C 3 to C 6 cycloalkoxy C 1 to C 6 alkyl, C 3 to C 6 halocycloalkoxy C 1 to C 6 alkyl groups, unsubstituted or mono- or poly-substituted phenyl substituted by substituent group α, unsubstituted or mono- or poly-substituted substituents selected by substituent group α Heteroaryl, unsubstituted or substituted by substituent group α mono- or polysubstituted phenyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α mono-substituted Or polysubstituted phenyl C 1 to C 3 haloalkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkyl, unsubstituted or The substituents selected through the substituent group α are mono- or polysubstituted heteroaryl C 1 to C 3 haloalkyl, cyano C 1 to C 6 alkyl, unsubstituted or selected through the substituent group α Substituted mono- or poly-substituted phenoxy C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted heteroaryloxy C 1 to C 3 alkyl Phenyl, unsubstituted or selected via substituent group α, mono- or polysubstituted phenyl C 1 to C 3 alkoxy C 1 to C 3 alkyl, unsubstituted or selected via substituent group α Substituent Mono- or poly-substituted heteroaryl C 1 to C 3 alkoxy C 1 to C 3 alkyl, mercapto C 1 to C 6 alkyl, C 1 to C 6 alkylthio C 1 to C 6 alkyl, C 1 to C 6 alkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylthio C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfinyl C 1 to C 6 alkyl, C 1 to C 6 haloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkane Alkylthio C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 cycloalkylsulfonyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylthio C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfinyl C 1 to C 6 alkyl, C 3 to C 6 halocycloalkylsulfonate Acyl C 1 to C 6 alkyl, C 1 to C 6 alkylsulfonyloxy C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonylthio C 1 to C 3 alkyl, unsubstituted Phenylthio C 1 to C3 alkyl substituted by the substituent selected by the substituent group α, unsubstituted or substituted by the substituent selected by the substituent group α Sulfenyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or poly-substituted phenylsulfonyl C 1 to C 3 alkyl, unsubstituted or Heteroarylthio C 1 to C3 alkyl substituted by substituents selected through substituent group α, unsubstituted or substituted monosubstituted or polysubstituted heteroaromatic groups selected through substituent group α Sulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroarylsulfonyl C 1 to C 3 alkyl, unsubstituted Or mono- or poly-substituted phenyl C 1 to C 3 alkylthio C 1 to C 3 alkyl, unsubstituted or selected by substituent group α Substituted or polysubstituted phenyl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted or substituted by substituent group α, mono- or poly-substituted phenyl C 1 To C 3 alkylsulfonyl C 1 to C 3 alkyl, unsubstituted or substituted via substituent group α, mono- or multi-substituted heteroaryl C 1 to C 3 alkylthio C 1 To C3 alkyl, unsubstituted or substituted via substituent group α, mono- or polysubstituted heteroaryl C 1 to C 3 alkylsulfinyl C 1 to C 3 alkyl, unsubstituted Or a mono- or poly-substituted heteroaryl C 1 to C 3 alkylsulfonyl C 1 to C 3 alkyl, heterocycloalkyl C 1 to C 6 alkyl selected from the substituents selected through the substituent group α, C 1 to C 6 alkylcarbonyl C 1 to C 6 alkyl, unsubstituted or substituted by a substituent group α, mono- or polysubstituted phenylcarbonyl C 1 to C 3 alkyl, Heteroarylcarbonyl C 1 to C 3 alkyl, hydroxycarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkoxy, unsubstituted or selected via substituent group α Carbonyl C 1 to C 3 alkyl, mono (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 1 to C 6 haloalkyl) aminocarbonyl C 1 to C 6 alkyl Group, mono (C 3 to C 6 cycloalkyl) aminocarbonyl C 1 to C 6 alkyl, mono (C 3 to C 6 halocycloalkyl) aminocarbonyl C 1 to C 6 alkyl, di (C 1 to C 6 alkyl) aminocarbonyl C 1 to C 6 alkyl, C 1 to C 6 alkylcarbonyloxy C 1 to C 3 alkyl, C 1 to C 6 haloalkylcarbonyloxy C 1 to C 3 alkyl, nitro, amine, carboxamide, C 1 to C 6 alkylcarbonyl, carboxy, C 1 to C 6 alkoxycarbonyl, amine carboxamide, mono (C 1 to C 6 alkyl )Aminocarbonyl, mono(C 1 to C 6 haloalkyl)aminocarbonyl, di(C 1 to C 6 alkyl)aminocarbonyl, di(C 1 to C 6 haloalkyl)aminocarbonyl, or (1,3-bi- pendant isoindoline-2-yl) C 1 to C 3 alkyl, and R 5 and R 7 can also form 3 to 3 together with the nitrogen atoms to which they are bonded 6-membered heterocyclic ring, or 3 to 6-membered heterocyclic ring having 1 to 4 heteroatoms selected from oxygen atom, sulfur atom and nitrogen atom, R6表示氫原子或C1至C6烷基, R 6 represents a hydrogen atom or a C 1 to C 6 alkyl group, R7表示氫原子、C1至C6烷基、C3至C6環烷基、C3至C6環烷基C1至C6烷基、C2至C6烯基、C2至C6炔基、甲醯基、C1至C6烷基羰基、C1至C6烷氧基羰基、C1至C6烷基磺醯基或C1至C6鹵烷基磺醯基, R 7 represents a hydrogen atom, C 1 to C 6 alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 cycloalkyl C 1 to C 6 alkyl, C 2 to C 6 alkenyl, C 2 to C 6 alkynyl, methyl acetyl, C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl, C 1 to C 6 alkylsulfonyl or C 1 to C 6 haloalkylsulfonyl , R9表示氫原子、鹵原子或氰基、 R 9 represents a hydrogen atom, a halogen atom or a cyano group, 取代基群組α表示鹵原子、C1至C6烷基、C1至C6鹵烷基、羥基、C1至C6烷氧基、C1至C6鹵烷氧基、硝基、氰基、巰基、C1至C6烷基硫基、C1至C6鹵烷基硫基、C1至C6烷基亞磺醯基、C1至C6鹵烷基亞磺醯基、C1至C6烷基磺醯基、C1至C6鹵烷基磺醯基、胺基、單(C1至C6烷基)胺基、二(C1至C6烷基)胺基、單(C1至C6烷基磺醯基)胺基、單(C1至C6鹵烷基磺醯基)胺基、N-(C1至C6烷基磺醯基)-N-(C1至C6烷基)胺基、N-(C1至 C6鹵烷基磺醯基)-N-(C1至C6烷基)胺基、甲醯基、羧基、C1至C6烷基羰基、C1至C6烷氧基羰基。 Substituent group α represents a halogen atom, C 1 to C 6 alkyl group, C 1 to C 6 haloalkyl group, hydroxyl group, C 1 to C 6 alkoxy group, C 1 to C 6 haloalkoxy group, nitro group, Cyano, mercapto, C 1 to C 6 alkylthio, C 1 to C 6 haloalkylthio, C 1 to C 6 alkylsulfinyl, C 1 to C 6 haloalkylsulfinyl , C 1 to C 6 alkylsulfonyl, C 1 to C 6 haloalkylsulfonyl, amine, mono (C 1 to C 6 alkyl) amine, di (C 1 to C 6 alkyl) Amino, mono (C 1 to C 6 alkylsulfonyl) amine, mono (C 1 to C 6 haloalkylsulfonyl) amine, N-(C 1 to C 6 alkylsulfonyl) -N-(C 1 to C 6 alkyl)amino, N-(C 1 to C 6 haloalkylsulfonyl)-N-(C 1 to C 6 alkyl)amino, carboxamide, carboxyl , C 1 to C 6 alkylcarbonyl, C 1 to C 6 alkoxycarbonyl.
TW108129125A 2018-08-17 2019-08-15 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative and noxious organism control agent TW202019888A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018153422 2018-08-17
JP2018-153422 2018-08-17

Publications (1)

Publication Number Publication Date
TW202019888A true TW202019888A (en) 2020-06-01

Family

ID=69525357

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108129125A TW202019888A (en) 2018-08-17 2019-08-15 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative and noxious organism control agent

Country Status (2)

Country Link
TW (1) TW202019888A (en)
WO (1) WO2020036134A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116082254A (en) * 2022-12-28 2023-05-09 浙江永太科技股份有限公司 A kind of preparation method of 1-alkyl-1,2,4-triazole-3-methanol

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021175822A1 (en) 2020-03-02 2021-09-10 Syngenta Crop Protection Ag Pesticidally amidine-substituted benzoic acid amide compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7528974A (en) * 1973-11-13 1976-06-10 Commonwealth Scientific And Industrial Research Organization Triazoles
JPH05310712A (en) * 1992-04-03 1993-11-22 Kumiai Chem Ind Co Ltd Diphenyltriazole deritative and insecticidal and miticidal agent
JP3682075B2 (en) * 1993-04-16 2005-08-10 クミアイ化学工業株式会社 Triazole derivatives and insecticides, acaricides
JPH07330742A (en) * 1994-06-09 1995-12-19 Nippon Soda Co Ltd Triazole derivative, its production and insect pest controlling agent
WO1995033732A1 (en) * 1994-06-09 1995-12-14 Nippon Soda Co., Ltd. Triazole compound, production process, and pest control agent
JPH0892224A (en) * 1994-09-16 1996-04-09 Kumiai Chem Ind Co Ltd 3,5-Substituted phenyltriazole derivatives and insecticides and acaricides
US6413992B1 (en) * 1998-10-23 2002-07-02 Dow Agrosciences Llc 3-(substituted pyridyl)-1,2,4-triazole compounds
JP2007308485A (en) * 2006-04-18 2007-11-29 Kumiai Chem Ind Co Ltd Phenyltriazole derivatives and insecticides, acaricides and nematicides containing them as active ingredients
US20170119786A1 (en) * 2011-03-08 2017-05-04 3-V Biosciences, Inc. Heterocyclic modulators of lipid synthesis
CN103857661B (en) * 2011-08-11 2016-11-16 拜耳知识产权有限责任公司 1,2,4‑triazolyl-substituted ketoenols
AR101816A1 (en) * 2014-04-02 2017-01-18 Bayer Cropscience Ag DERIVATIVES OF 3 - [(PIRAZOL-5-IL) -HETEROARIL] -BENZAMIDAS AS PESTICIDE AGENTS
JP2017110003A (en) * 2015-12-16 2017-06-22 日本曹達株式会社 Diaryltriazole compounds and pest control agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116082254A (en) * 2022-12-28 2023-05-09 浙江永太科技股份有限公司 A kind of preparation method of 1-alkyl-1,2,4-triazole-3-methanol
CN116082254B (en) * 2022-12-28 2025-04-11 浙江永太科技股份有限公司 A preparation method of 1-alkyl-1,2,4-triazole-3-methanol

Also Published As

Publication number Publication date
WO2020036134A1 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
KR102638962B1 (en) 3-Alkoxybenzoic acid amide derivatives and pest control agents
TWI606032B (en) Alkyl phenyl sulfide derivatives and pest control agents
TW202132273A (en) Azole derivatives and uses thereof
CN110612295B (en) Pyrazole-3-carboxylic acid amide derivative and pest control agent
TW202019889A (en) 3-(1h-1,2,4-triazol-1-yl) benzoic acid amide derivative and pest control agent
US12258326B2 (en) Pyrazole derivative and harmful organism-controlling agent
TW202019888A (en) 5-(1,2,4-triazol-5-yl) benzoic acid amide derivative and noxious organism control agent
JP2021121582A (en) 5- (Pyrazole-5-yl) benzoic acid amide derivative and pest control agent
JP2021121581A (en) 3- (Pyrazole-1-yl) benzoic acid amide derivative and pest control agent
JP7383850B2 (en) Heterocyclic compounds and their uses
RU2808434C2 (en) Pyrazole derivative and pest control agent
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载